,word,label,sentence_id
86407,a,O,4200
86408,risk,O,4200
86409,of,O,4200
86410,perforation,O,4200
86411,the,B-SIGN_AND_SYMPTOM,4200
86412,ocular,I-SIGN_AND_SYMPTOM,4200
86413,surface,I-SIGN_AND_SYMPTOM,4200
86414,may,O,4200
86415,be,O,4200
86416,stabilized,O,4200
86417,by,O,4200
86418,advancement,O,4200
86419,of,O,4200
86420,the,B-PART_OF_THE_EYES,4200
86421,perilimbal,I-PART_OF_THE_EYES,4200
86422,conjunctiva,I-PART_OF_THE_EYES,4200
86423,over,O,4200
86424,the,B-PART_OF_THE_EYES,4200
86425,corneal,I-PART_OF_THE_EYES,4200
86426,surface,I-PART_OF_THE_EYES,4200
86427,A,B-TREATMENT,4200
86428,temporary,I-TREATMENT,4200
86429,or,I-TREATMENT,4200
86430,permanent,I-TREATMENT,4200
86431,tarsorrhaphy,I-TREATMENT,4200
86432,is,O,4200
86433,a,O,4200
86434,helpful,O,4200
86435,adjunct,O,4200
86436,in,O,4200
86437,such,O,4200
86438,advanced,O,4201
86439,cases,O,4201
86440,Getting,O,4201
86441,a,O,4201
86442,Head,O,4201
86443,Start,O,4201
86444,NK,B-NAME_OF_DISEASE,4201
86445,may,O,4201
86446,be,O,4201
86447,more,O,4201
86448,common,O,4201
86449,than,O,4201
86450,initially,O,4201
86451,thought,O,4201
86452,thanks,O,4201
86453,to,O,4201
86454,a,O,4201
86455,fresh,O,4201
86456,focus,O,4201
86457,on,O,4201
86458,the,O,4201
86459,condition,O,4201
86460,spurred,O,4201
86461,by,O,4201
86462,recent,O,4201
86463,treatment,O,4201
86464,offerings,O,4201
86465,There,O,4202
86466,are,O,4202
86467,many,O,4202
86468,different,O,4202
86469,etiologies,O,4202
86470,of,O,4202
86471,NK,B-NAME_OF_DISEASE,4202
86472,however,O,4202
86473,all,O,4202
86474,of,O,4202
86475,them,O,4202
86476,are,O,4202
86477,characterized,O,4202
86478,by,O,4202
86479,impaired,B-CAUSE_OF_DISEASE,4202
86480,trigeminal,I-CAUSE_OF_DISEASE,4202
86481,innervation,I-CAUSE_OF_DISEASE,4202
86482,Recognizing,O,4202
86483,the,O,4202
86484,diagnosis,O,4202
86485,allows,O,4202
86486,us,O,4202
86487,to,O,4202
86488,intervene,O,4202
86489,earlier,O,4202
86490,in,O,4202
86491,the,O,4203
86492,disease,O,4203
86493,process,O,4203
86494,in,O,4203
86495,an,O,4203
86496,attempt,O,4203
86497,to,O,4203
86498,avoid,O,4204
86499,the,O,4204
86500,potential,O,4204
86501,severe,O,4204
86502,sequelae,O,4204
86503,that,O,4204
86504,can,O,4204
86505,ensue,O,4204
86506,We,O,4204
86507,are,O,4204
86508,fortunate,O,4204
86509,to,O,4204
86510,have,O,4204
86511,a,O,4204
86512,variety,O,4204
86513,of,O,4204
86514,tools,O,4204
86515,that,O,4204
86516,help,O,4204
86517,us,O,4204
86518,to,O,4204
86519,treat,O,4204
86520,these,O,4204
86521,patients,O,4204
86522,more,O,4204
86523,effectively,O,4204
86524,than,O,4205
86525,ever,O,4205
86526,before,O,4205
86527,Goniotomy,B-TREATMENT,4205
86528,and,O,4205
86529,other,O,4205
86530,Schlemm,B-PART_OF_THE_EYES,4205
86531,s,I-PART_OF_THE_EYES,4205
86532,canal,I-PART_OF_THE_EYES,4205
86533,procedures,O,4205
86534,appear,O,4205
86535,to,O,4205
86536,experience,O,4205
86537,a,O,4205
86538,floor,O,4205
86539,effect,O,4205
86540,of,O,4205
86541,greater,O,4205
86542,intraocular,O,4205
86543,pressure,O,4205
86544,IOP,O,4205
86545,lowering,O,4205
86546,due,O,4205
86547,to,O,4205
86548,their,O,4205
86549,inability,O,4205
86550,to,O,4206
86551,further,O,4206
86552,bypass,O,4206
86553,episcleral,O,4206
86554,venous,O,4206
86555,pressure,O,4206
86556,and,O,4206
86557,distal,O,4206
86558,resistance,O,4206
86559,in,O,4206
86560,the,O,4206
86561,conventional,O,4206
86562,outflow,O,4206
86563,pathway,O,4206
86564,Eyes,O,4206
86565,treated,O,4206
86566,with,O,4206
86567,goniotomy,B-TREATMENT,4206
86568,experience,O,4206
86569,greater,O,4206
86570,IOP-lowering,O,4206
86571,effects,O,4206
86572,from,O,4206
86573,netarsudil,B-NAME_OF_DRUG,4206
86574,than,O,4207
86575,eyes,O,4207
86576,without,O,4207
86577,history,O,4207
86578,of,O,4207
86579,prior,O,4207
86580,angle,O,4207
86581,surgery,O,4207
86582,Netarsudil,B-NAME_OF_DRUG,4207
86583,may,O,4207
86584,serve,O,4207
86585,as,O,4207
86586,a,O,4207
86587,promising,O,4207
86588,adjunctive,O,4207
86589,ocular,O,4208
86590,hypotensive,O,4208
86591,agent,O,4208
86592,to,O,4208
86593,further,O,4208
86594,reduce,O,4208
86595,IOP,O,4208
86596,in,O,4208
86597,eyes,O,4208
86598,with,O,4208
86599,prior,O,4208
86600,goniotomy,B-TREATMENT,4208
86601,Netarsudil,B-NAME_OF_DRUG,4208
86602,had,O,4208
86603,a,O,4208
86604,greater,O,4208
86605,IOP-lowering,O,4208
86606,effect,O,4208
86607,in,O,4208
86608,eyes,O,4208
86609,treated,O,4208
86610,with,O,4208
86611,prior,O,4208
86612,goniotomy,B-TREATMENT,4208
86613,and,O,4208
86614,may,O,4208
86615,serve,O,4208
86616,as,O,4208
86617,a,O,4208
86618,promising,O,4208
86619,adjunctive,O,4208
86620,ocular,O,4208
86621,hypotensive,O,4209
86622,agent,O,4209
86623,to,O,4209
86624,further,O,4209
86625,reduce,O,4209
86626,IOP,O,4209
86627,in,O,4209
86628,eyes,O,4209
86629,with,O,4209
86630,prior,O,4209
86631,goniotomy,B-TREATMENT,4209
86632,Retrospective,O,4209
86633,cohort,O,4209
86634,study,O,4209
86635,of,O,4209
86636,70,O,4209
86637,eyes,O,4209
86638,from,O,4209
86639,49,O,4209
86640,adult,O,4209
86641,glaucoma,B-NAME_OF_DISEASE,4209
86642,patients,O,4209
86643,treated,O,4209
86644,with,O,4209
86645,netarsudil,B-NAME_OF_DRUG,4209
86646,Thirty-five,O,4209
86647,eyes,O,4209
86648,received,O,4209
86649,sectoral,B-TREATMENT,4209
86650,goniotomy,I-TREATMENT,4209
86651,using,O,4209
86652,Kahook,B-SURGICAL_INSTRUMENT,4209
86653,Dual,I-SURGICAL_INSTRUMENT,4209
86654,Blade,I-SURGICAL_INSTRUMENT,4209
86655,KDB,B-SURGICAL_INSTRUMENT,4209
86656,combined,O,4210
86657,with,O,4210
86658,cataract,B-TREATMENT,4210
86659,surgery,I-TREATMENT,4210
86660,with,O,4210
86661,minimum,O,4210
86662,of,O,4210
86663,3,B-TIME_DURATION,4210
86664,months,I-TIME_DURATION,4210
86665,prior,O,4210
86666,to,O,4210
86667,netarsudil,B-NAME_OF_DRUG,4210
86668,treatment,O,4210
86669,Thirty-five,O,4210
86670,eyes,O,4210
86671,in,O,4210
86672,the,O,4210
86673,control,O,4210
86674,cohort,O,4210
86675,received,O,4210
86676,only,O,4210
86677,cataract,B-TREATMENT,4210
86678,surgery,I-TREATMENT,4210
86679,prior,O,4210
86680,to,O,4210
86681,netarsudil,B-NAME_OF_DRUG,4210
86682,Primary,O,4210
86683,outcome,O,4211
86684,was,O,4211
86685,treatment,O,4211
86686,success,O,4211
86687,defined,O,4211
86688,as ≥ 20%,O,4211
86689,decrease,O,4211
86690,in,O,4211
86691,IOP,O,4211
86692,at,O,4211
86693,minimum,O,4211
86694,1,B-TIME_DURATION,4211
86695,month,I-TIME_DURATION,4212
86696,follow-up,O,4212
86697,Secondary,O,4212
86698,outcome,O,4212
86699,measures,O,4212
86700,included,O,4212
86701,percent,O,4212
86702,of,O,4212
86703,IOP,O,4212
86704,reduction,O,4212
86705,adverse,O,4212
86706,effects,O,4212
86707,of,O,4212
86708,medication,O,4212
86709,medication,O,4212
86710,discontinuation,O,4212
86711,rate,O,4212
86712,and,O,4212
86713,relationship,O,4212
86714,between,O,4212
86715,KDB,B-SURGICAL_INSTRUMENT,4212
86716,goniotomy,B-TREATMENT,4212
86717,response,O,4212
86718,and,O,4212
86719,netarsudil,B-NAME_OF_DRUG,4212
86720,response,O,4212
86721,Netarsudil,B-NAME_OF_DRUG,4212
86722,ophthalmic,O,4213
86723,solution,O,4213
86724,is,O,4213
86725,a,O,4213
86726,novel,O,4213
86727,topical,O,4213
86728,intraocular,O,4213
86729,pressure,O,4213
86730,IOP,O,4213
86731,#NAME?,O,4213
86732,agent,O,4213
86733,that,O,4213
86734,has,O,4213
86735,been,O,4213
86736,approved,O,4213
86737,by,O,4213
86738,the,B-GPE,4213
86739,US,I-GPE,4213
86740,Food,B-ORGANIZATION,4213
86741,and,I-ORGANIZATION,4213
86742,Drug,I-ORGANIZATION,4213
86743,Administration,I-ORGANIZATION,4213
86744,FDA,I-ORGANIZATION,4213
86745,for,O,4213
86746,the,O,4213
86747,treatment,O,4213
86748,of,O,4213
86749,ocular,B-NAME_OF_DISEASE,4213
86750,hypertension,I-NAME_OF_DISEASE,4213
86751,and,O,4213
86752,open-angle,B-NAME_OF_DISEASE,4213
86753,glaucoma,B-NAME_OF_DISEASE,4213
86754,Its,O,4213
86755,unique,O,4213
86756,pharmacology,O,4213
86757,allows,O,4214
86758,for,O,4214
86759,IOP,O,4214
86760,lowering,O,4214
86761,as,O,4214
86762,a,O,4214
86763,result,O,4214
86764,of,O,4214
86765,direct,O,4214
86766,reduction,O,4214
86767,in,O,4214
86768,trabecular,O,4214
86769,outflow,O,4214
86770,resistance,O,4214
86771,in,O,4214
86772,addition,O,4214
86773,to,O,4214
86774,a,O,4214
86775,decrease,O,4214
86776,in,O,4214
86777,episcleral,O,4214
86778,venous,O,4214
86779,pressure,O,4214
86780,and,O,4214
86781,aqueous,O,4214
86782,humor,O,4214
86783,production,O,4214
86784,The,O,4215
86785,efficacy,O,4215
86786,of,O,4215
86787,netarsudil,B-NAME_OF_DRUG,4215
86788,has,O,4215
86789,been,O,4215
86790,shown,O,4215
86791,in,O,4215
86792,animal,O,4215
86793,studies,O,4215
86794,and,O,4215
86795,human,O,4215
86796,clinical,O,4215
86797,trials,O,4215
86798,It,O,4215
86799,has,O,4215
86800,been,O,4215
86801,shown,O,4215
86802,to,O,4215
86803,be,O,4215
86804,noninferior,O,4215
86805,to,O,4215
86806,the,O,4215
86807,therapy,O,4215
86808,with,O,4215
86809,topical,B-NAME_OF_DRUG,4215
86810,timolol,I-NAME_OF_DRUG,4215
86811,in,O,4215
86812,individuals,O,4215
86813,with,O,4215
86814,baseline,O,4215
86815,IOP,O,4215
86816,25,O,4215
86817,mmHg,O,4215
86818,Importantly,O,4215
86819,netarsudil,B-NAME_OF_DRUG,4216
86820,has,O,4216
86821,been,O,4216
86822,shown,O,4216
86823,to,O,4216
86824,reduce,O,4216
86825,IOP,O,4216
86826,to,O,4216
86827,the,O,4216
86828,same,O,4216
86829,degree,O,4216
86830,regardless,O,4216
86831,of,O,4216
86832,baseline,O,4216
86833,levels,O,4216
86834,There,O,4216
86835,are,O,4216
86836,no,O,4216
86837,known,O,4216
86838,systemic,O,4216
86839,safety,O,4216
86840,issues,O,4216
86841,associated,O,4216
86842,with,O,4216
86843,netarsudil,B-NAME_OF_DRUG,4216
86844,Glaucoma,B-NAME_OF_DISEASE,4216
86845,continues,O,4216
86846,to,O,4217
86847,be,O,4218
86848,a,O,4218
86849,leading,O,4218
86850,cause,O,4218
86851,of,O,4218
86852,irreversible,B-NAME_OF_DISEASE,4218
86853,blindness,I-NAME_OF_DISEASE,4218
86854,currently,O,4218
86855,affecting,O,4218
86856,over,O,4218
86857,70,O,4218
86858,million,O,4218
86859,people,O,4218
86860,worldwide,O,4218
86861,The,O,4218
86862,glaucoma,B-NAME_OF_DISEASE,4218
86863,population,O,4218
86864,is,O,4218
86865,estimated,O,4218
86866,to,O,4218
86867,increase,O,4218
86868,to,O,4218
86869,over,O,4218
86870,110,O,4218
86871,million,O,4218
86872,by,O,4218
86873,2040,O,4218
86874,augmenting,O,4218
86875,the,O,4219
86876,need,O,4219
86877,for,O,4219
86878,new,O,4219
86879,approaches,O,4219
86880,to,O,4219
86881,glaucoma,B-NAME_OF_DISEASE,4219
86882,therapy,O,4219
86883,Epidemiological,O,4219
86884,studies,O,4219
86885,have,O,4219
86886,shown,O,4219
86887,that,O,4219
86888,the,O,4219
86889,risk,O,4219
86890,of,O,4220
86891,open-angle,B-NAME_OF_DISEASE,4220
86892,glaucoma,B-NAME_OF_DISEASE,4220
86893,progression,O,4220
86894,increases,O,4220
86895,with,O,4220
86896,a,B-CAUSE_OF_DISEASE,4220
86897,higher,I-CAUSE_OF_DISEASE,4220
86898,intraocular,I-CAUSE_OF_DISEASE,4220
86899,pressure,I-CAUSE_OF_DISEASE,4220
86900,IOP,I-CAUSE_OF_DISEASE,4220
86901,at,O,4220
86902,an,O,4220
86903,estimated,O,4220
86904,12%,O,4220
86905,increase,O,4220
86906,in,O,4220
86907,risk,O,4220
86908,for,O,4220
86909,every,O,4220
86910,1,O,4220
86911,mmHg,O,4220
86912,increase,O,4220
86913,in,O,4220
86914,IOP,O,4220
86915,Medical,O,4220
86916,intervention,O,4220
86917,that,O,4220
86918,lowers,B-TREATMENT,4220
86919,IOP,I-TREATMENT,4220
86920,is,O,4221
86921,currently,O,4221
86922,the,O,4221
86923,first-line,O,4221
86924,therapy,O,4221
86925,for,O,4221
86926,preventing,O,4221
86927,progression,O,4221
86928,of,O,4221
86929,optic,B-SIGN_AND_SYMPTOM,4221
86930,nerve,I-SIGN_AND_SYMPTOM,4222
86931,damage,I-SIGN_AND_SYMPTOM,4222
86932,and,I-SIGN_AND_SYMPTOM,4222
86933,subsequent,I-SIGN_AND_SYMPTOM,4222
86934,vision,I-SIGN_AND_SYMPTOM,4222
86935,loss,I-SIGN_AND_SYMPTOM,4222
86936,IOP,O,4222
86937,is,O,4222
86938,regulated,O,4222
86939,by,O,4222
86940,a,O,4222
86941,balance,O,4222
86942,between,O,4222
86943,the,O,4222
86944,production,O,4222
86945,of,O,4222
86946,aqueous,O,4222
86947,humor,O,4222
86948,by,O,4223
86949,the,O,4223
86950,ciliary,O,4223
86951,processes,O,4223
86952,and,O,4223
86953,the,O,4223
86954,rate,O,4223
86955,of,O,4223
86956,aqueous,O,4223
86957,outflow,O,4223
86958,to,O,4224
86959,venous,O,4225
86960,circulation,O,4225
86961,through,O,4225
86962,the,O,4225
86963,uveoscleral,O,4225
86964,outflow,O,4226
86965,pathway,O,4226
86966,and,O,4226
86967,trabecular,B-PART_OF_THE_EYES,4226
86968,meshwork,I-PART_OF_THE_EYES,4226
86969,TM,B-PART_OF_THE_EYES,4227
86970,pathways,O,4227
86971,The,O,4227
86972,majority,O,4227
86973,of,O,4228
86974,the,O,4229
86975,aqueous,O,4229
86976,humor,O,4229
86977,is,O,4229
86978,filtered,O,4229
86979,through,O,4229
86980,the,B-PART_OF_THE_EYES,4229
86981,TM,I-PART_OF_THE_EYES,4229
86982,pathway,O,4229
86983,also,O,4229
86984,known,O,4229
86985,as,O,4229
86986,the,O,4229
86987,conventional,O,4229
86988,pathway,O,4229
86989,which,O,4229
86990,consists,O,4229
86991,of,O,4229
86992,the,B-PART_OF_THE_EYES,4229
86993,TM,I-PART_OF_THE_EYES,4229
86994,juxtacanalicular,B-PART_OF_THE_EYES,4229
86995,tissue,I-PART_OF_THE_EYES,4229
86996,JCT,I-PART_OF_THE_EYES,4229
86997,and,O,4229
86998,Schlemm,B-PART_OF_THE_EYES,4229
86999,s,I-PART_OF_THE_EYES,4229
87000,canal,I-PART_OF_THE_EYES,4229
87001,SC,I-PART_OF_THE_EYES,4229
87002,,O,4229
87003,Although,O,4229
87004,the,O,4229
87005,pathophysiology,O,4229
87006,of,O,4229
87007,glaucomatous,O,4229
87008,degeneration,O,4229
87009,is,O,4229
87010,not,O,4230
87011,completely,O,4230
87012,understood,O,4230
87013,a,B-CAUSE_OF_DISEASE,4230
87014,resistance,I-CAUSE_OF_DISEASE,4230
87015,to,I-CAUSE_OF_DISEASE,4230
87016,aqueous,I-CAUSE_OF_DISEASE,4230
87017,outflow,I-CAUSE_OF_DISEASE,4230
87018,through,I-CAUSE_OF_DISEASE,4230
87019,the,B-PART_OF_THE_EYES,4230
87020,TM,I-PART_OF_THE_EYES,4230
87021,is,O,4230
87022,thought,O,4230
87023,to,O,4230
87024,cause,O,4230
87025,an,O,4230
87026,increase,O,4230
87027,in,O,4230
87028,IOP,O,4230
87029,and,O,4230
87030,eventually,O,4230
87031,lead,O,4230
87032,to,O,4230
87033,optic,B-SIGN_AND_SYMPTOM,4230
87034,nerve,I-SIGN_AND_SYMPTOM,4230
87035,damage,I-SIGN_AND_SYMPTOM,4230
87036,Currently,O,4230
87037,available,O,4230
87038,therapeutic,O,4230
87039,options,O,4230
87040,mainly,O,4230
87041,increase,B-TREATMENT,4230
87042,uveoscleral,I-TREATMENT,4230
87043,outflow,I-TREATMENT,4230
87044,known,I-TREATMENT,4230
87045,as,I-TREATMENT,4230
87046,outflow,I-TREATMENT,4230
87047,drugs,I-TREATMENT,4230
87048,or,I-TREATMENT,4230
87049,decrease,I-TREATMENT,4231
87050,aqueous,I-TREATMENT,4231
87051,humor,I-TREATMENT,4231
87052,production,I-TREATMENT,4231
87053,inflow,I-TREATMENT,4231
87054,drugs,I-TREATMENT,4231
87055,in,I-TREATMENT,4231
87056,order,I-TREATMENT,4231
87057,to,I-TREATMENT,4232
87058,lower,I-TREATMENT,4232
87059,IOP,I-TREATMENT,4232
87060,instead,O,4232
87061,of,O,4232
87062,targeting,O,4232
87063,the,O,4232
87064,diseased,O,4232
87065,TM,B-PART_OF_THE_EYES,4232
87066,pathway,O,4233
87067,directly,O,4233
87068,Medications,O,4233
87069,that,O,4233
87070,increase,O,4233
87071,the,O,4233
87072,uveoscleral,O,4233
87073,outflow,O,4233
87074,include,O,4233
87075,the,B-NAME_OF_DRUG,4233
87076,prostaglandin,I-NAME_OF_DRUG,4233
87077,analogs,I-NAME_OF_DRUG,4233
87078,and,O,4233
87079,alpha,B-NAME_OF_DRUG,4233
87080,agonists,I-NAME_OF_DRUG,4233
87081,and,O,4233
87082,medications,O,4233
87083,that,O,4233
87084,decrease,O,4233
87085,the,O,4234
87086,aqueous,O,4234
87087,humor,O,4234
87088,production,O,4234
87089,include,O,4234
87090,beta,B-NAME_OF_DRUG,4234
87091,blockers,I-NAME_OF_DRUG,4235
87092,carbonic,B-NAME_OF_DRUG,4235
87093,anhydrase,I-NAME_OF_DRUG,4235
87094,inhibitors,I-NAME_OF_DRUG,4235
87095,and,O,4235
87096,alpha,B-NAME_OF_DRUG,4235
87097,agonists,I-NAME_OF_DRUG,4236
87098,Pilocarpine,B-NAME_OF_DRUG,4236
87099,is,O,4236
87100,a,O,4236
87101,unique,O,4237
87102,miotic,B-NAME_OF_DRUG,4237
87103,glaucoma,I-NAME_OF_DRUG,4237
87104,drug,I-NAME_OF_DRUG,4237
87105,that,O,4237
87106,works,O,4237
87107,to,O,4237
87108,increase,O,4237
87109,aqueous,O,4237
87110,humor,O,4237
87111,outflow,O,4237
87112,but,O,4237
87113,does,O,4237
87114,not,O,4237
87115,directly,O,4237
87116,target,O,4237
87117,the,B-PART_OF_THE_EYES,4237
87118,TM,I-PART_OF_THE_EYES,4237
87119,Rather,O,4237
87120,this,O,4237
87121,agent,O,4237
87122,induces,O,4237
87123,contraction,O,4237
87124,of,O,4237
87125,the,B-PART_OF_THE_EYES,4237
87126,ciliary,I-PART_OF_THE_EYES,4237
87127,muscle,I-PART_OF_THE_EYES,4237
87128,in,O,4237
87129,order,O,4237
87130,to,O,4237
87131,expand,O,4237
87132,the,B-PART_OF_THE_EYES,4237
87133,TM,I-PART_OF_THE_EYES,4237
87134,and,O,4237
87135,decrease,O,4237
87136,outflow,O,4237
87137,resistance,O,4237
87138,The,O,4237
87139,present,O,4237
87140,issue,O,4237
87141,with,O,4237
87142,the,O,4238
87143,current,O,4238
87144,medical,O,4238
87145,options,O,4238
87146,is,O,4238
87147,that,O,4238
87148,necessary,O,4238
87149,IOP,O,4238
87150,reductions,O,4238
87151,cannot,O,4238
87152,be,O,4238
87153,achieved,O,4239
87154,with,O,4239
87155,monotherapy,O,4239
87156,alone,O,4239
87157,in,O,4239
87158,many,O,4239
87159,patient,O,4239
87160,cases,O,4239
87161,Micro-invasive,B-TREATMENT,4239
87162,glaucoma,B-NAME_OF_DISEASE,4239
87163,surgery,I-TREATMENT,4239
87164,MIGS,B-TREATMENT,4239
87165,has,O,4239
87166,become,O,4239
87167,a,O,4239
87168,popular,O,4239
87169,option,O,4239
87170,for,O,4239
87171,facilitating,O,4239
87172,a,O,4239
87173,reduction,O,4239
87174,in,O,4239
87175,intraocular,O,4239
87176,pressure,O,4239
87177,IOP,O,4239
87178,when,O,4239
87179,medical,O,4239
87180,therapy,O,4239
87181,has,O,4239
87182,not,O,4239
87183,adequately,O,4239
87184,done,O,4239
87185,so,O,4239
87186,or,O,4239
87187,is,O,4239
87188,not,O,4240
87189,a,O,4240
87190,viable,O,4240
87191,option,O,4240
87192,These,O,4240
87193,procedures,O,4240
87194,involve,O,4240
87195,various,O,4240
87196,approaches,O,4240
87197,including,O,4240
87198,improving,O,4240
87199,aqueous,O,4240
87200,humor,O,4240
87201,outflow,O,4240
87202,through,O,4240
87203,the,B-PART_OF_THE_EYES,4240
87204,trabecular,I-PART_OF_THE_EYES,4240
87205,meshwork,I-PART_OF_THE_EYES,4240
87206,TM,B-PART_OF_THE_EYES,4240
87207,or,O,4240
87208,other,O,4240
87209,components,O,4240
87210,of,O,4240
87211,the,O,4241
87212,conventional,O,4241
87213,pathway,O,4241
87214,such,O,4241
87215,as,O,4241
87216,Schlemm,B-PART_OF_THE_EYES,4241
87217,s,I-PART_OF_THE_EYES,4241
87218,canal,I-PART_OF_THE_EYES,4241
87219,MIGS,B-TREATMENT,4241
87220,is,O,4241
87221,less,O,4241
87222,invasive,O,4241
87223,and,O,4241
87224,therefore,O,4241
87225,poses,O,4242
87226,a,O,4242
87227,lower,O,4242
87228,risk,O,4242
87229,for,O,4242
87230,complications,O,4242
87231,than,O,4242
87232,traditional,B-TREATMENT,4243
87233,glaucoma,B-NAME_OF_DISEASE,4243
87234,surgeries,I-TREATMENT,4243
87235,such,O,4243
87236,as,O,4243
87237,trabeculectomy,B-TREATMENT,4243
87238,and,O,4243
87239,glaucoma,B-NAME_OF_DISEASE,4243
87240,drainage,I-TREATMENT,4243
87241,devices,I-TREATMENT,4243
87242,tube,I-TREATMENT,4243
87243,shunts,I-TREATMENT,4243
87244,,O,4243
87245,However,O,4243
87246,MIGS,B-TREATMENT,4243
87247,not,O,4243
87248,always,O,4243
87249,achieve,O,4243
87250,target,O,4243
87251,IOP,O,4243
87252,This,O,4243
87253,presents,O,4243
87254,a,O,4243
87255,significant,O,4243
87256,glaucoma,B-NAME_OF_DISEASE,4243
87257,treatment,O,4243
87258,challenge,O,4243
87259,as,O,4243
87260,every,O,4243
87261,millimeter,O,4243
87262,of,O,4243
87263,mercury,O,4243
87264,above,O,4243
87265,target,O,4243
87266,pressure,O,4243
87267,represents,O,4243
87268,an,O,4243
87269,increased,O,4243
87270,risk,O,4243
87271,for,O,4244
87272,disease,O,4244
87273,progression,O,4244
87274,and,O,4244
87275,ultimately,O,4244
87276,vision,B-SIGN_AND_SYMPTOM,4244
87277,loss,I-SIGN_AND_SYMPTOM,4244
87278,Many,O,4244
87279,surgeons,O,4244
87280,believe,O,4244
87281,that,O,4244
87282,prescribing,O,4244
87283,topical,B-NAME_OF_DRUG,4244
87284,eye,I-NAME_OF_DRUG,4245
87285,drops,I-NAME_OF_DRUG,4245
87286,following,O,4245
87287,MIGS,B-TREATMENT,4245
87288,will,O,4245
87289,not,O,4245
87290,deliver,O,4245
87291,additional,O,4245
87292,IOP,O,4245
87293,reduction,O,4245
87294,particularly,O,4245
87295,when,O,4245
87296,the,O,4245
87297,procedure,O,4245
87298,has,O,4245
87299,already,O,4245
87300,targeted,O,4245
87301,the,O,4245
87302,diseased,O,4245
87303,TM,B-PART_OF_THE_EYES,4245
87304,My,O,4245
87305,colleagues,O,4245
87306,set,O,4245
87307,out,O,4245
87308,to,O,4245
87309,test,O,4245
87310,this,O,4245
87311,hypothesis,O,4245
87312,in,O,4245
87313,one,O,4245
87314,specific,O,4245
87315,treatment,O,4245
87316,scenario,O,4245
87317,by,O,4245
87318,comparing,O,4245
87319,the,O,4245
87320,IOP,O,4245
87321,lowering,O,4245
87322,effects,O,4245
87323,of,O,4245
87324,netarsudil,O,4245
87325,ophthalmic,O,4245
87326,solution,O,4245
87327,0.02,O,4245
87328,Rhopressa,O,4245
87329,Aerie,O,4245
87330,Pharmaceuticals,O,4245
87331,on,O,4245
87332,eyes,O,4246
87333,with,O,4246
87334,previous,O,4246
87335,Kahook,B-SURGICAL_INSTRUMENT,4246
87336,Dual,I-SURGICAL_INSTRUMENT,4246
87337,Blade,I-SURGICAL_INSTRUMENT,4246
87338,KDB,I-SURGICAL_INSTRUMENT,4246
87339,goniotomy,B-TREATMENT,4246
87340,versus,O,4246
87341,goniotomy-naïve,O,4246
87342,eyes,O,4246
87343,KDB,B-SURGICAL_INSTRUMENT,4246
87344,goniotomy,B-TREATMENT,4247
87345,KDB,B-SURGICAL_INSTRUMENT,4247
87346,New,B-ORGANIZATION,4247
87347,World,I-ORGANIZATION,4247
87348,Medical,I-ORGANIZATION,4247
87349,a,O,4247
87350,common,O,4247
87351,MIGS,B-TREATMENT,4247
87352,surgery,I-TREATMENT,4247
87353,involves,O,4247
87354,the,O,4247
87355,removal,O,4247
87356,of,O,4247
87357,a,O,4247
87358,small,O,4247
87359,section,O,4247
87360,of,O,4247
87361,TM,B-PART_OF_THE_EYES,4247
87362,to,O,4247
87363,create,O,4248
87364,an,O,4248
87365,opening,O,4248
87366,into,O,4248
87367,Schlemm,B-PART_OF_THE_EYES,4248
87368,s,I-PART_OF_THE_EYES,4248
87369,canal,I-PART_OF_THE_EYES,4248
87370,to,O,4248
87371,increase,O,4248
87372,aqueous,O,4248
87373,humor,O,4248
87374,outflow,O,4248
87375,MIGS,B-TREATMENT,4248
87376,procedures,I-TREATMENT,4248
87377,that,O,4248
87378,target,O,4248
87379,the,B-PART_OF_THE_EYES,4248
87380,TM,I-PART_OF_THE_EYES,4248
87381,including,O,4248
87382,KDB,B-SURGICAL_INSTRUMENT,4248
87383,goniotomy,B-TREATMENT,4248
87384,experience,O,4248
87385,a,O,4248
87386,floor,O,4248
87387,effect,O,4249
87388,of,O,4249
87389,IOP,O,4249
87390,lowering,O,4249
87391,due,O,4249
87392,to,O,4249
87393,their,O,4249
87394,inability,O,4249
87395,to,O,4249
87396,further,O,4249
87397,bypass,O,4249
87398,episcleral,O,4249
87399,venous,O,4249
87400,pressure,O,4249
87401,EVP,O,4249
87402,and,O,4249
87403,distal,O,4249
87404,resistance,O,4249
87405,in,O,4249
87406,the,O,4249
87407,conventional,O,4249
87408,outflow,O,4249
87409,pathway,O,4249
87410,Netarsudil,B-NAME_OF_DRUG,4249
87411,is,O,4249
87412,a,B-CHEMICAL_COMPOUND,4249
87413,Rho,I-CHEMICAL_COMPOUND,4249
87414,kinase,I-CHEMICAL_COMPOUND,4249
87415,inhibitor,I-CHEMICAL_COMPOUND,4249
87416,that,O,4249
87417,is,O,4249
87418,thought,O,4249
87419,to,O,4250
87420,lower,O,4250
87421,IOP,O,4250
87422,through,O,4250
87423,two,O,4250
87424,primary,O,4250
87425,mechanisms,O,4250
87426,1,O,4250
87427,increasing,O,4250
87428,aqueous,O,4250
87429,outflow,O,4250
87430,through,O,4250
87431,the,B-PART_OF_THE_EYES,4250
87432,TM,I-PART_OF_THE_EYES,4250
87433,cells,I-PART_OF_THE_EYES,4250
87434,2,O,4250
87435,reducing,O,4250
87436,EVP,O,4250
87437,This,O,4250
87438,MOA,O,4250
87439,is,O,4250
87440,unique,O,4250
87441,compared,O,4250
87442,to,O,4250
87443,other,O,4250
87444,available,O,4250
87445,IOP,O,4250
87446,lowering,O,4250
87447,pharmacologic,O,4250
87448,therapies,O,4250
87449,Dosed,O,4250
87450,as,O,4250
87451,one,O,4250
87452,drop,O,4250
87453,QD,O,4250
87454,and,O,4250
87455,prescribed,O,4250
87456,typically,O,4250
87457,as,O,4250
87458,an,O,4250
87459,adjunctive,O,4250
87460,therapy,O,4250
87461,netarsudil,B-NAME_OF_DRUG,4250
87462,has,O,4250
87463,been,O,4250
87464,shown,O,4250
87465,to,O,4250
87466,produce,O,4250
87467,consistent,O,4250
87468,IOP,O,4250
87469,reductions,O,4250
87470,across,O,4250
87471,a,O,4250
87472,range,O,4250
87473,of,O,4250
87474,baseline,O,4250
87475,pressures,O,4250
87476,Our,O,4250
87477,retrospective,O,4250
87478,chart,O,4250
87479,review,O,4250
87480,analyzed,O,4250
87481,data,O,4250
87482,on,O,4250
87483,50,O,4250
87484,eyes,O,4251
87485,of,O,4251
87486,37,O,4251
87487,adult,O,4251
87488,glaucoma,B-NAME_OF_DISEASE,4251
87489,patients,O,4251
87490,treated,O,4251
87491,with,O,4251
87492,netarsudil,B-NAME_OF_DRUG,4251
87493,at,O,4251
87494,Mason,B-ORGANIZATION,4251
87495,Eye,I-ORGANIZATION,4251
87496,Institute,I-ORGANIZATION,4251
87497,at,I-ORGANIZATION,4251
87498,the,I-ORGANIZATION,4251
87499,University,I-ORGANIZATION,4251
87500,of,I-ORGANIZATION,4251
87501,Missouri,B-GPE,4251
87502,in,O,4251
87503,Columbia,B-GPE,4251
87504,Missouri,B-GPE,4252
87505,between,B-TIME_DURATION,4252
87506,February,I-TIME_DURATION,4252
87507,2017,I-TIME_DURATION,4252
87508,and,I-TIME_DURATION,4252
87509,October,I-TIME_DURATION,4252
87510,2020,I-TIME_DURATION,4252
87511,The,O,4252
87512,KDB,B-SURGICAL_INSTRUMENT,4252
87513,group,O,4252
87514,n,O,4252
87515,=,O,4252
87516,25,O,4253
87517,included,O,4253
87518,adult,O,4253
87519,glaucoma,B-NAME_OF_DISEASE,4253
87520,patients,O,4253
87521,who,O,4253
87522,had,O,4253
87523,undergone,O,4253
87524,KDB,B-SURGICAL_INSTRUMENT,4253
87525,goniotomy,B-TREATMENT,4253
87526,with,O,4253
87527,cataract,B-TREATMENT,4253
87528,surgery,I-TREATMENT,4253
87529,then,O,4253
87530,started,O,4253
87531,on,O,4253
87532,netarsudil,B-NAME_OF_DRUG,4253
87533,with,O,4253
87534,no,O,4253
87535,additional,O,4253
87536,eye,O,4254
87537,surgeries,O,4254
87538,Control,O,4254
87539,eyes,O,4254
87540,n,O,4254
87541,=,O,4254
87542,25,O,4254
87543,included,O,4254
87544,those,O,4254
87545,with,O,4254
87546,history,O,4254
87547,of,O,4255
87548,cataract,B-TREATMENT,4255
87549,surgery,I-TREATMENT,4255
87550,but,O,4255
87551,no,O,4255
87552,goniotomy,B-TREATMENT,4255
87553,or,O,4255
87554,any,O,4255
87555,other,O,4255
87556,angle,O,4255
87557,surgeries,O,4255
87558,and,O,4255
87559,were,O,4255
87560,started,O,4255
87561,on,O,4255
87562,netarsudil,B-NAME_OF_DRUG,4255
87563,for,O,4255
87564,at,O,4255
87565,least,O,4255
87566,one,B-TIME_DURATION,4255
87567,month,I-TIME_DURATION,4255
87568,with,O,4255
87569,no,O,4255
87570,additional,O,4255
87571,ocular,O,4255
87572,procedures,O,4255
87573,The,O,4255
87574,two,O,4256
87575,groups,O,4256
87576,had,O,4256
87577,comparable,O,4256
87578,baseline,O,4256
87579,characteristics,O,4256
87580,including,O,4256
87581,age,O,4256
87582,gender,O,4256
87583,ethnicity,O,4257
87584,as,O,4257
87585,well,O,4257
87586,as,O,4257
87587,type,O,4257
87588,and,O,4257
87589,severity,O,4257
87590,of,O,4257
87591,glaucoma,B-NAME_OF_DISEASE,4257
87592,baseline,O,4257
87593,IOP,O,4257
87594,and,O,4257
87595,number,O,4257
87596,of,O,4257
87597,medications,O,4258
87598,all,O,4258
87599,P≥0.0,O,4258
87600,,O,4258
87601,We,O,4258
87602,defined,O,4258
87603,the,O,4258
87604,primary,O,4258
87605,outcome,O,4258
87606,as,O,4258
87607,≥,O,4258
87608,20%,O,4258
87609,decrease,O,4258
87610,in,O,4258
87611,IOP,O,4258
87612,at,O,4258
87613,the,O,4258
87614,1,B-TIME_DURATION,4258
87615,month,I-TIME_DURATION,4258
87616,follow-up,O,4258
87617,visit,O,4258
87618,compared,O,4258
87619,to,O,4258
87620,the,O,4258
87621,IOP,O,4258
87622,measured,O,4258
87623,at,O,4258
87624,the,O,4258
87625,time,O,4258
87626,of,O,4258
87627,netarsudil,B-NAME_OF_DRUG,4258
87628,prescription,O,4259
87629,Secondary,O,4259
87630,outcomes,O,4259
87631,included,O,4259
87632,adverse,O,4259
87633,reaction,O,4259
87634,to,O,4259
87635,medication,O,4259
87636,and,O,4259
87637,rate,O,4259
87638,of,O,4259
87639,medication,O,4259
87640,discontinuation,O,4260
87641,for,O,4260
87642,any,O,4260
87643,reason,O,4260
87644,Upon,O,4260
87645,completion,O,4260
87646,of,O,4260
87647,the,O,4260
87648,analysis,O,4260
87649,we,O,4260
87650,found,O,4260
87651,that,O,4260
87652,netarsudil,B-NAME_OF_DRUG,4260
87653,had,O,4260
87654,a,O,4260
87655,significantly,O,4260
87656,greater,O,4260
87657,IOP,O,4260
87658,lowering,O,4260
87659,effect,O,4261
87660,in,O,4261
87661,eyes,O,4261
87662,treated,O,4261
87663,with,O,4261
87664,prior,O,4261
87665,KDB,B-SURGICAL_INSTRUMENT,4261
87666,goniotomy,B-TREATMENT,4261
87667,compared,O,4261
87668,to,O,4261
87669,eyes,O,4261
87670,without,O,4261
87671,history,O,4261
87672,of,O,4261
87673,goniotomy,B-TREATMENT,4261
87674,This,O,4261
87675,effect,O,4261
87676,was,O,4261
87677,independent,O,4261
87678,of,O,4261
87679,surgical,O,4261
87680,outcomes,O,4261
87681,of,O,4261
87682,KDB,B-SURGICAL_INSTRUMENT,4261
87683,goniotomy,B-TREATMENT,4261
87684,Eighty,O,4261
87685,percent,O,4261
87686,of,O,4261
87687,KDB-treated,O,4261
87688,eyes,O,4261
87689,achieved,O,4261
87690,netarsudil,B-NAME_OF_DRUG,4261
87691,treatment,O,4262
87692,success,O,4262
87693,defined,O,4262
87694,as,O,4262
87695,minimum,O,4262
87696,20%,O,4262
87697,IOP,O,4262
87698,reduction,O,4262
87699,compared,O,4262
87700,to,O,4262
87701,52,O,4262
87702,13,O,4262
87703,out,O,4262
87704,of,O,4262
87705,25,O,4262
87706,of,O,4262
87707,control,O,4262
87708,eyes,O,4262
87709,P,O,4262
87710,=,O,4262
87711,0.03,O,4262
87712,,O,4262
87713,Percent,O,4262
87714,IOP,O,4262
87715,reduction,O,4262
87716,was,O,4262
87717,29.5±16.1,O,4262
87718,in,O,4262
87719,KDB-treated,O,4262
87720,eyes,O,4262
87721,and,O,4262
87722,19.4±14.0,O,4262
87723,in,O,4262
87724,control,O,4262
87725,eyes,O,4262
87726,P=0.02,O,4262
87727,,O,4262
87728,Based,O,4262
87729,on,O,4262
87730,these,O,4262
87731,results,O,4262
87732,which,O,4262
87733,we,O,4262
87734,presented,O,4262
87735,at,O,4262
87736,the,B-ORGANIZATION,4262
87737,American,I-ORGANIZATION,4262
87738,Glaucoma,I-ORGANIZATION,4262
87739,Society,I-ORGANIZATION,4262
87740,annual,O,4262
87741,meeting,O,4262
87742,we,O,4262
87743,hypothesize,O,4262
87744,that,O,4262
87745,netarsudil,B-NAME_OF_DRUG,4262
87746,may,O,4262
87747,facilitate,O,4262
87748,additional,O,4262
87749,IOP-lowering,O,4262
87750,effects,O,4262
87751,through,O,4262
87752,its,O,4262
87753,unique,O,4262
87754,MOA,O,4262
87755,which,O,4262
87756,targets,O,4263
87757,EVP,O,4263
87758,in,O,4263
87759,addition,O,4263
87760,to,O,4263
87761,the,B-PART_OF_THE_EYES,4263
87762,trabecular,I-PART_OF_THE_EYES,4263
87763,meshwork,I-PART_OF_THE_EYES,4263
87764,In,O,4263
87765,KDB-treated,O,4263
87766,eyes,O,4263
87767,the,O,4263
87768,excision,O,4263
87769,of,O,4263
87770,TM,B-PART_OF_THE_EYES,4263
87771,at,O,4263
87772,the,O,4263
87773,nasal,O,4263
87774,angle,O,4263
87775,may,O,4263
87776,allow,O,4264
87777,for,O,4264
87778,a,O,4264
87779,greater,O,4264
87780,concentration,O,4264
87781,of,O,4264
87782,netarsudil,B-NAME_OF_DRUG,4264
87783,to,O,4264
87784,travel,O,4264
87785,downstream,O,4264
87786,to,O,4264
87787,the,O,4264
87788,distal,O,4264
87789,outflow,O,4264
87790,system,O,4264
87791,and,O,4264
87792,act,O,4264
87793,on,O,4264
87794,episcleral,B-PART_OF_THE_EYES,4264
87795,veins,I-PART_OF_THE_EYES,4264
87796,to,O,4264
87797,reduce,O,4264
87798,EVP,O,4264
87799,producing,O,4264
87800,a,O,4264
87801,synergistic,O,4264
87802,affect,O,4264
87803,The,O,4264
87804,overall,O,4264
87805,rate,O,4264
87806,of,O,4264
87807,adverse,O,4264
87808,reactions,O,4264
87809,was,O,4264
87810,48,O,4264
87811,most,O,4264
87812,commonly,O,4264
87813,reported,O,4264
87814,as,O,4264
87815,redness,B-SIGN_AND_SYMPTOM,4264
87816,allergy,I-SIGN_AND_SYMPTOM,4264
87817,and,I-SIGN_AND_SYMPTOM,4264
87818,blurred,I-SIGN_AND_SYMPTOM,4264
87819,vision,I-SIGN_AND_SYMPTOM,4264
87820,Consistent,O,4264
87821,with,O,4264
87822,previous,O,4265
87823,studies,O,4265
87824,no,O,4265
87825,adverse,O,4265
87826,reactions,O,4265
87827,were,O,4265
87828,serious,O,4265
87829,or,O,4265
87830,vision-threatening,O,4265
87831,and,O,4265
87832,all,O,4265
87833,resolved,O,4265
87834,upon,O,4265
87835,discontinuation,O,4265
87836,of,O,4265
87837,the,O,4265
87838,medication,O,4265
87839,The,O,4265
87840,overall,O,4265
87841,discontinuation,O,4265
87842,rate,O,4265
87843,was,O,4265
87844,58,O,4265
87845,with,O,4265
87846,average,O,4265
87847,treatment,O,4265
87848,duration,O,4265
87849,of,O,4265
87850,5,O,4265
87851,months,O,4265
87852,prior,O,4265
87853,to,O,4265
87854,discontinuation,O,4265
87855,Though,O,4265
87856,adverse,O,4265
87857,events,O,4265
87858,led,O,4265
87859,to,O,4265
87860,some,O,4265
87861,discontinuations,O,4265
87862,insurance-related,O,4265
87863,challenges,O,4265
87864,were,O,4265
87865,the,O,4265
87866,most,O,4265
87867,common,O,4265
87868,reason,O,4265
87869,as,O,4265
87870,the,O,4265
87871,timeframe,O,4266
87872,in,O,4266
87873,which,O,4266
87874,these,O,4266
87875,cases,O,4266
87876,were,O,4266
87877,treated,O,4266
87878,includes,O,4266
87879,a,O,4266
87880,period,O,4266
87881,prior,O,4266
87882,to,O,4266
87883,widespread,O,4266
87884,coverage,O,4266
87885,adoption,O,4266
87886,of,O,4266
87887,Rhopressa,B-NAME_OF_DRUG,4266
87888,which,O,4266
87889,was,O,4266
87890,the,B-ORGANIZATION,4266
87891,FDA,I-ORGANIZATION,4266
87892,approved,O,4266
87893,in,O,4266
87894,December,O,4266
87895,2017,O,4266
87896,Currently,O,4266
87897,8,O,4266
87898,out,O,4266
87899,of,O,4266
87900,10,O,4266
87901,insured,O,4267
87902,patients,O,4267
87903,have,O,4267
87904,coverage,O,4267
87905,for,O,4267
87906,Rhopressa,B-NAME_OF_DRUG,4267
87907,Contrary,O,4267
87908,to,O,4267
87909,a,O,4267
87910,widely,O,4267
87911,held,O,4267
87912,perception,O,4267
87913,these,O,4267
87914,data,O,4267
87915,clearly,O,4267
87916,indicate,O,4267
87917,that,O,4268
87918,patients,O,4268
87919,who,O,4268
87920,do,O,4268
87921,not,O,4268
87922,achieve,O,4268
87923,a,O,4268
87924,target,O,4268
87925,IOP,O,4268
87926,after,O,4268
87927,an,O,4268
87928,angle,O,4268
87929,surgery,O,4268
87930,such,O,4268
87931,as,O,4268
87932,KDB,B-SURGICAL_INSTRUMENT,4269
87933,goniotomy,B-TREATMENT,4269
87934,may,O,4269
87935,benefit,O,4269
87936,from,O,4269
87937,the,O,4269
87938,use,O,4269
87939,of,O,4269
87940,netarsudil,B-NAME_OF_DRUG,4269
87941,post-surgery,O,4269
87942,Though,O,4269
87943,adverse,O,4269
87944,reactions,O,4269
87945,such,O,4269
87946,as,O,4269
87947,hyperemia,B-SIGN_AND_SYMPTOM,4269
87948,are,O,4269
87949,common,O,4269
87950,netarsudil,B-NAME_OF_DRUG,4269
87951,is,O,4269
87952,not,O,4269
87953,known,O,4269
87954,to,O,4269
87955,cause,O,4269
87956,any,O,4269
87957,systemic,O,4269
87958,side,O,4269
87959,effects,O,4269
87960,and,O,4269
87961,is,O,4269
87962,generally,O,4269
87963,well,O,4269
87964,tolerated,O,4269
87965,Continued,O,4269
87966,improvement,O,4269
87967,in,O,4269
87968,insurance,O,4269
87969,coverage,O,4269
87970,makes,O,4269
87971,this,O,4269
87972,medication,O,4269
87973,a,O,4269
87974,viable,O,4269
87975,option,O,4270
87976,for,O,4270
87977,many,O,4270
87978,patients,O,4270
87979,Once-a-day,O,4270
87980,dosing,O,4270
87981,also,O,4270
87982,helps,O,4270
87983,to,O,4270
87984,promote,O,4270
87985,adherence,O,4270
87986,Taking,O,4270
87987,all,O,4270
87988,of,O,4270
87989,these,O,4270
87990,factors,O,4270
87991,into,O,4270
87992,consideration,O,4270
87993,and,O,4270
87994,recognizing,O,4270
87995,the,O,4270
87996,critical,O,4270
87997,importance,O,4270
87998,of,O,4270
87999,getting,O,4270
88000,glaucoma,B-NAME_OF_DISEASE,4270
88001,patients,O,4270
88002,to,O,4270
88003,their,O,4270
88004,target,O,4270
88005,IOP,O,4270
88006,surgeons,O,4270
88007,may,O,4270
88008,want,O,4271
88009,to,O,4271
88010,consider,O,4271
88011,prescribing,O,4271
88012,this,O,4271
88013,medication,O,4271
88014,to,O,4271
88015,patients,O,4271
88016,with,O,4271
88017,previous,O,4271
88018,angle,O,4271
88019,surgery,O,4271
88020,to,O,4271
88021,facilitate,O,4271
88022,greater,O,4271
88023,IOP,O,4271
88024,reduction,O,4271
88025,Of,O,4271
88026,course,O,4271
88027,further,O,4271
88028,research,O,4271
88029,is,O,4271
88030,needed,O,4271
88031,to,O,4271
88032,evaluate,O,4271
88033,this,O,4271
88034,and,O,4271
88035,other,O,4271
88036,combination,O,4271
88037,approaches,O,4271
88038,As,O,4271
88039,such,O,4271
88040,we,O,4271
88041,are,O,4271
88042,in,O,4271
88043,the,O,4271
88044,process,O,4271
88045,of,O,4271
88046,planning,O,4271
88047,a,O,4271
88048,randomized,O,4271
88049,controlled,O,4271
88050,trial,O,4271
88051,to,O,4271
88052,determine,O,4271
88053,if,O,4271
88054,this,O,4271
88055,result,O,4271
88056,is,O,4271
88057,unique,O,4271
88058,to,O,4271
88059,the,O,4271
88060,combination,O,4271
88061,of,O,4271
88062,KDB,B-SURGICAL_INSTRUMENT,4271
88063,goniotomy,B-TREATMENT,4272
88064,and,O,4272
88065,netarsudil,B-NAME_OF_DRUG,4272
88066,therapy,O,4272
88067,or,O,4272
88068,if,O,4272
88069,additional,O,4272
88070,IOP-lowering,O,4272
88071,might,O,4272
88072,be,O,4272
88073,achieved,O,4272
88074,through,O,4272
88075,the,O,4272
88076,use,O,4272
88077,of,O,4272
88078,other,O,4272
88079,topical,B-NAME_OF_DRUG,4272
88080,eye,I-NAME_OF_DRUG,4272
88081,drops,I-NAME_OF_DRUG,4272
88082,following,O,4272
88083,various,O,4272
88084,MIGS,B-TREATMENT,4272
88085,procedures,I-TREATMENT,4272
88086,Asian,B-CAUSE_OF_DISEASE,4272
88087,ethnicity,I-CAUSE_OF_DISEASE,4272
88088,is,O,4273
88089,a,O,4273
88090,mostly,O,4273
88091,consistent,O,4273
88092,dry,B-NAME_OF_DISEASE,4273
88093,eye,I-NAME_OF_DISEASE,4273
88094,disease,I-NAME_OF_DISEASE,4273
88095,DED,B-NAME_OF_DISEASE,4273
88096,risk,O,4273
88097,factor,O,4273
88098,Co-located,O,4273
88099,ethnic,O,4273
88100,population,O,4273
88101,studies,O,4273
88102,reducing,O,4273
88103,potential,O,4273
88104,confounding,O,4274
88105,effects,O,4274
88106,of,O,4274
88107,methodological,O,4274
88108,and,O,4274
88109,environmental,O,4274
88110,heterogeneity,O,4274
88111,may,O,4274
88112,help,O,4274
88113,explain,O,4274
88114,DED,B-NAME_OF_DISEASE,4274
88115,natural,O,4274
88116,history,O,4274
88117,From,O,4274
88118,96,O,4274
88119,references,O,4274
88120,identified,O,4274
88121,through,O,4274
88122,the,O,4274
88123,systematic,O,4274
88124,literature,O,4274
88125,search,O,4274
88126,strategy,O,4275
88127,of,O,4275
88128,the,O,4275
88129,current,O,4275
88130,review,O,4275
88131,3,O,4275
88132,relevant,O,4275
88133,studies,O,4275
88134,possessed,O,4275
88135,sufficient,O,4275
88136,methodological,O,4275
88137,homogeneity,O,4275
88138,for,O,4275
88139,pooled,O,4275
88140,analysis,O,4275
88141,Results,O,4276
88142,show,O,4276
88143,earliest,O,4276
88144,disparities,O,4276
88145,detected,O,4276
88146,between,O,4276
88147,Asian,O,4276
88148,and,O,4276
88149,Caucasian,O,4276
88150,populations,O,4276
88151,being,O,4276
88152,higher,O,4276
88153,degrees,O,4276
88154,of,O,4276
88155,incomplete,B-NAME_OF_DISEASE,4276
88156,blinking,I-NAME_OF_DISEASE,4276
88157,and,O,4276
88158,lid,B-NAME_OF_DISEASE,4276
88159,wiper,I-NAME_OF_DISEASE,4276
88160,epitheliopathy,I-NAME_OF_DISEASE,4276
88161,in,O,4276
88162,pediatric,O,4276
88163,Asian,O,4276
88164,participants,O,4276
88165,likely,O,4276
88166,associated,O,4276
88167,with,O,4276
88168,anatomically,O,4276
88169,predisposed,O,4276
88170,increased,O,4277
88171,eyelid,O,4277
88172,tension,O,4277
88173,Interethnic,O,4277
88174,divergence,O,4277
88175,in,O,4277
88176,meibomian,B-PART_OF_THE_EYES,4277
88177,gland,I-PART_OF_THE_EYES,4277
88178,dropout,O,4277
88179,in,O,4277
88180,the,O,4277
88181,young,O,4277
88182,adult,O,4277
88183,population,O,4277
88184,follows,O,4277
88185,while,O,4277
88186,other,O,4277
88187,ocular,B-PART_OF_THE_EYES,4277
88188,surface,I-PART_OF_THE_EYES,4277
88189,characteristics,O,4277
88190,remain,O,4277
88191,within,O,4277
88192,physiological,O,4277
88193,limits,O,4277
88194,significant,O,4277
88195,differences,O,4277
88196,in,O,4277
88197,meibomian,B-PART_OF_THE_EYES,4277
88198,gland,I-PART_OF_THE_EYES,4277
88199,function,O,4277
88200,tear,B-PART_OF_THE_EYES,4277
88201,film,I-PART_OF_THE_EYES,4277
88202,stability,O,4277
88203,and,O,4277
88204,osmolarity,O,4278
88205,DED,B-NAME_OF_DISEASE,4278
88206,symptomology,O,4278
88207,and,O,4278
88208,overall,O,4278
88209,disease,O,4278
88210,diagnosis,O,4278
88211,based,O,4278
88212,on,O,4278
88213,TFOS,B-DIAGNOSTIC_TEST,4278
88214,DEWS,I-DIAGNOSTIC_TEST,4278
88215,II,I-DIAGNOSTIC_TEST,4278
88216,criteria,I-DIAGNOSTIC_TEST,4278
88217,do,O,4278
88218,not,O,4278
88219,manifest,O,4279
88220,until,O,4279
88221,the,O,4279
88222,middle,O,4279
88223,adult,O,4279
88224,population,O,4279
88225,and,O,4279
88226,disparities,O,4279
88227,in,O,4279
88228,corneal,O,4279
88229,and,O,4279
88230,conjunctival,O,4279
88231,staining,O,4279
88232,become,O,4279
88233,significant,O,4279
88234,only,O,4279
88235,with,O,4280
88236,older,O,4280
88237,age,B-CAUSE_OF_DISEASE,4280
88238,Aqueous,O,4280
88239,tear,O,4280
88240,deficiency,O,4280
88241,appears,O,4280
88242,less,O,4280
88243,likely,O,4280
88244,than,O,4280
88245,evaporative,O,4280
88246,mechanisms,O,4280
88247,to,O,4280
88248,be,O,4280
88249,implicated,O,4280
88250,in,O,4280
88251,the,O,4280
88252,Asian,O,4280
88253,ethnic,O,4280
88254,propensity,O,4280
88255,towards,O,4280
88256,DED,B-NAME_OF_DISEASE,4280
88257,development,O,4280
88258,Several,O,4280
88259,factors,O,4280
88260,play,O,4280
88261,a,O,4280
88262,role,O,4280
88263,in,O,4281
88264,the,O,4281
88265,risk,O,4281
88266,of,O,4281
88267,developing,O,4281
88268,eye,O,4281
88269,diseases,O,4281
88270,Some,O,4281
88271,are,O,4281
88272,controllable,O,4281
88273,such,O,4281
88274,as,O,4281
88275,smoking,B-CAUSE_OF_DISEASE,4281
88276,and,O,4281
88277,UV,B-CAUSE_OF_DISEASE,4281
88278,exposure,I-CAUSE_OF_DISEASE,4281
88279,but,O,4281
88280,other,O,4281
88281,factors,O,4281
88282,are,O,4281
88283,out,O,4281
88284,of,O,4281
88285,our,O,4281
88286,control,O,4281
88287,such,O,4281
88288,as,O,4281
88289,age,B-CAUSE_OF_DISEASE,4281
88290,Ancestry,B-CAUSE_OF_DISEASE,4281
88291,can,O,4281
88292,also,O,4281
88293,affect,O,4281
88294,your,O,4282
88295,chances,O,4282
88296,of,O,4282
88297,developing,O,4282
88298,some,O,4282
88299,eye,O,4282
88300,conditions,O,4282
88301,According,O,4282
88302,to,O,4282
88303,the,B-ORGANIZATION,4282
88304,American,I-ORGANIZATION,4282
88305,Academy,I-ORGANIZATION,4282
88306,of,I-ORGANIZATION,4282
88307,Ophthalmology,I-ORGANIZATION,4282
88308,African-American,O,4282
88309,and,O,4282
88310,Latino-American,O,4282
88311,people,O,4282
88312,are,O,4282
88313,more,O,4282
88314,likely,O,4282
88315,to,O,4282
88316,develop,O,4282
88317,diseases,O,4283
88318,such,O,4283
88319,as,O,4283
88320,glaucoma,B-NAME_OF_DISEASE,4283
88321,cataracts,B-NAME_OF_DISEASE,4283
88322,and,O,4283
88323,diabetic,B-NAME_OF_DISEASE,4283
88324,retinopathy,I-NAME_OF_DISEASE,4283
88325,compared,O,4283
88326,to,O,4283
88327,Caucasians,O,4283
88328,Additionally,O,4283
88329,Asian-Americans,O,4283
88330,have,O,4284
88331,an,O,4284
88332,increased,O,4284
88333,risk,O,4284
88334,of,O,4284
88335,angle-closure,B-NAME_OF_DISEASE,4284
88336,glaucoma,I-NAME_OF_DISEASE,4284
88337,The,O,4284
88338,findings,O,4284
88339,demonstrate,O,4284
88340,that,O,4284
88341,racial,O,4284
88342,and,O,4284
88343,ethnic,O,4284
88344,minorities,O,4284
88345,present,O,4284
88346,with,O,4284
88347,worse,O,4284
88348,dry,B-NAME_OF_DISEASE,4284
88349,eye,I-NAME_OF_DISEASE,4284
88350,parameters,O,4285
88351,This,O,4285
88352,might,O,4285
88353,be,O,4285
88354,due,O,4285
88355,to,O,4285
88356,disproportionate,O,4285
88357,access,O,4285
88358,to,O,4285
88359,dry,B-NAME_OF_DISEASE,4285
88360,eye,I-NAME_OF_DISEASE,4285
88361,care,O,4285
88362,potentially,O,4285
88363,secondary,O,4285
88364,to,O,4285
88365,socioeconomic,O,4285
88366,barriers,O,4285
88367,as,O,4285
88368,well,O,4285
88369,as,O,4285
88370,underappreciation,O,4285
88371,of,O,4285
88372,dry,B-NAME_OF_DISEASE,4285
88373,eye,I-NAME_OF_DISEASE,4285
88374,among,O,4285
88375,minorities,O,4285
88376,leading,O,4285
88377,to,O,4285
88378,differential,O,4285
88379,treatment,O,4285
88380,by,O,4285
88381,providers,O,4285
88382,Asian,O,4285
88383,ethnicity,O,4285
88384,is,O,4285
88385,a,O,4285
88386,mostly,O,4285
88387,consistent,O,4286
88388,dry,B-NAME_OF_DISEASE,4286
88389,eye,I-NAME_OF_DISEASE,4286
88390,disease,I-NAME_OF_DISEASE,4286
88391,DED,B-NAME_OF_DISEASE,4286
88392,risk,O,4286
88393,factor,O,4286
88394,Co-located,O,4286
88395,ethnic,O,4286
88396,population,O,4286
88397,studies,O,4286
88398,reducing,O,4286
88399,potential,O,4286
88400,confounding,O,4286
88401,effects,O,4286
88402,of,O,4286
88403,methodological,O,4287
88404,and,O,4287
88405,environmental,O,4287
88406,heterogeneity,O,4287
88407,may,O,4288
88408,help,O,4288
88409,explain,O,4288
88410,DED,B-NAME_OF_DISEASE,4288
88411,natural,O,4289
88412,history,O,4290
88413,Results,O,4290
88414,show,O,4290
88415,earliest,O,4290
88416,disparities,O,4290
88417,detected,O,4290
88418,between,O,4290
88419,Asian,O,4290
88420,and,O,4290
88421,Caucasian,O,4290
88422,populations,O,4290
88423,being,O,4290
88424,higher,O,4290
88425,degrees,O,4290
88426,of,O,4290
88427,incomplete,B-NAME_OF_DISEASE,4290
88428,blinking,I-NAME_OF_DISEASE,4290
88429,and,O,4290
88430,lid,B-NAME_OF_DISEASE,4290
88431,wiper,I-NAME_OF_DISEASE,4290
88432,epitheliopathy,I-NAME_OF_DISEASE,4290
88433,in,O,4290
88434,pediatric,O,4290
88435,Asian,O,4290
88436,participants,O,4290
88437,likely,O,4291
88438,associated,O,4291
88439,with,O,4291
88440,anatomically,O,4291
88441,predisposed,O,4291
88442,increased,O,4291
88443,eyelid,O,4291
88444,tension,O,4291
88445,Interethnic,O,4291
88446,divergence,O,4291
88447,in,O,4291
88448,meibomian,B-PART_OF_THE_EYES,4291
88449,gland,I-PART_OF_THE_EYES,4291
88450,dropout,I-PART_OF_THE_EYES,4291
88451,in,O,4291
88452,the,O,4291
88453,young,O,4291
88454,adult,O,4291
88455,population,O,4291
88456,follows,O,4291
88457,while,O,4292
88458,other,O,4292
88459,ocular,B-PART_OF_THE_EYES,4292
88460,surface,I-PART_OF_THE_EYES,4292
88461,characteristics,O,4292
88462,remain,O,4292
88463,within,O,4292
88464,physiological,O,4292
88465,limits,O,4292
88466,significant,O,4292
88467,differences,O,4292
88468,in,O,4293
88469,meibomian,B-PART_OF_THE_EYES,4293
88470,gland,I-PART_OF_THE_EYES,4293
88471,function,O,4293
88472,tear,B-PART_OF_THE_EYES,4294
88473,film,I-PART_OF_THE_EYES,4294
88474,stability,O,4294
88475,and,O,4294
88476,osmolarity,O,4294
88477,DED,B-NAME_OF_DISEASE,4294
88478,symptomology,O,4294
88479,and,O,4294
88480,overall,O,4294
88481,disease,O,4294
88482,diagnosis,O,4294
88483,based,O,4294
88484,on,O,4294
88485,TFOS,B-DIAGNOSTIC_TEST,4294
88486,DEWS,I-DIAGNOSTIC_TEST,4294
88487,II,I-DIAGNOSTIC_TEST,4294
88488,criteria,I-DIAGNOSTIC_TEST,4294
88489,do,O,4294
88490,not,O,4294
88491,manifest,O,4294
88492,until,O,4294
88493,the,O,4294
88494,middle,O,4294
88495,adult,O,4294
88496,population,O,4294
88497,and,O,4294
88498,disparities,O,4294
88499,in,O,4294
88500,corneal,O,4294
88501,and,O,4294
88502,conjunctival,O,4294
88503,staining,O,4294
88504,become,O,4295
88505,significant,O,4295
88506,only,O,4295
88507,with,O,4295
88508,older,O,4295
88509,age,O,4295
88510,Aqueous,O,4295
88511,tear,O,4295
88512,deficiency,O,4295
88513,appears,O,4295
88514,less,O,4295
88515,likely,O,4295
88516,than,O,4295
88517,evaporative,O,4295
88518,mechanisms,O,4295
88519,to,O,4295
88520,be,O,4295
88521,implicated,O,4295
88522,in,O,4295
88523,the,O,4295
88524,Asian,O,4295
88525,ethnic,O,4295
88526,propensity,O,4295
88527,towards,O,4295
88528,DED,B-NAME_OF_DISEASE,4295
88529,development,O,4295
88530,Patients,O,4295
88531,who,O,4295
88532,are,O,4295
88533,members,O,4295
88534,of,O,4295
88535,racial,O,4296
88536,and,O,4296
88537,ethnic,O,4296
88538,minority,O,4296
88539,groups,O,4296
88540,present,O,4296
88541,clinically,O,4296
88542,with,O,4296
88543,worse,O,4296
88544,objective,O,4296
88545,measures,O,4296
88546,of,O,4296
88547,dry,B-NAME_OF_DISEASE,4296
88548,eye,I-NAME_OF_DISEASE,4296
88549,than,O,4296
88550,patients,O,4296
88551,who,O,4296
88552,do,O,4296
88553,not,O,4296
88554,belong,O,4296
88555,to,O,4296
88556,these,O,4296
88557,groups,O,4296
88558,according,O,4296
88559,to,O,4296
88560,poster,O,4296
88561,research,O,4296
88562,presented,O,4296
88563,at,O,4296
88564,the,O,4296
88565,annual,O,4296
88566,meeting,O,4296
88567,of,O,4297
88568,the,B-ORGANIZATION,4297
88569,Association,I-ORGANIZATION,4297
88570,for,I-ORGANIZATION,4297
88571,Research,I-ORGANIZATION,4297
88572,in,I-ORGANIZATION,4297
88573,Vision,I-ORGANIZATION,4297
88574,and,I-ORGANIZATION,4297
88575,Ophthalmology,I-ORGANIZATION,4297
88576,Dry,B-NAME_OF_DISEASE,4297
88577,eye,I-NAME_OF_DISEASE,4297
88578,is,O,4297
88579,a,O,4297
88580,condition,O,4297
88581,that,O,4297
88582,is,O,4297
88583,very,O,4297
88584,prevalent,O,4297
88585,and,O,4297
88586,very,O,4297
88587,expensive,O,4297
88588,to,O,4297
88589,treat,O,4297
88590,said,O,4297
88591,David,B-PERSON,4297
88592,Cui,B-PERSON,4297
88593,a,O,4297
88594,medical,O,4298
88595,student,O,4298
88596,at,O,4298
88597,Penn,B-ORGANIZATION,4298
88598,State,I-ORGANIZATION,4298
88599,College,I-ORGANIZATION,4298
88600,of,I-ORGANIZATION,4298
88601,Medicine,I-ORGANIZATION,4298
88602,in,O,4298
88603,Hershey,B-GPE,4298
88604,Pennsylvania,I-GPE,4298
88605,one,O,4298
88606,of,O,4298
88607,the,O,4298
88608,study,O,4298
88609,s,O,4298
88610,investigators,O,4298
88611,and,O,4298
88612,a,O,4298
88613,research,O,4298
88614,assistant,O,4298
88615,at,O,4298
88616,Johns,B-ORGANIZATION,4298
88617,Hopkins,I-ORGANIZATION,4298
88618,University,I-ORGANIZATION,4298
88619,School,I-ORGANIZATION,4298
88620,of,I-ORGANIZATION,4298
88621,Medicine,I-ORGANIZATION,4298
88622,in,O,4298
88623,Baltimore,B-GPE,4298
88624,Maryland,I-GPE,4298
88625,Cui,B-PERSON,4298
88626,noted,O,4298
88627,that,O,4298
88628,estimates,O,4298
88629,of,O,4299
88630,global,O,4299
88631,prevalence,O,4299
88632,for,O,4299
88633,dry,B-NAME_OF_DISEASE,4299
88634,eye,I-NAME_OF_DISEASE,4299
88635,range,O,4299
88636,from,O,4299
88637,5%,O,4299
88638,to,O,4299
88639,50%,O,4299
88640,and,O,4299
88641,the,O,4299
88642,disease,O,4299
88643,is,O,4299
88644,a,O,4299
88645,leading,O,4299
88646,cause,O,4299
88647,for,O,4299
88648,patient,O,4299
88649,visits,O,4299
88650,to,O,4299
88651,an,O,4299
88652,eye,O,4300
88653,care,O,4300
88654,clinician,O,4300
88655,In,O,4300
88656,the,B-GPE,4300
88657,United,I-GPE,4300
88658,States,I-GPE,4300
88659,the,O,4300
88660,estimated,O,4300
88661,price,O,4300
88662,tag,O,4300
88663,associated,O,4300
88664,with,O,4300
88665,dry,B-NAME_OF_DISEASE,4300
88666,eye,I-NAME_OF_DISEASE,4300
88667,disease,I-NAME_OF_DISEASE,4300
88668,treatment,O,4300
88669,is,O,4300
88670,3,O,4300
88671,billion,O,4301
88672,annually,O,4301
88673,representing,O,4301
88674,a,O,4301
88675,substantial,O,4301
88676,stress,O,4301
88677,on,O,4301
88678,the,O,4301
88679,country,O,4301
88680,s,O,4301
88681,health,O,4301
88682,care,O,4301
88683,system,O,4302
88684,said,O,4302
88685,Cui,B-PERSON,4302
88686,Cui,B-PERSON,4302
88687,noted,O,4302
88688,the,O,4302
88689,need,O,4302
88690,to,O,4302
88691,look,O,4302
88692,at,O,4302
88693,the,O,4302
88694,topic,O,4302
88695,of,O,4302
88696,race,O,4302
88697,whether,O,4302
88698,it,O,4302
88699,influences,O,4302
88700,access,O,4303
88701,to,O,4303
88702,dry,B-NAME_OF_DISEASE,4303
88703,eye,I-NAME_OF_DISEASE,4303
88704,care,O,4303
88705,and,O,4303
88706,whether,O,4303
88707,patients,O,4303
88708,have,O,4303
88709,greater,O,4303
88710,dry,B-NAME_OF_DISEASE,4303
88711,eye,I-NAME_OF_DISEASE,4303
88712,severity,O,4303
88713,pointing,O,4303
88714,out,O,4303
88715,that,O,4303
88716,no,O,4303
88717,published,O,4303
88718,literature,O,4303
88719,on,O,4303
88720,disparities,O,4304
88721,regarding,O,4304
88722,race,O,4304
88723,ethnicity,O,4304
88724,and,O,4304
88725,dry,B-NAME_OF_DISEASE,4304
88726,eye,I-NAME_OF_DISEASE,4304
88727,patients,O,4304
88728,exists,O,4304
88729,He,O,4304
88730,added,O,4304
88731,that,O,4304
88732,existing,O,4304
88733,literature,O,4304
88734,on,O,4304
88735,dry,B-NAME_OF_DISEASE,4304
88736,eye,I-NAME_OF_DISEASE,4305
88737,and,O,4305
88738,racial,O,4305
88739,minority,O,4305
88740,groups,O,4305
88741,is,O,4305
88742,limited,O,4305
88743,to,O,4305
88744,patients,O,4305
88745,in,O,4305
88746,Asia,B-GPE,4305
88747,and,O,4305
88748,that,O,4305
88749,research,O,4305
88750,demonstrates,O,4305
88751,that,O,4305
88752,these,O,4305
88753,patients,O,4306
88754,have,O,4306
88755,a,O,4306
88756,greater,O,4306
88757,prevalence,O,4306
88758,with,O,4306
88759,potentially,O,4306
88760,increased,O,4306
88761,severity,O,4306
88762,The,O,4306
88763,retrospective,O,4306
88764,investigation,O,4306
88765,involved,O,4306
88766,review,O,4306
88767,of,O,4306
88768,electronic,O,4306
88769,health,O,4306
88770,records,O,4306
88771,of,O,4306
88772,patients,O,4307
88773,who,O,4307
88774,were,O,4307
88775,treated,O,4307
88776,at,O,4307
88777,a,O,4307
88778,single,O,4307
88779,center,O,4307
88780,by,O,4307
88781,a,O,4307
88782,single,O,4307
88783,ophthalmologist,O,4307
88784,Esen,B-PERSON,4307
88785,Karamursel,I-PERSON,4307
88786,Akpek,I-PERSON,4307
88787,MD,I-PERSON,4307
88788,the,O,4307
88789,Bendann,O,4307
88790,Family,O,4307
88791,Professor,O,4308
88792,of,O,4308
88793,Ophthalmology,O,4308
88794,and,O,4308
88795,founder,O,4308
88796,of,O,4308
88797,the,B-ORGANIZATION,4308
88798,Ocular,I-ORGANIZATION,4308
88799,Surface,I-ORGANIZATION,4308
88800,Disease,I-ORGANIZATION,4308
88801,Clinic,I-ORGANIZATION,4308
88802,at,I-ORGANIZATION,4308
88803,the,I-ORGANIZATION,4308
88804,Wilmer,I-ORGANIZATION,4308
88805,Eye,I-ORGANIZATION,4308
88806,Institute,I-ORGANIZATION,4308
88807,Johns,B-ORGANIZATION,4308
88808,Hopkins,I-ORGANIZATION,4308
88809,University,I-ORGANIZATION,4308
88810,School,I-ORGANIZATION,4308
88811,of,I-ORGANIZATION,4308
88812,Medicine,I-ORGANIZATION,4308
88813,Baltimore,B-GPE,4308
88814,Maryland,I-GPE,4309
88815,noted,O,4309
88816,Cui,B-PERSON,4309
88817,Investigators,O,4309
88818,excluded,O,4309
88819,patients,O,4309
88820,whose,O,4309
88821,dry,B-NAME_OF_DISEASE,4309
88822,eye,I-NAME_OF_DISEASE,4309
88823,was,O,4309
88824,secondary,O,4309
88825,to,O,4309
88826,another,O,4309
88827,ocular,O,4309
88828,surface,O,4309
88829,disease,O,4309
88830,such,O,4309
88831,as,O,4309
88832,mucous,B-NAME_OF_DISEASE,4309
88833,membrane,I-NAME_OF_DISEASE,4309
88834,pemphigoid,I-NAME_OF_DISEASE,4309
88835,Stevens-Johnson,B-NAME_OF_DISEASE,4309
88836,syndrome,I-NAME_OF_DISEASE,4309
88837,atopic,B-NAME_OF_DISEASE,4309
88838,keratoconjunctivitis,I-NAME_OF_DISEASE,4309
88839,or,O,4309
88840,graft-vs-host,B-NAME_OF_DISEASE,4309
88841,disease,I-NAME_OF_DISEASE,4310
88842,Cui,B-PERSON,4310
88843,and,O,4310
88844,fellow,O,4310
88845,investigators,O,4310
88846,divided,O,4310
88847,patients,O,4310
88848,into,O,4310
88849,four,O,4310
88850,categories,O,4310
88851,Asian,O,4310
88852,Black,O,4310
88853,Hispanic,O,4310
88854,or,O,4310
88855,Latino,O,4310
88856,and,O,4310
88857,White,O,4310
88858,A,O,4310
88859,total,O,4310
88860,of,O,4310
88861,465,O,4310
88862,patients,O,4310
88863,were,O,4310
88864,included,O,4310
88865,157,O,4310
88866,were,O,4310
88867,White,O,4310
88868,157,O,4310
88869,were,O,4310
88870,Black,O,4310
88871,85,O,4310
88872,were,O,4310
88873,Asian,O,4310
88874,and,O,4310
88875,66,O,4310
88876,were,O,4310
88877,Hispanic,O,4310
88878,or,O,4310
88879,Latino,O,4310
88880,Most,O,4311
88881,patients,O,4311
88882,78%,O,4311
88883,were,O,4311
88884,women,O,4311
88885,and,O,4311
88886,the,O,4311
88887,gender,O,4311
88888,of,O,4311
88889,patients,O,4311
88890,was,O,4311
88891,equivalent,O,4311
88892,in,O,4311
88893,all,O,4311
88894,cohorts,O,4311
88895,They,O,4311
88896,used,O,4311
88897,objective,O,4311
88898,dry,B-NAME_OF_DISEASE,4311
88899,eye,I-NAME_OF_DISEASE,4311
88900,measures,O,4311
88901,such,O,4312
88902,as,O,4312
88903,conjunctival,B-DIAGNOSTIC_TEST,4312
88904,staining,I-DIAGNOSTIC_TEST,4312
88905,corneal,B-DIAGNOSTIC_TEST,4312
88906,staining,I-DIAGNOSTIC_TEST,4312
88907,combined,B-DIAGNOSTIC_TEST,4312
88908,ocular,I-DIAGNOSTIC_TEST,4312
88909,surface,I-DIAGNOSTIC_TEST,4312
88910,staining,I-DIAGNOSTIC_TEST,4312
88911,Schirmer,B-DIAGNOSTIC_TEST,4313
88912,s,I-DIAGNOSTIC_TEST,4313
88913,test,I-DIAGNOSTIC_TEST,4313
88914,and,O,4313
88915,tear,B-DIAGNOSTIC_TEST,4313
88916,osmolarity,I-DIAGNOSTIC_TEST,4313
88917,at,O,4313
88918,baseline,O,4313
88919,and,O,4313
88920,at,O,4313
88921,a,O,4313
88922,final,O,4313
88923,visit,O,4313
88924,Investigators,O,4313
88925,found,O,4313
88926,that,O,4313
88927,a,O,4313
88928,larger,O,4313
88929,amount,O,4313
88930,of,O,4313
88931,minority,O,4313
88932,patients,O,4313
88933,were,O,4313
88934,without,O,4313
88935,health,O,4313
88936,insurance,O,4313
88937,or,O,4313
88938,were,O,4313
88939,on,O,4313
88940,Medicaid,O,4313
88941,and,O,4313
88942,that,O,4313
88943,Black,O,4314
88944,and,O,4314
88945,Hispanic,O,4314
88946,patients,O,4314
88947,had,O,4314
88948,a,O,4314
88949,lower,O,4314
88950,estimated,O,4314
88951,median,O,4314
88952,household,O,4314
88953,income,O,4314
88954,compared,O,4314
88955,with,O,4314
88956,White,O,4314
88957,patients,O,4314
88958,Another,O,4314
88959,finding,O,4314
88960,that,O,4314
88961,emerged,O,4314
88962,was,O,4314
88963,that,O,4315
88964,fewer,O,4315
88965,minority,O,4315
88966,patients,O,4315
88967,previously,O,4315
88968,received,O,4315
88969,prescription,O,4315
88970,treatments,O,4315
88971,or,O,4315
88972,procedures,O,4315
88973,At,O,4315
88974,their,O,4315
88975,baseline,O,4315
88976,visit,O,4315
88977,patients,O,4315
88978,from,O,4315
88979,minority,O,4315
88980,groups,O,4315
88981,had,O,4315
88982,worse,O,4315
88983,mean,O,4315
88984,conjunctival,O,4315
88985,and,O,4315
88986,corneal,O,4315
88987,staining,O,4315
88988,scores,O,4315
88989,There,O,4315
88990,were,O,4315
88991,however,O,4315
88992,no,O,4315
88993,statistically,O,4316
88994,significant,O,4316
88995,diff,O,4316
88996,erences,O,4316
88997,noted,O,4316
88998,in,O,4316
88999,objective,O,4316
89000,dry,B-NAME_OF_DISEASE,4316
89001,eye,I-NAME_OF_DISEASE,4316
89002,measures,O,4316
89003,at,O,4316
89004,the,O,4316
89005,final,O,4316
89006,visit,O,4316
89007,for,O,4316
89008,patients,O,4316
89009,with,O,4316
89010,a,O,4316
89011,minimum,O,4316
89012,of,O,4316
89013,18,B-TIME_DURATION,4316
89014,months,I-TIME_DURATION,4316
89015,of,O,4316
89016,follow-up,O,4316
89017,Cui,B-PERSON,4316
89018,drew,O,4316
89019,an,O,4316
89020,analogy,O,4316
89021,between,O,4316
89022,the,O,4316
89023,treatment,O,4316
89024,of,O,4316
89025,dry,B-NAME_OF_DISEASE,4316
89026,eye,I-NAME_OF_DISEASE,4316
89027,disease,I-NAME_OF_DISEASE,4316
89028,often,O,4316
89029,a,O,4316
89030,chronic,O,4316
89031,disease,O,4316
89032,in,O,4316
89033,which,O,4317
89034,the,O,4317
89035,chief,O,4317
89036,symptom,O,4317
89037,is,O,4317
89038,ocular,B-SIGN_AND_SYMPTOM,4317
89039,discomfort,I-SIGN_AND_SYMPTOM,4317
89040,and,O,4317
89041,data,O,4317
89042,on,O,4317
89043,the,O,4317
89044,treatment,O,4317
89045,of,O,4317
89046,chronic,B-SIGN_AND_SYMPTOM,4317
89047,pain,I-SIGN_AND_SYMPTOM,4317
89048,There,O,4317
89049,are,O,4317
89050,a,O,4317
89051,lot,O,4317
89052,of,O,4317
89053,publications,O,4317
89054,that,O,4317
89055,show,O,4317
89056,providers,O,4317
89057,treat,O,4317
89058,people,O,4318
89059,with,O,4318
89060,chronic,B-SIGN_AND_SYMPTOM,4318
89061,pain,I-SIGN_AND_SYMPTOM,4318
89062,differently,O,4318
89063,based,O,4318
89064,on,O,4318
89065,their,O,4318
89066,race,O,4318
89067,and,O,4318
89068,ethnicity,O,4318
89069,he,O,4318
89070,said,O,4318
89071,Patients,O,4318
89072,who,O,4318
89073,are,O,4318
89074,non-White,O,4318
89075,typically,O,4318
89076,will,O,4318
89077,be,O,4318
89078,prescribed,O,4318
89079,less,O,4318
89080,treatment,O,4318
89081,for,O,4318
89082,their,O,4318
89083,pain,O,4319
89084,Moreover,O,4319
89085,Cui,B-PERSON,4319
89086,pointed,O,4319
89087,out,O,4319
89088,that,O,4319
89089,clinicians,O,4319
89090,are,O,4319
89091,less,O,4319
89092,likely,O,4319
89093,to,O,4319
89094,empathize,O,4319
89095,with,O,4319
89096,non-White,O,4319
89097,patients,O,4319
89098,or,O,4319
89099,validate,O,4319
89100,their,O,4319
89101,pain,O,4319
89102,and,O,4319
89103,suffering,O,4319
89104,Because,O,4319
89105,dry,B-NAME_OF_DISEASE,4319
89106,eye,I-NAME_OF_DISEASE,4319
89107,disease,I-NAME_OF_DISEASE,4319
89108,is,O,4319
89109,not,O,4319
89110,a,O,4319
89111,condition,O,4319
89112,that,O,4319
89113,can,O,4319
89114,lead,O,4319
89115,to,O,4319
89116,permanent,B-NAME_OF_DISEASE,4319
89117,vision,I-NAME_OF_DISEASE,4319
89118,loss,I-NAME_OF_DISEASE,4319
89119,if,O,4319
89120,left,O,4319
89121,untreated,O,4320
89122,clinicians,O,4320
89123,may,O,4320
89124,be,O,4320
89125,routinely,O,4320
89126,undertreating,O,4320
89127,the,O,4320
89128,condition,O,4320
89129,despite,O,4320
89130,it,O,4320
89131,having,O,4320
89132,an,O,4320
89133,adverse,O,4320
89134,impact,O,4320
89135,on,O,4320
89136,quality,O,4320
89137,of,O,4320
89138,life,O,4320
89139,Cui,B-PERSON,4320
89140,explained,O,4320
89141,Cui,B-PERSON,4321
89142,and,O,4321
89143,fellow,O,4321
89144,investigators,O,4321
89145,found,O,4321
89146,fewer,O,4321
89147,minority,O,4321
89148,patients,O,4321
89149,received,O,4321
89150,prescription,O,4321
89151,treatments,O,4321
89152,or,O,4321
89153,procedures,O,4321
89154,White,O,4321
89155,patients,O,4321
89156,61.8,O,4321
89157,vs,O,4321
89158,minority,O,4321
89159,patients,O,4321
89160,30.6%-43.9,O,4321
89161,all,O,4321
89162,P,O,4321
89163,≤,O,4321
89164,0.01,O,4321
89165,,O,4321
89166,Medicaid,O,4321
89167,patients,O,4321
89168,are,O,4321
89169,often,O,4321
89170,of,O,4321
89171,low-income,O,4321
89172,status,O,4321
89173,making,O,4321
89174,it,O,4321
89175,diffi,O,4321
89176,cult,O,4321
89177,to,O,4321
89178,access,O,4321
89179,care,O,4321
89180,and,O,4321
89181,these,O,4321
89182,insurances,O,4321
89183,almost,O,4321
89184,never,O,4321
89185,cover,O,4321
89186,dry,B-NAME_OF_DISEASE,4321
89187,eye,I-NAME_OF_DISEASE,4321
89188,treatments,O,4321
89189,he,O,4321
89190,said,O,4321
89191,Cui,B-PERSON,4321
89192,noted,O,4321
89193,the,O,4321
89194,study,O,4321
89195,is,O,4321
89196,limited,O,4321
89197,by,O,4321
89198,the,O,4321
89199,fact,O,4321
89200,that,O,4321
89201,is,O,4321
89202,it,O,4321
89203,retrospective,O,4321
89204,and,O,4321
89205,was,O,4321
89206,conducted,O,4321
89207,at,O,4321
89208,a,O,4321
89209,single,O,4322
89210,center,O,4322
89211,Because,O,4322
89212,of,O,4322
89213,that,O,4322
89214,it,O,4322
89215,is,O,4322
89216,hard,O,4322
89217,to,O,4322
89218,draw,O,4322
89219,causation,O,4322
89220,he,O,4322
89221,said,O,4322
89222,We,O,4322
89223,can,O,4322
89224,draw,O,4322
89225,correlation,O,4322
89226,We,O,4322
89227,see,O,4322
89228,that,O,4323
89229,minority,O,4323
89230,patients,O,4323
89231,do,O,4323
89232,have,O,4323
89233,barriers,O,4323
89234,to,O,4323
89235,care,O,4323
89236,such,O,4323
89237,as,O,4323
89238,having,O,4323
89239,lower,O,4323
89240,household,O,4323
89241,income,O,4323
89242,are,O,4323
89243,more,O,4323
89244,likely,O,4323
89245,to,O,4323
89246,be,O,4323
89247,uninsured,O,4323
89248,or,O,4323
89249,are,O,4323
89250,on,O,4323
89251,Medicaid,O,4323
89252,and,O,4324
89253,have,O,4324
89254,less,O,4324
89255,than,O,4324
89256,full-time,O,4324
89257,employment,O,4324
89258,Cui,B-PERSON,4324
89259,said,O,4324
89260,investigators,O,4324
89261,also,O,4324
89262,see,O,4324
89263,that,O,4324
89264,members,O,4324
89265,of,O,4324
89266,these,O,4324
89267,groups,O,4324
89268,receive,O,4324
89269,less,O,4324
89270,care,O,4324
89271,and,O,4324
89272,present,O,4324
89273,with,O,4324
89274,worse,O,4324
89275,objective,O,4324
89276,dry,B-NAME_OF_DISEASE,4325
89277,eye,I-NAME_OF_DISEASE,4325
89278,parameters,O,4325
89279,but,O,4325
89280,the,O,4325
89281,diff,O,4325
89282,erences,O,4325
89283,disappear,O,4325
89284,after,O,4325
89285,adequate,O,4325
89286,treatment,O,4325
89287,and,O,4325
89288,follow-up,O,4326
89289,Cui,B-PERSON,4326
89290,thanked,O,4326
89291,his,O,4326
89292,mentors,O,4326
89293,for,O,4326
89294,their,O,4326
89295,guidance,O,4326
89296,and,O,4326
89297,noted,O,4326
89298,that,O,4326
89299,this,O,4326
89300,study,O,4326
89301,will,O,4326
89302,serve,O,4326
89303,as,O,4326
89304,a,O,4326
89305,foundation,O,4326
89306,for,O,4326
89307,their,O,4326
89308,team,O,4326
89309,for,O,4326
89310,future,O,4326
89311,studies,O,4326
89312,regarding,O,4326
89313,disparities,O,4326
89314,associated,O,4327
89315,with,O,4327
89316,dry,B-NAME_OF_DISEASE,4327
89317,eye,I-NAME_OF_DISEASE,4327
89318,diagnosis,O,4327
89319,and,O,4327
89320,management,O,4327
89321,Canaloplasty,B-TREATMENT,4327
89322,performed,O,4327
89323,with,O,4327
89324,an,O,4327
89325,ab-interno,B-TREATMENT,4327
89326,approach,O,4327
89327,to,O,4327
89328,Schlemm,B-PART_OF_THE_EYES,4327
89329,s,I-PART_OF_THE_EYES,4327
89330,canal,I-PART_OF_THE_EYES,4328
89331,-,O,4328
89332,is,O,4328
89333,a,O,4328
89334,new,O,4328
89335,MIGS,B-TREATMENT,4328
89336,procedure,I-TREATMENT,4328
89337,that,O,4328
89338,can,O,4328
89339,comprehensively,O,4328
89340,restore,O,4328
89341,the,O,4328
89342,natural,O,4328
89343,outflow,O,4328
89344,pathways,O,4328
89345,in,O,4328
89346,glaucoma,B-NAME_OF_DISEASE,4328
89347,patients,O,4328
89348,Performed,O,4328
89349,via,O,4328
89350,a,O,4328
89351,self-sealing,O,4328
89352,clear,O,4328
89353,corneal,O,4328
89354,incision,O,4328
89355,ABiC,B-TREATMENT,4328
89356,conserves,O,4328
89357,the,O,4328
89358,clinicallyproven,O,4328
89359,benefits,O,4328
89360,of,O,4328
89361,360°,O,4328
89362,viscodilation,O,4328
89363,of,O,4328
89364,Schlemm,B-PART_OF_THE_EYES,4328
89365,s,I-PART_OF_THE_EYES,4328
89366,canal,I-PART_OF_THE_EYES,4328
89367,provided,O,4328
89368,by,O,4328
89369,traditional,O,4329
89370,Canaloplasty,B-TREATMENT,4329
89371,but,O,4329
89372,with,O,4329
89373,the,O,4329
89374,speed,O,4329
89375,and,O,4329
89376,ease,O,4329
89377,of,O,4329
89378,implementation,O,4329
89379,of,O,4329
89380,a,O,4329
89381,MIGS,B-TREATMENT,4329
89382,procedure,I-TREATMENT,4329
89383,Unlike,O,4329
89384,other,O,4329
89385,currently,O,4329
89386,available,O,4329
89387,MIGS,B-TREATMENT,4329
89388,procedures,I-TREATMENT,4329
89389,however,O,4329
89390,ABiC,B-TREATMENT,4329
89391,preserves,O,4329
89392,tissue,O,4330
89393,and,O,4330
89394,does,O,4330
89395,not,O,4330
89396,require,O,4330
89397,the,O,4330
89398,permanent,O,4330
89399,placement,O,4330
89400,of,O,4330
89401,an,O,4330
89402,implant,O,4330
89403,in,O,4330
89404,the,O,4330
89405,eye,O,4330
89406,It,O,4330
89407,has,O,4330
89408,also,O,4330
89409,been,O,4330
89410,shown,O,4330
89411,to,O,4330
89412,be,O,4330
89413,effective,O,4330
89414,as,O,4330
89415,both,O,4330
89416,a,O,4330
89417,standalone,O,4330
89418,procedure,O,4330
89419,and,O,4330
89420,when,O,4330
89421,combined,O,4330
89422,with,O,4330
89423,cataract,B-TREATMENT,4330
89424,surgery,I-TREATMENT,4330
89425,It,O,4330
89426,is,O,4330
89427,also,O,4330
89428,the,O,4330
89429,only,O,4330
89430,MIGS,B-TREATMENT,4330
89431,indicated,O,4330
89432,for,O,4330
89433,use,O,4330
89434,outside,O,4330
89435,cataract,B-TREATMENT,4331
89436,surgery,I-TREATMENT,4331
89437,How,O,4331
89438,the,O,4331
89439,glaucoma,B-NAME_OF_DISEASE,4331
89440,treatment,O,4331
89441,paradigm,O,4331
89442,has,O,4331
89443,shifted,O,4331
89444,from,O,4331
89445,long-term,O,4331
89446,use,O,4331
89447,of,O,4331
89448,topical,O,4331
89449,medications,O,4331
89450,to,O,4331
89451,restoring,B-TREATMENT,4331
89452,natural,I-TREATMENT,4331
89453,outflow,I-TREATMENT,4331
89454,The,O,4332
89455,primary,O,4332
89456,treatment,O,4332
89457,for,O,4332
89458,glaucoma,B-NAME_OF_DISEASE,4332
89459,is,O,4332
89460,to,B-TREATMENT,4332
89461,lower,I-TREATMENT,4332
89462,the,I-TREATMENT,4332
89463,intraocular,I-TREATMENT,4332
89464,pressure,I-TREATMENT,4332
89465,IOP,I-TREATMENT,4332
89466,whether,I-TREATMENT,4332
89467,through,I-TREATMENT,4332
89468,medications,I-TREATMENT,4332
89469,laser,I-TREATMENT,4332
89470,procedures,I-TREATMENT,4332
89471,or,I-TREATMENT,4332
89472,surgical,I-TREATMENT,4332
89473,procedures,I-TREATMENT,4332
89474,Ab,B-TREATMENT,4332
89475,interno,I-TREATMENT,4332
89476,canaloplasty,I-TREATMENT,4332
89477,is,O,4332
89478,a,O,4332
89479,surgical,O,4332
89480,procedure,O,4332
89481,intended,O,4332
89482,to,O,4332
89483,lower,O,4333
89484,the,O,4333
89485,IOP,O,4333
89486,in,O,4333
89487,patients,O,4333
89488,with,O,4333
89489,glaucoma,B-NAME_OF_DISEASE,4333
89490,This,O,4333
89491,surgery,O,4333
89492,involves,O,4333
89493,an,O,4333
89494,internal,O,4333
89495,approach,O,4333
89496,to,O,4333
89497,viscodilation,O,4333
89498,of,O,4333
89499,Schlemm,B-PART_OF_THE_EYES,4333
89500,s,I-PART_OF_THE_EYES,4333
89501,canal,I-PART_OF_THE_EYES,4333
89502,through,O,4334
89503,a,O,4334
89504,clear,O,4334
89505,corneal,O,4334
89506,incision,O,4334
89507,Ab,B-TREATMENT,4334
89508,interno,I-TREATMENT,4334
89509,canaloplasty,I-TREATMENT,4334
89510,is,O,4334
89511,one,O,4334
89512,of,O,4334
89513,a,O,4334
89514,variety,O,4334
89515,of,O,4334
89516,surgical,O,4334
89517,procedures,O,4334
89518,described,O,4334
89519,as,O,4334
89520,minimally,B-TREATMENT,4334
89521,invasive,I-TREATMENT,4334
89522,glaucoma,I-TREATMENT,4334
89523,surgery,I-TREATMENT,4334
89524,MIGS,I-TREATMENT,4334
89525,,O,4334
89526,These,O,4334
89527,surgeries,O,4334
89528,differ,O,4334
89529,from,O,4334
89530,traditional,B-TREATMENT,4334
89531,glaucoma,I-TREATMENT,4334
89532,surgery,I-TREATMENT,4334
89533,in,O,4334
89534,that,O,4334
89535,the,B-PART_OF_THE_EYES,4334
89536,conjunctiva,I-PART_OF_THE_EYES,4334
89537,is,O,4334
89538,not,O,4334
89539,disturbed,O,4334
89540,and,O,4334
89541,no,O,4334
89542,bleb,O,4334
89543,is,O,4334
89544,created,O,4334
89545,In,O,4334
89546,addition,O,4334
89547,efforts,O,4334
89548,are,O,4334
89549,made,O,4334
89550,to,O,4334
89551,improve,O,4334
89552,or,O,4334
89553,rehabilitate,O,4334
89554,the,O,4334
89555,function,O,4335
89556,of,O,4335
89557,the,O,4335
89558,normal,O,4335
89559,outflow,O,4335
89560,pathway,O,4335
89561,rather,O,4335
89562,than,O,4335
89563,creating,O,4335
89564,a,O,4335
89565,new,O,4335
89566,outflow,O,4335
89567,pathway,O,4335
89568,Ab,B-TREATMENT,4335
89569,interno,I-TREATMENT,4335
89570,canaloplasty,I-TREATMENT,4335
89571,is,O,4335
89572,unique,O,4335
89573,amongst,O,4335
89574,MIGS,B-TREATMENT,4335
89575,procedures,I-TREATMENT,4335
89576,in,O,4335
89577,that,O,4335
89578,no,O,4335
89579,devices,O,4335
89580,or,O,4335
89581,hardware,O,4336
89582,are,O,4336
89583,implanted,O,4336
89584,in,O,4336
89585,the,O,4336
89586,eye,O,4336
89587,and,O,4336
89588,no,O,4336
89589,significant,O,4336
89590,amount,O,4336
89591,of,O,4336
89592,tissue,O,4336
89593,damage,O,4336
89594,occurs,O,4336
89595,Many,O,4336
89596,of,O,4336
89597,the,B-TREATMENT,4336
89598,MIGS,I-TREATMENT,4336
89599,procedures,I-TREATMENT,4336
89600,attempt,O,4336
89601,to,O,4336
89602,increase,O,4336
89603,the,O,4336
89604,function,O,4336
89605,of,O,4336
89606,the,O,4336
89607,outflow,O,4336
89608,pathway,O,4336
89609,of,O,4336
89610,the,O,4336
89611,eye,O,4337
89612,by,O,4337
89613,implanting,O,4337
89614,devices,O,4337
89615,into,O,4337
89616,the,B-PART_OF_THE_EYES,4337
89617,trabecular,I-PART_OF_THE_EYES,4337
89618,meshwork,I-PART_OF_THE_EYES,4337
89619,and,O,4337
89620,or,O,4337
89621,Schlemm,B-PART_OF_THE_EYES,4337
89622,s,I-PART_OF_THE_EYES,4337
89623,canal,I-PART_OF_THE_EYES,4337
89624,or,O,4337
89625,by,O,4337
89626,cutting,O,4337
89627,or,O,4337
89628,removing,O,4337
89629,part,O,4337
89630,of,O,4338
89631,the,B-PART_OF_THE_EYES,4338
89632,trabecular,I-PART_OF_THE_EYES,4338
89633,meshwork,I-PART_OF_THE_EYES,4338
89634,Ab,B-TREATMENT,4338
89635,interno,I-TREATMENT,4338
89636,canaloplasty,I-TREATMENT,4338
89637,involves,O,4338
89638,only,O,4338
89639,a,O,4338
89640,small,O,4338
89641,perforation,O,4338
89642,of,O,4338
89643,the,B-PART_OF_THE_EYES,4338
89644,trabecular,I-PART_OF_THE_EYES,4338
89645,meshwork,I-PART_OF_THE_EYES,4338
89646,followed,O,4338
89647,by,O,4338
89648,cannulation,O,4338
89649,and,O,4338
89650,viscodilation,O,4338
89651,of,O,4338
89652,Schlemm,B-PART_OF_THE_EYES,4338
89653,s,I-PART_OF_THE_EYES,4338
89654,canal,I-PART_OF_THE_EYES,4338
89655,The,O,4339
89656,past,O,4339
89657,decade,O,4339
89658,has,O,4339
89659,been,O,4339
89660,very,O,4339
89661,exciting,O,4339
89662,for,O,4339
89663,glaucoma,B-NAME_OF_DISEASE,4339
89664,surgeons,O,4339
89665,The,O,4339
89666,advent,O,4339
89667,of,O,4339
89668,minimally,B-NAME_OF_DISEASE,4339
89669,invasive,I-NAME_OF_DISEASE,4339
89670,glaucoma,I-NAME_OF_DISEASE,4339
89671,surgery,I-NAME_OF_DISEASE,4339
89672,MIGS,I-NAME_OF_DISEASE,4339
89673,has,O,4339
89674,filled,O,4339
89675,the,O,4339
89676,frustrating,O,4339
89677,treatment,O,4339
89678,gap,O,4339
89679,between,O,4339
89680,topical,O,4339
89681,medications,O,4339
89682,and,O,4339
89683,invasive,O,4339
89684,filtration,O,4340
89685,surgery,O,4340
89686,for,O,4340
89687,patients,O,4340
89688,who,O,4340
89689,have,O,4340
89690,uncontrolled,O,4340
89691,intraocular,O,4340
89692,pressure,O,4340
89693,IOP,O,4340
89694,despite,O,4340
89695,topical,O,4340
89696,therapy,O,4340
89697,It,O,4340
89698,is,O,4340
89699,a,O,4340
89700,long-awaited,O,4340
89701,change,O,4340
89702,and,O,4341
89703,one,O,4341
89704,that,O,4341
89705,supports,O,4341
89706,growing,O,4341
89707,awareness,O,4341
89708,of,O,4341
89709,the,O,4341
89710,need,O,4341
89711,to,O,4341
89712,preserve,O,4341
89713,patient,O,4341
89714,qualify,O,4341
89715,of,O,4341
89716,life,O,4341
89717,Although,O,4341
89718,filtration,O,4341
89719,surgery,O,4341
89720,such,O,4341
89721,as,O,4341
89722,trabeculectomy,B-TREATMENT,4341
89723,and,O,4341
89724,aqueous,B-TREATMENT,4341
89725,shunts,I-TREATMENT,4341
89726,is,O,4341
89727,undeniably,O,4342
89728,effective,O,4342
89729,it,O,4342
89730,is,O,4342
89731,invasive,O,4342
89732,and,O,4342
89733,often,O,4342
89734,associated,O,4342
89735,with,O,4342
89736,infections,O,4342
89737,and,O,4342
89738,bleb-related,O,4342
89739,problems,O,4342
89740,that,O,4342
89741,negatively,O,4342
89742,impact,O,4342
89743,patient,O,4342
89744,quality,O,4342
89745,of,O,4342
89746,life,O,4342
89747,In,O,4342
89748,contrast,O,4342
89749,topical,O,4342
89750,medication,O,4343
89751,use,O,4343
89752,may,O,4343
89753,seem,O,4343
89754,innocuous,O,4343
89755,in,O,4343
89756,the,O,4343
89757,short,O,4343
89758,term,O,4343
89759,but,O,4343
89760,because,O,4343
89761,glaucoma,B-NAME_OF_DISEASE,4343
89762,is,O,4343
89763,a,O,4343
89764,chronic,O,4343
89765,disease,O,4343
89766,it,O,4343
89767,is,O,4343
89768,important,O,4343
89769,to,O,4343
89770,consider,O,4343
89771,the,O,4343
89772,consequences,O,4343
89773,of,O,4343
89774,long-term,O,4343
89775,exposure,O,4343
89776,that,O,4343
89777,can,O,4343
89778,lead,O,4343
89779,to,O,4343
89780,a,O,4343
89781,higher,O,4343
89782,risk,O,4343
89783,of,O,4343
89784,ocular,B-PART_OF_THE_EYES,4344
89785,surface,I-PART_OF_THE_EYES,4344
89786,disease,O,4344
89787,For,O,4344
89788,example,O,4344
89789,the,O,4344
89790,damaging,O,4344
89791,effect,O,4344
89792,of,O,4344
89793,benzalkonium,B-NAME_OF_DRUG,4345
89794,chloride,I-NAME_OF_DRUG,4345
89795,BAK,B-NAME_OF_DRUG,4345
89796,the,O,4345
89797,most,O,4345
89798,commonly,O,4345
89799,used,O,4345
89800,preservative,O,4345
89801,in,O,4345
89802,topical,O,4345
89803,glaucoma,B-NAME_OF_DISEASE,4345
89804,medications,O,4345
89805,on,O,4345
89806,trabecular,B-PART_OF_THE_EYES,4345
89807,meshwork,I-PART_OF_THE_EYES,4345
89808,cells,I-PART_OF_THE_EYES,4345
89809,may,O,4345
89810,be,O,4345
89811,underappreciated,O,4345
89812,Exposure,O,4345
89813,to,O,4345
89814,BAK,B-NAME_OF_DRUG,4345
89815,is,O,4345
89816,toxic,O,4345
89817,to,O,4345
89818,trabecular,B-PART_OF_THE_EYES,4345
89819,meshwork,I-PART_OF_THE_EYES,4345
89820,cells,I-PART_OF_THE_EYES,4345
89821,and,O,4345
89822,was,O,4345
89823,found,O,4345
89824,responsible,O,4345
89825,for,O,4345
89826,inducing,O,4345
89827,apoptosis,O,4346
89828,in,O,4346
89829,the,O,4346
89830,endothelial,O,4346
89831,cells,O,4346
89832,and,O,4346
89833,along,O,4346
89834,the,O,4346
89835,trabecular,O,4346
89836,columns,O,4346
89837,The,O,4346
89838,deterioration,O,4346
89839,of,O,4346
89840,the,B-PART_OF_THE_EYES,4346
89841,trabecular,I-PART_OF_THE_EYES,4346
89842,cells,I-PART_OF_THE_EYES,4346
89843,might,O,4346
89844,cause,O,4346
89845,major,O,4346
89846,changes,O,4346
89847,including,O,4346
89848,fusion,O,4346
89849,of,O,4346
89850,the,B-PART_OF_THE_EYES,4346
89851,trabecular,I-PART_OF_THE_EYES,4346
89852,meshwork,I-PART_OF_THE_EYES,4346
89853,with,O,4347
89854,collapse,O,4347
89855,of,O,4347
89856,Schlemm,B-PART_OF_THE_EYES,4347
89857,s,I-PART_OF_THE_EYES,4347
89858,canal,I-PART_OF_THE_EYES,4347
89859,and,O,4347
89860,obstruction,O,4347
89861,of,O,4347
89862,the,B-PART_OF_THE_EYES,4347
89863,collector,I-PART_OF_THE_EYES,4347
89864,channels,I-PART_OF_THE_EYES,4347
89865,compromising,O,4347
89866,the,O,4347
89867,natural,O,4347
89868,outflow,O,4347
89869,and,O,4347
89870,the,O,4348
89871,viability,O,4348
89872,of,O,4348
89873,other,O,4348
89874,treatments,O,4348
89875,Ultimately,O,4348
89876,glaucoma,B-NAME_OF_DISEASE,4348
89877,patients,O,4348
89878,often,O,4348
89879,fail,O,4348
89880,to,O,4348
89881,adhere,O,4348
89882,to,O,4348
89883,topical,O,4348
89884,treatment,O,4348
89885,as,O,4348
89886,advised,O,4348
89887,leading,O,4348
89888,to,O,4348
89889,optic,B-PART_OF_THE_EYES,4348
89890,nerve,I-PART_OF_THE_EYES,4348
89891,damage,O,4348
89892,and,O,4348
89893,disease,O,4348
89894,progression,O,4348
89895,Bearing,O,4348
89896,in,O,4348
89897,mind,O,4348
89898,that,O,4348
89899,patients,O,4348
89900,with,O,4348
89901,mild,O,4348
89902,to,O,4348
89903,moderate,O,4348
89904,glaucoma,B-NAME_OF_DISEASE,4348
89905,who,O,4348
89906,are,O,4348
89907,controlled,O,4348
89908,with,O,4348
89909,multiple,O,4348
89910,antiglaucoma,O,4348
89911,therapies,O,4348
89912,may,O,4348
89913,benefit,O,4349
89914,from,O,4349
89915,a,O,4349
89916,reduction,O,4349
89917,in,O,4349
89918,the,O,4349
89919,number,O,4349
89920,of,O,4349
89921,topical,O,4350
89922,medications,O,4350
89923,required,O,4350
89924,to,O,4350
89925,maintain,O,4350
89926,their,O,4350
89927,IOP,O,4350
89928,finding,O,4350
89929,a,O,4350
89930,safer,O,4350
89931,but,O,4350
89932,equally,O,4350
89933,effective,O,4351
89934,way,O,4351
89935,to,B-TREATMENT,4351
89936,lower,I-TREATMENT,4351
89937,IOP,I-TREATMENT,4351
89938,has,O,4351
89939,long,O,4352
89940,been,O,4352
89941,the,O,4352
89942,goal,O,4352
89943,in,O,4352
89944,glaucoma,B-NAME_OF_DISEASE,4352
89945,treatment,O,4352
89946,especially,O,4352
89947,because,O,4352
89948,just,O,4352
89949,a,O,4352
89950,1-mmHg,O,4352
89951,reduction,O,4352
89952,in,O,4352
89953,IOP,O,4353
89954,is,O,4353
89955,associated,O,4353
89956,with,O,4353
89957,an,O,4353
89958,11%,O,4353
89959,decrease,O,4353
89960,in,O,4353
89961,disease,O,4353
89962,progression,O,4353
89963,This,O,4353
89964,is,O,4353
89965,why,O,4353
89966,I,O,4353
89967,was,O,4353
89968,an,O,4353
89969,early,O,4353
89970,adopter,O,4353
89971,of,O,4353
89972,canaloplasty,B-TREATMENT,4353
89973,via,I-TREATMENT,4353
89974,an,I-TREATMENT,4353
89975,ab-externo,I-TREATMENT,4353
89976,approach,I-TREATMENT,4353
89977,as,O,4353
89978,an,O,4353
89979,alternative,O,4354
89980,to,O,4354
89981,trabeculectomy,B-TREATMENT,4354
89982,Indeed,O,4354
89983,its,O,4354
89984,improved,O,4354
89985,safety,O,4354
89986,and,O,4354
89987,efficacy,O,4354
89988,profile,O,4354
89989,as,O,4354
89990,compared,O,4354
89991,to,O,4354
89992,trabeculectomy,B-TREATMENT,4354
89993,is,O,4354
89994,the,O,4354
89995,reason,O,4354
89996,why,O,4354
89997,we,O,4354
89998,continue,O,4354
89999,to,O,4354
90000,use,O,4355
90001,it,O,4355
90002,in,O,4355
90003,advanced,B-NAME_OF_DISEASE,4355
90004,glaucoma,I-NAME_OF_DISEASE,4355
90005,patients,O,4355
90006,More,O,4355
90007,recently,O,4355
90008,inspired,O,4355
90009,by,O,4356
90010,MIGS,B-TREATMENT,4356
90011,a,O,4356
90012,less,O,4356
90013,invasive,O,4356
90014,yet,O,4356
90015,equally,O,4356
90016,effective,O,4356
90017,approach,O,4356
90018,to,O,4356
90019,canaloplasty,B-TREATMENT,4356
90020,was,O,4356
90021,introduced,O,4357
90022,for,O,4357
90023,mild,O,4358
90024,to,O,4358
90025,moderate,O,4358
90026,glaucoma,B-NAME_OF_DISEASE,4358
90027,patients,O,4358
90028,ab-interno,B-TREATMENT,4358
90029,canaloplasty,I-TREATMENT,4358
90030,Ab-interno,B-TREATMENT,4358
90031,canaloplasty,I-TREATMENT,4358
90032,ticks,O,4358
90033,all,O,4358
90034,the,O,4358
90035,boxes,O,4358
90036,of,O,4358
90037,MIGS,B-TREATMENT,4358
90038,but,O,4358
90039,then,O,4358
90040,it,O,4358
90041,excels,O,4358
90042,It,O,4358
90043,uses,O,4358
90044,an,B-TREATMENT,4358
90045,ab-interno,I-TREATMENT,4358
90046,approach,I-TREATMENT,4358
90047,has,O,4358
90048,a,O,4358
90049,high,O,4358
90050,safety,O,4358
90051,profile,O,4358
90052,does,O,4358
90053,not,O,4358
90054,damage,O,4358
90055,eye,O,4358
90056,tissue,O,4358
90057,is,O,4358
90058,effective,O,4358
90059,at,O,4358
90060,lowering,O,4358
90061,IOP,O,4358
90062,and,O,4358
90063,has,O,4358
90064,a,O,4358
90065,rapid,O,4358
90066,recovery,O,4358
90067,time,O,4358
90068,Importantly,O,4358
90069,it,O,4358
90070,addresses,O,4358
90071,and,O,4358
90072,treats,O,4358
90073,both,O,4358
90074,the,O,4358
90075,proximal,O,4358
90076,and,O,4358
90077,distal,O,4358
90078,portions,O,4358
90079,of,O,4358
90080,the,O,4358
90081,conventional,O,4358
90082,outflow,O,4358
90083,pathway,O,4358
90084,Most,O,4358
90085,types,O,4358
90086,of,O,4358
90087,MIGS,B-TREATMENT,4358
90088,are,O,4358
90089,focal,O,4358
90090,in,O,4358
90091,their,O,4358
90092,approach,O,4358
90093,and,O,4358
90094,aim,O,4358
90095,to,O,4358
90096,improve,O,4358
90097,outflow,O,4358
90098,facility,O,4358
90099,using,O,4358
90100,an,O,4358
90101,implant,O,4358
90102,to,O,4358
90103,bypass,O,4358
90104,the,B-PART_OF_THE_EYES,4359
90105,trabecular,I-PART_OF_THE_EYES,4359
90106,meshwork,I-PART_OF_THE_EYES,4359
90107,or,O,4359
90108,to,O,4359
90109,increase,O,4359
90110,drainage,O,4359
90111,via,O,4359
90112,the,O,4359
90113,subconjunctival,O,4359
90114,or,O,4359
90115,suprachoroidal,O,4359
90116,space,O,4359
90117,but,O,4359
90118,this,O,4359
90119,can,O,4359
90120,lead,O,4359
90121,to,O,4359
90122,complications,O,4359
90123,More,O,4359
90124,importantly,O,4359
90125,however,O,4359
90126,they,O,4359
90127,fail,O,4359
90128,to,O,4359
90129,address,O,4359
90130,that,O,4359
90131,glaucoma,B-NAME_OF_DISEASE,4359
90132,is,O,4359
90133,associated,O,4359
90134,with,O,4360
90135,a,O,4360
90136,pathophysiology,O,4360
90137,of,O,4360
90138,the,O,4360
90139,entire,O,4360
90140,outflow,O,4360
90141,system,O,4360
90142,both,O,4360
90143,proximal,O,4360
90144,and,O,4360
90145,distal,O,4360
90146,In,O,4360
90147,contrast,O,4360
90148,ab-interno,B-TREATMENT,4360
90149,canaloplasty,I-TREATMENT,4360
90150,employs,O,4360
90151,a,O,4360
90152,comprehensive,O,4360
90153,approach,O,4360
90154,designed,O,4360
90155,to,O,4360
90156,restore,O,4360
90157,the,O,4360
90158,natural,O,4360
90159,outflow,O,4360
90160,of,O,4360
90161,the,O,4360
90162,eye,O,4360
90163,by,O,4360
90164,targeting,O,4361
90165,all,O,4361
90166,sites,O,4361
90167,of,O,4361
90168,resistance,O,4361
90169,in,O,4361
90170,both,O,4361
90171,the,O,4361
90172,proximal,O,4361
90173,and,O,4361
90174,distal,O,4361
90175,outflow,O,4361
90176,pathways,O,4361
90177,such,O,4361
90178,as,O,4361
90179,Schlemm,B-PART_OF_THE_EYES,4361
90180,s,I-PART_OF_THE_EYES,4361
90181,canal,I-PART_OF_THE_EYES,4361
90182,the,B-PART_OF_THE_EYES,4361
90183,trabecular,I-PART_OF_THE_EYES,4361
90184,meshwork,I-PART_OF_THE_EYES,4361
90185,and,O,4361
90186,occluded,O,4361
90187,collector,B-PART_OF_THE_EYES,4361
90188,channels,I-PART_OF_THE_EYES,4361
90189,And,O,4362
90190,it,O,4362
90191,does,O,4362
90192,it,O,4362
90193,atraumatically,O,4362
90194,sparing,O,4362
90195,the,B-PART_OF_THE_EYES,4362
90196,conjunctiva,I-PART_OF_THE_EYES,4362
90197,from,O,4362
90198,manipulation,O,4362
90199,and,O,4362
90200,allowing,O,4362
90201,future,O,4363
90202,procedures,O,4363
90203,to,O,4364
90204,be,O,4364
90205,performed,O,4364
90206,if,O,4364
90207,necessary,O,4364
90208,The,O,4364
90209,Surgical,O,4364
90210,Procedure,O,4364
90211,In,O,4365
90212,my,O,4365
90213,practice,O,4366
90214,we,O,4366
90215,have,O,4366
90216,been,O,4366
90217,using,O,4366
90218,the,B-SURGICAL_INSTRUMENT,4366
90219,iTrack,I-SURGICAL_INSTRUMENT,4366
90220,canaloplasty,I-SURGICAL_INSTRUMENT,4366
90221,microcatheter,I-SURGICAL_INSTRUMENT,4367
90222,Nova,B-ORGANIZATION,4367
90223,Eye,I-ORGANIZATION,4367
90224,Medical,I-ORGANIZATION,4367
90225,for,O,4367
90226,more,O,4367
90227,than,O,4367
90228,a,O,4367
90229,decade,O,4367
90230,with,O,4367
90231,excellent,O,4367
90232,results,O,4367
90233,and,O,4367
90234,no,O,4367
90235,significant,O,4367
90236,complications,O,4367
90237,During,O,4367
90238,the,B-TREATMENT,4367
90239,ab-interno,I-TREATMENT,4367
90240,procedure,I-TREATMENT,4367
90241,the,B-SURGICAL_INSTRUMENT,4367
90242,iTrack,I-SURGICAL_INSTRUMENT,4367
90243,canaloplasty,I-SURGICAL_INSTRUMENT,4367
90244,microcatheter,I-SURGICAL_INSTRUMENT,4367
90245,is,O,4367
90246,inserted,O,4367
90247,via,O,4367
90248,a,O,4367
90249,clear,O,4367
90250,corneal,O,4367
90251,incision,O,4367
90252,into,O,4367
90253,Schlemm,B-PART_OF_THE_EYES,4367
90254,s,I-PART_OF_THE_EYES,4367
90255,canal,I-PART_OF_THE_EYES,4367
90256,The,B-SURGICAL_INSTRUMENT,4367
90257,microcatheter,I-SURGICAL_INSTRUMENT,4367
90258,has,O,4367
90259,an,O,4368
90260,LED,O,4368
90261,light,O,4368
90262,at,O,4368
90263,its,O,4368
90264,tip,O,4368
90265,which,O,4368
90266,allows,O,4368
90267,the,O,4368
90268,surgeon,O,4368
90269,to,O,4368
90270,know,O,4368
90271,exactly,O,4368
90272,where,O,4368
90273,it,O,4368
90274,is,O,4368
90275,going,O,4368
90276,and,O,4368
90277,feel,O,4368
90278,confident,O,4368
90279,that,O,4368
90280,it,O,4368
90281,is,O,4368
90282,in,O,4368
90283,the,O,4368
90284,right,O,4368
90285,position,O,4368
90286,while,O,4368
90287,passing,O,4368
90288,through,O,4369
90289,the,O,4369
90290,full,O,4369
90291,length,O,4369
90292,of,O,4369
90293,Schlemm,B-PART_OF_THE_EYES,4369
90294,s,I-PART_OF_THE_EYES,4369
90295,canal,I-PART_OF_THE_EYES,4369
90296,breaking,O,4369
90297,adhesions,O,4369
90298,and,O,4369
90299,separating,O,4369
90300,herniations,O,4369
90301,of,O,4369
90302,the,O,4369
90303,inner,O,4369
90304,wall,O,4369
90305,of,O,4369
90306,the,B-PART_OF_THE_EYES,4369
90307,trabecular,I-PART_OF_THE_EYES,4369
90308,meshwork,I-PART_OF_THE_EYES,4369
90309,Once,O,4369
90310,the,O,4369
90311,device,O,4369
90312,has,O,4369
90313,circumnavigated,O,4369
90314,all,O,4369
90315,360°,O,4369
90316,of,O,4369
90317,Schlemm,B-PART_OF_THE_EYES,4369
90318,s,I-PART_OF_THE_EYES,4369
90319,canal,I-PART_OF_THE_EYES,4369
90320,the,O,4369
90321,surgeon,O,4369
90322,withdraws,O,4369
90323,it,O,4369
90324,while,O,4370
90325,injecting,O,4370
90326,high-molecular-weight,O,4370
90327,hyaluronic-acid-based,O,4371
90328,ophthalmic,B-SURGICAL_INSTRUMENT,4371
90329,viscosurgical,I-SURGICAL_INSTRUMENT,4371
90330,device,I-SURGICAL_INSTRUMENT,4371
90331,OVD,B-SURGICAL_INSTRUMENT,4371
90332,through,O,4371
90333,the,B-SURGICAL_INSTRUMENT,4371
90334,microcatheter,I-SURGICAL_INSTRUMENT,4371
90335,The,B-SURGICAL_INSTRUMENT,4371
90336,OVD,B-SURGICAL_INSTRUMENT,4371
90337,delivery,O,4371
90338,is,O,4372
90339,not,O,4372
90340,automatic,O,4372
90341,but,O,4372
90342,performed,O,4372
90343,by,O,4372
90344,clicking,O,4372
90345,the,B-SURGICAL_INSTRUMENT,4372
90346,viscoinjector,I-SURGICAL_INSTRUMENT,4372
90347,device,I-SURGICAL_INSTRUMENT,4372
90348,and,O,4372
90349,counting,O,4372
90350,allowing,O,4372
90351,the,O,4372
90352,surgeon,O,4372
90353,to,O,4372
90354,precisely,O,4372
90355,control,O,4372
90356,the,O,4372
90357,amount,O,4372
90358,of,O,4372
90359,OVD,B-SURGICAL_INSTRUMENT,4373
90360,used,O,4373
90361,to,O,4373
90362,dilate,O,4373
90363,the,O,4373
90364,canal,O,4373
90365,The,O,4373
90366,speed,O,4373
90367,of,O,4373
90368,withdrawal,O,4373
90369,of,O,4373
90370,the,B-SURGICAL_INSTRUMENT,4373
90371,iTrack,I-SURGICAL_INSTRUMENT,4373
90372,microcatheter,I-SURGICAL_INSTRUMENT,4373
90373,can,O,4373
90374,also,O,4373
90375,be,O,4373
90376,adjusted,O,4374
90377,to,O,4374
90378,impact,O,4374
90379,the,O,4374
90380,volume,O,4374
90381,of,O,4374
90382,OVD,B-SURGICAL_INSTRUMENT,4374
90383,delivered,O,4374
90384,Pressurized,O,4374
90385,OVD,B-SURGICAL_INSTRUMENT,4374
90386,delivery,O,4374
90387,with,O,4374
90388,the,B-SURGICAL_INSTRUMENT,4374
90389,iTrack,I-SURGICAL_INSTRUMENT,4374
90390,canaloplasty,I-SURGICAL_INSTRUMENT,4374
90391,microcatheter,I-SURGICAL_INSTRUMENT,4374
90392,has,O,4374
90393,been,O,4374
90394,shown,O,4374
90395,to,O,4374
90396,dilate,O,4374
90397,the,O,4374
90398,full,O,4374
90399,circumference,O,4374
90400,of,O,4374
90401,Schlemm,B-PART_OF_THE_EYES,4374
90402,s,I-PART_OF_THE_EYES,4374
90403,canal,I-PART_OF_THE_EYES,4374
90404,leading,O,4374
90405,to,O,4374
90406,enhanced,O,4374
90407,outflow,O,4374
90408,facility,O,4374
90409,In,O,4374
90410,our,O,4374
90411,experience,O,4374
90412,40,O,4374
90413,clicks,O,4375
90414,on,O,4375
90415,average,O,4375
90416,using,O,4375
90417,Healon,B-SURGICAL_INSTRUMENT,4375
90418,Pro,I-SURGICAL_INSTRUMENT,4375
90419,Johnson,B-ORGANIZATION,4375
90420,Johnson,I-ORGANIZATION,4375
90421,Vision,I-ORGANIZATION,4375
90422,successfully,O,4375
90423,viscodilates,O,4375
90424,the,O,4375
90425,canal,O,4375
90426,over,O,4375
90427,360°,O,4375
90428,but,O,4375
90429,this,O,4375
90430,is,O,4375
90431,dependent,O,4375
90432,on,O,4375
90433,the,O,4376
90434,patency,O,4376
90435,of,O,4376
90436,the,O,4376
90437,canal,O,4376
90438,If,O,4376
90439,I,O,4376
90440,consider,O,4376
90441,the,O,4376
90442,canal,O,4376
90443,to,O,4376
90444,be,O,4376
90445,particularly,O,4376
90446,stenotic,O,4376
90447,or,O,4376
90448,occluded,O,4376
90449,I,O,4376
90450,will,O,4376
90451,deliver,O,4376
90452,50,O,4376
90453,or,O,4376
90454,more,O,4376
90455,clicks,O,4376
90456,One,O,4376
90457,of,O,4376
90458,the,O,4376
90459,benefits,O,4376
90460,of,O,4376
90461,the,B-SURGICAL_INSTRUMENT,4376
90462,iTrack,I-SURGICAL_INSTRUMENT,4376
90463,canaloplasty,I-SURGICAL_INSTRUMENT,4376
90464,microcatheter,I-SURGICAL_INSTRUMENT,4376
90465,is,O,4376
90466,that,O,4376
90467,the,O,4376
90468,surgeon,O,4376
90469,can,O,4376
90470,adjust,O,4376
90471,the,O,4376
90472,amount,O,4376
90473,of,O,4376
90474,OVD,B-SURGICAL_INSTRUMENT,4376
90475,delivered,O,4376
90476,on,O,4376
90477,an,O,4376
90478,individual,O,4376
90479,patient,O,4376
90480,basis,O,4376
90481,It,O,4376
90482,is,O,4376
90483,a,O,4376
90484,procedure,O,4376
90485,designed,O,4376
90486,to,O,4376
90487,leave,O,4376
90488,no,O,4376
90489,implant,O,4376
90490,or,O,4376
90491,tensioning,O,4376
90492,suture,O,4376
90493,in,O,4376
90494,place,O,4376
90495,therefore,O,4376
90496,allowing,O,4376
90497,the,O,4376
90498,eye,O,4376
90499,to,O,4376
90500,re-establish,O,4376
90501,its,O,4376
90502,natural,O,4376
90503,functions,O,4376
90504,The,O,4377
90505,noninvasive,O,4377
90506,approach,O,4377
90507,also,O,4377
90508,avoids,O,4377
90509,damage,O,4377
90510,to,O,4377
90511,delicate,O,4377
90512,ocular,B-PART_OF_THE_EYES,4377
90513,tissue,I-PART_OF_THE_EYES,4377
90514,which,O,4377
90515,is,O,4377
90516,one,O,4377
90517,of,O,4377
90518,the,O,4377
90519,reasons,O,4377
90520,why,O,4377
90521,the,O,4377
90522,intraoperative,O,4377
90523,and,O,4377
90524,postsurgical,O,4377
90525,complications,O,4377
90526,rate,O,4377
90527,in,O,4377
90528,my,O,4377
90529,practice,O,4377
90530,and,O,4377
90531,in,O,4377
90532,the,O,4377
90533,published,O,4377
90534,literature,O,4377
90535,is,O,4377
90536,so,O,4377
90537,low,O,4377
90538,To,O,4377
90539,date,O,4377
90540,no,O,4377
90541,serious,O,4377
90542,adverse,O,4377
90543,events,O,4377
90544,have,O,4377
90545,been,O,4377
90546,recorded,O,4377
90547,Intraoperative,O,4377
90548,bleeding,O,4378
90549,at,O,4378
90550,the,O,4378
90551,goniotomy,B-TREATMENT,4378
90552,site,O,4378
90553,postoperative,O,4378
90554,IOP,O,4378
90555,elevation,O,4378
90556,and,O,4378
90557,postoperative,O,4378
90558,microhyphema,O,4378
90559,development,O,4378
90560,are,O,4378
90561,the,O,4378
90562,only,O,4378
90563,notable,O,4378
90564,side,O,4378
90565,effects,O,4378
90566,associated,O,4378
90567,with,O,4378
90568,ab-interno,B-TREATMENT,4378
90569,canaloplasty,I-TREATMENT,4378
90570,but,O,4378
90571,these,O,4378
90572,usually,O,4378
90573,resolve,O,4378
90574,within,B-TIME_DURATION,4378
90575,1,I-TIME_DURATION,4378
90576,week,I-TIME_DURATION,4378
90577,postoperatively,O,4378
90578,and,O,4378
90579,without,O,4378
90580,sequelae,O,4378
90581,Reducing,O,4378
90582,Patient,O,4378
90583,Reliance,O,4379
90584,on,O,4379
90585,Glaucoma,B-NAME_OF_DISEASE,4379
90586,Medications,O,4379
90587,As,O,4379
90588,noted,O,4379
90589,earlier,O,4379
90590,reducing,O,4379
90591,the,O,4379
90592,burden,O,4379
90593,of,O,4379
90594,glaucoma,B-NAME_OF_DISEASE,4379
90595,medications,O,4379
90596,can,O,4379
90597,contribute,O,4379
90598,significantly,O,4379
90599,to,O,4379
90600,improved,O,4379
90601,quality,O,4379
90602,of,O,4379
90603,life,O,4379
90604,for,O,4379
90605,glaucoma,B-NAME_OF_DISEASE,4379
90606,patients,O,4380
90607,In,O,4380
90608,a,O,4380
90609,consecutive,O,4380
90610,case,O,4380
90611,series,O,4380
90612,at,O,4380
90613,our,O,4380
90614,eye,O,4380
90615,center,O,4380
90616,Dean,B-ORGANIZATION,4380
90617,McGee,I-ORGANIZATION,4380
90618,Eye,I-ORGANIZATION,4380
90619,Institute,I-ORGANIZATION,4380
90620,University,B-ORGANIZATION,4380
90621,of,I-ORGANIZATION,4380
90622,Oklahoma,I-ORGANIZATION,4380
90623,M.A,O,4380
90624,Khaimi,O,4380
90625,MD,O,4381
90626,unpublished,O,4381
90627,data,O,4381
90628,2020,O,4381
90629,we,O,4381
90630,assessed,O,4381
90631,the,O,4381
90632,ability,O,4381
90633,of,O,4381
90634,ab-interno,B-TREATMENT,4381
90635,canaloplasty,I-TREATMENT,4381
90636,to,O,4381
90637,reduce,O,4381
90638,the,O,4381
90639,mean,O,4382
90640,number,O,4382
90641,of,O,4382
90642,medications,O,4382
90643,required,O,4382
90644,to,O,4382
90645,maintain,O,4382
90646,IOP,O,4382
90647,below,O,4382
90648,18,O,4382
90649,mmHg,O,4382
90650,in,O,4382
90651,a,O,4383
90652,cohort,O,4383
90653,of,O,4383
90654,45,O,4383
90655,eyes,O,4383
90656,of,O,4383
90657,35,O,4383
90658,patients,O,4383
90659,mean,O,4383
90660,age,O,4383
90661,of,O,4383
90662,73,O,4383
90663,years,O,4383
90664,with,O,4383
90665,controlled,O,4383
90666,glaucoma,B-NAME_OF_DISEASE,4383
90667,The,O,4383
90668,baseline,O,4383
90669,mean,O,4383
90670,number,O,4383
90671,of,O,4383
90672,medications,O,4383
90673,was,O,4383
90674,1.89±0.93,O,4383
90675,At,O,4383
90676,36,B-TIME_DURATION,4383
90677,months,I-TIME_DURATION,4383
90678,postoperatively,O,4383
90679,the,O,4383
90680,mean,O,4383
90681,number,O,4383
90682,of,O,4383
90683,medications,O,4383
90684,fell,O,4383
90685,to,O,4384
90686,0.60±0.8,O,4384
90687,-,O,4384
90688,a,O,4384
90689,61%,O,4384
90690,reduction,O,4384
90691,from,O,4384
90692,baseline,O,4384
90693,Even,O,4384
90694,more,O,4384
90695,encouraging,O,4384
90696,was,O,4384
90697,that,O,4384
90698,56%,O,4384
90699,of,O,4384
90700,eyes,O,4384
90701,were,O,4384
90702,medication,O,4384
90703,free,O,4384
90704,at,O,4384
90705,36,B-TIME_DURATION,4384
90706,months,I-TIME_DURATION,4384
90707,In,O,4385
90708,this,O,4385
90709,cohort,O,4385
90710,11,O,4385
90711,eyes,O,4385
90712,underwent,O,4385
90713,ab-interno,B-TREATMENT,4385
90714,canaloplasty,I-TREATMENT,4385
90715,outside,O,4385
90716,of,O,4385
90717,cataract,B-TREATMENT,4385
90718,surgery,I-TREATMENT,4385
90719,iTrack-alone,I-TREATMENT,4385
90720,while,O,4385
90721,34,O,4385
90722,eyes,O,4385
90723,underwent,O,4385
90724,ab-interno,B-TREATMENT,4386
90725,canaloplasty,I-TREATMENT,4386
90726,in,O,4386
90727,combination,O,4386
90728,with,O,4386
90729,cataract,B-TREATMENT,4386
90730,surgery,I-TREATMENT,4386
90731,iTrack+phaco,I-TREATMENT,4386
90732,,O,4386
90733,At,O,4386
90734,12,B-TIME_DURATION,4386
90735,months,I-TIME_DURATION,4386
90736,and,O,4386
90737,36,B-TIME_DURATION,4386
90738,months,I-TIME_DURATION,4387
90739,there,O,4387
90740,was,O,4387
90741,no,O,4387
90742,significant,O,4387
90743,difference,O,4387
90744,in,O,4387
90745,the,O,4387
90746,percentage,O,4387
90747,reduction,O,4387
90748,in,O,4387
90749,medication,O,4387
90750,use,O,4387
90751,between,O,4387
90752,the,O,4387
90753,groups,O,4388
90754,Mean,O,4388
90755,IOP,O,4388
90756,was,O,4388
90757,within,O,4388
90758,the,O,4388
90759,target,O,4388
90760,at,O,4388
90761,baseline,O,4388
90762,14.42±2.,O,4388
90763,mmHg,O,4388
90764,and,O,4388
90765,remained,O,4388
90766,under,O,4388
90767,control,O,4388
90768,at,O,4388
90769,12,B-TIME_DURATION,4388
90770,24,I-TIME_DURATION,4388
90771,and,I-TIME_DURATION,4388
90772,36,I-TIME_DURATION,4388
90773,months,I-TIME_DURATION,4388
90774,14.19±2.9,O,4388
90775,mmHg,O,4388
90776,,O,4388
90777,Reducing,O,4388
90778,IOP,O,4388
90779,and,O,4388
90780,Medications,O,4388
90781,In,O,4388
90782,addition,O,4388
90783,to,O,4388
90784,those,O,4388
90785,36-month,B-TIME_DURATION,4388
90786,results,O,4389
90787,demonstrating,O,4389
90788,the,O,4389
90789,ability,O,4389
90790,of,O,4389
90791,ab-interno,B-TREATMENT,4389
90792,canaloplasty,I-TREATMENT,4389
90793,to,O,4389
90794,effectively,O,4389
90795,reduce,O,4389
90796,the,O,4389
90797,number,O,4389
90798,of,O,4389
90799,glaucoma,B-NAME_OF_DISEASE,4389
90800,medications,O,4389
90801,required,O,4389
90802,to,O,4389
90803,control,O,4389
90804,IOP,O,4389
90805,results,O,4389
90806,presented,O,4389
90807,at,O,4389
90808,the,O,4389
90809,2020,O,4389
90810,annual,O,4390
90811,meeting,O,4390
90812,of,O,4390
90813,the,B-ORGANIZATION,4390
90814,American,I-ORGANIZATION,4390
90815,Society,I-ORGANIZATION,4390
90816,of,I-ORGANIZATION,4390
90817,Cataract,I-ORGANIZATION,4391
90818,and,I-ORGANIZATION,4391
90819,Refractive,I-ORGANIZATION,4391
90820,Surgery,I-ORGANIZATION,4391
90821,arise,O,4391
90822,from,O,4391
90823,859,O,4391
90824,eyes,O,4391
90825,treated,O,4391
90826,with,O,4391
90827,ab-interno,B-TREATMENT,4391
90828,canaloplasty,I-TREATMENT,4391
90829,at,O,4391
90830,our,O,4391
90831,eye,O,4391
90832,center,O,4392
90833,594,O,4392
90834,eyes,O,4392
90835,in,O,4392
90836,the,O,4392
90837,iTrack+phaco,B-TREATMENT,4392
90838,and,O,4392
90839,275,O,4392
90840,eyes,O,4392
90841,in,O,4392
90842,the,O,4392
90843,iTrack-alone,B-TREATMENT,4392
90844,group,O,4392
90845,and,O,4392
90846,they,O,4392
90847,show,O,4392
90848,a,O,4393
90849,meaningful,O,4393
90850,reduction,O,4393
90851,in,O,4393
90852,IOP,O,4393
90853,and,O,4393
90854,medications,O,4393
90855,in,O,4393
90856,both,O,4393
90857,groups,O,4393
90858,At,O,4393
90859,the,O,4393
90860,24-month,B-TIME_DURATION,4394
90861,follow-up,O,4394
90862,the,O,4394
90863,percentage,O,4394
90864,reduction,O,4394
90865,in,O,4394
90866,IOP,O,4394
90867,among,O,4394
90868,the,O,4394
90869,iTrack+phaco,B-TREATMENT,4394
90870,group,O,4394
90871,remained,O,4394
90872,in,O,4394
90873,line,O,4394
90874,with,O,4394
90875,that,O,4394
90876,of,O,4394
90877,the,O,4394
90878,iTrack-alone,B-TREATMENT,4395
90879,group,O,4395
90880,particularly,O,4395
90881,in,O,4395
90882,patients,O,4395
90883,with,O,4395
90884,a,O,4395
90885,high,O,4395
90886,baseline,O,4395
90887,IOP,O,4395
90888,Specifically,O,4395
90889,at,O,4395
90890,24,B-TIME_DURATION,4395
90891,months,I-TIME_DURATION,4395
90892,patients,O,4395
90893,with,O,4395
90894,a,O,4396
90895,baseline,O,4396
90896,IOP,O,4396
90897,of,O,4396
90898,22,O,4396
90899,mmHg,O,4396
90900,or,O,4396
90901,higher,O,4396
90902,experienced,O,4396
90903,a,O,4396
90904,fall,O,4396
90905,in,O,4396
90906,IOP,O,4396
90907,of,O,4396
90908,34%,O,4396
90909,and,O,4396
90910,39%,O,4397
90911,in,O,4397
90912,the,O,4397
90913,iTrack+phaco,B-TREATMENT,4397
90914,and,O,4397
90915,iTrack-alone,B-TREATMENT,4397
90916,groups,O,4397
90917,respectively,O,4397
90918,And,O,4397
90919,among,O,4397
90920,patients,O,4397
90921,with,O,4397
90922,a,O,4397
90923,baseline,O,4397
90924,IOP,O,4397
90925,of,O,4397
90926,25,O,4397
90927,mmHg,O,4397
90928,or,O,4397
90929,higher,O,4397
90930,IOP,O,4397
90931,fell,O,4397
90932,by,O,4397
90933,38%,O,4397
90934,and,O,4397
90935,39%,O,4398
90936,in,O,4398
90937,the,O,4398
90938,iTrack+phaco,B-TREATMENT,4398
90939,and,O,4398
90940,iTrack-alone,B-TREATMENT,4398
90941,groups,O,4398
90942,respectively,O,4398
90943,At,O,4398
90944,24,B-TIME_DURATION,4398
90945,months,I-TIME_DURATION,4398
90946,the,O,4398
90947,number,O,4398
90948,of,O,4398
90949,medications,O,4399
90950,used,O,4399
90951,had,O,4399
90952,fallen,O,4399
90953,from,O,4399
90954,1,O,4399
90955,and,O,4399
90956,2,O,4399
90957,in,O,4399
90958,the,O,4399
90959,iTrack+phaco,B-TREATMENT,4399
90960,and,O,4399
90961,iTrack-alone,B-TREATMENT,4399
90962,groups,O,4399
90963,to,O,4399
90964,0,O,4399
90965,and,O,4399
90966,1,O,4399
90967,respectively,O,4399
90968,reflecting,O,4399
90969,reductions,O,4399
90970,of,O,4399
90971,approximately,O,4399
90972,59%,O,4399
90973,and,O,4399
90974,43%,O,4400
90975,When,O,4400
90976,stratifying,O,4400
90977,the,O,4400
90978,data,O,4400
90979,to,O,4400
90980,account,O,4400
90981,for,O,4400
90982,baseline,O,4400
90983,IOP,O,4400
90984,there,O,4400
90985,was,O,4400
90986,a,O,4400
90987,reduction,O,4400
90988,of,O,4400
90989,47%,O,4400
90990,and,O,4400
90991,38%,O,4400
90992,at,O,4400
90993,24,B-TIME_DURATION,4400
90994,months,I-TIME_DURATION,4400
90995,in,O,4400
90996,the,O,4400
90997,iTrack+phaco,B-TREATMENT,4400
90998,and,O,4400
90999,iTrack-alone,B-TREATMENT,4400
91000,groups,O,4400
91001,respectively,O,4400
91002,in,O,4401
91003,patients,O,4401
91004,with,O,4401
91005,a,O,4401
91006,baseline,O,4401
91007,IOP,O,4401
91008,of,O,4401
91009,22,O,4401
91010,mmHg,O,4401
91011,or,O,4401
91012,higher,O,4401
91013,In,O,4401
91014,patients,O,4401
91015,with,O,4401
91016,a,O,4401
91017,baseline,O,4401
91018,IOP,O,4401
91019,of,O,4401
91020,25,O,4401
91021,mmHg,O,4401
91022,or,O,4401
91023,higher,O,4401
91024,the,O,4401
91025,number,O,4401
91026,of,O,4401
91027,medications,O,4401
91028,fell,O,4401
91029,by,O,4401
91030,44%,O,4401
91031,and,O,4401
91032,41%,O,4401
91033,in,O,4401
91034,the,O,4402
91035,iTrack+phaco,B-TREATMENT,4402
91036,and,O,4402
91037,iTrack-alone,B-TREATMENT,4402
91038,groups,O,4402
91039,at,O,4402
91040,24,B-TIME_DURATION,4402
91041,months,I-TIME_DURATION,4402
91042,There,O,4402
91043,were,O,4402
91044,few,O,4402
91045,adverse,O,4402
91046,events,O,4402
91047,reported,O,4402
91048,across,O,4402
91049,both,O,4402
91050,treatment,O,4402
91051,groups,O,4402
91052,postoperative,O,4402
91053,IOP,O,4402
91054,elevation,O,4402
91055,≥30,O,4402
91056,mmHg,O,4402
91057,predominantly,O,4403
91058,at,O,4403
91059,1,O,4403
91060,week,O,4403
91061,which,O,4403
91062,resolved,O,4403
91063,spontaneously,O,4403
91064,occurred,O,4403
91065,in,O,4403
91066,8%,O,4403
91067,and,O,4403
91068,10%,O,4403
91069,of,O,4403
91070,eyes,O,4403
91071,in,O,4403
91072,the,O,4403
91073,iTrack+phaco,B-TREATMENT,4403
91074,and,O,4403
91075,iTrack-alone,B-TREATMENT,4403
91076,groups,O,4403
91077,respectively,O,4403
91078,Two,O,4403
91079,eyes,O,4403
91080,0.3,O,4403
91081,in,O,4403
91082,the,O,4403
91083,iTrack+phaco,B-TREATMENT,4403
91084,group,O,4403
91085,required,O,4404
91086,additional,O,4404
91087,surgery,O,4404
91088,to,O,4404
91089,address,O,4404
91090,IOP,O,4404
91091,spikes,O,4404
91092,In,O,4404
91093,total,O,4404
91094,6%,O,4404
91095,of,O,4404
91096,iTrack+phaco,B-TREATMENT,4404
91097,eyes,O,4404
91098,and,O,4404
91099,14%,O,4404
91100,of,O,4404
91101,iTrack-alone,B-TREATMENT,4404
91102,eyes,O,4404
91103,underwent,O,4404
91104,additional,O,4404
91105,surgery,O,4404
91106,to,O,4404
91107,keep,O,4404
91108,IOP,O,4404
91109,under,O,4404
91110,control,O,4404
91111,during,O,4404
91112,follow-up,O,4404
91113,Other,O,4404
91114,minor,O,4405
91115,complications,O,4405
91116,included,O,4405
91117,intraoperative,O,4405
91118,bleeding,O,4405
91119,at,O,4405
91120,the,O,4405
91121,goniotomy,B-TREATMENT,4405
91122,site,O,4405
91123,and,O,4405
91124,microhyphema,O,4405
91125,development,O,4405
91126,but,O,4405
91127,these,O,4405
91128,resolved,O,4405
91129,spontaneously,O,4405
91130,iTrack,B-SURGICAL_INSTRUMENT,4405
91131,and,O,4406
91132,the,O,4406
91133,Evolving,O,4406
91134,Glaucoma,B-NAME_OF_DISEASE,4406
91135,Treatment,O,4406
91136,Algorithm,O,4406
91137,Ab-interno,B-TREATMENT,4406
91138,canaloplasty,I-TREATMENT,4406
91139,represents,O,4406
91140,a,O,4406
91141,highly,O,4406
91142,effective,O,4406
91143,minimally,B-TREATMENT,4406
91144,invasive,I-TREATMENT,4406
91145,glaucoma,B-NAME_OF_DISEASE,4406
91146,treatment,I-TREATMENT,4406
91147,that,O,4406
91148,enables,O,4406
91149,glaucoma,B-NAME_OF_DISEASE,4406
91150,specialists,O,4406
91151,to,O,4406
91152,reduce,O,4407
91153,both,O,4407
91154,medication,O,4407
91155,dependence,O,4407
91156,and,O,4407
91157,IOP,O,4407
91158,-,O,4407
91159,and,O,4407
91160,so,O,4407
91161,to,O,4407
91162,enhance,O,4407
91163,patient,O,4407
91164,quality,O,4407
91165,of,O,4407
91166,life,O,4407
91167,Importantly,O,4407
91168,it,O,4408
91169,also,O,4408
91170,provides,O,4408
91171,surgeons,O,4408
91172,with,O,4408
91173,an,O,4408
91174,opportunity,O,4408
91175,to,O,4408
91176,rethink,O,4408
91177,their,O,4408
91178,use,O,4408
91179,of,O,4408
91180,medications,O,4408
91181,in,O,4408
91182,the,O,4408
91183,management,O,4408
91184,of,O,4408
91185,glaucoma,B-NAME_OF_DISEASE,4408
91186,patients,O,4408
91187,There,O,4408
91188,is,O,4408
91189,a,O,4408
91190,broad,O,4408
91191,consensus,O,4408
91192,that,O,4408
91193,long-term,O,4408
91194,use,O,4408
91195,of,O,4408
91196,topical,O,4408
91197,glaucoma,B-NAME_OF_DISEASE,4408
91198,medications,O,4408
91199,can,O,4408
91200,be,O,4408
91201,linked,O,4408
91202,to,O,4408
91203,ocular,B-PART_OF_THE_EYES,4408
91204,surface,I-PART_OF_THE_EYES,4408
91205,diseases,O,4409
91206,in,O,4409
91207,both,O,4409
91208,the,B-PART_OF_THE_EYES,4409
91209,cornea,I-PART_OF_THE_EYES,4409
91210,and,O,4409
91211,conjunctiva,B-PART_OF_THE_EYES,4409
91212,and,O,4409
91213,based,O,4409
91214,on,O,4409
91215,the,O,4409
91216,excellent,O,4409
91217,clinical,O,4409
91218,results,O,4409
91219,We,O,4409
91220,have,O,4409
91221,achieved,O,4409
91222,with,O,4409
91223,ab-interno,B-TREATMENT,4409
91224,canaloplasty,I-TREATMENT,4409
91225,I,O,4409
91226,am,O,4409
91227,of,O,4409
91228,the,O,4409
91229,opinion,O,4410
91230,that,O,4410
91231,in,O,4410
91232,the,O,4410
91233,treatment,O,4410
91234,of,O,4410
91235,mild-to-moderate,O,4410
91236,glaucoma,B-NAME_OF_DISEASE,4410
91237,topical,O,4410
91238,medications,O,4410
91239,should,O,4410
91240,be,O,4410
91241,avoided,O,4410
91242,or,O,4410
91243,used,O,4410
91244,occasionally,O,4410
91245,as,O,4410
91246,an,O,4410
91247,adjunct,O,4410
91248,between,O,4410
91249,different,O,4410
91250,procedures,O,4410
91251,like,O,4410
91252,selective,B-TREATMENT,4410
91253,laser,I-TREATMENT,4410
91254,trabeculoplasty,I-TREATMENT,4410
91255,or,O,4410
91256,ab-interno,B-TREATMENT,4411
91257,canaloplasty,I-TREATMENT,4411
91258,Based,O,4411
91259,on,O,4411
91260,the,O,4411
91261,results,O,4411
91262,achieved,O,4411
91263,to,O,4411
91264,date,O,4411
91265,the,O,4411
91266,safety,O,4411
91267,profile,O,4411
91268,of,O,4411
91269,ab-interno,B-TREATMENT,4411
91270,canaloplasty,I-TREATMENT,4411
91271,with,O,4411
91272,the,B-SURGICAL_INSTRUMENT,4411
91273,iTrack,I-SURGICAL_INSTRUMENT,4411
91274,microcatheter,I-SURGICAL_INSTRUMENT,4411
91275,and,O,4411
91276,its,O,4411
91277,long-term,O,4411
91278,efficacy,O,4411
91279,make,O,4411
91280,it,O,4411
91281,an,O,4411
91282,excellent,O,4411
91283,option,O,4411
91284,for,O,4411
91285,patients,O,4411
91286,with,O,4412
91287,mild-to-moderate,O,4412
91288,glaucoma,B-NAME_OF_DISEASE,4412
91289,undergoing,O,4412
91290,cataract,B-TREATMENT,4412
91291,surgery,I-TREATMENT,4412
91292,as,O,4412
91293,well,O,4412
91294,as,O,4412
91295,for,O,4412
91296,those,O,4412
91297,who,O,4412
91298,need,O,4412
91299,a,O,4412
91300,standalone,O,4412
91301,procedure,O,4412
91302,Although,O,4412
91303,our,O,4412
91304,24-month,B-TIME_DURATION,4412
91305,and,O,4412
91306,36-month,B-TIME_DURATION,4412
91307,results,O,4412
91308,are,O,4413
91309,promising,O,4413
91310,I,O,4413
91311,am,O,4413
91312,very,O,4413
91313,much,O,4413
91314,looking,O,4413
91315,forward,O,4413
91316,to,O,4413
91317,confirming,O,4413
91318,these,O,4413
91319,data,O,4413
91320,with,O,4413
91321,the,O,4413
91322,prospective,O,4413
91323,randomized,O,4413
91324,multicenter,O,4413
91325,MAGIC,B-NAME_OF_STUDY,4413
91326,study,I-NAME_OF_STUDY,4413
91327,NCT0469453,I-NAME_OF_STUDY,4413
91328,currently,O,4413
91329,involving,O,4413
91330,8,O,4413
91331,surgery,O,4413
91332,centers,O,4413
91333,in,O,4413
91334,the,B-GPE,4413
91335,United,I-GPE,4413
91336,States,I-GPE,4413
91337,In,O,4413
91338,the,O,4413
91339,meantime,O,4413
91340,current,O,4413
91341,evidence,O,4413
91342,suggests,O,4413
91343,that,O,4413
91344,ab-interno,B-TREATMENT,4414
91345,canaloplasty,I-TREATMENT,4414
91346,provides,O,4414
91347,a,O,4414
91348,tissue-preserving,O,4414
91349,implant-free,O,4414
91350,glaucoma,B-NAME_OF_DISEASE,4414
91351,procedure,O,4414
91352,that,O,4414
91353,will,O,4414
91354,greatly,O,4414
91355,benefit,O,4414
91356,patients,O,4414
91357,and,O,4414
91358,surgeons,O,4414
91359,alike,O,4414
91360,Fundamentals,O,4415
91361,of,O,4415
91362,Ultrasonic,O,4415
91363,Phacoemulsification,B-TREATMENT,4415
91364,Power,O,4415
91365,-,O,4415
91366,Phacoemulsification,B-TREATMENT,4415
91367,accomplishes,O,4415
91368,three,O,4415
91369,simultaneous,O,4415
91370,functions,O,4415
91371,through,O,4415
91372,a,O,4415
91373,closed,O,4415
91374,system,O,4415
91375,emulsification,O,4415
91376,aspiration,O,4415
91377,and,O,4415
91378,irrigation,O,4416
91379,It,O,4416
91380,is,O,4416
91381,important,O,4416
91382,to,O,4416
91383,understand,O,4416
91384,each,O,4416
91385,component,O,4416
91386,to,O,4416
91387,perform,O,4416
91388,safe,O,4416
91389,and,O,4417
91390,effective,O,4417
91391,cataract,B-TREATMENT,4417
91392,surgery,I-TREATMENT,4417
91393,The,O,4417
91394,term,O,4417
91395,phaco,O,4417
91396,fluidics,O,4417
91397,describes,O,4417
91398,irrigation,O,4417
91399,inflow,O,4417
91400,and,O,4417
91401,aspiration,O,4417
91402,outflow,O,4418
91403,during,O,4418
91404,phacoemulsification,B-TREATMENT,4418
91405,The,O,4418
91406,goals,O,4418
91407,of,O,4418
91408,phaco,O,4418
91409,fluidics,O,4418
91410,are,O,4418
91411,to,O,4418
91412,have,O,4418
91413,sufficient,O,4418
91414,power,O,4418
91415,to,O,4418
91416,remove,O,4418
91417,emulsified,O,4418
91418,particles,O,4418
91419,maintain,O,4418
91420,the,O,4418
91421,stability,O,4418
91422,of,O,4418
91423,the,B-PART_OF_THE_EYES,4418
91424,anterior,I-PART_OF_THE_EYES,4418
91425,chamber,I-PART_OF_THE_EYES,4418
91426,while,O,4418
91427,removing,O,4418
91428,the,B-NAME_OF_DISEASE,4418
91429,cataract,I-NAME_OF_DISEASE,4418
91430,and,O,4418
91431,minimise,O,4418
91432,heat,O,4418
91433,production,O,4418
91434,by,O,4418
91435,the,B-SURGICAL_INSTRUMENT,4418
91436,oscillating,I-SURGICAL_INSTRUMENT,4418
91437,phaco,I-SURGICAL_INSTRUMENT,4418
91438,needle,I-SURGICAL_INSTRUMENT,4418
91439,The,O,4418
91440,energy,O,4418
91441,sent,O,4418
91442,into,O,4418
91443,the,O,4418
91444,eye,O,4418
91445,by,O,4418
91446,the,B-SURGICAL_INSTRUMENT,4418
91447,phacoemulsification,B-TREATMENT,4418
91448,ultrasonic,I-SURGICAL_INSTRUMENT,4419
91449,probe,I-SURGICAL_INSTRUMENT,4419
91450,is,O,4419
91451,used,O,4419
91452,to,O,4419
91453,fragment,O,4419
91454,the,B-NAME_OF_DISEASE,4419
91455,cataract,I-NAME_OF_DISEASE,4419
91456,and,O,4419
91457,enable,O,4419
91458,emulsification,O,4419
91459,and,O,4419
91460,suction,O,4419
91461,It,O,4419
91462,achieves,O,4419
91463,this,O,4419
91464,by,O,4419
91465,vibrating,O,4419
91466,when,O,4419
91467,the,B-SURGICAL_INSTRUMENT,4420
91468,foot,I-SURGICAL_INSTRUMENT,4420
91469,pedal,I-SURGICAL_INSTRUMENT,4420
91470,is,O,4420
91471,placed,O,4420
91472,into,O,4420
91473,position,O,4420
91474,at,O,4420
91475,a,O,4420
91476,set,O,4420
91477,frequency,O,4420
91478,The,O,4420
91479,device,O,4420
91480,merely,O,4420
91481,lengthens,O,4420
91482,the,B-SURGICAL_INSTRUMENT,4421
91483,probe,I-SURGICAL_INSTRUMENT,4421
91484,s,O,4421
91485,stroke,O,4421
91486,in,O,4421
91487,order,O,4421
91488,to,O,4421
91489,boost,O,4421
91490,ultrasonic,O,4421
91491,power,O,4421
91492,Only,O,4421
91493,the,O,4421
91494,stroke,O,4421
91495,length,O,4421
91496,is,O,4421
91497,affected,O,4421
91498,when,O,4421
91499,the,O,4421
91500,power,O,4421
91501,is,O,4421
91502,changed,O,4421
91503,the,O,4421
91504,frequency,O,4421
91505,is,O,4421
91506,unaffected,O,4421
91507,Power,O,4421
91508,generates,O,4421
91509,heat,O,4421
91510,and,O,4421
91511,may,O,4421
91512,cause,O,4422
91513,flow,O,4422
91514,resistance,O,4422
91515,but,O,4422
91516,using,O,4422
91517,too,O,4422
91518,much,O,4422
91519,of,O,4422
91520,it,O,4422
91521,can,O,4422
91522,cause,O,4422
91523,energy,O,4422
91524,dispersion,O,4422
91525,in,O,4422
91526,the,O,4422
91527,eye,O,4422
91528,which,O,4422
91529,can,O,4422
91530,cause,O,4422
91531,the,B-PART_OF_THE_EYES,4422
91532,anterior,I-PART_OF_THE_EYES,4422
91533,chamber,I-PART_OF_THE_EYES,4422
91534,to,O,4422
91535,release,O,4422
91536,potentially,O,4422
91537,hazardous,O,4422
91538,free,O,4422
91539,radicals,O,4422
91540,Free,O,4422
91541,radical,O,4423
91542,production,O,4423
91543,is,O,4423
91544,time,O,4423
91545,and,O,4423
91546,power,O,4423
91547,related,O,4423
91548,so,O,4423
91549,we,O,4423
91550,need,O,4423
91551,to,O,4423
91552,use,O,4423
91553,as,O,4423
91554,little,O,4423
91555,power,O,4423
91556,as,O,4423
91557,we,O,4423
91558,can,O,4423
91559,for,O,4423
91560,the,O,4423
91561,shortest,O,4423
91562,time,O,4423
91563,possible,O,4423
91564,However,O,4423
91565,too,O,4423
91566,little,O,4424
91567,power,O,4424
91568,stresses,O,4424
91569,the,B-PART_OF_THE_EYES,4424
91570,zonules,I-PART_OF_THE_EYES,4424
91571,Power,O,4424
91572,modulation,O,4424
91573,decreases,O,4424
91574,free,O,4424
91575,radicals,O,4424
91576,endothelial,O,4424
91577,damage,O,4424
91578,and,O,4424
91579,ultrasonic,O,4424
91580,power,O,4424
91581,in,O,4424
91582,the,O,4424
91583,eye,O,4424
91584,during,O,4424
91585,surgery,O,4424
91586,It,O,4424
91587,is,O,4424
91588,possible,O,4424
91589,to,O,4424
91590,switch,O,4424
91591,between,O,4424
91592,unoccluded,O,4424
91593,and,O,4424
91594,occluded,O,4424
91595,pulse,O,4424
91596,modes,O,4424
91597,linear,O,4424
91598,control,O,4424
91599,micropulsing,O,4424
91600,and,O,4424
91601,microbursts,O,4424
91602,Alternative,O,4424
91603,phaco,B-SURGICAL_INSTRUMENT,4425
91604,tip,I-SURGICAL_INSTRUMENT,4425
91605,movements,O,4425
91606,such,O,4425
91607,as,O,4425
91608,torsional,O,4425
91609,and,O,4425
91610,transversal,O,4425
91611,are,O,4425
91612,also,O,4425
91613,useful,O,4425
91614,Traditionally,O,4425
91615,the,B-SURGICAL_INSTRUMENT,4425
91616,probe,I-SURGICAL_INSTRUMENT,4425
91617,delivers,O,4425
91618,power,O,4425
91619,only,O,4425
91620,in,O,4425
91621,a,O,4425
91622,longitudinal,O,4425
91623,manner,O,4425
91624,with,O,4426
91625,the,B-SURGICAL_INSTRUMENT,4426
91626,phaco,I-SURGICAL_INSTRUMENT,4426
91627,needle,I-SURGICAL_INSTRUMENT,4426
91628,moving,O,4426
91629,forward,O,4426
91630,and,O,4426
91631,back,O,4426
91632,Recent,O,4426
91633,innovations,O,4426
91634,in,O,4426
91635,phaco,O,4427
91636,technology,O,4427
91637,also,O,4427
91638,allow,O,4427
91639,for,O,4427
91640,the,O,4427
91641,delivery,O,4427
91642,of,O,4427
91643,power,O,4427
91644,through,O,4427
91645,a,O,4427
91646,lateral,O,4427
91647,motion,O,4427
91648,Delivering,O,4427
91649,ultrasound,O,4427
91650,power,O,4427
91651,through,O,4427
91652,lateral,O,4427
91653,motion,O,4427
91654,can,O,4427
91655,increase,O,4427
91656,cutting,O,4427
91657,efficiency,O,4427
91658,by,O,4427
91659,reducing,O,4427
91660,repulsion,O,4428
91661,of,O,4428
91662,lens,O,4428
91663,material,O,4428
91664,The,O,4428
91665,goal,O,4428
91666,in,O,4428
91667,cataract,B-TREATMENT,4428
91668,surgery,I-TREATMENT,4428
91669,is,O,4429
91670,perfection,O,4429
91671,in,O,4429
91672,nuclear,O,4429
91673,disassembly,O,4429
91674,performed,O,4429
91675,with,O,4429
91676,just,O,4429
91677,the,O,4429
91678,right,O,4429
91679,amount,O,4429
91680,of,O,4429
91681,phaco,O,4429
91682,energy-,O,4429
91683,not,O,4429
91684,too,O,4429
91685,much,O,4429
91686,not,O,4429
91687,too,O,4429
91688,little,O,4429
91689,Excessive,O,4429
91690,ultrasound,O,4429
91691,can,O,4429
91692,result,O,4430
91693,in,O,4430
91694,endothelial,B-SIGN_AND_SYMPTOM,4430
91695,cell,I-SIGN_AND_SYMPTOM,4430
91696,loss,I-SIGN_AND_SYMPTOM,4430
91697,corneal,I-SIGN_AND_SYMPTOM,4430
91698,edema,I-SIGN_AND_SYMPTOM,4430
91699,and,I-SIGN_AND_SYMPTOM,4430
91700,corneal,I-SIGN_AND_SYMPTOM,4430
91701,wound,I-SIGN_AND_SYMPTOM,4430
91702,burn,I-SIGN_AND_SYMPTOM,4430
91703,Too,O,4430
91704,little,O,4430
91705,can,O,4430
91706,result,O,4430
91707,in,O,4431
91708,movement,O,4431
91709,of,O,4431
91710,the,B-PART_OF_THE_EYES,4431
91711,capsular,I-PART_OF_THE_EYES,4431
91712,bag,I-PART_OF_THE_EYES,4431
91713,or,O,4431
91714,zonular,O,4431
91715,stress,O,4431
91716,difficult,O,4431
91717,nuclear,O,4431
91718,disassembly,O,4431
91719,too,O,4431
91720,much,O,4431
91721,irrigation,O,4431
91722,fluid,O,4431
91723,used,O,4432
91724,and,O,4432
91725,long,O,4432
91726,surgical,O,4432
91727,times,O,4432
91728,Transversal,B-TREATMENT,4432
91729,Torsional,I-TREATMENT,4432
91730,Phaco,I-TREATMENT,4432
91731,Traditional,B-TREATMENT,4432
91732,longitudinal,B-TREATMENT,4432
91733,phaco,I-TREATMENT,4432
91734,is,O,4432
91735,a,O,4432
91736,powerful,O,4432
91737,technology,O,4432
91738,to,O,4432
91739,break,O,4432
91740,up,O,4432
91741,very,O,4432
91742,dense,O,4432
91743,nuclei,O,4432
91744,using,O,4432
91745,a,O,4432
91746,back-and,O,4432
91747,forth,O,4432
91748,jackhammer,O,4432
91749,motion,O,4432
91750,but,O,4432
91751,that,O,4432
91752,comes,O,4432
91753,with,O,4432
91754,associated,O,4432
91755,disadvantages,O,4432
91756,As,O,4432
91757,a,O,4432
91758,result,O,4432
91759,of,O,4433
91760,the,O,4433
91761,procedure,O,4433
91762,s,O,4433
91763,lengthy,O,4433
91764,stroke,O,4433
91765,length,O,4433
91766,and,O,4433
91767,high,O,4433
91768,power,O,4433
91769,nuclear,O,4433
91770,fragments,O,4433
91771,may,O,4433
91772,repel,O,4433
91773,at,O,4433
91774,the,B-SURGICAL_INSTRUMENT,4434
91775,phaco,I-SURGICAL_INSTRUMENT,4434
91776,tip,I-SURGICAL_INSTRUMENT,4434
91777,and,O,4434
91778,no,O,4434
91779,cutting,O,4434
91780,may,O,4434
91781,occur,O,4434
91782,during,O,4434
91783,the,O,4434
91784,tip,O,4434
91785,s,O,4434
91786,backward,O,4434
91787,movement,O,4434
91788,It,O,4434
91789,is,O,4434
91790,crucial,O,4434
91791,to,O,4434
91792,limit,O,4434
91793,power,O,4434
91794,settings,O,4435
91795,that,O,4435
91796,result,O,4435
91797,in,O,4435
91798,an,O,4435
91799,excessive,O,4435
91800,buildup,O,4435
91801,of,O,4435
91802,heat,O,4435
91803,because,O,4435
91804,doing,O,4435
91805,so,O,4435
91806,could,O,4435
91807,harm,O,4435
91808,the,B-PART_OF_THE_EYES,4435
91809,ocular,I-PART_OF_THE_EYES,4436
91810,tissues,I-PART_OF_THE_EYES,4436
91811,New,O,4436
91812,adjunctive,O,4436
91813,developments,O,4436
91814,in,O,4436
91815,phaco,B-TREATMENT,4436
91816,technology,I-TREATMENT,4436
91817,can,O,4436
91818,alter,O,4436
91819,the,O,4436
91820,direction,O,4436
91821,by,O,4436
91822,which,O,4436
91823,the,O,4436
91824,power,O,4436
91825,is,O,4436
91826,delivered,O,4436
91827,using,O,4436
91828,lateral,O,4436
91829,and,O,4436
91830,rotational,O,4437
91831,motions,O,4437
91832,referred,O,4437
91833,to,O,4437
91834,as,O,4437
91835,transversal,B-TREATMENT,4437
91836,and,I-TREATMENT,4437
91837,torsional,I-TREATMENT,4437
91838,phaco,I-TREATMENT,4437
91839,In,O,4437
91840,contrast,O,4437
91841,to,O,4437
91842,the,O,4437
91843,jackhammer,O,4437
91844,effect,O,4437
91845,of,O,4437
91846,longitudinal,B-TREATMENT,4437
91847,phaco,I-TREATMENT,4437
91848,a,O,4437
91849,combination,O,4437
91850,approach,O,4437
91851,results,O,4437
91852,in,O,4437
91853,transversal,O,4437
91854,ultrasound,O,4437
91855,that,O,4437
91856,combines,O,4437
91857,simultaneous,O,4437
91858,longitudinal,O,4437
91859,back-and-forth,O,4437
91860,motion,O,4437
91861,with,O,4437
91862,transversal,O,4437
91863,movement,O,4437
91864,in,O,4437
91865,an,O,4437
91866,elliptical,O,4437
91867,fashion,O,4437
91868,This,O,4437
91869,adds,O,4437
91870,to,O,4437
91871,the,O,4437
91872,cutting,O,4437
91873,efficiency,O,4438
91874,because,O,4438
91875,the,O,4438
91876,nuclear,O,4438
91877,material,O,4438
91878,is,O,4438
91879,emulsified,O,4438
91880,in,O,4438
91881,more,O,4438
91882,than,O,4438
91883,one,O,4438
91884,direction,O,4438
91885,In,O,4438
91886,torsional,B-TREATMENT,4438
91887,phaco,I-TREATMENT,4438
91888,the,O,4438
91889,tip,O,4438
91890,oscillates,O,4438
91891,in,O,4438
91892,a,O,4438
91893,rotational,O,4438
91894,manner,O,4438
91895,along,O,4438
91896,its,O,4438
91897,primary,O,4438
91898,axis,O,4438
91899,works,O,4438
91900,best,O,4438
91901,with,O,4438
91902,an,B-SURGICAL_INSTRUMENT,4438
91903,angled,I-SURGICAL_INSTRUMENT,4438
91904,phaco,I-SURGICAL_INSTRUMENT,4438
91905,needle,I-SURGICAL_INSTRUMENT,4438
91906,Using,O,4438
91907,this,O,4438
91908,technology,O,4438
91909,the,O,4438
91910,rotation,O,4438
91911,of,O,4438
91912,the,O,4438
91913,tip,O,4438
91914,provides,O,4438
91915,an,O,4438
91916,additional,O,4438
91917,cutting,O,4438
91918,movement,O,4438
91919,through,O,4438
91920,the,O,4438
91921,nucleus,O,4439
91922,The,O,4439
91923,primary,O,4439
91924,advantage,O,4439
91925,increases,O,4439
91926,energy,O,4439
91927,efficiency,O,4439
91928,with,O,4439
91929,minimal,O,4439
91930,repulsion,O,4439
91931,at,O,4439
91932,the,O,4439
91933,tip,O,4439
91934,the,O,4439
91935,disadvantages,O,4439
91936,are,O,4439
91937,that,O,4439
91938,a,B-SURGICAL_INSTRUMENT,4439
91939,curved,I-SURGICAL_INSTRUMENT,4439
91940,phaco,I-SURGICAL_INSTRUMENT,4439
91941,tip,I-SURGICAL_INSTRUMENT,4439
91942,can,O,4439
91943,be,O,4439
91944,difficult,O,4439
91945,to,O,4439
91946,move,O,4439
91947,through,O,4439
91948,a,O,4439
91949,dense,O,4439
91950,nucleus,O,4439
91951,and,O,4439
91952,there,O,4439
91953,is,O,4439
91954,significant,O,4439
91955,movement,O,4440
91956,of,O,4440
91957,the,O,4440
91958,tip,O,4440
91959,Phaco,B-TREATMENT,4440
91960,Timing,O,4440
91961,The,O,4440
91962,timing,O,4440
91963,of,O,4440
91964,power,O,4440
91965,delivery,O,4440
91966,can,O,4440
91967,be,O,4440
91968,modified,O,4440
91969,to,O,4440
91970,increase,O,4440
91971,phaco,B-TREATMENT,4440
91972,efficiency,O,4440
91973,with,O,4440
91974,the,O,4440
91975,basic,O,4441
91976,settings,O,4441
91977,of,O,4441
91978,continuous,O,4441
91979,pulse,O,4441
91980,and,O,4441
91981,burst,O,4441
91982,power,O,4441
91983,When,O,4441
91984,power,O,4441
91985,is,O,4441
91986,continuous,O,4441
91987,the,O,4441
91988,maximum,O,4441
91989,power,O,4441
91990,delivered,O,4441
91991,is,O,4441
91992,controlled,O,4441
91993,by,O,4441
91994,depressing,O,4441
91995,the,B-SURGICAL_INSTRUMENT,4441
91996,foot,I-SURGICAL_INSTRUMENT,4441
91997,pedal,I-SURGICAL_INSTRUMENT,4441
91998,the,O,4441
91999,power,O,4441
92000,increases,O,4441
92001,with,O,4441
92002,the,O,4441
92003,degree,O,4441
92004,of,O,4441
92005,depression,O,4441
92006,of,O,4441
92007,the,B-SURGICAL_INSTRUMENT,4441
92008,foot,I-SURGICAL_INSTRUMENT,4441
92009,pedal,I-SURGICAL_INSTRUMENT,4441
92010,The,O,4441
92011,amount,O,4441
92012,of,O,4441
92013,power,O,4441
92014,delivered,O,4441
92015,can,O,4441
92016,be,O,4441
92017,limited,O,4441
92018,by,O,4441
92019,using,O,4441
92020,phaco,B-TREATMENT,4441
92021,pulse,O,4441
92022,mode,O,4441
92023,after,O,4441
92024,each,O,4441
92025,pulse,O,4441
92026,is,O,4441
92027,delivered,O,4441
92028,there,O,4441
92029,is,O,4441
92030,a,O,4441
92031,period,O,4441
92032,of,O,4441
92033,time,O,4441
92034,in,O,4441
92035,which,O,4442
92036,no,O,4442
92037,energy,O,4442
92038,is,O,4442
92039,delivered,O,4442
92040,These,O,4442
92041,periods,O,4442
92042,of,O,4442
92043,rest,O,4442
92044,in,O,4442
92045,power,O,4442
92046,delivery,O,4442
92047,allow,O,4442
92048,cooling,O,4442
92049,of,O,4442
92050,the,B-SURGICAL_INSTRUMENT,4442
92051,phaco,B-TREATMENT,4442
92052,needle,I-SURGICAL_INSTRUMENT,4442
92053,and,O,4443
92054,reduce,O,4443
92055,heat,O,4443
92056,and,O,4443
92057,energy,O,4443
92058,delivered,O,4443
92059,to,O,4443
92060,the,O,4443
92061,eye,O,4443
92062,These,O,4443
92063,on-and-off,O,4443
92064,periods,O,4443
92065,are,O,4443
92066,referred,O,4443
92067,to,O,4443
92068,as,O,4443
92069,the,O,4443
92070,duty,O,4443
92071,cycle,O,4443
92072,standard,O,4443
92073,pulse,O,4443
92074,has,O,4444
92075,a,O,4444
92076,50%,O,4444
92077,duty,O,4444
92078,cycle,O,4444
92079,during,O,4444
92080,which,O,4444
92081,the,O,4444
92082,ultrasound,O,4444
92083,is,O,4444
92084,on,O,4444
92085,half,O,4444
92086,of,O,4444
92087,the,O,4444
92088,time,O,4445
92089,no,O,4445
92090,matter,O,4445
92091,how,O,4445
92092,many,O,4445
92093,pulses,O,4445
92094,per,O,4445
92095,second,O,4445
92096,are,O,4445
92097,delivered,O,4445
92098,The,O,4445
92099,duty,O,4445
92100,cycle,O,4445
92101,can,O,4445
92102,be,O,4445
92103,altered,O,4445
92104,to,O,4445
92105,change,O,4445
92106,the,O,4445
92107,ratio,O,4445
92108,of,O,4445
92109,the,O,4445
92110,on,O,4445
92111,and,O,4445
92112,off,O,4445
92113,time,O,4445
92114,For,O,4445
92115,example,O,4445
92116,a,O,4446
92117,20%,O,4446
92118,duty,O,4446
92119,cycle,O,4446
92120,results,O,4446
92121,in,O,4446
92122,20,B-TIME_DURATION,4446
92123,milliseconds,I-TIME_DURATION,4446
92124,on,O,4446
92125,and,O,4447
92126,80,B-TIME_DURATION,4447
92127,milliseconds,I-TIME_DURATION,4447
92128,off,O,4447
92129,during,O,4447
92130,each,O,4447
92131,cycle,O,4447
92132,The,O,4447
92133,long,O,4447
92134,off,O,4447
92135,time,O,4447
92136,allows,O,4447
92137,easy,O,4448
92138,aspiration,O,4448
92139,of,O,4448
92140,the,O,4448
92141,nuclear,O,4448
92142,fragments,O,4448
92143,There,O,4448
92144,may,O,4448
92145,be,O,4448
92146,circumstances,O,4448
92147,where,O,4448
92148,greater,O,4448
92149,or,O,4448
92150,lower,O,4448
92151,duty,O,4448
92152,cycles,O,4448
92153,are,O,4448
92154,more,O,4448
92155,beneficial,O,4448
92156,When,O,4448
92157,sculpting,O,4448
92158,higher,O,4449
92159,rates,O,4449
92160,are,O,4449
92161,more,O,4449
92162,effective,O,4449
92163,because,O,4449
92164,the,O,4449
92165,energy,O,4449
92166,is,O,4449
92167,delivered,O,4449
92168,more,O,4450
92169,smoothly,O,4450
92170,due,O,4450
92171,to,O,4450
92172,the,O,4450
92173,shorter,O,4450
92174,time,O,4450
92175,between,O,4450
92176,pulses,O,4450
92177,but,O,4450
92178,when,O,4450
92179,removing,O,4450
92180,nuclear,O,4450
92181,quadrants,O,4450
92182,a,O,4450
92183,lower,O,4450
92184,duty,O,4450
92185,cycle,O,4450
92186,is,O,4450
92187,more,O,4451
92188,effective,O,4451
92189,since,O,4451
92190,the,O,4451
92191,aspiration,O,4451
92192,process,O,4451
92193,is,O,4451
92194,made,O,4451
92195,easier,O,4451
92196,by,O,4451
92197,the,O,4451
92198,longer,O,4451
92199,time,O,4451
92200,between,O,4451
92201,pulses,O,4451
92202,Finally,O,4451
92203,using,O,4451
92204,burst,O,4451
92205,mode,O,4451
92206,each,O,4451
92207,burst,O,4451
92208,has,O,4452
92209,the,O,4452
92210,same,O,4452
92211,power,O,4452
92212,but,O,4452
92213,the,O,4452
92214,interval,O,4452
92215,between,O,4452
92216,bursts,O,4452
92217,decreases,O,4452
92218,with,O,4452
92219,foot-pedal,O,4452
92220,depression,O,4452
92221,With,O,4452
92222,more,O,4452
92223,depression,O,4452
92224,of,O,4452
92225,the,B-SURGICAL_INSTRUMENT,4452
92226,foot,I-SURGICAL_INSTRUMENT,4452
92227,pedal,I-SURGICAL_INSTRUMENT,4452
92228,the,O,4452
92229,shorter,O,4452
92230,the,O,4452
92231,off,O,4452
92232,time,O,4452
92233,is,O,4452
92234,between,O,4452
92235,bursts,O,4452
92236,The,O,4452
92237,identical,O,4452
92238,bursts,O,4452
92239,of,O,4452
92240,energy,O,4452
92241,are,O,4452
92242,delivered,O,4452
92243,more,O,4452
92244,and,O,4452
92245,more,O,4452
92246,rapidly,O,4452
92247,with,O,4452
92248,foot-pedal,O,4452
92249,depression,O,4452
92250,with,O,4452
92251,maximal,O,4452
92252,depression,O,4452
92253,the,O,4452
92254,time,O,4452
92255,interval,O,4452
92256,between,O,4452
92257,bursts,O,4452
92258,is,O,4452
92259,very,O,4452
92260,small,O,4452
92261,making,O,4452
92262,for,O,4453
92263,continuous,O,4453
92264,energy,O,4453
92265,delivery,O,4453
92266,The,O,4453
92267,fluidics,O,4453
92268,and,O,4453
92269,vacuum,O,4453
92270,can,O,4453
92271,be,O,4453
92272,employed,O,4453
92273,for,O,4453
92274,aspiration,O,4453
92275,and,O,4453
92276,to,O,4453
92277,provide,O,4453
92278,brief,O,4453
92279,bursts,O,4453
92280,of,O,4453
92281,power,O,4453
92282,as,O,4453
92283,required,O,4453
92284,in,O,4453
92285,this,O,4453
92286,mode,O,4453
92287,which,O,4454
92288,enables,O,4454
92289,genuine,O,4454
92290,phaco-assisted,O,4454
92291,aspiration,O,4454
92292,of,O,4454
92293,the,O,4454
92294,nucleus,O,4454
92295,Given,O,4454
92296,that,O,4454
92297,there,O,4454
92298,is,O,4454
92299,no,O,4454
92300,linear,O,4454
92301,control,O,4454
92302,at,O,4454
92303,the,O,4454
92304,phaco,B-TREATMENT,4454
92305,power,O,4454
92306,level,O,4454
92307,burst,O,4454
92308,mode,O,4454
92309,should,O,4454
92310,employ,O,4454
92311,lower,O,4454
92312,phaco,B-TREATMENT,4454
92313,power,O,4454
92314,levels,O,4454
92315,than,O,4454
92316,pulse,O,4454
92317,or,O,4454
92318,continuous,O,4454
92319,mode,O,4454
92320,Regarding,O,4454
92321,the,O,4455
92322,choice,O,4455
92323,of,O,4455
92324,these,O,4455
92325,3,O,4455
92326,modes,O,4455
92327,the,O,4455
92328,ability,O,4455
92329,to,O,4455
92330,program,O,4455
92331,timing,O,4455
92332,and,O,4455
92333,duration,O,4455
92334,combined,O,4455
92335,with,O,4455
92336,the,O,4455
92337,directional,O,4455
92338,modes,O,4455
92339,ie,O,4455
92340,transverse,B-TREATMENT,4455
92341,and,I-TREATMENT,4455
92342,torsional,I-TREATMENT,4455
92343,phaco,B-TREATMENT,4455
92344,allow,O,4455
92345,the,O,4455
92346,surgeon,O,4455
92347,to,O,4455
92348,have,O,4455
92349,highly,O,4455
92350,elegant,O,4455
92351,control,O,4455
92352,and,O,4455
92353,precise,O,4455
92354,ultrasound,O,4455
92355,power,O,4455
92356,delivery,O,4455
92357,Femtosecond,B-TREATMENT,4455
92358,Laser-Assisted,I-TREATMENT,4456
92359,Cataract,I-TREATMENT,4456
92360,Surgery,I-TREATMENT,4456
92361,Femtosecond,B-TREATMENT,4456
92362,laser-assisted,I-TREATMENT,4456
92363,cataract,B-TREATMENT,4456
92364,surgery,I-TREATMENT,4456
92365,FLACS,B-TREATMENT,4456
92366,is,O,4456
92367,another,O,4456
92368,technology,O,4456
92369,that,O,4456
92370,has,O,4456
92371,resulted,O,4456
92372,in,O,4456
92373,increased,O,4456
92374,efficiency,O,4456
92375,in,O,4456
92376,nuclear,O,4456
92377,disassembly,O,4456
92378,FLACS,B-TREATMENT,4456
92379,allows,O,4456
92380,the,O,4456
92381,surgeon,O,4456
92382,to,O,4456
92383,decide,O,4456
92384,the,O,4456
92385,pattern,O,4456
92386,of,O,4457
92387,lens,O,4457
92388,fragmentation,O,4457
92389,The,O,4457
92390,femtosecond,O,4457
92391,pretreatment,O,4457
92392,significantly,O,4457
92393,reduces,O,4457
92394,the,O,4457
92395,effective,O,4457
92396,phaco,B-TREATMENT,4457
92397,time,O,4457
92398,compared,O,4457
92399,with,O,4457
92400,conventional,B-TREATMENT,4457
92401,phaco,I-TREATMENT,4457
92402,surgery,I-TREATMENT,4457
92403,thus,O,4457
92404,reducing,O,4457
92405,loss,O,4457
92406,of,O,4457
92407,endothelial,O,4457
92408,cells,O,4457
92409,and,O,4457
92410,allowing,O,4457
92411,faster,O,4457
92412,visual,O,4457
92413,rehabilitation,O,4457
92414,FLACS,B-TREATMENT,4457
92415,works,O,4457
92416,through,O,4457
92417,photodisruption,O,4457
92418,which,O,4457
92419,vaporizes,O,4457
92420,the,O,4457
92421,targeted,O,4457
92422,tissues,O,4457
92423,This,O,4457
92424,is,O,4457
92425,similar,O,4457
92426,to,O,4457
92427,the,O,4457
92428,mechanism,O,4458
92429,of,O,4458
92430,phaco,B-TREATMENT,4458
92431,but,O,4458
92432,it,O,4458
92433,occurs,O,4458
92434,at,O,4458
92435,the,O,4458
92436,near-infrared,O,4458
92437,wavelength,O,4458
92438,which,O,4458
92439,is,O,4458
92440,not,O,4458
92441,absorbed,O,4458
92442,by,O,4458
92443,optically,O,4458
92444,clear,O,4458
92445,tissues,O,4458
92446,This,O,4458
92447,laser,O,4458
92448,is,O,4458
92449,focused,O,4458
92450,to,O,4458
92451,3,O,4458
92452,microns,O,4459
92453,and,O,4459
92454,is,O,4459
92455,especially,O,4459
92456,useful,O,4459
92457,for,O,4459
92458,targeting,O,4459
92459,specific,O,4459
92460,depths,O,4459
92461,The,O,4459
92462,waves,O,4459
92463,dissipate,O,4459
92464,approximately,O,4459
92465,100,O,4459
92466,microns,O,4459
92467,from,O,4459
92468,the,O,4459
92469,targeted,O,4459
92470,tissue,O,4459
92471,and,O,4459
92472,the,O,4459
92473,endothelium,O,4459
92474,is,O,4459
92475,not,O,4459
92476,affected,O,4459
92477,Using,O,4459
92478,FLACS,B-TREATMENT,4459
92479,to,O,4459
92480,create,O,4459
92481,the,O,4459
92482,quadrants,O,4459
92483,there,O,4459
92484,is,O,4459
92485,no,O,4459
92486,need,O,4459
92487,to,O,4459
92488,phaco,B-TREATMENT,4459
92489,to,O,4459
92490,sculpt,O,4459
92491,the,O,4459
92492,lens,O,4459
92493,the,O,4459
92494,surgeon,O,4459
92495,can,O,4460
92496,go,O,4460
92497,directly,O,4460
92498,to,O,4460
92499,removal,O,4460
92500,of,O,4460
92501,the,O,4460
92502,quadrants,O,4460
92503,after,O,4460
92504,nuclear,O,4460
92505,disassembly,O,4460
92506,along,O,4461
92507,the,O,4461
92508,lines,O,4461
92509,created,O,4461
92510,by,O,4461
92511,the,O,4461
92512,laser,O,4461
92513,As,O,4461
92514,a,O,4461
92515,result,O,4461
92516,lower,O,4461
92517,total,O,4461
92518,energy,O,4461
92519,is,O,4461
92520,used,O,4461
92521,in,O,4461
92522,the,O,4461
92523,eye,O,4461
92524,making,O,4461
92525,nuclear,O,4461
92526,removal,O,4461
92527,easier,O,4461
92528,The,O,4462
92529,disadvantages,O,4462
92530,of,O,4462
92531,FLACS,B-TREATMENT,4462
92532,for,O,4462
92533,experienced,O,4462
92534,highvolume,O,4462
92535,surgeons,O,4462
92536,are,O,4462
92537,the,O,4462
92538,cost,O,4462
92539,increased,O,4462
92540,surgical,O,4463
92541,time,O,4463
92542,and,O,4463
92543,minimal,O,4463
92544,long-term,O,4463
92545,enhanced,O,4463
92546,visual,O,4463
92547,outcome,O,4463
92548,However,O,4463
92549,FLACS,B-TREATMENT,4463
92550,may,O,4463
92551,be,O,4463
92552,advantageous,O,4463
92553,for,O,4463
92554,use,O,4463
92555,in,O,4463
92556,brunescent,B-SIGN_AND_SYMPTOM,4463
92557,cataracts,I-SIGN_AND_SYMPTOM,4463
92558,of,O,4463
92559,patients,O,4463
92560,with,O,4463
92561,Fuchs,B-NAME_OF_DISEASE,4463
92562,dystrophy,I-NAME_OF_DISEASE,4463
92563,There,O,4463
92564,are,O,4463
92565,many,O,4464
92566,means,O,4464
92567,of,O,4464
92568,modulating,O,4464
92569,phaco,B-TREATMENT,4464
92570,power,O,4464
92571,to,O,4464
92572,achieve,O,4464
92573,outstanding,O,4464
92574,results,O,4464
92575,in,O,4464
92576,cataract,B-TREATMENT,4464
92577,surgery,I-TREATMENT,4464
92578,and,O,4464
92579,provide,O,4464
92580,the,O,4464
92581,best,O,4464
92582,patient,O,4464
92583,care,O,4464
92584,Bifocal,B-TREATMENT,4464
92585,and,I-TREATMENT,4464
92586,multifocal,I-TREATMENT,4464
92587,contact,B-TREATMENT,4465
92588,lenses,I-TREATMENT,4465
92589,CLs,B-TREATMENT,4465
92590,for,O,4465
92591,presbyopia,B-NAME_OF_DISEASE,4465
92592,correction,O,4465
92593,and,O,4465
92594,or,O,4465
92595,myopia,B-NAME_OF_DISEASE,4465
92596,control,O,4465
92597,can,O,4465
92598,be,O,4465
92599,made,O,4465
92600,available,O,4465
92601,in,O,4465
92602,a,O,4465
92603,wide,O,4465
92604,variety,O,4465
92605,of,O,4465
92606,platforms,O,4465
92607,including,O,4465
92608,rigid,B-TREATMENT,4465
92609,gas,I-TREATMENT,4465
92610,permeable,I-TREATMENT,4465
92611,RGP,I-TREATMENT,4465
92612,lenses,I-TREATMENT,4465
92613,of,O,4465
92614,different,O,4465
92615,sizes,O,4466
92616,from,O,4466
92617,corneal,O,4466
92618,to,O,4466
92619,scleral,O,4466
92620,supported,O,4466
92621,soft,B-TREATMENT,4466
92622,contact,B-TREATMENT,4466
92623,lenses,I-TREATMENT,4466
92624,and,O,4466
92625,hybrid,B-TREATMENT,4466
92626,lenses,I-TREATMENT,4466
92627,In,O,4466
92628,addition,O,4466
92629,to,O,4466
92630,the,O,4466
92631,lens,O,4466
92632,optical,O,4466
92633,structure,O,4466
92634,bifocality,O,4466
92635,and,O,4466
92636,multifocality,O,4467
92637,can,O,4467
92638,also,O,4467
92639,be,O,4467
92640,achieved,O,4467
92641,by,O,4467
92642,reshaping,O,4467
92643,the,B-PART_OF_THE_EYES,4467
92644,cornea,I-PART_OF_THE_EYES,4467
92645,with,O,4467
92646,the,O,4467
92647,application,O,4467
92648,of,O,4467
92649,CLs,B-TREATMENT,4467
92650,in,O,4467
92651,the,O,4467
92652,technique,O,4467
92653,called,O,4467
92654,orthokeratology,B-TREATMENT,4467
92655,and,O,4467
92656,has,O,4467
92657,been,O,4467
92658,used,O,4467
92659,widely,O,4467
92660,for,O,4467
92661,myopia,B-NAME_OF_DISEASE,4467
92662,correction,O,4467
92663,and,O,4467
92664,myopia,B-NAME_OF_DISEASE,4467
92665,control,O,4467
92666,although,O,4467
92667,its,O,4467
92668,application,O,4467
92669,for,O,4468
92670,presbyopia,B-NAME_OF_DISEASE,4468
92671,correction,O,4468
92672,is,O,4468
92673,still,O,4468
92674,limited,O,4468
92675,While,O,4468
92676,presbyopia,B-NAME_OF_DISEASE,4468
92677,correction,O,4468
92678,with,O,4468
92679,contact,B-TREATMENT,4468
92680,lenses,I-TREATMENT,4468
92681,accounts,O,4468
92682,for,O,4468
92683,up,O,4468
92684,to,O,4468
92685,25-35%,O,4468
92686,of,O,4468
92687,the,O,4468
92688,contact,O,4468
92689,lens,O,4468
92690,fittings,O,4468
92691,in,O,4468
92692,several,O,4468
92693,countries,O,4468
92694,myopia,B-NAME_OF_DISEASE,4468
92695,control,O,4468
92696,contact,O,4468
92697,lens,O,4468
92698,fittings,O,4468
92699,are,O,4468
92700,still,O,4468
92701,limited,O,4468
92702,to,O,4468
92703,2-5%,O,4468
92704,of,O,4468
92705,the,B-TREATMENT,4469
92706,contact,I-TREATMENT,4469
92707,lenses,I-TREATMENT,4469
92708,fitted,O,4469
92709,Presbyopia,B-TREATMENT,4469
92710,the,O,4469
92711,gradual,O,4469
92712,loss,O,4469
92713,of,O,4469
92714,accommodation,O,4469
92715,that,O,4469
92716,becomes,O,4469
92717,clinically,O,4469
92718,significant,O,4469
92719,during,O,4469
92720,the,O,4469
92721,fifth,O,4469
92722,decade,O,4469
92723,of,O,4469
92724,life,O,4469
92725,is,O,4470
92726,a,O,4470
92727,physiologic,O,4470
92728,inevitability,O,4470
92729,Different,O,4470
92730,technologies,O,4470
92731,are,O,4470
92732,being,O,4470
92733,pursued,O,4470
92734,to,O,4470
92735,achieve,O,4470
92736,surgical,O,4470
92737,correction,O,4470
92738,of,O,4471
92739,this,O,4471
92740,disability,O,4471
92741,however,O,4471
92742,a,O,4471
92743,number,O,4471
92744,of,O,4471
92745,limitations,O,4471
92746,have,O,4471
92747,prevented,O,4471
92748,widespread,O,4471
92749,acceptance,O,4471
92750,of,O,4471
92751,surgical,O,4471
92752,presbyopia,B-NAME_OF_DISEASE,4471
92753,correction,O,4471
92754,such,O,4471
92755,as,O,4471
92756,optical,O,4471
92757,and,O,4471
92758,visual,O,4471
92759,distortion,O,4471
92760,induced,O,4471
92761,corneal,O,4471
92762,ectasia,O,4471
92763,haze,O,4471
92764,anisometropy,O,4471
92765,with,O,4471
92766,monovision,O,4471
92767,regression,O,4471
92768,of,O,4471
92769,effect,O,4471
92770,decline,O,4471
92771,in,O,4471
92772,uncorrected,O,4471
92773,distance,O,4471
92774,vision,O,4471
92775,and,O,4471
92776,the,O,4471
92777,inherent,O,4471
92778,risks,O,4471
92779,with,O,4471
92780,invasive,O,4472
92781,techniques,O,4472
92782,limiting,O,4472
92783,the,O,4472
92784,development,O,4472
92785,of,O,4472
92786,an,O,4472
92787,ideal,O,4472
92788,solution,O,4472
92789,The,O,4472
92790,correction,O,4472
92791,of,O,4472
92792,the,O,4472
92793,presbyopia,B-NAME_OF_DISEASE,4472
92794,and,O,4472
92795,the,O,4472
92796,restoration,O,4472
92797,of,O,4472
92798,accommodation,O,4472
92799,are,O,4473
92800,considered,O,4473
92801,the,O,4473
92802,final,O,4473
92803,frontier,O,4473
92804,of,O,4473
92805,refractive,B-TREATMENT,4473
92806,surgery,I-TREATMENT,4473
92807,The,O,4473
92808,purpose,O,4473
92809,of,O,4474
92810,this,O,4474
92811,paper,O,4475
92812,is,O,4475
92813,to,O,4475
92814,provide,O,4475
92815,an,O,4475
92816,update,O,4475
92817,about,O,4475
92818,current,O,4476
92819,procedures,O,4476
92820,available,O,4477
92821,for,O,4478
92822,presbyopia,B-NAME_OF_DISEASE,4478
92823,correction,O,4478
92824,their,O,4478
92825,advantages,O,4478
92826,and,O,4478
92827,disadvantages,O,4478
92828,The,O,4478
92829,use,O,4478
92830,of,O,4478
92831,multifocal,B-TREATMENT,4479
92832,lenses,I-TREATMENT,4479
92833,is,O,4480
92834,a,O,4480
92835,definitive,O,4480
92836,solution,O,4480
92837,in,O,4480
92838,the,O,4480
92839,treatment,O,4480
92840,of,O,4481
92841,presbyopia,B-NAME_OF_DISEASE,4481
92842,Lens,O,4481
92843,implants,O,4481
92844,are,O,4481
92845,the,O,4481
92846,most,O,4481
92847,advanced,O,4482
92848,solution,O,4482
92849,in,O,4482
92850,terms,O,4482
92851,of,O,4482
92852,design,O,4482
92853,and,O,4482
92854,technology,O,4483
92855,since,O,4483
92856,this,O,4484
92857,prevents,O,4484
92858,the,O,4484
92859,need,O,4484
92860,for,O,4484
92861,glasses,B-TREATMENT,4484
92862,and,O,4485
92863,allows,O,4485
92864,you,O,4486
92865,to,O,4486
92866,focus,O,4486
92867,at,O,4486
92868,all,O,4486
92869,distances,O,4486
92870,Some,O,4487
92871,people,O,4488
92872,decide,O,4488
92873,to,O,4488
92874,have,O,4488
92875,surgery,O,4488
92876,to,O,4488
92877,achieve,O,4488
92878,monovision,O,4488
92879,This,O,4488
92880,can,O,4488
92881,reduce,O,4488
92882,their,O,4488
92883,need,O,4488
92884,for,O,4488
92885,glasses,B-TREATMENT,4488
92886,for,O,4489
92887,near,O,4489
92888,and,O,4490
92889,far,O,4490
92890,objects,O,4491
92891,Using,O,4491
92892,a,O,4492
92893,laser,O,4493
92894,an,O,4493
92895,ophthalmologist,O,4493
92896,reshapes,O,4493
92897,the,B-PART_OF_THE_EYES,4493
92898,cornea,I-PART_OF_THE_EYES,4493
92899,for,O,4493
92900,clear,O,4493
92901,far,O,4493
92902,vision,O,4494
92903,in,O,4494
92904,one,O,4495
92905,eye,O,4495
92906,and,O,4496
92907,close-up,O,4496
92908,vision,O,4497
92909,in,O,4497
92910,the,O,4497
92911,other,O,4498
92912,In,O,4498
92913,many,O,4498
92914,ways,O,4499
92915,this,O,4499
92916,is,O,4500
92917,like,O,4501
92918,wearing,B-TREATMENT,4501
92919,monovision,I-TREATMENT,4502
92920,contact,I-TREATMENT,4503
92921,lenses,I-TREATMENT,4503
92922,The,O,4504
92923,use,O,4505
92924,of,O,4505
92925,scleral,B-TREATMENT,4506
92926,contact,I-TREATMENT,4506
92927,lenses,I-TREATMENT,4507
92928,has,O,4507
92929,grown,O,4508
92930,significantly,O,4508
92931,in,O,4508
92932,the,O,4508
92933,past,O,4509
92934,year,O,4509
92935,with,O,4509
92936,an,O,4509
92937,associated,O,4509
92938,increase,O,4509
92939,in,O,4509
92940,research,O,4509
92941,This,O,4509
92942,type,O,4509
92943,of,O,4509
92944,lens,O,4509
92945,can,O,4509
92946,be,O,4509
92947,classified,O,4509
92948,as,O,4509
92949,corneo-scleral,O,4510
92950,or,O,4510
92951,fully,O,4510
92952,scleral,O,4510
92953,depending,O,4510
92954,on,O,4510
92955,the,O,4510
92956,presence,O,4510
92957,or,O,4510
92958,absence,O,4510
92959,of,O,4511
92960,corneal,O,4511
92961,bearing,O,4511
92962,One,O,4511
92963,of,O,4511
92964,the,O,4511
92965,main,O,4511
92966,advantages,O,4511
92967,of,O,4511
92968,this,O,4511
92969,option,O,4511
92970,for,O,4511
92971,refractive,O,4511
92972,correction,O,4511
92973,is,O,4511
92974,that,O,4511
92975,the,O,4511
92976,tear,O,4511
92977,reservoir,O,4511
92978,between,O,4511
92979,the,O,4511
92980,posterior,O,4511
92981,surface,O,4511
92982,of,O,4511
92983,the,O,4511
92984,contact,O,4511
92985,lens,O,4511
92986,and,O,4511
92987,the,B-PART_OF_THE_EYES,4511
92988,anterior,I-PART_OF_THE_EYES,4511
92989,corneal,I-PART_OF_THE_EYES,4511
92990,surface,I-PART_OF_THE_EYES,4511
92991,allows,O,4511
92992,a,O,4511
92993,significant,O,4511
92994,neutralization,O,4511
92995,of,O,4512
92996,anterior,O,4512
92997,corneal,O,4512
92998,aberrations,O,4512
92999,which,O,4512
93000,are,O,4512
93001,relevant,O,4512
93002,considering,O,4512
93003,the,O,4512
93004,contribution,O,4512
93005,of,O,4512
93006,this,O,4512
93007,optical,O,4512
93008,surface,O,4512
93009,to,O,4512
93010,the,O,4512
93011,total,O,4512
93012,power,O,4512
93013,of,O,4512
93014,the,O,4512
93015,eye,O,4512
93016,Because,O,4512
93017,these,O,4512
93018,lenses,O,4512
93019,are,O,4512
93020,fitted,O,4512
93021,with,O,4512
93022,minimal,O,4512
93023,or,O,4513
93024,no,O,4513
93025,corneal,O,4513
93026,bear,O,4513
93027,the,O,4513
93028,fitting,O,4513
93029,process,O,4513
93030,can,O,4513
93031,be,O,4513
93032,simplified,O,4513
93033,in,O,4513
93034,patients,O,4513
93035,with,O,4513
93036,highly,O,4513
93037,irregular,O,4513
93038,anterior,O,4513
93039,corneal,O,4513
93040,profiles,O,4513
93041,For,O,4513
93042,this,O,4513
93043,reason,O,4514
93044,the,O,4514
93045,use,O,4514
93046,of,O,4514
93047,these,O,4514
93048,contact,O,4514
93049,lenses,O,4514
93050,has,O,4514
93051,been,O,4514
93052,intensively,O,4514
93053,investigated,O,4514
93054,for,O,4514
93055,the,O,4514
93056,correction,O,4514
93057,of,O,4514
93058,irregular,B-NAME_OF_DISEASE,4514
93059,astigmatism,I-NAME_OF_DISEASE,4514
93060,in,O,4514
93061,post-corneal,O,4514
93062,refractive,B-TREATMENT,4514
93063,surgery,I-TREATMENT,4514
93064,and,O,4514
93065,post,O,4514
93066,keratoplasty,B-TREATMENT,4514
93067,corneas,B-PART_OF_THE_EYES,4514
93068,as,O,4514
93069,well,O,4515
93070,as,O,4515
93071,in,O,4515
93072,ectatic,O,4515
93073,corneal,O,4515
93074,disorders,O,4515
93075,Although,O,4515
93076,there,O,4515
93077,is,O,4515
93078,a,O,4515
93079,consensus,O,4515
93080,among,O,4515
93081,practitioners,O,4515
93082,with,O,4515
93083,more,O,4515
93084,than,O,4516
93085,5,O,4516
93086,years,O,4516
93087,of,O,4516
93088,scleral,O,4516
93089,lens,O,4516
93090,experience,O,4516
93091,about,O,4516
93092,most,O,4516
93093,aspects,O,4516
93094,of,O,4516
93095,contact,O,4516
93096,lens,O,4516
93097,management,O,4516
93098,some,O,4516
93099,factors,O,4516
93100,require,O,4517
93101,more,O,4517
93102,research,O,4517
93103,such,O,4517
93104,as,O,4517
93105,the,O,4517
93106,management,O,4517
93107,of,O,4517
93108,multifocality,O,4517
93109,for,O,4517
93110,presbyopia,B-NAME_OF_DISEASE,4517
93111,correction,O,4517
93112,To,O,4517
93113,date,O,4517
93114,only,O,4517
93115,the,O,4517
93116,outcomes,O,4517
93117,of,O,4517
93118,conventional,B-TREATMENT,4517
93119,soft,I-TREATMENT,4517
93120,or,I-TREATMENT,4517
93121,rigid,I-TREATMENT,4517
93122,gas,I-TREATMENT,4517
93123,permeable,I-TREATMENT,4517
93124,corneal,I-TREATMENT,4517
93125,contact,I-TREATMENT,4517
93126,lenses,I-TREATMENT,4517
93127,have,O,4517
93128,been,O,4517
93129,evaluated,O,4517
93130,despite,O,4517
93131,the,O,4517
93132,availability,O,4517
93133,of,O,4517
93134,some,O,4517
93135,multifocal,B-TREATMENT,4517
93136,scleral,I-TREATMENT,4517
93137,contact,I-TREATMENT,4517
93138,lens,I-TREATMENT,4517
93139,designs,O,4517
93140,Recently,O,4518
93141,a,O,4518
93142,new,O,4518
93143,model,O,4518
93144,of,O,4518
93145,multifocal,B-TREATMENT,4518
93146,corneo-scleral,I-TREATMENT,4518
93147,contact,I-TREATMENT,4518
93148,lens,I-TREATMENT,4518
93149,has,O,4518
93150,been,O,4518
93151,commercially,O,4518
93152,released,O,4518
93153,called,O,4518
93154,Presbycustom,B-TREATMENT,4518
93155,which,O,4518
93156,provides,O,4518
93157,the,O,4518
93158,option,O,4518
93159,of,O,4518
93160,customizing,O,4518
93161,not,O,4518
93162,only,O,4518
93163,the,O,4518
93164,fitting,O,4518
93165,parameters,O,4518
93166,to,O,4518
93167,adjust,O,4518
93168,the,O,4518
93169,lens,O,4518
93170,over,O,4518
93171,the,B-PART_OF_THE_EYES,4518
93172,cornea,I-PART_OF_THE_EYES,4518
93173,and,O,4519
93174,sclera,B-PART_OF_THE_EYES,4519
93175,but,O,4519
93176,also,O,4519
93177,the,O,4519
93178,type,O,4519
93179,of,O,4519
93180,multifocality,O,4519
93181,induced,O,4519
93182,What,O,4519
93183,follows,O,4519
93184,are,O,4519
93185,the,O,4519
93186,results,O,4519
93187,obtained,O,4519
93188,with,O,4519
93189,this,O,4519
93190,new,O,4519
93191,modality,O,4519
93192,of,O,4519
93193,contact,O,4519
93194,lens,O,4519
93195,in,O,4520
93196,eyes,O,4520
93197,with,O,4520
93198,previous,O,4520
93199,refractive,B-TREATMENT,4520
93200,surgery,I-TREATMENT,4520
93201,and,O,4520
93202,significant,O,4520
93203,high-order,O,4520
93204,corneal,O,4520
93205,aberrations,O,4520
93206,Contact,O,4520
93207,Lens,O,4520
93208,Design,O,4520
93209,The,B-TREATMENT,4520
93210,Presbycustom,I-TREATMENT,4520
93211,contact,I-TREATMENT,4520
93212,lens,I-TREATMENT,4520
93213,paflufocon,O,4520
93214,D,O,4520
93215,Dk,O,4520
93216,100,O,4521
93217,Fatt,O,4522
93218,units,O,4522
93219,is,O,4522
93220,the,O,4522
93221,result,O,4522
93222,of,O,4522
93223,a,O,4522
93224,proof-of-concept,O,4522
93225,research,O,4522
93226,project,O,4522
93227,developed,O,4522
93228,by,O,4522
93229,Laboratorios,B-ORGANIZATION,4522
93230,Lenticon,I-ORGANIZATION,4522
93231,SA,I-ORGANIZATION,4522
93232,in,O,4522
93233,collaboration,O,4522
93234,with,O,4523
93235,the,B-ORGANIZATION,4523
93236,Group,I-ORGANIZATION,4523
93237,of,I-ORGANIZATION,4523
93238,Optics,I-ORGANIZATION,4523
93239,and,I-ORGANIZATION,4523
93240,Visual,I-ORGANIZATION,4524
93241,Perception,I-ORGANIZATION,4524
93242,of,I-ORGANIZATION,4524
93243,the,I-ORGANIZATION,4524
93244,University,I-ORGANIZATION,4524
93245,of,I-ORGANIZATION,4524
93246,Alicante,I-ORGANIZATION,4524
93247,in,O,4525
93248,Spain,B-GPE,4525
93249,It,O,4525
93250,is,O,4525
93251,a,B-TREATMENT,4525
93252,corneo-scleral,I-TREATMENT,4525
93253,contact,I-TREATMENT,4525
93254,lens,I-TREATMENT,4525
93255,made,O,4525
93256,of,O,4525
93257,highly,O,4525
93258,gas-permeable,O,4525
93259,material,O,4525
93260,The,O,4525
93261,lens,O,4525
93262,is,O,4525
93263,customized,O,4525
93264,according,O,4525
93265,to,O,4525
93266,the,O,4525
93267,anterior,O,4525
93268,corneal,O,4525
93269,geometry,O,4525
93270,the,O,4525
93271,level,O,4525
93272,of,O,4525
93273,ocular,O,4525
93274,high-order,O,4525
93275,aberrations,O,4525
93276,and,O,4525
93277,the,O,4525
93278,peculiarities,O,4525
93279,of,O,4526
93280,pupil,B-PART_OF_THE_EYES,4526
93281,dynamics,O,4526
93282,It,O,4526
93283,comprises,O,4526
93284,3,O,4526
93285,different,O,4526
93286,areas,O,4526
93287,corneal,O,4526
93288,limbal,O,4526
93289,and,O,4526
93290,scleral,O,4526
93291,Figure,O,4526
93292,1,O,4526
93293,,O,4526
93294,The,O,4526
93295,corneal,O,4526
93296,area,O,4526
93297,has,O,4526
93298,a,O,4526
93299,variable,O,4526
93300,diameter,O,4526
93301,with,O,4526
93302,fixed,O,4526
93303,back-surface,O,4526
93304,asphericity,O,4526
93305,and,O,4526
93306,central,O,4527
93307,anterior,O,4527
93308,surface,O,4527
93309,asphericity,O,4527
93310,that,O,4527
93311,is,O,4527
93312,modified,O,4527
93313,according,O,4527
93314,to,O,4527
93315,the,O,4527
93316,aberrometric,O,4527
93317,induction,O,4527
93318,required,O,4527
93319,Specifically,O,4527
93320,the,O,4527
93321,depth,O,4527
93322,of,O,4527
93323,focus,O,4527
93324,achieved,O,4527
93325,with,O,4527
93326,the,O,4528
93327,contact,O,4528
93328,lens,O,4528
93329,is,O,4528
93330,set,O,4528
93331,by,O,4528
93332,customizing,O,4528
93333,the,O,4528
93334,induction,O,4528
93335,of,O,4528
93336,primary,O,4528
93337,and,O,4528
93338,secondary,O,4528
93339,spherical,O,4528
93340,aberration,O,4529
93341,It,O,4529
93342,has,O,4529
93343,been,O,4529
93344,demonstrated,O,4529
93345,that,O,4529
93346,combining,O,4529
93347,primary,O,4529
93348,and,O,4529
93349,secondary,O,4530
93350,spherical,O,4530
93351,aberrations,O,4530
93352,of,O,4530
93353,opposite,O,4530
93354,sign,O,4530
93355,is,O,4530
93356,significantly,O,4530
93357,more,O,4530
93358,effective,O,4530
93359,for,O,4530
93360,expanding,O,4530
93361,the,O,4530
93362,depth,O,4531
93363,of,O,4531
93364,focus,O,4531
93365,than,O,4531
93366,other,O,4531
93367,aberrometric,O,4531
93368,options,O,4531
93369,The,O,4531
93370,scleral,O,4531
93371,area,O,4531
93372,of,O,4531
93373,the,O,4531
93374,contact,O,4531
93375,lens,O,4531
93376,allows,O,4531
93377,a,O,4531
93378,smooth,O,4531
93379,bearing,O,4531
93380,over,O,4531
93381,the,B-PART_OF_THE_EYES,4531
93382,sclero-conjunctival,I-PART_OF_THE_EYES,4531
93383,surface,I-PART_OF_THE_EYES,4531
93384,facilitating,O,4531
93385,comfortable,O,4531
93386,wearing,O,4531
93387,Figure,O,4531
93388,2,O,4531
93389,,O,4531
93390,The,O,4531
93391,distribution,O,4531
93392,of,O,4532
93393,the,B-PART_OF_THE_EYES,4532
93394,tear,I-PART_OF_THE_EYES,4532
93395,film,I-PART_OF_THE_EYES,4532
93396,below,O,4532
93397,the,O,4532
93398,different,O,4532
93399,areas,O,4532
93400,of,O,4532
93401,the,O,4532
93402,contact,O,4532
93403,lens,O,4532
93404,generates,O,4532
93405,a,O,4532
93406,characteristic,O,4532
93407,fluorogram,O,4532
93408,consisting,O,4532
93409,of,O,4532
93410,central,O,4532
93411,tear,O,4532
93412,pooling,O,4532
93413,with,O,4532
93414,paracentral,O,4532
93415,alignment,O,4532
93416,and,O,4532
93417,significant,O,4532
93418,edge,O,4532
93419,clearing,O,4532
93420,Figure,O,4532
93421,3,O,4532
93422,,O,4532
93423,Preliminary,O,4533
93424,Clinical,O,4533
93425,Experience,O,4533
93426,There,O,4533
93427,has,O,4533
93428,been,O,4533
93429,recently,O,4533
93430,conducted,O,4533
93431,a,O,4533
93432,prospective,O,4533
93433,pilot,O,4533
93434,study,O,4533
93435,in,O,4533
93436,the,B-ORGANIZATION,4533
93437,Department,I-ORGANIZATION,4533
93438,of,I-ORGANIZATION,4533
93439,Ophthalmology,I-ORGANIZATION,4533
93440,of,I-ORGANIZATION,4533
93441,the,I-ORGANIZATION,4533
93442,Vithas,I-ORGANIZATION,4533
93443,Medimar,I-ORGANIZATION,4533
93444,International,I-ORGANIZATION,4533
93445,Hospital,I-ORGANIZATION,4533
93446,in,O,4533
93447,Alicante,B-GPE,4533
93448,Spain,I-GPE,4533
93449,and,O,4533
93450,in,O,4533
93451,the,B-ORGANIZATION,4533
93452,Optometry,I-ORGANIZATION,4533
93453,Clinic,I-ORGANIZATION,4533
93454,of,I-ORGANIZATION,4533
93455,the,I-ORGANIZATION,4533
93456,University,I-ORGANIZATION,4533
93457,of,I-ORGANIZATION,4533
93458,Alicante,I-ORGANIZATION,4533
93459,The,O,4533
93460,study,O,4533
93461,included,O,4533
93462,8,O,4534
93463,eyes,O,4534
93464,of,O,4534
93465,8,O,4534
93466,patients,O,4534
93467,age,O,4534
93468,45,O,4534
93469,to,O,4534
93470,56,O,4534
93471,years,O,4534
93472,with,O,4534
93473,previous,O,4534
93474,LASIK,B-TREATMENT,4534
93475,surgery,I-TREATMENT,4534
93476,requiring,O,4534
93477,presbyopia,B-NAME_OF_DISEASE,4534
93478,correction,O,4534
93479,All,O,4534
93480,cases,O,4534
93481,had,O,4534
93482,reduced,O,4534
93483,corrected,O,4534
93484,distance,O,4534
93485,visual,O,4535
93486,acuity,O,4535
93487,CDVA,O,4535
93488,and,O,4535
93489,significant,O,4535
93490,corneal,O,4535
93491,irregularity,O,4535
93492,A,O,4535
93493,complete,O,4535
93494,ocular,O,4535
93495,examination,O,4535
93496,was,O,4535
93497,performed,O,4535
93498,before,O,4535
93499,and,O,4535
93500,1,O,4535
93501,month,O,4535
93502,after,O,4535
93503,fitting,O,4536
93504,the,B-TREATMENT,4536
93505,customized,I-TREATMENT,4536
93506,multifocal,I-TREATMENT,4536
93507,scleral,I-TREATMENT,4536
93508,contract,I-TREATMENT,4536
93509,lens,I-TREATMENT,4536
93510,including,O,4536
93511,visual,B-DIAGNOSTIC_TEST,4536
93512,and,I-DIAGNOSTIC_TEST,4536
93513,refractive,I-DIAGNOSTIC_TEST,4536
93514,analysis,I-DIAGNOSTIC_TEST,4536
93515,corneal,B-DIAGNOSTIC_TEST,4536
93516,topography,I-DIAGNOSTIC_TEST,4536
93517,pachymetry,B-DIAGNOSTIC_TEST,4536
93518,and,O,4536
93519,evaluation,O,4536
93520,of,O,4536
93521,corneal,O,4536
93522,and,O,4536
93523,ocular,O,4536
93524,aberrations,O,4536
93525,with,O,4536
93526,the,B-DIAGNOSTIC_TEST,4536
93527,VX120,I-DIAGNOSTIC_TEST,4537
93528,multidiagnostic,I-DIAGNOSTIC_TEST,4537
93529,system,I-DIAGNOSTIC_TEST,4537
93530,Luneau,B-ORGANIZATION,4537
93531,Technology,I-ORGANIZATION,4537
93532,Inc,I-ORGANIZATION,4537
93533,,O,4537
93534,The,O,4537
93535,contact,O,4537
93536,lens,O,4537
93537,was,O,4537
93538,customized,O,4537
93539,according,O,4537
93540,to,O,4537
93541,the,O,4537
93542,anterior,O,4537
93543,corneal,O,4537
93544,geometry,O,4537
93545,level,O,4537
93546,of,O,4537
93547,ocular,O,4537
93548,higher-order,O,4537
93549,aberrations,O,4537
93550,and,O,4537
93551,pupil,B-PART_OF_THE_EYES,4537
93552,diameter,O,4537
93553,The,O,4537
93554,mean,O,4537
93555,corneal,O,4537
93556,radius,O,4537
93557,of,O,4537
93558,the,O,4537
93559,lens,O,4537
93560,fitted,O,4537
93561,was,O,4537
93562,8,O,4538
93563,±,O,4538
93564,0.4,O,4538
93565,mm,O,4538
93566,the,O,4538
93567,mean,O,4538
93568,scleral,O,4538
93569,radius,O,4538
93570,was,O,4538
93571,7.6,O,4538
93572,±,O,4538
93573,0.2,O,4538
93574,mm,O,4538
93575,The,O,4538
93576,mean,O,4538
93577,central,O,4538
93578,eccentricity,O,4538
93579,used,O,4538
93580,for,O,4538
93581,the,O,4538
93582,lenses,O,4538
93583,was,O,4538
93584,0.4,O,4538
93585,±,O,4538
93586,0.3,O,4538
93587,whereas,O,4538
93588,a,O,4539
93589,fixed,O,4539
93590,posterior,O,4539
93591,eccentricity,O,4539
93592,of,O,4539
93593,0.6,O,4539
93594,was,O,4539
93595,used,O,4539
93596,in,O,4539
93597,all,O,4539
93598,contact,B-TREATMENT,4539
93599,lenses,I-TREATMENT,4539
93600,fitted,O,4539
93601,Mean,O,4539
93602,monocular,O,4539
93603,logMAR,O,4539
93604,CDVA,O,4539
93605,changed,O,4539
93606,from,O,4540
93607,0.2,O,4540
93608,±,O,4540
93609,0,O,4540
93610,with,O,4540
93611,spectacles,O,4540
93612,before,O,4540
93613,fitting,O,4540
93614,to,O,4540
93615,0,O,4540
93616,±,O,4540
93617,0,O,4540
93618,with,O,4540
93619,the,O,4540
93620,contact,O,4540
93621,lens,O,4540
93622,fitted,O,4541
93623,P=.0,O,4541
93624,,O,4541
93625,Mean,O,4541
93626,logMAR,O,4541
93627,binocular,O,4541
93628,distance,O,4541
93629,and,O,4541
93630,near,O,4541
93631,visual,O,4541
93632,acuity,O,4541
93633,values,O,4541
93634,with,O,4541
93635,the,O,4541
93636,contact,O,4541
93637,lens,O,4541
93638,were,O,4541
93639,0,O,4541
93640,±,O,4541
93641,0,O,4542
93642,and,O,4542
93643,0.1,O,4542
93644,±,O,4542
93645,0.1,O,4542
93646,respectively,O,4542
93647,Mean,O,4542
93648,logMAR-corrected,O,4542
93649,visual,O,4542
93650,acuities,O,4542
93651,for,O,4542
93652,defocus,O,4542
93653,levels,O,4542
93654,of,O,4542
93655,-0.5,O,4542
93656,D,O,4542
93657,-1,O,4542
93658,D,O,4542
93659,-1.5,O,4542
93660,D,O,4542
93661,-2,O,4542
93662,D,O,4542
93663,and,O,4543
93664,-2.5,O,4543
93665,D,O,4543
93666,were,O,4543
93667,0,O,4543
93668,±,O,4543
93669,0,O,4543
93670,0,O,4543
93671,±,O,4543
93672,0,O,4543
93673,0.1,O,4543
93674,±,O,4543
93675,0.1,O,4543
93676,0.2,O,4543
93677,±,O,4543
93678,0.1,O,4543
93679,and,O,4543
93680,0.3,O,4543
93681,±,O,4543
93682,0.1,O,4543
93683,respectively,O,4543
93684,Figure,O,4543
93685,4,O,4543
93686,,O,4543
93687,All,O,4543
93688,patients,O,4543
93689,reported,O,4543
93690,spectacle,O,4543
93691,independence,O,4544
93692,for,O,4544
93693,reading,O,4544
93694,and,O,4544
93695,high,O,4544
93696,levels,O,4544
93697,of,O,4544
93698,contact,O,4544
93699,lens,O,4544
93700,tolerance,O,4544
93701,and,O,4544
93702,satisfaction,O,4544
93703,No,O,4544
93704,complications,O,4544
93705,were,O,4544
93706,reported,O,4544
93707,during,O,4544
93708,the,O,4544
93709,first,O,4544
93710,year,O,4544
93711,of,O,4545
93712,follow-up,O,4545
93713,The,O,4545
93714,selection,O,4545
93715,of,O,4545
93716,an,O,4545
93717,appropriate,O,4545
93718,combination,O,4545
93719,of,O,4545
93720,primary,O,4545
93721,and,O,4545
93722,secondary,O,4545
93723,spherical,O,4545
93724,aberration,O,4545
93725,of,O,4545
93726,opposite,O,4545
93727,sign,O,4545
93728,according,O,4545
93729,to,O,4545
93730,the,O,4545
93731,aberrometric,O,4545
93732,status,O,4545
93733,of,O,4545
93734,the,O,4545
93735,eye,O,4545
93736,can,O,4545
93737,be,O,4546
93738,useful,O,4546
93739,to,O,4546
93740,optimize,O,4546
93741,the,O,4546
93742,depth,O,4546
93743,of,O,4546
93744,focus,O,4546
93745,required,O,4546
93746,for,O,4546
93747,presbyopia,B-NAME_OF_DISEASE,4546
93748,correction,O,4546
93749,After,O,4546
93750,using,O,4546
93751,an,B-CHEMICAL_COMPOUND,4546
93752,enzyme,I-CHEMICAL_COMPOUND,4546
93753,to,O,4546
93754,loosen,O,4546
93755,the,O,4546
93756,connective,O,4546
93757,fibers,O,4546
93758,of,O,4546
93759,the,B-PART_OF_THE_EYES,4546
93760,internal,I-PART_OF_THE_EYES,4546
93761,limiting,I-PART_OF_THE_EYES,4546
93762,membrane,I-PART_OF_THE_EYES,4546
93763,the,O,4547
93764,researchers,O,4547
93765,removed,O,4547
93766,the,O,4547
93767,membrane,O,4547
93768,and,O,4547
93769,applied,O,4547
93770,the,O,4547
93771,transplanted,O,4547
93772,human,O,4547
93773,cells,O,4547
93774,to,O,4547
93775,the,B-PART_OF_THE_EYES,4547
93776,retinas,B-PART_OF_THE_EYES,4547
93777,They,O,4547
93778,found,O,4547
93779,that,O,4547
93780,most,O,4547
93781,of,O,4547
93782,the,B-PART_OF_THE_EYES,4547
93783,transplanted,I-PART_OF_THE_EYES,4547
93784,retinal,B-PART_OF_THE_EYES,4547
93785,ganglion,I-PART_OF_THE_EYES,4547
93786,cells,I-PART_OF_THE_EYES,4547
93787,grew,O,4547
93788,in,O,4547
93789,a,O,4548
93790,more,O,4548
93791,normal,O,4548
93792,pattern,O,4548
93793,integrating,O,4548
93794,themselves,O,4548
93795,more,O,4548
93796,fully,O,4548
93797,The,O,4548
93798,transplanted,O,4548
93799,cells,O,4548
93800,also,O,4548
93801,showed,O,4548
93802,signs,O,4548
93803,of,O,4548
93804,establishing,O,4549
93805,new,O,4549
93806,nerve,O,4549
93807,connections,O,4549
93808,to,O,4549
93809,the,O,4549
93810,rest,O,4549
93811,of,O,4549
93812,the,O,4549
93813,retinal,O,4549
93814,structure,O,4549
93815,when,O,4549
93816,compared,O,4549
93817,with,O,4549
93818,retinas,B-PART_OF_THE_EYES,4549
93819,that,O,4549
93820,had,O,4549
93821,intact,O,4549
93822,membranes,O,4549
93823,Retinal,B-TREATMENT,4549
93824,ganglion,I-TREATMENT,4550
93825,cell,I-TREATMENT,4550
93826,RGC,I-TREATMENT,4550
93827,replacement,I-TREATMENT,4550
93828,holds,O,4550
93829,the,O,4550
93830,potential,O,4550
93831,for,O,4550
93832,restoring,O,4550
93833,vision,B-SIGN_AND_SYMPTOM,4550
93834,lost,I-SIGN_AND_SYMPTOM,4550
93835,to,O,4550
93836,optic,B-NAME_OF_DISEASE,4550
93837,neuropathy,I-NAME_OF_DISEASE,4550
93838,Transplanted,O,4550
93839,RGCs,O,4551
93840,must,O,4551
93841,undergo,O,4551
93842,neuroretinal,O,4551
93843,integration,O,4551
93844,to,O,4551
93845,receive,O,4551
93846,afferent,O,4551
93847,visual,O,4551
93848,signals,O,4551
93849,for,O,4551
93850,processing,O,4551
93851,and,O,4551
93852,efferent,O,4551
93853,transmission,O,4551
93854,In,O,4551
93855,experiments,O,4551
93856,in,O,4551
93857,mouse,O,4551
93858,tissues,O,4551
93859,and,O,4551
93860,human,O,4551
93861,cells,O,4551
93862,Johns,B-ORGANIZATION,4551
93863,Hopkins,I-ORGANIZATION,4552
93864,Medicine,I-ORGANIZATION,4552
93865,researchers,O,4552
93866,say,O,4552
93867,they,O,4552
93868,have,O,4552
93869,found,O,4552
93870,that,O,4552
93871,removing,O,4552
93872,a,O,4552
93873,membrane,O,4552
93874,that,O,4552
93875,lines,O,4552
93876,the,O,4552
93877,back,O,4552
93878,of,O,4552
93879,the,O,4552
93880,eye,O,4552
93881,may,O,4552
93882,improve,O,4552
93883,the,O,4552
93884,success,O,4552
93885,rate,O,4552
93886,for,O,4552
93887,regrowing,O,4552
93888,nerve,O,4552
93889,cells,O,4552
93890,damaged,O,4552
93891,by,O,4553
93892,blinding,B-NAME_OF_DISEASE,4553
93893,diseases,I-NAME_OF_DISEASE,4553
93894,The,O,4553
93895,findings,O,4553
93896,are,O,4553
93897,specifically,O,4553
93898,aimed,O,4553
93899,at,O,4553
93900,discovering,O,4553
93901,new,O,4553
93902,ways,O,4553
93903,to,O,4553
93904,reverse,O,4553
93905,vision,B-SIGN_AND_SYMPTOM,4553
93906,loss,I-SIGN_AND_SYMPTOM,4554
93907,caused,O,4554
93908,by,O,4554
93909,glaucoma,B-NAME_OF_DISEASE,4554
93910,and,O,4554
93911,other,O,4554
93912,diseases,O,4554
93913,that,O,4554
93914,affect,O,4554
93915,the,B-PART_OF_THE_EYES,4554
93916,optic,I-PART_OF_THE_EYES,4554
93917,nerve,I-PART_OF_THE_EYES,4554
93918,the,O,4554
93919,information,O,4554
93920,highway,O,4554
93921,from,O,4554
93922,the,O,4554
93923,eye,O,4554
93924,to,O,4554
93925,the,O,4555
93926,brain,O,4555
93927,The,O,4555
93928,idea,O,4555
93929,of,O,4555
93930,restoring,O,4555
93931,vision,O,4555
93932,to,O,4555
93933,someone,O,4555
93934,who,O,4555
93935,has,O,4555
93936,lost,O,4555
93937,it,O,4555
93938,from,O,4555
93939,optic,B-NAME_OF_DISEASE,4555
93940,nerve,I-NAME_OF_DISEASE,4555
93941,disease,I-NAME_OF_DISEASE,4555
93942,has,O,4555
93943,been,O,4555
93944,considered,O,4556
93945,science,O,4556
93946,fiction,O,4556
93947,for,O,4556
93948,decades,O,4556
93949,But,O,4556
93950,in,O,4556
93951,the,O,4556
93952,last,O,4556
93953,five,O,4556
93954,years,O,4556
93955,stem,O,4556
93956,cell,O,4556
93957,biology,O,4556
93958,has,O,4557
93959,reached,O,4557
93960,a,O,4557
93961,point,O,4557
93962,where,O,4557
93963,it,O,4557
93964,s,O,4557
93965,feasible,O,4557
93966,says,O,4557
93967,Thomas,O,4557
93968,Johnson,O,4557
93969,M.D,O,4557
93970,Ph.D,O,4557
93971,assistant,O,4557
93972,professor,O,4557
93973,of,O,4557
93974,ophthalmology,O,4557
93975,at,O,4558
93976,the,B-ORGANIZATION,4558
93977,Wilmer,I-ORGANIZATION,4558
93978,Eye,I-ORGANIZATION,4558
93979,Institute,I-ORGANIZATION,4558
93980,at,I-ORGANIZATION,4558
93981,the,I-ORGANIZATION,4558
93982,Johns,I-ORGANIZATION,4558
93983,Hopkins,I-ORGANIZATION,4558
93984,University,I-ORGANIZATION,4558
93985,School,I-ORGANIZATION,4558
93986,of,I-ORGANIZATION,4558
93987,Medicine,I-ORGANIZATION,4558
93988,The,O,4558
93989,research,O,4558
93990,was,O,4558
93991,published,O,4558
93992,on,O,4558
93993,Jan,O,4558
93994,12,O,4558
93995,in,O,4558
93996,the,B-PUBLICATION_VENUE,4558
93997,journal,I-PUBLICATION_VENUE,4558
93998,Stem,I-PUBLICATION_VENUE,4558
93999,Cell,I-PUBLICATION_VENUE,4558
94000,Reports,I-PUBLICATION_VENUE,4559
94001,A,O,4559
94002,human,O,4559
94003,eye,O,4559
94004,has,O,4559
94005,more,O,4559
94006,than,O,4559
94007,1,O,4559
94008,million,O,4559
94009,small,O,4559
94010,nerve,O,4559
94011,cells,O,4559
94012,called,O,4559
94013,retinal,B-PART_OF_THE_EYES,4560
94014,ganglion,I-PART_OF_THE_EYES,4560
94015,cells,I-PART_OF_THE_EYES,4560
94016,that,O,4560
94017,transmit,O,4560
94018,signals,O,4560
94019,from,O,4560
94020,light-collecting,O,4560
94021,cells,O,4560
94022,called,O,4560
94023,photoreceptors,B-PART_OF_THE_EYES,4560
94024,in,O,4560
94025,the,O,4560
94026,back,O,4560
94027,of,O,4560
94028,the,O,4561
94029,eye,O,4561
94030,to,O,4561
94031,the,O,4561
94032,brain,O,4561
94033,Retinal,B-PART_OF_THE_EYES,4561
94034,ganglion,I-PART_OF_THE_EYES,4561
94035,cells,I-PART_OF_THE_EYES,4561
94036,send,O,4561
94037,out,O,4561
94038,long,O,4561
94039,arms,O,4561
94040,or,O,4561
94041,axons,O,4561
94042,that,O,4561
94043,bundle,O,4561
94044,together,O,4562
94045,with,O,4562
94046,other,O,4562
94047,retinal,B-PART_OF_THE_EYES,4562
94048,ganglion,I-PART_OF_THE_EYES,4562
94049,cell,I-PART_OF_THE_EYES,4562
94050,projections,O,4562
94051,forming,O,4562
94052,the,B-PART_OF_THE_EYES,4562
94053,optic,I-PART_OF_THE_EYES,4562
94054,nerve,I-PART_OF_THE_EYES,4562
94055,that,O,4562
94056,leads,O,4562
94057,to,O,4562
94058,the,O,4562
94059,brain,O,4562
94060,When,O,4562
94061,the,O,4562
94062,eye,O,4563
94063,is,O,4563
94064,subjected,O,4563
94065,to,O,4563
94066,high,O,4563
94067,pressure,O,4563
94068,as,O,4563
94069,occurs,O,4563
94070,in,O,4563
94071,glaucoma,B-NAME_OF_DISEASE,4563
94072,it,O,4563
94073,damages,O,4563
94074,and,O,4563
94075,eventually,O,4563
94076,kills,O,4563
94077,retinal,B-PART_OF_THE_EYES,4563
94078,ganglion,I-PART_OF_THE_EYES,4563
94079,cells,I-PART_OF_THE_EYES,4564
94080,In,O,4564
94081,other,O,4564
94082,conditions,O,4564
94083,inflammation,O,4564
94084,blocked,O,4564
94085,blood,O,4564
94086,vessels,O,4564
94087,or,O,4564
94088,tumors,O,4564
94089,can,O,4564
94090,kill,O,4564
94091,retinal,B-PART_OF_THE_EYES,4564
94092,ganglion,I-PART_OF_THE_EYES,4564
94093,cells,I-PART_OF_THE_EYES,4564
94094,Once,O,4564
94095,they,O,4564
94096,die,O,4565
94097,retinal,B-PART_OF_THE_EYES,4565
94098,ganglion,I-PART_OF_THE_EYES,4565
94099,cells,I-PART_OF_THE_EYES,4565
94100,don,O,4565
94101,t,O,4565
94102,regenerate,O,4565
94103,That,O,4565
94104,s,O,4565
94105,why,O,4565
94106,it,O,4565
94107,is,O,4565
94108,so,O,4565
94109,important,O,4565
94110,to,O,4565
94111,detect,O,4565
94112,glaucoma,B-NAME_OF_DISEASE,4566
94113,early,O,4566
94114,says,O,4566
94115,Johnson,O,4566
94116,We,O,4566
94117,know,O,4566
94118,a,O,4566
94119,lot,O,4566
94120,about,O,4566
94121,how,O,4566
94122,to,O,4566
94123,treat,O,4566
94124,glaucoma,B-NAME_OF_DISEASE,4566
94125,and,O,4566
94126,help,O,4566
94127,nerve,O,4566
94128,cells,O,4566
94129,survive,O,4567
94130,an,O,4567
94131,injury,O,4567
94132,but,O,4567
94133,once,O,4567
94134,the,O,4567
94135,cells,O,4567
94136,die,O,4567
94137,off,O,4567
94138,the,O,4567
94139,damage,O,4567
94140,to,O,4567
94141,someone,O,4567
94142,s,O,4567
94143,vision,O,4567
94144,becomes,O,4567
94145,permanent,O,4567
94146,Johnson,B-PERSON,4567
94147,is,O,4567
94148,a,O,4567
94149,member,O,4567
94150,of,O,4567
94151,a,O,4567
94152,team,O,4567
94153,of,O,4567
94154,researchers,O,4568
94155,at,O,4568
94156,the,B-ORGANIZATION,4568
94157,Johns,I-ORGANIZATION,4568
94158,Hopkins,I-ORGANIZATION,4568
94159,Wilmer,I-ORGANIZATION,4568
94160,Eye,I-ORGANIZATION,4568
94161,Institute,I-ORGANIZATION,4568
94162,looking,O,4568
94163,for,O,4568
94164,ways,O,4568
94165,scientists,O,4568
94166,can,O,4568
94167,repair,O,4569
94168,or,O,4569
94169,replace,O,4569
94170,lost,O,4569
94171,optic,O,4569
94172,neurons,O,4569
94173,by,O,4569
94174,growing,O,4569
94175,new,O,4570
94176,cells,O,4570
94177,In,O,4570
94178,the,O,4570
94179,current,O,4570
94180,study,O,4570
94181,Johnson,B-PERSON,4570
94182,and,O,4570
94183,his,O,4570
94184,team,O,4570
94185,grew,O,4571
94186,mouse,O,4571
94187,retinas,B-PART_OF_THE_EYES,4571
94188,in,O,4572
94189,a,O,4572
94190,laboratory,O,4572
94191,dish,O,4572
94192,and,O,4572
94193,tracked,O,4573
94194,what,O,4573
94195,happens,O,4573
94196,when,O,4574
94197,they,O,4574
94198,added,O,4574
94199,human,O,4574
94200,retinal,B-PART_OF_THE_EYES,4575
94201,ganglion,I-PART_OF_THE_EYES,4575
94202,cells,I-PART_OF_THE_EYES,4576
94203,derived,O,4576
94204,from,O,4576
94205,human,O,4577
94206,embryonic,O,4577
94207,stem,O,4577
94208,cells,O,4577
94209,to,O,4577
94210,the,O,4577
94211,surface,O,4577
94212,of,O,4577
94213,the,O,4577
94214,mouse,O,4577
94215,retinas,B-PART_OF_THE_EYES,4577
94216,They,O,4577
94217,found,O,4577
94218,that,O,4577
94219,most,O,4577
94220,of,O,4577
94221,the,O,4577
94222,transplanted,O,4577
94223,human,O,4577
94224,cells,O,4577
94225,were,O,4577
94226,unable,O,4577
94227,to,O,4577
94228,integrate,O,4577
94229,into,O,4577
94230,the,B-PART_OF_THE_EYES,4578
94231,retinal,I-PART_OF_THE_EYES,4578
94232,tissue,I-PART_OF_THE_EYES,4578
94233,which,O,4578
94234,contains,O,4578
94235,several,O,4578
94236,layers,O,4578
94237,of,O,4578
94238,cells,O,4578
94239,The,O,4578
94240,transplanted,O,4578
94241,cells,O,4578
94242,clumped,O,4578
94243,together,O,4578
94244,rather,O,4578
94245,than,O,4579
94246,dispersing,O,4579
94247,from,O,4579
94248,one,O,4579
94249,another,O,4579
94250,like,O,4579
94251,on,O,4579
94252,a,O,4579
94253,living,O,4579
94254,retina,B-PART_OF_THE_EYES,4579
94255,says,O,4579
94256,Johnson,B-PERSON,4579
94257,However,O,4579
94258,the,O,4579
94259,researchers,O,4579
94260,found,O,4580
94261,that,O,4580
94262,a,O,4580
94263,small,O,4580
94264,number,O,4580
94265,of,O,4580
94266,transplanted,O,4580
94267,retinal,B-PART_OF_THE_EYES,4580
94268,cells,I-PART_OF_THE_EYES,4581
94269,were,O,4581
94270,able,O,4581
94271,to,O,4581
94272,settle,O,4581
94273,uniformly,O,4581
94274,into,O,4581
94275,certain,O,4581
94276,areas,O,4581
94277,of,O,4581
94278,the,O,4581
94279,mouse,O,4581
94280,retina,B-PART_OF_THE_EYES,4581
94281,Looking,O,4581
94282,more,O,4581
94283,closely,O,4581
94284,the,O,4582
94285,areas,O,4582
94286,where,O,4582
94287,the,O,4582
94288,transplanted,O,4582
94289,cells,O,4582
94290,integrated,O,4582
94291,well,O,4582
94292,aligned,O,4582
94293,with,O,4582
94294,locations,O,4582
94295,where,O,4582
94296,the,O,4582
94297,researchers,O,4582
94298,had,O,4582
94299,to,O,4582
94300,make,O,4582
94301,incisions,O,4582
94302,into,O,4582
94303,the,O,4582
94304,mouse,O,4582
94305,retinas,B-PART_OF_THE_EYES,4582
94306,to,O,4582
94307,get,O,4582
94308,them,O,4582
94309,to,O,4582
94310,lie,O,4582
94311,flat,O,4582
94312,in,O,4582
94313,the,O,4583
94314,culture,O,4583
94315,dish,O,4583
94316,At,O,4583
94317,these,O,4583
94318,incision,O,4583
94319,points,O,4583
94320,some,O,4583
94321,of,O,4583
94322,the,O,4583
94323,transplanted,O,4583
94324,cells,O,4583
94325,were,O,4583
94326,able,O,4583
94327,to,O,4583
94328,crawl,O,4583
94329,into,O,4583
94330,the,B-PART_OF_THE_EYES,4583
94331,retina,I-PART_OF_THE_EYES,4583
94332,and,O,4583
94333,integrate,O,4583
94334,themselves,O,4583
94335,in,O,4583
94336,the,O,4584
94337,proper,O,4584
94338,place,O,4584
94339,within,O,4584
94340,the,O,4584
94341,tissue,O,4584
94342,This,O,4584
94343,suggested,O,4584
94344,that,O,4584
94345,there,O,4584
94346,was,O,4584
94347,some,O,4584
94348,type,O,4584
94349,of,O,4584
94350,barrier,O,4584
94351,that,O,4584
94352,had,O,4584
94353,been,O,4584
94354,broken,O,4585
94355,by,O,4585
94356,these,O,4585
94357,incisions,O,4585
94358,Johnson,B-PERSON,4585
94359,says,O,4585
94360,If,O,4585
94361,we,O,4585
94362,could,O,4586
94363,find,O,4586
94364,a,O,4586
94365,way,O,4586
94366,to,O,4586
94367,remove,O,4586
94368,it,O,4586
94369,we,O,4586
94370,may,O,4586
94371,have,O,4586
94372,more,O,4587
94373,success,O,4587
94374,with,O,4587
94375,transplantation,O,4587
94376,It,O,4587
94377,turns,O,4587
94378,out,O,4587
94379,that,O,4587
94380,the,O,4587
94381,barrier,O,4587
94382,is,O,4587
94383,a,O,4587
94384,well-known,O,4587
94385,anatomical,O,4587
94386,structure,O,4587
94387,of,O,4587
94388,the,B-PART_OF_THE_EYES,4587
94389,retina,I-PART_OF_THE_EYES,4587
94390,called,O,4588
94391,the,B-PART_OF_THE_EYES,4588
94392,internal,I-PART_OF_THE_EYES,4588
94393,limiting,I-PART_OF_THE_EYES,4588
94394,membrane,I-PART_OF_THE_EYES,4588
94395,It,O,4588
94396,s,O,4588
94397,a,O,4588
94398,translucent,O,4588
94399,connective,O,4588
94400,tissue,O,4588
94401,created,O,4588
94402,by,O,4588
94403,the,B-PART_OF_THE_EYES,4588
94404,retina,I-PART_OF_THE_EYES,4589
94405,s,I-PART_OF_THE_EYES,4589
94406,cells,I-PART_OF_THE_EYES,4589
94407,to,O,4589
94408,separate,O,4589
94409,the,O,4589
94410,fluid,O,4589
94411,of,O,4589
94412,the,O,4589
94413,eye,O,4589
94414,from,O,4589
94415,the,B-PART_OF_THE_EYES,4589
94416,retina,I-PART_OF_THE_EYES,4589
94417,After,O,4589
94418,using,O,4589
94419,an,O,4589
94420,enzyme,B-CHEMICAL_COMPOUND,4589
94421,to,O,4589
94422,loosen,O,4589
94423,the,O,4590
94424,connective,O,4590
94425,fibers,O,4591
94426,of,O,4591
94427,the,B-PART_OF_THE_EYES,4591
94428,internal,I-PART_OF_THE_EYES,4591
94429,limiting,I-PART_OF_THE_EYES,4591
94430,membrane,I-PART_OF_THE_EYES,4591
94431,the,O,4591
94432,researchers,O,4591
94433,removed,O,4591
94434,the,O,4591
94435,membrane,O,4591
94436,and,O,4591
94437,applied,O,4591
94438,the,O,4591
94439,transplanted,O,4591
94440,human,O,4591
94441,cells,O,4591
94442,to,O,4591
94443,the,B-PART_OF_THE_EYES,4591
94444,retinas,I-PART_OF_THE_EYES,4591
94445,They,O,4592
94446,found,O,4592
94447,that,O,4592
94448,most,O,4593
94449,of,O,4593
94450,the,O,4593
94451,transplanted,O,4593
94452,retinal,B-PART_OF_THE_EYES,4593
94453,ganglion,I-PART_OF_THE_EYES,4593
94454,cells,I-PART_OF_THE_EYES,4593
94455,grew,O,4593
94456,in,O,4593
94457,a,O,4593
94458,more,O,4593
94459,normal,O,4593
94460,pattern,O,4593
94461,integrating,O,4593
94462,themselves,O,4593
94463,more,O,4593
94464,fully,O,4593
94465,The,O,4593
94466,transplanted,O,4593
94467,cells,O,4594
94468,also,O,4594
94469,showed,O,4594
94470,signs,O,4594
94471,of,O,4595
94472,establishing,O,4595
94473,new,O,4595
94474,nerve,O,4595
94475,connections,O,4595
94476,to,O,4595
94477,the,O,4595
94478,rest,O,4595
94479,of,O,4595
94480,the,O,4595
94481,retinal,O,4595
94482,structure,O,4595
94483,when,O,4595
94484,compared,O,4595
94485,with,O,4595
94486,retinas,B-PART_OF_THE_EYES,4595
94487,that,O,4595
94488,had,O,4595
94489,intact,O,4595
94490,membranes,O,4595
94491,These,O,4595
94492,findings,O,4596
94493,suggest,O,4596
94494,that,O,4596
94495,altering,O,4596
94496,the,B-PART_OF_THE_EYES,4596
94497,internal,I-PART_OF_THE_EYES,4596
94498,limiting,I-PART_OF_THE_EYES,4596
94499,membrane,I-PART_OF_THE_EYES,4596
94500,may,O,4596
94501,be,O,4596
94502,a,O,4596
94503,necessary,O,4596
94504,step,O,4596
94505,in,O,4596
94506,our,O,4596
94507,aim,O,4596
94508,to,O,4596
94509,regrow,O,4596
94510,new,O,4596
94511,cells,O,4596
94512,in,O,4596
94513,damaged,O,4596
94514,retinas,B-PART_OF_THE_EYES,4596
94515,says,O,4596
94516,Johnson,B-PERSON,4596
94517,The,O,4597
94518,researchers,O,4597
94519,plan,O,4597
94520,to,O,4597
94521,continue,O,4597
94522,investigating,O,4597
94523,the,O,4597
94524,development,O,4597
94525,of,O,4597
94526,transplanted,O,4597
94527,retinal,B-PART_OF_THE_EYES,4597
94528,ganglion,I-PART_OF_THE_EYES,4597
94529,cells,I-PART_OF_THE_EYES,4597
94530,to,O,4597
94531,determine,O,4597
94532,the,O,4597
94533,factors,O,4597
94534,they,O,4597
94535,need,O,4597
94536,to,O,4597
94537,function,O,4597
94538,once,O,4597
94539,integrated,O,4597
94540,into,O,4597
94541,the,B-PART_OF_THE_EYES,4597
94542,retina,I-PART_OF_THE_EYES,4597
94543,Open-angle,B-NAME_OF_DISEASE,4597
94544,glaucoma,B-NAME_OF_DISEASE,4597
94545,is,O,4597
94546,a,O,4597
94547,common,O,4597
94548,type,O,4597
94549,of,O,4597
94550,eye,O,4597
94551,disorder,O,4597
94552,that,O,4598
94553,affects,O,4598
94554,millions,O,4598
94555,of,O,4598
94556,people,O,4598
94557,worldwide,O,4598
94558,It,O,4598
94559,is,O,4598
94560,also,O,4598
94561,known,O,4598
94562,as,O,4598
94563,primary,B-NAME_OF_DISEASE,4598
94564,open-angle,B-NAME_OF_DISEASE,4598
94565,glaucoma,I-NAME_OF_DISEASE,4598
94566,and,O,4598
94567,is,O,4598
94568,the,O,4598
94569,most,O,4598
94570,common,O,4598
94571,form,O,4598
94572,of,O,4598
94573,glaucoma,B-NAME_OF_DISEASE,4598
94574,in,O,4598
94575,the,B-GPE,4598
94576,United,I-GPE,4598
94577,States,I-GPE,4599
94578,It,O,4599
94579,is,O,4599
94580,a,O,4599
94581,progressive,O,4599
94582,eye,O,4599
94583,disease,O,4599
94584,that,O,4599
94585,can,O,4599
94586,cause,O,4599
94587,permanent,B-NAME_OF_DISEASE,4599
94588,vision,I-NAME_OF_DISEASE,4599
94589,loss,I-NAME_OF_DISEASE,4599
94590,if,O,4599
94591,left,O,4599
94592,untreated,O,4599
94593,In,O,4600
94594,this,O,4600
94595,article,O,4600
94596,we,O,4600
94597,will,O,4600
94598,explore,O,4600
94599,what,O,4600
94600,open-angle,B-NAME_OF_DISEASE,4600
94601,glaucoma,I-NAME_OF_DISEASE,4600
94602,is,O,4600
94603,what,O,4600
94604,causes,O,4600
94605,it,O,4600
94606,the,O,4600
94607,symptoms,O,4600
94608,diagnosis,O,4600
94609,treatment,O,4600
94610,options,O,4600
94611,and,O,4600
94612,how,O,4600
94613,it,O,4600
94614,can,O,4600
94615,be,O,4600
94616,prevented,O,4600
94617,What,O,4600
94618,Is,O,4600
94619,Open-Angle,B-NAME_OF_DISEASE,4600
94620,Glaucoma,I-NAME_OF_DISEASE,4600
94621,Open-angle,B-NAME_OF_DISEASE,4600
94622,glaucoma,B-NAME_OF_DISEASE,4600
94623,is,O,4600
94624,a,O,4601
94625,type,O,4601
94626,of,O,4601
94627,eye,O,4601
94628,disease,O,4601
94629,that,O,4601
94630,occurs,O,4601
94631,when,O,4601
94632,the,B-SIGN_AND_SYMPTOM,4601
94633,pressure,I-SIGN_AND_SYMPTOM,4601
94634,inside,I-SIGN_AND_SYMPTOM,4601
94635,the,I-SIGN_AND_SYMPTOM,4601
94636,eye,I-SIGN_AND_SYMPTOM,4601
94637,increases,I-SIGN_AND_SYMPTOM,4601
94638,leading,O,4601
94639,to,O,4601
94640,damage,B-SIGN_AND_SYMPTOM,4601
94641,of,I-SIGN_AND_SYMPTOM,4602
94642,the,I-SIGN_AND_SYMPTOM,4602
94643,optic,I-SIGN_AND_SYMPTOM,4602
94644,nerve,I-SIGN_AND_SYMPTOM,4602
94645,The,B-PART_OF_THE_EYES,4602
94646,optic,I-PART_OF_THE_EYES,4602
94647,nerve,I-PART_OF_THE_EYES,4602
94648,is,O,4602
94649,responsible,O,4602
94650,for,O,4602
94651,carrying,O,4602
94652,visual,O,4602
94653,information,O,4602
94654,from,O,4602
94655,the,O,4602
94656,eye,O,4602
94657,to,O,4602
94658,the,O,4602
94659,brain,O,4602
94660,In,O,4602
94661,open-angle,B-NAME_OF_DISEASE,4602
94662,glaucoma,I-NAME_OF_DISEASE,4602
94663,the,B-SIGN_AND_SYMPTOM,4602
94664,drainage,I-SIGN_AND_SYMPTOM,4602
94665,system,I-SIGN_AND_SYMPTOM,4603
94666,of,I-SIGN_AND_SYMPTOM,4603
94667,the,I-SIGN_AND_SYMPTOM,4603
94668,eye,I-SIGN_AND_SYMPTOM,4603
94669,becomes,I-SIGN_AND_SYMPTOM,4603
94670,clogged,I-SIGN_AND_SYMPTOM,4603
94671,leading,O,4603
94672,to,O,4603
94673,an,B-SIGN_AND_SYMPTOM,4603
94674,increase,I-SIGN_AND_SYMPTOM,4603
94675,in,I-SIGN_AND_SYMPTOM,4603
94676,the,I-SIGN_AND_SYMPTOM,4603
94677,intraocular,I-SIGN_AND_SYMPTOM,4603
94678,pressure,I-SIGN_AND_SYMPTOM,4603
94679,The,B-SIGN_AND_SYMPTOM,4603
94680,damage,B-SIGN_AND_SYMPTOM,4603
94681,to,I-SIGN_AND_SYMPTOM,4603
94682,the,I-SIGN_AND_SYMPTOM,4603
94683,optic,I-SIGN_AND_SYMPTOM,4603
94684,nerve,I-SIGN_AND_SYMPTOM,4603
94685,caused,O,4603
94686,by,O,4603
94687,open-angle,B-NAME_OF_DISEASE,4604
94688,glaucoma,I-NAME_OF_DISEASE,4604
94689,is,O,4604
94690,irreversible,O,4604
94691,and,O,4604
94692,can,O,4604
94693,result,O,4605
94694,in,O,4605
94695,permanent,B-NAME_OF_DISEASE,4605
94696,vision,I-NAME_OF_DISEASE,4605
94697,loss,I-NAME_OF_DISEASE,4605
94698,What,O,4605
94699,Causes,O,4605
94700,Open-angle,B-NAME_OF_DISEASE,4605
94701,Glaucoma,I-NAME_OF_DISEASE,4605
94702,The,O,4605
94703,exact,O,4605
94704,cause,O,4605
94705,of,O,4605
94706,open-angle,B-NAME_OF_DISEASE,4605
94707,glaucoma,I-NAME_OF_DISEASE,4605
94708,is,O,4605
94709,not,O,4605
94710,fully,O,4605
94711,understood,O,4605
94712,However,O,4605
94713,it,O,4606
94714,is,O,4606
94715,believed,O,4606
94716,that,O,4606
94717,a,O,4606
94718,combination,O,4606
94719,of,O,4606
94720,factors,O,4606
94721,can,O,4606
94722,contribute,O,4606
94723,to,O,4606
94724,the,O,4606
94725,development,O,4606
94726,of,O,4606
94727,the,O,4606
94728,disease,O,4606
94729,These,O,4606
94730,include,O,4606
94731,Increased,B-CAUSE_OF_DISEASE,4606
94732,Intraocular,I-CAUSE_OF_DISEASE,4606
94733,Pressure,I-CAUSE_OF_DISEASE,4606
94734,The,B-CAUSE_OF_DISEASE,4606
94735,pressure,I-CAUSE_OF_DISEASE,4606
94736,inside,I-CAUSE_OF_DISEASE,4606
94737,the,I-CAUSE_OF_DISEASE,4606
94738,eye,I-CAUSE_OF_DISEASE,4606
94739,can,I-CAUSE_OF_DISEASE,4606
94740,increase,I-CAUSE_OF_DISEASE,4606
94741,when,I-CAUSE_OF_DISEASE,4607
94742,the,I-CAUSE_OF_DISEASE,4607
94743,drainage,I-CAUSE_OF_DISEASE,4607
94744,system,I-CAUSE_OF_DISEASE,4607
94745,becomes,I-CAUSE_OF_DISEASE,4607
94746,clogged,I-CAUSE_OF_DISEASE,4607
94747,leading,O,4607
94748,to,O,4607
94749,damage,B-SIGN_AND_SYMPTOM,4607
94750,to,I-SIGN_AND_SYMPTOM,4607
94751,the,I-SIGN_AND_SYMPTOM,4607
94752,optic,I-SIGN_AND_SYMPTOM,4607
94753,nerve,I-SIGN_AND_SYMPTOM,4607
94754,Age,B-CAUSE_OF_DISEASE,4607
94755,Open-angle,B-NAME_OF_DISEASE,4607
94756,glaucoma,B-NAME_OF_DISEASE,4607
94757,is,O,4607
94758,more,O,4607
94759,common,O,4607
94760,in,O,4608
94761,individuals,O,4608
94762,over,O,4608
94763,the,O,4608
94764,age,O,4608
94765,of,O,4608
94766,40,O,4608
94767,Ethnicity,B-CAUSE_OF_DISEASE,4608
94768,African,O,4608
94769,Americans,O,4608
94770,Hispanics,O,4608
94771,and,O,4608
94772,Asians,O,4608
94773,are,O,4608
94774,at,O,4608
94775,a,O,4608
94776,higher,O,4608
94777,risk,O,4608
94778,of,O,4608
94779,developing,O,4608
94780,open-angle,B-NAME_OF_DISEASE,4608
94781,glaucoma,I-NAME_OF_DISEASE,4608
94782,Family,B-CAUSE_OF_DISEASE,4608
94783,History,I-CAUSE_OF_DISEASE,4608
94784,A,B-CAUSE_OF_DISEASE,4609
94785,family,I-CAUSE_OF_DISEASE,4609
94786,history,I-CAUSE_OF_DISEASE,4609
94787,of,I-CAUSE_OF_DISEASE,4609
94788,open-angle,I-CAUSE_OF_DISEASE,4609
94789,glaucoma,I-CAUSE_OF_DISEASE,4609
94790,can,O,4609
94791,increase,O,4609
94792,the,O,4609
94793,risk,O,4609
94794,of,O,4609
94795,developing,O,4609
94796,the,O,4609
94797,disease,O,4609
94798,Medical,B-CAUSE_OF_DISEASE,4609
94799,Conditions,I-CAUSE_OF_DISEASE,4609
94800,Certain,B-CAUSE_OF_DISEASE,4609
94801,medical,I-CAUSE_OF_DISEASE,4609
94802,conditions,I-CAUSE_OF_DISEASE,4609
94803,such,I-CAUSE_OF_DISEASE,4609
94804,as,I-CAUSE_OF_DISEASE,4609
94805,diabetes,I-CAUSE_OF_DISEASE,4609
94806,and,I-CAUSE_OF_DISEASE,4609
94807,hypertension,I-CAUSE_OF_DISEASE,4609
94808,can,O,4609
94809,increase,O,4609
94810,the,O,4609
94811,risk,O,4609
94812,of,O,4609
94813,developing,O,4609
94814,open-angle,B-NAME_OF_DISEASE,4610
94815,glaucoma,I-NAME_OF_DISEASE,4610
94816,Do,O,4610
94817,Genetics,O,4610
94818,Play,O,4610
94819,A,O,4610
94820,Role,O,4610
94821,In,O,4610
94822,Open-Angle,B-NAME_OF_DISEASE,4610
94823,Glaucoma,I-NAME_OF_DISEASE,4610
94824,Yes,O,4610
94825,genetics,O,4610
94826,can,O,4610
94827,play,O,4610
94828,a,O,4611
94829,role,O,4611
94830,in,O,4611
94831,open-angle,B-NAME_OF_DISEASE,4611
94832,glaucoma,I-NAME_OF_DISEASE,4611
94833,Individuals,O,4611
94834,with,O,4611
94835,a,B-CAUSE_OF_DISEASE,4611
94836,family,I-CAUSE_OF_DISEASE,4611
94837,history,I-CAUSE_OF_DISEASE,4611
94838,of,I-CAUSE_OF_DISEASE,4611
94839,the,I-CAUSE_OF_DISEASE,4612
94840,disease,I-CAUSE_OF_DISEASE,4612
94841,are,O,4612
94842,at,O,4612
94843,a,O,4612
94844,higher,O,4612
94845,risk,O,4612
94846,of,O,4612
94847,developing,O,4612
94848,open-angle,B-NAME_OF_DISEASE,4612
94849,glaucoma,I-NAME_OF_DISEASE,4612
94850,Researchers,O,4612
94851,have,O,4612
94852,identified,O,4612
94853,several,O,4612
94854,genes,O,4612
94855,that,O,4612
94856,are,O,4612
94857,associated,O,4612
94858,with,O,4612
94859,open-angle,B-NAME_OF_DISEASE,4612
94860,glaucoma,I-NAME_OF_DISEASE,4612
94861,including,O,4612
94862,MYOC,B-CHEMICAL_COMPOUND,4613
94863,OPTN,B-CHEMICAL_COMPOUND,4613
94864,and,O,4613
94865,WDR36,B-CHEMICAL_COMPOUND,4613
94866,However,O,4613
94867,having,O,4613
94868,a,O,4613
94869,genetic,O,4613
94870,predisposition,O,4613
94871,to,O,4613
94872,the,O,4613
94873,disease,O,4613
94874,does,O,4613
94875,not,O,4613
94876,guarantee,O,4613
94877,that,O,4614
94878,an,O,4614
94879,individual,O,4614
94880,will,O,4614
94881,develop,O,4614
94882,it,O,4614
94883,Does,O,4614
94884,Open-Angle,B-NAME_OF_DISEASE,4614
94885,Glaucoma,I-NAME_OF_DISEASE,4614
94886,Have,O,4614
94887,Any,O,4614
94888,Symptoms,O,4614
94889,Open-angle,B-NAME_OF_DISEASE,4614
94890,glaucoma,I-NAME_OF_DISEASE,4614
94891,is,O,4614
94892,often,O,4614
94893,called,O,4614
94894,the,O,4614
94895,silent,O,4615
94896,thief,O,4615
94897,of,O,4615
94898,sight,O,4615
94899,because,O,4615
94900,it,O,4615
94901,can,O,4615
94902,develop,O,4615
94903,slowly,O,4615
94904,and,O,4615
94905,without,O,4615
94906,any,O,4615
94907,symptoms,O,4615
94908,In,O,4615
94909,the,O,4615
94910,early,O,4615
94911,stages,O,4615
94912,of,O,4615
94913,the,O,4615
94914,disease,O,4615
94915,there,O,4615
94916,may,O,4616
94917,be,O,4616
94918,no,O,4616
94919,noticeable,O,4616
94920,symptoms,O,4616
94921,As,O,4616
94922,the,O,4616
94923,disease,O,4616
94924,progresses,O,4616
94925,individuals,O,4616
94926,may,O,4616
94927,experience,O,4616
94928,1,O,4616
94929,Patchy,B-SIGN_AND_SYMPTOM,4617
94930,blind,I-SIGN_AND_SYMPTOM,4617
94931,spots,I-SIGN_AND_SYMPTOM,4617
94932,in,I-SIGN_AND_SYMPTOM,4617
94933,the,I-SIGN_AND_SYMPTOM,4617
94934,peripheral,I-SIGN_AND_SYMPTOM,4617
94935,or,I-SIGN_AND_SYMPTOM,4617
94936,central,I-SIGN_AND_SYMPTOM,4617
94937,vision,I-SIGN_AND_SYMPTOM,4617
94938,2,O,4617
94939,Tunnel,B-SIGN_AND_SYMPTOM,4617
94940,vision,I-SIGN_AND_SYMPTOM,4617
94941,3,O,4617
94942,Difficulty,B-SIGN_AND_SYMPTOM,4617
94943,adjusting,I-SIGN_AND_SYMPTOM,4617
94944,to,I-SIGN_AND_SYMPTOM,4617
94945,darkness,I-SIGN_AND_SYMPTOM,4617
94946,4,O,4617
94947,Blurred,B-SIGN_AND_SYMPTOM,4617
94948,vision,I-SIGN_AND_SYMPTOM,4617
94949,5,O,4617
94950,Halos,B-SIGN_AND_SYMPTOM,4617
94951,around,I-SIGN_AND_SYMPTOM,4617
94952,lights,I-SIGN_AND_SYMPTOM,4617
94953,6,O,4617
94954,Headaches,B-SIGN_AND_SYMPTOM,4617
94955,7,O,4617
94956,Eye,B-SIGN_AND_SYMPTOM,4618
94957,pain,I-SIGN_AND_SYMPTOM,4618
94958,8,O,4618
94959,Redness,B-SIGN_AND_SYMPTOM,4618
94960,in,I-SIGN_AND_SYMPTOM,4618
94961,the,I-SIGN_AND_SYMPTOM,4618
94962,eye,I-SIGN_AND_SYMPTOM,4618
94963,It,O,4618
94964,is,O,4618
94965,important,O,4618
94966,to,O,4618
94967,note,O,4618
94968,that,O,4618
94969,by,O,4618
94970,the,O,4618
94971,time,O,4618
94972,symptoms,O,4618
94973,appear,O,4618
94974,significant,O,4618
94975,damage,O,4618
94976,to,O,4618
94977,the,B-PART_OF_THE_EYES,4619
94978,optic,I-PART_OF_THE_EYES,4619
94979,nerve,I-PART_OF_THE_EYES,4619
94980,may,O,4619
94981,have,O,4619
94982,already,O,4619
94983,occurred,O,4619
94984,How,O,4619
94985,Is,O,4619
94986,Open-Angle,B-NAME_OF_DISEASE,4619
94987,Glaucoma,I-NAME_OF_DISEASE,4619
94988,Diagnosed,O,4620
94989,Open-angle,B-NAME_OF_DISEASE,4620
94990,glaucoma,I-NAME_OF_DISEASE,4620
94991,can,O,4620
94992,be,O,4620
94993,diagnosed,O,4620
94994,through,O,4620
94995,a,O,4620
94996,comprehensive,O,4620
94997,eye,O,4620
94998,exam,O,4620
94999,The,O,4620
95000,exam,O,4620
95001,will,O,4620
95002,include,O,4620
95003,Tonometry,B-DIAGNOSTIC_TEST,4620
95004,This,O,4620
95005,measures,O,4620
95006,the,O,4620
95007,pressure,O,4620
95008,inside,O,4620
95009,the,O,4620
95010,eye,O,4620
95011,Intra,O,4620
95012,Ocular,O,4621
95013,Pressure,O,4621
95014,Visual,B-DIAGNOSTIC_TEST,4621
95015,Field,I-DIAGNOSTIC_TEST,4621
95016,Test,I-DIAGNOSTIC_TEST,4621
95017,This,O,4621
95018,measures,O,4621
95019,the,O,4621
95020,peripheral,O,4621
95021,vision,O,4621
95022,Dilated,B-DIAGNOSTIC_TEST,4621
95023,Eye,I-DIAGNOSTIC_TEST,4621
95024,Exam,I-DIAGNOSTIC_TEST,4621
95025,This,O,4621
95026,allows,O,4621
95027,the,O,4621
95028,ophthalmologist,O,4621
95029,to,O,4621
95030,examine,O,4621
95031,the,B-PART_OF_THE_EYES,4621
95032,optic,I-PART_OF_THE_EYES,4621
95033,nerve,I-PART_OF_THE_EYES,4621
95034,for,O,4621
95035,signs,O,4621
95036,of,O,4621
95037,damage,O,4621
95038,Optical,B-DIAGNOSTIC_TEST,4621
95039,Coherence,I-DIAGNOSTIC_TEST,4621
95040,Tomography,I-DIAGNOSTIC_TEST,4621
95041,OCT,I-DIAGNOSTIC_TEST,4621
95042,This,O,4621
95043,is,O,4622
95044,a,O,4622
95045,non-invasive,O,4622
95046,imaging,O,4622
95047,test,O,4622
95048,that,O,4622
95049,can,O,4622
95050,measure,O,4622
95051,the,O,4623
95052,thickness,O,4623
95053,of,O,4623
95054,the,B-PART_OF_THE_EYES,4623
95055,optic,I-PART_OF_THE_EYES,4623
95056,nerve,I-PART_OF_THE_EYES,4623
95057,and,O,4623
95058,changes,O,4623
95059,in,O,4623
95060,the,B-PART_OF_THE_EYES,4623
95061,retinal,I-PART_OF_THE_EYES,4623
95062,nerve,I-PART_OF_THE_EYES,4623
95063,fiber,I-PART_OF_THE_EYES,4623
95064,layer,I-PART_OF_THE_EYES,4623
95065,RNFL,I-PART_OF_THE_EYES,4623
95066,,O,4623
95067,Treatment,O,4623
95068,Options,O,4624
95069,For,O,4624
95070,Open-Angle,B-NAME_OF_DISEASE,4624
95071,Glaucoma,I-NAME_OF_DISEASE,4624
95072,Primary,B-NAME_OF_DISEASE,4624
95073,open-angle,I-NAME_OF_DISEASE,4624
95074,glaucoma,I-NAME_OF_DISEASE,4624
95075,POAG,B-NAME_OF_DISEASE,4624
95076,is,O,4624
95077,a,O,4624
95078,progressive,O,4624
95079,eye,O,4624
95080,disease,O,4624
95081,that,O,4624
95082,can,O,4624
95083,cause,O,4624
95084,permanent,B-NAME_OF_DISEASE,4625
95085,vision,I-NAME_OF_DISEASE,4625
95086,loss,I-NAME_OF_DISEASE,4625
95087,if,O,4625
95088,left,O,4625
95089,untreated,O,4625
95090,The,O,4625
95091,management,O,4625
95092,of,O,4625
95093,POAG,B-NAME_OF_DISEASE,4625
95094,involves,O,4625
95095,lowering,O,4625
95096,the,O,4625
95097,intraocular,O,4625
95098,pressure,O,4625
95099,IOP,O,4625
95100,to,O,4625
95101,prevent,O,4625
95102,further,O,4625
95103,damage,O,4625
95104,to,O,4625
95105,the,B-PART_OF_THE_EYES,4625
95106,optic,I-PART_OF_THE_EYES,4625
95107,nerve,I-PART_OF_THE_EYES,4625
95108,Treatment,O,4625
95109,options,O,4625
95110,include,O,4625
95111,medication,B-TREATMENT,4625
95112,laser,B-TREATMENT,4625
95113,therapy,I-TREATMENT,4625
95114,and,O,4625
95115,surgery,B-TREATMENT,4625
95116,Medications,B-TREATMENT,4625
95117,Eye,B-TREATMENT,4626
95118,drops,I-TREATMENT,4626
95119,are,O,4626
95120,the,O,4626
95121,most,O,4626
95122,common,O,4626
95123,treatment,O,4626
95124,for,O,4626
95125,POAG,B-NAME_OF_DISEASE,4626
95126,They,O,4626
95127,work,O,4626
95128,by,O,4626
95129,either,O,4626
95130,reducing,O,4626
95131,the,O,4626
95132,production,O,4626
95133,of,O,4627
95134,fluid,O,4627
95135,in,O,4627
95136,the,O,4627
95137,eye,O,4627
95138,or,O,4627
95139,increasing,O,4627
95140,the,O,4627
95141,drainage,O,4627
95142,of,O,4627
95143,fluid,O,4627
95144,There,O,4627
95145,are,O,4627
95146,several,O,4627
95147,classes,O,4627
95148,of,O,4628
95149,medications,B-TREATMENT,4628
95150,used,O,4628
95151,to,O,4628
95152,treat,O,4628
95153,POAG,B-NAME_OF_DISEASE,4628
95154,including,O,4628
95155,Prostaglandin,B-NAME_OF_DRUG,4628
95156,Analogs,I-NAME_OF_DRUG,4628
95157,e.g,O,4628
95158,latanoprost,B-NAME_OF_DRUG,4628
95159,bimatoprost,B-NAME_OF_DRUG,4628
95160,These,O,4628
95161,medications,B-TREATMENT,4628
95162,increase,O,4628
95163,the,O,4628
95164,outflow,O,4629
95165,of,O,4629
95166,fluid,O,4629
95167,in,O,4629
95168,the,O,4629
95169,eye,O,4629
95170,and,O,4629
95171,are,O,4629
95172,highly,O,4629
95173,effective,O,4629
95174,at,O,4629
95175,reducing,O,4629
95176,IOP,O,4629
95177,Beta-Blockers,B-NAME_OF_DRUG,4629
95178,e.g,O,4629
95179,timolol,B-NAME_OF_DRUG,4629
95180,These,O,4629
95181,medications,B-TREATMENT,4629
95182,reduce,O,4629
95183,the,O,4629
95184,production,O,4629
95185,of,O,4629
95186,fluid,O,4630
95187,in,O,4630
95188,the,O,4630
95189,eye,O,4630
95190,and,O,4630
95191,can,O,4630
95192,be,O,4630
95193,used,O,4630
95194,in,O,4630
95195,combination,O,4630
95196,with,O,4630
95197,prostaglandin,B-NAME_OF_DRUG,4630
95198,analogs,I-NAME_OF_DRUG,4630
95199,Alpha-Adrenergic,B-NAME_OF_DRUG,4630
95200,Agonists,I-NAME_OF_DRUG,4630
95201,e.g,O,4630
95202,brimonidine,B-NAME_OF_DRUG,4630
95203,These,O,4630
95204,medications,B-TREATMENT,4630
95205,reduce,O,4630
95206,the,O,4630
95207,production,O,4630
95208,of,O,4630
95209,fluid,O,4630
95210,in,O,4630
95211,the,O,4630
95212,eye,O,4630
95213,and,O,4630
95214,can,O,4630
95215,also,O,4630
95216,increase,O,4630
95217,the,O,4630
95218,outflow,O,4630
95219,of,O,4630
95220,fluid,O,4630
95221,Carbonic,B-NAME_OF_DRUG,4631
95222,Anhydrase,I-NAME_OF_DRUG,4631
95223,Inhibitors,I-NAME_OF_DRUG,4631
95224,e.g,O,4631
95225,dorzolamide,B-NAME_OF_DRUG,4631
95226,These,O,4631
95227,medications,B-TREATMENT,4631
95228,reduce,O,4631
95229,the,O,4631
95230,production,O,4631
95231,of,O,4631
95232,fluid,O,4631
95233,in,O,4631
95234,the,O,4631
95235,eye,O,4631
95236,and,O,4631
95237,can,O,4631
95238,be,O,4631
95239,used,O,4631
95240,in,O,4631
95241,combination,O,4631
95242,with,O,4631
95243,other,O,4631
95244,eye,O,4631
95245,drops,O,4631
95246,Laser,B-TREATMENT,4631
95247,Therapy,I-TREATMENT,4631
95248,Laser,B-TREATMENT,4631
95249,therapy,I-TREATMENT,4631
95250,also,O,4631
95251,known,O,4631
95252,as,O,4631
95253,trabeculoplasty,B-TREATMENT,4631
95254,is,O,4631
95255,a,O,4631
95256,non-invasive,O,4631
95257,procedure,O,4631
95258,that,O,4631
95259,uses,O,4631
95260,a,O,4632
95261,laser,O,4632
95262,to,O,4632
95263,improve,O,4632
95264,the,O,4632
95265,drainage,O,4632
95266,of,O,4632
95267,fluid,O,4632
95268,in,O,4632
95269,the,O,4632
95270,eye,O,4632
95271,There,O,4632
95272,are,O,4632
95273,two,O,4632
95274,types,O,4632
95275,of,O,4632
95276,laser,B-TREATMENT,4632
95277,therapy,I-TREATMENT,4632
95278,used,O,4632
95279,to,O,4632
95280,treat,O,4632
95281,POAG,B-NAME_OF_DISEASE,4632
95282,Argon,B-TREATMENT,4632
95283,Laser,I-TREATMENT,4632
95284,Trabeculoplasty,I-TREATMENT,4632
95285,ALT,I-TREATMENT,4632
95286,This,O,4632
95287,procedure,O,4632
95288,uses,O,4632
95289,a,O,4632
95290,laser,O,4632
95291,to,O,4632
95292,make,O,4632
95293,small,O,4632
95294,burns,O,4633
95295,in,O,4633
95296,the,O,4633
95297,drainage,O,4633
95298,area,O,4633
95299,of,O,4633
95300,the,O,4633
95301,eye,O,4633
95302,to,O,4633
95303,improve,O,4633
95304,fluid,O,4633
95305,outflow,O,4633
95306,Selective,B-TREATMENT,4633
95307,Laser,I-TREATMENT,4633
95308,Trabeculoplasty,I-TREATMENT,4633
95309,SLT,I-TREATMENT,4633
95310,This,O,4633
95311,procedure,O,4633
95312,uses,O,4633
95313,a,O,4633
95314,laser,O,4633
95315,to,O,4633
95316,stimulate,O,4634
95317,the,O,4634
95318,cells,O,4634
95319,in,O,4634
95320,the,O,4634
95321,drainage,O,4634
95322,area,O,4634
95323,of,O,4634
95324,the,O,4634
95325,eye,O,4634
95326,which,O,4634
95327,can,O,4634
95328,improve,O,4634
95329,fluid,O,4634
95330,outflow,O,4634
95331,Surgery,B-TREATMENT,4634
95332,If,O,4634
95333,medications,B-TREATMENT,4634
95334,and,O,4634
95335,laser,B-TREATMENT,4634
95336,therapy,I-TREATMENT,4634
95337,are,O,4634
95338,not,O,4634
95339,effective,O,4634
95340,in,O,4634
95341,controlling,O,4634
95342,IOP,O,4634
95343,surgery,B-TREATMENT,4634
95344,may,O,4634
95345,be,O,4634
95346,recommended,O,4634
95347,There,O,4634
95348,are,O,4634
95349,several,O,4634
95350,types,O,4634
95351,of,O,4634
95352,surgery,B-TREATMENT,4635
95353,used,O,4635
95354,to,O,4635
95355,treat,O,4635
95356,POAG,B-NAME_OF_DISEASE,4635
95357,including,O,4635
95358,Trabeculectomy,B-TREATMENT,4635
95359,This,O,4635
95360,procedure,O,4635
95361,involves,O,4635
95362,creating,O,4635
95363,a,O,4635
95364,small,O,4635
95365,hole,O,4635
95366,in,O,4635
95367,the,O,4635
95368,eye,O,4635
95369,to,O,4635
95370,allow,O,4636
95371,fluid,O,4636
95372,to,O,4636
95373,drain,O,4636
95374,out,O,4636
95375,of,O,4636
95376,the,O,4636
95377,eye,O,4636
95378,Glaucoma,B-TREATMENT,4636
95379,Drainage,I-TREATMENT,4636
95380,Devices,I-TREATMENT,4636
95381,These,O,4636
95382,are,O,4636
95383,small,O,4636
95384,implants,O,4636
95385,that,O,4636
95386,are,O,4637
95387,placed,O,4637
95388,in,O,4637
95389,the,O,4637
95390,eye,O,4637
95391,to,O,4637
95392,improve,O,4637
95393,fluid,O,4637
95394,drainage,O,4637
95395,Minimally,B-TREATMENT,4637
95396,Invasive,I-TREATMENT,4637
95397,Glaucoma,I-TREATMENT,4637
95398,Surgery,I-TREATMENT,4637
95399,MIGS,I-TREATMENT,4637
95400,These,O,4637
95401,are,O,4637
95402,a,O,4637
95403,group,O,4637
95404,of,O,4637
95405,new,O,4637
95406,surgical,O,4637
95407,procedures,O,4637
95408,that,O,4637
95409,use,O,4637
95410,small,O,4637
95411,incisions,O,4637
95412,and,O,4637
95413,specialized,O,4637
95414,instruments,O,4637
95415,to,O,4638
95416,improve,O,4638
95417,fluid,O,4638
95418,drainage,O,4638
95419,It,O,4638
95420,is,O,4638
95421,important,O,4638
95422,to,O,4638
95423,note,O,4638
95424,that,O,4638
95425,the,O,4638
95426,goal,O,4638
95427,of,O,4638
95428,treatment,O,4638
95429,is,O,4638
95430,to,B-TREATMENT,4638
95431,lower,I-TREATMENT,4638
95432,IOP,I-TREATMENT,4639
95433,to,I-TREATMENT,4639
95434,prevent,I-TREATMENT,4639
95435,further,I-TREATMENT,4639
95436,damage,I-TREATMENT,4639
95437,to,I-TREATMENT,4639
95438,the,I-TREATMENT,4639
95439,optic,I-TREATMENT,4639
95440,nerve,I-TREATMENT,4639
95441,Treatment,O,4639
95442,does,O,4639
95443,not,O,4639
95444,reverse,O,4639
95445,existing,O,4639
95446,damage,O,4639
95447,Regular,O,4639
95448,eye,O,4640
95449,exams,O,4640
95450,and,O,4640
95451,monitoring,O,4640
95452,are,O,4640
95453,necessary,O,4640
95454,to,O,4640
95455,assess,O,4640
95456,the,O,4640
95457,effectiveness,O,4640
95458,of,O,4640
95459,treatment,O,4640
95460,and,O,4640
95461,adjust,O,4640
95462,the,O,4640
95463,management,O,4640
95464,plan,O,4640
95465,as,O,4640
95466,needed,O,4640
95467,In,O,4640
95468,addition,O,4640
95469,to,O,4640
95470,medical,O,4640
95471,and,O,4640
95472,surgical,O,4640
95473,management,O,4640
95474,lifestyle,B-PREVENTION,4640
95475,changes,I-PREVENTION,4640
95476,such,I-PREVENTION,4640
95477,as,I-PREVENTION,4640
95478,regular,I-PREVENTION,4640
95479,exercise,I-PREVENTION,4640
95480,maintaining,I-PREVENTION,4640
95481,a,I-PREVENTION,4640
95482,healthy,I-PREVENTION,4640
95483,weight,I-PREVENTION,4640
95484,and,I-PREVENTION,4640
95485,avoiding,I-PREVENTION,4640
95486,smoking,I-PREVENTION,4641
95487,can,O,4641
95488,also,O,4641
95489,help,O,4641
95490,in,O,4641
95491,the,O,4641
95492,management,O,4641
95493,of,O,4641
95494,POAG,B-NAME_OF_DISEASE,4641
95495,Dietary,B-PREVENTION,4641
95496,changes,I-PREVENTION,4641
95497,such,I-PREVENTION,4641
95498,as,I-PREVENTION,4642
95499,reducing,I-PREVENTION,4642
95500,caffeine,I-PREVENTION,4642
95501,intake,I-PREVENTION,4642
95502,and,I-PREVENTION,4642
95503,increasing,I-PREVENTION,4642
95504,the,I-PREVENTION,4642
95505,consumption,I-PREVENTION,4642
95506,of,I-PREVENTION,4642
95507,green,I-PREVENTION,4642
95508,leafy,I-PREVENTION,4642
95509,vegetables,I-PREVENTION,4642
95510,may,O,4642
95511,also,O,4642
95512,be,O,4642
95513,beneficial,O,4642
95514,How,O,4642
95515,Can,O,4642
95516,Open-Angle,B-NAME_OF_DISEASE,4642
95517,Glaucoma,I-NAME_OF_DISEASE,4642
95518,Be,O,4642
95519,Prevented,O,4642
95520,Regular,B-PREVENTION,4642
95521,Eye,I-PREVENTION,4642
95522,Exams,I-PREVENTION,4642
95523,Routine,B-PREVENTION,4642
95524,eye,I-PREVENTION,4642
95525,exams,I-PREVENTION,4642
95526,can,O,4643
95527,detect,O,4643
95528,signs,O,4643
95529,of,O,4643
95530,POAG,B-NAME_OF_DISEASE,4643
95531,and,O,4643
95532,allow,O,4643
95533,for,O,4643
95534,early,O,4643
95535,diagnosis,O,4643
95536,and,O,4644
95537,treatment,O,4644
95538,The,B-ORGANIZATION,4644
95539,American,I-ORGANIZATION,4644
95540,Academy,I-ORGANIZATION,4644
95541,of,I-ORGANIZATION,4644
95542,Ophthalmology,I-ORGANIZATION,4644
95543,recommends,O,4644
95544,a,O,4644
95545,comprehensive,O,4644
95546,eye,O,4644
95547,exam,O,4644
95548,at,O,4644
95549,least,O,4644
95550,once,O,4644
95551,every,O,4644
95552,two,B-TIME_DURATION,4644
95553,years,I-TIME_DURATION,4644
95554,for,O,4644
95555,adults,O,4644
95556,over,O,4644
95557,40,O,4644
95558,and,O,4644
95559,more,O,4644
95560,frequently,O,4644
95561,for,O,4644
95562,those,O,4644
95563,with,O,4644
95564,risk,O,4644
95565,factors,O,4644
95566,for,O,4644
95567,glaucoma,B-NAME_OF_DISEASE,4644
95568,Lifestyle,B-PREVENTION,4644
95569,Changes,I-PREVENTION,4645
95570,Maintaining,B-PREVENTION,4645
95571,a,I-PREVENTION,4645
95572,healthy,I-PREVENTION,4645
95573,lifestyle,I-PREVENTION,4645
95574,can,O,4645
95575,help,O,4645
95576,reduce,O,4645
95577,the,O,4645
95578,risk,O,4645
95579,of,O,4645
95580,developing,O,4645
95581,POAG,B-NAME_OF_DISEASE,4645
95582,This,O,4645
95583,includes,O,4645
95584,regular,B-PREVENTION,4645
95585,exercise,I-PREVENTION,4645
95586,maintaining,I-PREVENTION,4645
95587,a,I-PREVENTION,4645
95588,healthy,I-PREVENTION,4645
95589,weight,I-PREVENTION,4645
95590,and,I-PREVENTION,4645
95591,avoiding,I-PREVENTION,4645
95592,smoking,I-PREVENTION,4645
95593,Dietary,B-PREVENTION,4645
95594,Changes,I-PREVENTION,4645
95595,Increasing,B-PREVENTION,4645
95596,the,I-PREVENTION,4645
95597,consumption,I-PREVENTION,4645
95598,of,I-PREVENTION,4645
95599,green,I-PREVENTION,4646
95600,leafy,I-PREVENTION,4646
95601,vegetables,I-PREVENTION,4646
95602,which,O,4646
95603,are,O,4646
95604,high,O,4646
95605,in,O,4646
95606,antioxidants,B-CHEMICAL_COMPOUND,4646
95607,and,O,4646
95608,other,O,4646
95609,nutrients,B-CHEMICAL_COMPOUND,4646
95610,may,O,4646
95611,be,O,4646
95612,beneficial,O,4646
95613,for,O,4646
95614,eye,O,4646
95615,health,O,4646
95616,Some,O,4646
95617,studies,O,4646
95618,have,O,4646
95619,also,O,4646
95620,suggested,O,4646
95621,that,O,4647
95622,reducing,B-PREVENTION,4647
95623,caffeine,I-PREVENTION,4647
95624,intake,I-PREVENTION,4647
95625,may,O,4647
95626,help,O,4647
95627,to,O,4647
95628,lower,O,4647
95629,intraocular,O,4647
95630,pressure,O,4647
95631,Managing,B-PREVENTION,4647
95632,Medical,I-PREVENTION,4647
95633,Conditions,I-PREVENTION,4647
95634,Certain,O,4647
95635,medical,O,4647
95636,conditions,O,4648
95637,such,O,4648
95638,as,O,4648
95639,diabetes,B-NAME_OF_DISEASE,4648
95640,and,O,4648
95641,hypertension,B-NAME_OF_DISEASE,4648
95642,can,O,4648
95643,increase,O,4648
95644,the,O,4648
95645,risk,O,4648
95646,of,O,4648
95647,developing,O,4648
95648,POAG,B-NAME_OF_DISEASE,4648
95649,Managing,B-PREVENTION,4648
95650,these,I-PREVENTION,4648
95651,conditions,I-PREVENTION,4648
95652,with,I-PREVENTION,4648
95653,regular,I-PREVENTION,4648
95654,medical,I-PREVENTION,4648
95655,care,I-PREVENTION,4648
95656,and,I-PREVENTION,4648
95657,following,I-PREVENTION,4648
95658,recommended,I-PREVENTION,4648
95659,lifestyle,B-PREVENTION,4648
95660,changes,I-PREVENTION,4648
95661,can,O,4648
95662,help,O,4648
95663,to,O,4648
95664,reduce,O,4649
95665,the,O,4649
95666,risk,O,4649
95667,of,O,4649
95668,developing,O,4649
95669,POAG,B-NAME_OF_DISEASE,4649
95670,Eye,B-PREVENTION,4649
95671,Protection,I-PREVENTION,4649
95672,Protecting,B-PREVENTION,4649
95673,the,I-PREVENTION,4649
95674,eyes,I-PREVENTION,4649
95675,from,I-PREVENTION,4649
95676,injury,I-PREVENTION,4649
95677,is,O,4649
95678,also,O,4649
95679,important,O,4649
95680,in,O,4649
95681,preventing,O,4649
95682,POAG,B-NAME_OF_DISEASE,4649
95683,Wearing,B-PREVENTION,4649
95684,protective,I-PREVENTION,4649
95685,eyewear,I-PREVENTION,4649
95686,during,I-PREVENTION,4649
95687,certain,I-PREVENTION,4649
95688,activities,I-PREVENTION,4649
95689,such,I-PREVENTION,4649
95690,as,I-PREVENTION,4649
95691,sports,I-PREVENTION,4649
95692,or,I-PREVENTION,4649
95693,work,I-PREVENTION,4649
95694,that,I-PREVENTION,4649
95695,involves,I-PREVENTION,4649
95696,exposure,I-PREVENTION,4649
95697,to,I-PREVENTION,4649
95698,chemicals,I-PREVENTION,4649
95699,or,I-PREVENTION,4649
95700,flying,I-PREVENTION,4650
95701,debris,I-PREVENTION,4650
95702,can,O,4650
95703,help,O,4650
95704,reduce,O,4650
95705,the,O,4650
95706,risk,O,4650
95707,of,O,4650
95708,eye,O,4650
95709,injury,O,4650
95710,Conclusion,O,4650
95711,In,O,4650
95712,conclusion,O,4650
95713,primary,B-NAME_OF_DISEASE,4650
95714,open-angle,I-NAME_OF_DISEASE,4650
95715,glaucoma,I-NAME_OF_DISEASE,4650
95716,POAG,I-NAME_OF_DISEASE,4650
95717,is,O,4650
95718,a,O,4651
95719,progressive,O,4651
95720,eye,O,4651
95721,disease,O,4651
95722,that,O,4651
95723,can,O,4651
95724,cause,O,4651
95725,permanent,B-NAME_OF_DISEASE,4651
95726,vision,I-NAME_OF_DISEASE,4651
95727,loss,I-NAME_OF_DISEASE,4651
95728,if,O,4651
95729,left,O,4651
95730,untreated,O,4651
95731,It,O,4651
95732,is,O,4651
95733,a,O,4651
95734,common,O,4651
95735,condition,O,4651
95736,that,O,4652
95737,affects,O,4652
95738,millions,O,4652
95739,of,O,4652
95740,people,O,4652
95741,worldwide,O,4652
95742,While,O,4652
95743,the,O,4652
95744,exact,O,4652
95745,cause,O,4652
95746,of,O,4652
95747,POAG,B-NAME_OF_DISEASE,4652
95748,is,O,4652
95749,not,O,4652
95750,fully,O,4652
95751,understood,O,4652
95752,there,O,4652
95753,are,O,4652
95754,several,O,4652
95755,risk,O,4652
95756,factors,O,4652
95757,that,O,4652
95758,can,O,4652
95759,increase,O,4652
95760,the,O,4652
95761,likelihood,O,4652
95762,of,O,4652
95763,developing,O,4652
95764,the,O,4652
95765,disease,O,4652
95766,Regular,B-PREVENTION,4652
95767,eye,I-PREVENTION,4652
95768,exams,I-PREVENTION,4653
95769,lifestyle,B-PREVENTION,4653
95770,changes,I-PREVENTION,4653
95771,managing,B-PREVENTION,4653
95772,medical,I-PREVENTION,4653
95773,conditions,I-PREVENTION,4653
95774,and,O,4653
95775,eye,B-PREVENTION,4653
95776,protection,I-PREVENTION,4653
95777,are,O,4653
95778,some,O,4654
95779,of,O,4654
95780,the,O,4654
95781,ways,O,4654
95782,individuals,O,4654
95783,can,O,4654
95784,reduce,O,4654
95785,their,O,4654
95786,risk,O,4654
95787,of,O,4654
95788,developing,O,4654
95789,POAG,B-NAME_OF_DISEASE,4654
95790,or,O,4654
95791,slow,O,4654
95792,its,O,4655
95793,progression,O,4655
95794,if,O,4655
95795,already,O,4655
95796,diagnosed,O,4655
95797,Treatment,O,4655
95798,options,O,4655
95799,include,O,4655
95800,medication,B-TREATMENT,4655
95801,laser,B-TREATMENT,4655
95802,therapy,I-TREATMENT,4655
95803,and,O,4655
95804,surgery,B-TREATMENT,4655
95805,Early,O,4655
95806,diagnosis,O,4655
95807,and,O,4655
95808,treatment,O,4655
95809,are,O,4655
95810,critical,O,4655
95811,in,O,4655
95812,preventing,O,4655
95813,further,O,4655
95814,damage,O,4655
95815,to,O,4655
95816,the,B-PART_OF_THE_EYES,4656
95817,optic,I-PART_OF_THE_EYES,4656
95818,nerve,I-PART_OF_THE_EYES,4656
95819,and,O,4656
95820,preserving,O,4656
95821,vision,O,4656
95822,It,O,4656
95823,is,O,4656
95824,important,O,4656
95825,to,O,4656
95826,consult,O,4656
95827,with,O,4656
95828,an,O,4656
95829,Ophthalmologist,O,4656
95830,for,O,4656
95831,individualized,O,4656
95832,recommendations,O,4656
95833,on,O,4656
95834,preventing,O,4656
95835,and,O,4656
95836,managing,O,4656
95837,POAG,B-NAME_OF_DISEASE,4656
95838,Age‐related,B-NAME_OF_DISEASE,4656
95839,macular,I-NAME_OF_DISEASE,4656
95840,degeneration,I-NAME_OF_DISEASE,4657
95841,AMD,B-NAME_OF_DISEASE,4657
95842,is,O,4657
95843,a,O,4657
95844,retinal,O,4657
95845,degenerative,O,4657
95846,disease,O,4657
95847,that,O,4657
95848,causes,O,4657
95849,irreversible,O,4657
95850,and,O,4657
95851,profound,O,4657
95852,vision,B-SIGN_AND_SYMPTOM,4657
95853,loss,I-SIGN_AND_SYMPTOM,4657
95854,in,O,4658
95855,people,O,4658
95856,over,O,4658
95857,the,O,4658
95858,age,O,4658
95859,of,O,4658
95860,60,O,4658
95861,years,O,4658
95862,with,O,4658
95863,estimates,O,4658
95864,of,O,4658
95865,AMD,B-NAME_OF_DISEASE,4658
95866,patients,O,4658
95867,nearing,O,4658
95868,70,O,4658
95869,million,O,4658
95870,worldwide,O,4658
95871,It,O,4658
95872,is,O,4658
95873,emerging,O,4658
95874,as,O,4658
95875,one,O,4658
95876,of,O,4658
95877,the,O,4658
95878,primary,O,4658
95879,causes,O,4658
95880,of,O,4658
95881,vision,B-NAME_OF_DISEASE,4658
95882,impairment,I-NAME_OF_DISEASE,4658
95883,in,O,4658
95884,the,O,4658
95885,developed,O,4659
95886,world,O,4659
95887,Age‐related,B-NAME_OF_DISEASE,4659
95888,macular,I-NAME_OF_DISEASE,4659
95889,degeneration,I-NAME_OF_DISEASE,4659
95890,AMD,B-NAME_OF_DISEASE,4659
95891,occurs,O,4659
95892,in,O,4659
95893,two,O,4659
95894,major,O,4659
95895,forms,O,4659
95896,exudative,B-NAME_OF_DISEASE,4660
95897,wet,I-NAME_OF_DISEASE,4660
95898,and,I-NAME_OF_DISEASE,4660
95899,atrophic,I-NAME_OF_DISEASE,4660
95900,dry,B-NAME_OF_DISEASE,4660
95901,AMD,I-NAME_OF_DISEASE,4660
95902,Dry,B-NAME_OF_DISEASE,4660
95903,AMD,I-NAME_OF_DISEASE,4660
95904,is,O,4660
95905,characterized,O,4660
95906,by,O,4660
95907,drusen,B-SIGN_AND_SYMPTOM,4660
95908,retinal,I-SIGN_AND_SYMPTOM,4660
95909,pigment,I-SIGN_AND_SYMPTOM,4661
95910,epithelial,I-SIGN_AND_SYMPTOM,4661
95911,RPE,I-SIGN_AND_SYMPTOM,4661
95912,cell,I-SIGN_AND_SYMPTOM,4661
95913,atrophy,I-SIGN_AND_SYMPTOM,4661
95914,and,I-SIGN_AND_SYMPTOM,4661
95915,subjacent,I-SIGN_AND_SYMPTOM,4661
95916,photoreceptor,I-SIGN_AND_SYMPTOM,4661
95917,degeneration,I-SIGN_AND_SYMPTOM,4661
95918,Factors,O,4661
95919,involved,O,4661
95920,in,O,4661
95921,causing,O,4661
95922,RPE,B-SIGN_AND_SYMPTOM,4661
95923,cell,I-SIGN_AND_SYMPTOM,4661
95924,injury,I-SIGN_AND_SYMPTOM,4661
95925,and,I-SIGN_AND_SYMPTOM,4661
95926,dysfunction,I-SIGN_AND_SYMPTOM,4661
95927,have,O,4661
95928,been,O,4661
95929,shown,O,4661
95930,to,O,4662
95931,include,O,4662
95932,mitochondrial,B-CAUSE_OF_DISEASE,4662
95933,dysfunction,I-CAUSE_OF_DISEASE,4662
95934,oxidative,B-CAUSE_OF_DISEASE,4662
95935,stress,I-CAUSE_OF_DISEASE,4662
95936,inflammation,B-CAUSE_OF_DISEASE,4662
95937,and,O,4662
95938,genetic,B-CAUSE_OF_DISEASE,4662
95939,disposition,I-CAUSE_OF_DISEASE,4662
95940,The,O,4662
95941,vast,O,4662
95942,majority,O,4662
95943,of,O,4662
95944,AMD,B-NAME_OF_DISEASE,4662
95945,patients,O,4662
95946,suffering,O,4662
95947,from,O,4662
95948,dry,B-NAME_OF_DISEASE,4662
95949,AMD,I-NAME_OF_DISEASE,4662
95950,marked,O,4662
95951,by,O,4662
95952,RPE,B-SIGN_AND_SYMPTOM,4662
95953,dysfunction,I-SIGN_AND_SYMPTOM,4662
95954,with,I-SIGN_AND_SYMPTOM,4662
95955,drusen,I-SIGN_AND_SYMPTOM,4662
95956,formation,I-SIGN_AND_SYMPTOM,4662
95957,and,I-SIGN_AND_SYMPTOM,4662
95958,eventual,I-SIGN_AND_SYMPTOM,4662
95959,retinal,I-SIGN_AND_SYMPTOM,4662
95960,atrophy,I-SIGN_AND_SYMPTOM,4662
95961,have,O,4662
95962,no,O,4662
95963,effective,O,4662
95964,treatment,O,4663
95965,options,O,4663
95966,other,O,4663
95967,than,O,4663
95968,lifestyle,B-TREATMENT,4663
95969,modification,I-TREATMENT,4663
95970,and,O,4663
95971,the,B-TREATMENT,4663
95972,use,I-TREATMENT,4663
95973,of,I-TREATMENT,4663
95974,vitamins,I-TREATMENT,4663
95975,A,O,4663
95976,safe,O,4663
95977,and,O,4663
95978,globally,O,4663
95979,expanding,O,4663
95980,medical,O,4663
95981,intervention,O,4663
95982,is,O,4663
95983,the,O,4663
95984,use,O,4663
95985,of,O,4663
95986,low‐level,B-TREATMENT,4663
95987,laser,I-TREATMENT,4663
95988,light,I-TREATMENT,4663
95989,therapy,I-TREATMENT,4663
95990,LLLT,I-TREATMENT,4663
95991,that,O,4663
95992,now,O,4663
95993,includes,O,4663
95994,diabetic,O,4664
95995,wound,O,4664
95996,repair,O,4664
95997,arthritis,B-NAME_OF_DISEASE,4664
95998,cancer,B-NAME_OF_DISEASE,4664
95999,radiation,O,4664
96000,protection,O,4664
96001,oral,O,4664
96002,mucositis,O,4664
96003,dental,O,4664
96004,sports,O,4664
96005,medicine,O,4664
96006,and,O,4664
96007,skeletal,B-NAME_OF_DISEASE,4664
96008,muscle,I-NAME_OF_DISEASE,4664
96009,disorders,I-NAME_OF_DISEASE,4664
96010,trauma,O,4664
96011,and,O,4664
96012,pain,O,4664
96013,,O,4664
96014,In,O,4664
96015,the,O,4664
96016,last,O,4664
96017,couple,O,4664
96018,of,O,4664
96019,decades,O,4664
96020,Photobiomodulation,B-TREATMENT,4664
96021,PBM,I-TREATMENT,4664
96022,therapy,I-TREATMENT,4664
96023,-,O,4665
96024,a,O,4665
96025,light-based,O,4665
96026,treatment,O,4665
96027,approach,O,4665
96028,used,O,4665
96029,widely,O,4665
96030,for,O,4665
96031,tissue,O,4665
96032,repair,O,4665
96033,and,O,4665
96034,reducing,O,4665
96035,pain,B-SIGN_AND_SYMPTOM,4665
96036,and,I-SIGN_AND_SYMPTOM,4665
96037,inflammation,I-SIGN_AND_SYMPTOM,4665
96038,-,O,4665
96039,has,O,4665
96040,gained,O,4665
96041,recognition,O,4665
96042,among,O,4665
96043,biomedical,O,4665
96044,researchers,O,4665
96045,and,O,4666
96046,healthcare,O,4666
96047,professionals,O,4666
96048,Low‐level,B-TREATMENT,4666
96049,laser,I-TREATMENT,4666
96050,therapy,I-TREATMENT,4666
96051,exerts,O,4666
96052,its,O,4666
96053,beneficial,O,4666
96054,effects,O,4666
96055,through,O,4666
96056,increased,O,4666
96057,blood,O,4666
96058,flow,O,4666
96059,and,O,4666
96060,stimulation,O,4666
96061,of,O,4666
96062,cellular,O,4666
96063,functions,O,4667
96064,a,O,4667
96065,process,O,4667
96066,called,O,4667
96067,photobiomodulation,B-TREATMENT,4667
96068,PBM,I-TREATMENT,4667
96069,,O,4667
96070,Photobiomodulation,B-TREATMENT,4667
96071,PBM,I-TREATMENT,4667
96072,involves,O,4667
96073,the,O,4667
96074,use,O,4667
96075,of,O,4667
96076,visible,O,4667
96077,to,O,4667
96078,near‐infrared,O,4667
96079,NIR,O,4667
96080,light,O,4667
96081,500-1000,O,4667
96082,nm,O,4668
96083,produced,O,4668
96084,by,O,4668
96085,a,O,4668
96086,laser,O,4668
96087,or,O,4668
96088,non‐coherent,O,4668
96089,light,O,4668
96090,sources,O,4668
96091,such,O,4668
96092,as,O,4668
96093,light,O,4668
96094,emitting,O,4668
96095,diodes,O,4668
96096,LEDs,O,4668
96097,applied,O,4668
96098,to,O,4668
96099,the,O,4668
96100,body,O,4668
96101,to,O,4668
96102,produce,O,4669
96103,beneficial,O,4669
96104,cellular,O,4669
96105,effects,O,4669
96106,Light,O,4669
96107,in,O,4669
96108,this,O,4669
96109,range,O,4669
96110,penetrates,O,4669
96111,tissue,O,4669
96112,depending,O,4669
96113,on,O,4670
96114,the,O,4670
96115,wavelength,O,4670
96116,and,O,4670
96117,stimulates,O,4670
96118,cellular,O,4670
96119,function,O,4670
96120,via,O,4670
96121,activation,O,4670
96122,of,O,4670
96123,photoacceptors,O,4670
96124,How,O,4670
96125,PBM,B-TREATMENT,4670
96126,Works,O,4670
96127,PBM,B-TREATMENT,4670
96128,works,O,4670
96129,by,O,4670
96130,activating,O,4670
96131,mitochondrial,O,4670
96132,respiratory,O,4670
96133,chain,O,4670
96134,components,O,4670
96135,and,O,4670
96136,stabilizing,O,4670
96137,their,O,4670
57373,able,O,7400
57374,to,O,7400
57375,prescribe,O,7400
57376,medication,O,7400
57377,for,O,7400
57378,children,O,7400
57379,with,O,7400
57380,a,O,7400
57381,better,O,7400
57382,evidence,O,7400
57383,base,O,7400
57384,of,O,7400
57385,efficacy,O,7400
57386,and,O,7400
57387,safety,O,7400
57388,We,O,7400
57389,anticipate,O,7400
57390,that,O,7401
57391,the,O,7401
57392,need,O,7401
57393,to,O,7401
57394,grow,O,7401
57395,and,O,7401
57396,enhance,O,7401
57397,the,O,7401
57398,currently,O,7401
57399,limited,O,7401
57400,evidence,O,7401
57401,base,O,7401
57402,for,O,7401
57403,much,O,7401
57404,pediatric,O,7401
57405,eye,O,7401
57406,care,O,7401
57407,will,O,7401
57408,lead,O,7401
57409,to,O,7401
57410,more,O,7401
57411,research,O,7401
57412,and,O,7401
57413,specifically,O,7401
57414,the,O,7401
57415,establishment,O,7402
57416,of,O,7402
57417,new,O,7402
57418,clinical,O,7402
57419,trials,O,7402
57420,in,O,7402
57421,this,O,7402
57422,area,O,7402
57423,Changes,O,7402
57424,to,O,7402
57425,the,O,7403
57426,way,O,7403
57427,we,O,7403
57428,care,O,7403
57429,for,O,7403
57430,children,O,7403
57431,in,O,7403
57432,pediatric,O,7403
57433,ophthalmology,O,7403
57434,Children,O,7403
57435,in,O,7403
57436,2020,O,7403
57437,are,O,7403
57438,rarely,O,7403
57439,seen,O,7403
57440,within,O,7403
57441,a,O,7403
57442,general,O,7403
57443,predominantly,O,7404
57444,adult,O,7404
57445,clinic,O,7404
57446,and,O,7404
57447,are,O,7404
57448,much,O,7404
57449,more,O,7404
57450,likely,O,7404
57451,to,O,7404
57452,be,O,7404
57453,assessed,O,7404
57454,in,O,7404
57455,child-focused,O,7404
57456,dedicated,O,7404
57457,pediatric,O,7404
57458,clinics,O,7404
57459,with,O,7404
57460,facilities,O,7404
57461,specifically,O,7404
57462,pitched,O,7405
57463,towards,O,7405
57464,children,O,7405
57465,and,O,7405
57466,by,O,7405
57467,experienced,O,7405
57468,staff,O,7405
57469,with,O,7405
57470,appropriate,O,7405
57471,safeguarding,O,7405
57472,training,O,7405
57473,This,O,7405
57474,has,O,7406
57475,substantially,O,7406
57476,improved,O,7406
57477,the,O,7406
57478,experience,O,7406
57479,of,O,7406
57480,care,O,7406
57481,for,O,7406
57482,the,O,7406
57483,children,O,7406
57484,and,O,7406
57485,their,O,7406
57486,families,O,7406
57487,The,O,7407
57488,majority,O,7407
57489,of,O,7407
57490,consultants,O,7407
57491,who,O,7407
57492,regularly,O,7407
57493,deal,O,7407
57494,with,O,7407
57495,children,O,7407
57496,now,O,7407
57497,have,O,7407
57498,a,O,7407
57499,subspeciality,O,7407
57500,interest,O,7407
57501,in,O,7407
57502,pediatric,O,7407
57503,ophthalmology,O,7407
57504,usually,O,7407
57505,following,O,7408
57506,post-CCT,O,7408
57507,fellowship,O,7408
57508,training,O,7408
57509,Pediatric,O,7408
57510,ophthalmology,O,7408
57511,clinics,O,7408
57512,require,O,7408
57513,multidisciplinary,O,7408
57514,expertise,O,7408
57515,Orthoptists,O,7408
57516,have,O,7408
57517,traditionally,O,7408
57518,played,O,7408
57519,a,O,7408
57520,key,O,7408
57521,part,O,7408
57522,but,O,7408
57523,other,O,7408
57524,allied,O,7408
57525,health,O,7408
57526,professionals,O,7408
57527,AHPs,O,7408
57528,such,O,7408
57529,as,O,7408
57530,pediatric,O,7408
57531,optometrists,O,7408
57532,vision,O,7408
57533,scientists,O,7408
57534,and,O,7408
57535,eye,O,7408
57536,clinic,O,7408
57537,liaison,O,7408
57538,officers,O,7408
57539,ECLOs,O,7408
57540,have,O,7409
57541,crucial,O,7409
57542,roles,O,7409
57543,in,O,7409
57544,the,O,7409
57545,delivery,O,7409
57546,of,O,7409
57547,high-quality,O,7409
57548,pediatric,O,7409
57549,ophthalmology,O,7409
57550,AHPs,O,7409
57551,often,O,7409
57552,work,O,7409
57553,independently,O,7409
57554,both,O,7409
57555,within,O,7409
57556,the,O,7409
57557,hospital,O,7409
57558,setting,O,7409
57559,and,O,7409
57560,in,O,7409
57561,community,O,7409
57562,clinics,O,7409
57563,and,O,7409
57564,support,O,7409
57565,traditional,O,7409
57566,outpatient,O,7409
57567,clinics,O,7409
57568,by,O,7409
57569,working,O,7410
57570,closely,O,7410
57571,with,O,7410
57572,pediatric,O,7410
57573,ophthalmologists,O,7410
57574,Clinics,O,7410
57575,are,O,7410
57576,ideally,O,7410
57577,supported,O,7410
57578,by,O,7410
57579,pediatric,O,7410
57580,nurses,O,7410
57581,with,O,7410
57582,the,O,7410
57583,appropriate,O,7410
57584,training,O,7410
57585,and,O,7410
57586,expertise,O,7410
57587,Examples,O,7410
57588,of,O,7410
57589,current,O,7410
57590,modern,O,7410
57591,practice,O,7410
57592,would,O,7410
57593,be,O,7410
57594,orthoptic,O,7410
57595,optometry-led,O,7410
57596,clinics,O,7410
57597,in,O,7410
57598,both,O,7410
57599,the,O,7410
57600,community,O,7410
57601,and,O,7410
57602,in,O,7410
57603,hospital,O,7410
57604,This,O,7410
57605,could,O,7410
57606,include,O,7410
57607,specialized,O,7410
57608,follow-up,O,7411
57609,clinics,O,7411
57610,in,O,7411
57611,for,O,7411
57612,instance,O,7411
57613,pediatric,B-NAME_OF_DISEASE,7411
57614,cataract,I-NAME_OF_DISEASE,7411
57615,or,O,7411
57616,uveitis,B-NAME_OF_DISEASE,7411
57617,led,O,7411
57618,by,O,7411
57619,orthoptists,O,7411
57620,or,O,7411
57621,optometrists,O,7411
57622,running,O,7412
57623,in,O,7412
57624,parallel,O,7412
57625,with,O,7412
57626,a,O,7412
57627,consultant-led,O,7412
57628,clinic,O,7412
57629,All,O,7412
57630,staff,O,7412
57631,dealing,O,7412
57632,with,O,7412
57633,children,O,7412
57634,now,O,7412
57635,receive,O,7412
57636,mandatory,O,7412
57637,safeguarding,O,7412
57638,training,O,7412
57639,This,O,7412
57640,helps,O,7412
57641,ensure,O,7412
57642,that,O,7412
57643,child,O,7412
57644,protection,O,7412
57645,issues,O,7412
57646,or,O,7412
57647,signs,O,7412
57648,of,O,7412
57649,abuse,O,7412
57650,can,O,7412
57651,be,O,7412
57652,detected,O,7412
57653,and,O,7412
57654,acted,O,7412
57655,upon,O,7412
57656,appropriately,O,7412
57657,Advances,O,7412
57658,in,O,7412
57659,imaging,O,7413
57660,and,O,7413
57661,diagnostic,O,7413
57662,tools,O,7413
57663,Accurate,O,7413
57664,assessment,O,7413
57665,and,O,7413
57666,monitoring,O,7413
57667,of,O,7413
57668,eye,O,7413
57669,disease,O,7413
57670,in,O,7413
57671,children,O,7413
57672,has,O,7413
57673,always,O,7413
57674,been,O,7413
57675,challenging,O,7413
57676,Young,O,7413
57677,children,O,7413
57678,and,O,7413
57679,children,O,7413
57680,with,O,7413
57681,neurodevelopmental,O,7413
57682,problems,O,7413
57683,can,O,7413
57684,be,O,7413
57685,difficult,O,7414
57686,to,O,7414
57687,examine,O,7414
57688,They,O,7414
57689,may,O,7414
57690,be,O,7414
57691,anxious,O,7414
57692,upset,O,7414
57693,or,O,7414
57694,fractious,O,7414
57695,and,O,7414
57696,thus,O,7414
57697,fail,O,7414
57698,to,O,7414
57699,fully,O,7414
57700,cooperate,O,7414
57701,Physical,O,7414
57702,limitations,O,7414
57703,can,O,7414
57704,also,O,7414
57705,present,O,7414
57706,boundaries,O,7414
57707,when,O,7414
57708,using,O,7414
57709,instruments,O,7414
57710,and,O,7414
57711,techniques,O,7414
57712,that,O,7414
57713,were,O,7415
57714,designed,O,7415
57715,for,O,7415
57716,use,O,7415
57717,in,O,7415
57718,adults,O,7415
57719,In,O,7415
57720,the,O,7415
57721,past,O,7415
57722,clinicians,O,7415
57723,frequently,O,7415
57724,resorted,O,7415
57725,to,O,7415
57726,examination,B-TREATMENT,7415
57727,under,I-TREATMENT,7415
57728,anesthesia,I-TREATMENT,7415
57729,EUA,I-TREATMENT,7415
57730,for,O,7415
57731,a,O,7415
57732,child,O,7415
57733,in,O,7415
57734,whom,O,7415
57735,it,O,7415
57736,was,O,7415
57737,impossible,O,7415
57738,to,O,7415
57739,obtain,O,7415
57740,an,B-DIAGNOSTIC_TEST,7416
57741,IOP,B-DIAGNOSTIC_TEST,7416
57742,measurement,I-DIAGNOSTIC_TEST,7416
57743,or,O,7416
57744,when,O,7416
57745,a,O,7416
57746,fundal,B-DIAGNOSTIC_TEST,7416
57747,examination,I-DIAGNOSTIC_TEST,7416
57748,was,O,7416
57749,similarly,O,7416
57750,difficult,O,7416
57751,but,O,7416
57752,very,O,7416
57753,important,O,7416
57754,The,O,7416
57755,availability,O,7416
57756,of,O,7416
57757,i-Care,B-TREATMENT,7416
57758,rebound,I-TREATMENT,7416
57759,tonometry,I-TREATMENT,7416
57760,which,O,7416
57761,can,O,7416
57762,be,O,7416
57763,used,O,7416
57764,swiftly,O,7417
57765,without,O,7417
57766,eye,O,7417
57767,drops,O,7417
57768,on,O,7417
57769,a,O,7417
57770,child,O,7417
57771,with,O,7417
57772,minimal,O,7417
57773,cooperation,O,7417
57774,has,O,7417
57775,greatly,O,7417
57776,reduced,O,7417
57777,the,O,7417
57778,number,O,7417
57779,of,O,7417
57780,EUAs,B-TREATMENT,7417
57781,carried,O,7417
57782,out,O,7417
57783,This,O,7417
57784,has,O,7417
57785,been,O,7417
57786,particularly,O,7417
57787,beneficial,O,7417
57788,for,O,7417
57789,children,O,7417
57790,with,O,7417
57791,conditions,O,7417
57792,such,O,7417
57793,as,O,7417
57794,glaucoma,B-NAME_OF_DISEASE,7417
57795,aniridia,B-NAME_OF_DISEASE,7417
57796,or,O,7417
57797,facial,B-NAME_OF_DISEASE,7417
57798,port-wine,I-NAME_OF_DISEASE,7417
57799,stains,I-NAME_OF_DISEASE,7417
57800,where,O,7417
57801,regular,O,7417
57802,IOP,B-DIAGNOSTIC_TEST,7418
57803,measurement,I-DIAGNOSTIC_TEST,7418
57804,is,O,7418
57805,a,O,7418
57806,crucial,O,7418
57807,part,O,7418
57808,of,O,7418
57809,assessment,O,7418
57810,and,O,7418
57811,monitoring,O,7418
57812,but,O,7418
57813,repeated,O,7418
57814,anesthesia,O,7418
57815,carries,O,7418
57816,concerns,O,7418
57817,about,O,7418
57818,the,O,7418
57819,impact,O,7418
57820,on,O,7418
57821,neurodevelopment,O,7418
57822,OCT,B-DIAGNOSTIC_TEST,7418
57823,has,O,7418
57824,also,O,7419
57825,made,O,7419
57826,a,O,7419
57827,huge,O,7419
57828,impact,O,7419
57829,on,O,7419
57830,diagnosis,O,7419
57831,and,O,7419
57832,assessment,O,7419
57833,in,O,7419
57834,pediatric,O,7419
57835,ophthalmology,O,7419
57836,An,O,7419
57837,experienced,O,7419
57838,imaging,O,7419
57839,technician,O,7419
57840,can,O,7419
57841,successfully,O,7419
57842,obtain,O,7419
57843,useful,O,7419
57844,OCT,B-DIAGNOSTIC_TEST,7419
57845,images,O,7419
57846,in,O,7419
57847,a,O,7419
57848,cooperative,O,7419
57849,child,O,7419
57850,from,O,7419
57851,the,O,7420
57852,age,O,7420
57853,of,O,7420
57854,three,O,7420
57855,upwards,O,7420
57856,and,O,7420
57857,it,O,7420
57858,has,O,7420
57859,thus,O,7420
57860,become,O,7420
57861,invaluable,O,7420
57862,in,O,7420
57863,the,O,7420
57864,assessment,O,7420
57865,of,O,7420
57866,both,O,7420
57867,anterior,O,7420
57868,and,O,7421
57869,posterior,O,7421
57870,segment,O,7421
57871,pediatric,O,7421
57872,pathology,O,7421
57873,For,O,7421
57874,instance,O,7421
57875,OCT,B-DIAGNOSTIC_TEST,7421
57876,imaging,O,7421
57877,of,O,7421
57878,swollen,B-SIGN_AND_SYMPTOM,7421
57879,optic,I-SIGN_AND_SYMPTOM,7421
57880,discs,I-SIGN_AND_SYMPTOM,7421
57881,can,O,7421
57882,help,O,7421
57883,the,O,7421
57884,clinician,O,7421
57885,distinguish,O,7421
57886,between,O,7421
57887,anomalous,B-SIGN_AND_SYMPTOM,7421
57888,looking,I-SIGN_AND_SYMPTOM,7421
57889,discs,I-SIGN_AND_SYMPTOM,7421
57890,due,O,7421
57891,to,O,7421
57892,optic,B-NAME_OF_DISEASE,7421
57893,disc,I-NAME_OF_DISEASE,7421
57894,drusen,I-NAME_OF_DISEASE,7421
57895,as,O,7421
57896,compared,O,7422
57897,to,O,7422
57898,papilloedema,B-SIGN_AND_SYMPTOM,7422
57899,Similarly,O,7422
57900,OCT,B-DIAGNOSTIC_TEST,7422
57901,is,O,7422
57902,invaluable,O,7422
57903,for,O,7422
57904,retinal,O,7422
57905,assessment,O,7422
57906,and,O,7422
57907,diagnosis,O,7422
57908,retinal,B-NAME_OF_DISEASE,7422
57909,dystrophies,I-NAME_OF_DISEASE,7422
57910,foveal,B-NAME_OF_DISEASE,7422
57911,hypoplasia,I-NAME_OF_DISEASE,7422
57912,developmental,O,7422
57913,disorders,O,7422
57914,as,O,7422
57915,well,O,7422
57916,as,O,7422
57917,macular,B-SIGN_AND_SYMPTOM,7423
57918,edema,I-SIGN_AND_SYMPTOM,7423
57919,diagnosis,O,7423
57920,and,O,7423
57921,monitoring,O,7423
57922,in,O,7423
57923,uveitis,B-NAME_OF_DISEASE,7423
57924,and,O,7423
57925,other,O,7423
57926,conditions,O,7423
57927,The,O,7423
57928,advent,O,7423
57929,of,O,7423
57930,the,B-DIAGNOSTIC_TEST,7423
57931,handheld,I-DIAGNOSTIC_TEST,7423
57932,or,I-DIAGNOSTIC_TEST,7423
57933,microscope,I-DIAGNOSTIC_TEST,7423
57934,mounted,I-DIAGNOSTIC_TEST,7423
57935,OCT,I-DIAGNOSTIC_TEST,7423
57936,has,O,7423
57937,meant,O,7424
57938,that,O,7424
57939,images,O,7424
57940,can,O,7424
57941,now,O,7424
57942,be,O,7424
57943,obtained,O,7424
57944,both,O,7424
57945,in,O,7424
57946,infants,O,7424
57947,and,O,7424
57948,during,O,7424
57949,surgery,O,7424
57950,or,O,7424
57951,examination,O,7424
57952,under,O,7424
57953,anesthetic,O,7425
57954,This,O,7425
57955,can,O,7425
57956,be,O,7425
57957,invaluable,O,7425
57958,in,O,7425
57959,the,O,7425
57960,diagnosis,O,7425
57961,and,O,7425
57962,assessment,O,7425
57963,of,O,7425
57964,young,O,7425
57965,children,O,7425
57966,with,O,7425
57967,nystagmus,B-NAME_OF_DISEASE,7425
57968,glaucoma,B-NAME_OF_DISEASE,7425
57969,retinal,O,7425
57970,pathology,O,7425
57971,and,O,7425
57972,the,O,7425
57973,retinal,O,7425
57974,complications,O,7425
57975,of,O,7425
57976,non-accidental,O,7425
57977,injury,O,7425
57978,OCT,B-DIAGNOSTIC_TEST,7426
57979,angiography,I-DIAGNOSTIC_TEST,7426
57980,is,O,7426
57981,currently,O,7426
57982,seldom,O,7426
57983,used,O,7426
57984,in,O,7426
57985,children,O,7426
57986,but,O,7426
57987,has,O,7426
57988,the,O,7426
57989,potential,O,7426
57990,to,O,7426
57991,be,O,7426
57992,a,O,7426
57993,powerful,O,7426
57994,tool,O,7426
57995,for,O,7426
57996,non-invasive,O,7426
57997,delineation,O,7426
57998,of,O,7426
57999,pediatric,O,7427
58000,retinal,O,7427
58001,vascular,O,7427
58002,and,O,7427
58003,structural,O,7427
58004,diseases,O,7427
58005,such,O,7427
58006,as,O,7427
58007,familial,B-NAME_OF_DISEASE,7427
58008,exudative,I-NAME_OF_DISEASE,7427
58009,vitreoretinopathy,I-NAME_OF_DISEASE,7427
58010,FEVR,I-NAME_OF_DISEASE,7427
58011,Incontinentia,B-NAME_OF_DISEASE,7427
58012,Pigmentii,I-NAME_OF_DISEASE,7427
58013,and,O,7427
58014,foveal,B-NAME_OF_DISEASE,7427
58015,hypoplasia,I-NAME_OF_DISEASE,7427
58016,Advances,O,7427
58017,in,O,7427
58018,digital,B-DIAGNOSTIC_TEST,7427
58019,fundal,I-DIAGNOSTIC_TEST,7427
58020,imaging,I-DIAGNOSTIC_TEST,7427
58021,in,O,7427
58022,children,O,7427
58023,have,O,7427
58024,transformed,O,7427
58025,the,O,7427
58026,diagnosis,O,7427
58027,and,O,7427
58028,monitoring,O,7428
58029,of,O,7428
58030,a,O,7428
58031,wide,O,7428
58032,range,O,7428
58033,of,O,7428
58034,children,O,7428
58035,s,O,7428
58036,eye,O,7428
58037,diseases,O,7428
58038,RetCam,B-DIAGNOSTIC_TEST,7428
58039,and,O,7428
58040,newer,O,7428
58041,more,O,7428
58042,portable,B-DIAGNOSTIC_TEST,7428
58043,digital,I-DIAGNOSTIC_TEST,7429
58044,fundal,I-DIAGNOSTIC_TEST,7429
58045,imaging,I-DIAGNOSTIC_TEST,7429
58046,devices,I-DIAGNOSTIC_TEST,7429
58047,such,I-DIAGNOSTIC_TEST,7429
58048,as,I-DIAGNOSTIC_TEST,7429
58049,PanoCam,I-DIAGNOSTIC_TEST,7429
58050,are,O,7429
58051,now,O,7429
58052,routinely,O,7429
58053,used,O,7429
58054,in,O,7429
58055,infants,O,7429
58056,and,O,7429
58057,young,O,7429
58058,children,O,7429
58059,for,O,7429
58060,the,O,7429
58061,documentation,O,7429
58062,of,O,7429
58063,retinal,O,7429
58064,disease,O,7429
58065,Digital,B-DIAGNOSTIC_TEST,7430
58066,imaging,I-DIAGNOSTIC_TEST,7430
58067,is,O,7430
58068,particularly,O,7430
58069,important,O,7430
58070,for,O,7430
58071,the,O,7430
58072,diagnosis,O,7430
58073,monitoring,O,7430
58074,and,O,7430
58075,documentation,O,7430
58076,of,O,7430
58077,retinopathy,B-NAME_OF_DISEASE,7430
58078,of,I-NAME_OF_DISEASE,7430
58079,prematurity,I-NAME_OF_DISEASE,7430
58080,ROP,B-NAME_OF_DISEASE,7430
58081,,O,7430
58082,It,O,7430
58083,has,O,7431
58084,significantly,O,7431
58085,enabled,O,7431
58086,trained,O,7431
58087,non-medical,O,7431
58088,users,O,7431
58089,to,O,7431
58090,send,O,7431
58091,images,O,7431
58092,obtained,O,7431
58093,in,O,7431
58094,the,O,7431
58095,neonatal,O,7431
58096,intensive,O,7431
58097,care,O,7431
58098,unit,O,7431
58099,NICU,O,7431
58100,to,O,7431
58101,a,O,7431
58102,remote,O,7431
58103,expert,O,7431
58104,for,O,7431
58105,interpretation,O,7431
58106,-,O,7431
58107,TRUE,O,7431
58108,telemedicine,B-TREATMENT,7431
58109,,O,7431
58110,This,O,7431
58111,principle,O,7431
58112,may,O,7431
58113,be,O,7431
58114,transformative,O,7431
58115,for,O,7432
58116,the,O,7432
58117,delivery,O,7432
58118,of,O,7432
58119,high-quality,O,7432
58120,ROP,B-NAME_OF_DISEASE,7432
58121,care,O,7432
58122,in,O,7432
58123,the,O,7432
58124,developing,O,7432
58125,world,O,7432
58126,where,O,7432
58127,pediatric,O,7432
58128,ophthalmologists,O,7432
58129,are,O,7432
58130,scarce,O,7432
58131,Digital,O,7433
58132,documentation,O,7433
58133,of,O,7433
58134,retinal,B-NAME_OF_DISEASE,7433
58135,hemorrhages,I-NAME_OF_DISEASE,7433
58136,in,O,7433
58137,cases,O,7433
58138,of,O,7433
58139,suspected,O,7433
58140,non-accidental,O,7433
58141,injury,O,7433
58142,is,O,7433
58143,important,O,7433
58144,both,O,7433
58145,clinically,O,7433
58146,and,O,7433
58147,from,O,7433
58148,a,O,7433
58149,medico-legal,O,7433
58150,aspect,O,7433
58151,The,O,7433
58152,images,O,7433
58153,obtained,O,7433
58154,are,O,7433
58155,important,O,7433
58156,evidence,O,7433
58157,for,O,7433
58158,subsequent,O,7433
58159,hearings,O,7433
58160,in,O,7433
58161,both,O,7433
58162,the,O,7433
58163,family,O,7433
58164,and,O,7433
58165,criminal,O,7433
58166,courts,O,7434
58167,Optos,B-DIAGNOSTIC_TEST,7434
58168,widescreen,I-DIAGNOSTIC_TEST,7434
58169,digital,I-DIAGNOSTIC_TEST,7434
58170,imaging,I-DIAGNOSTIC_TEST,7434
58171,can,O,7434
58172,be,O,7434
58173,carried,O,7434
58174,out,O,7435
58175,from,O,7435
58176,at,O,7435
58177,least,O,7435
58178,four,O,7435
58179,years,O,7435
58180,of,O,7435
58181,age,O,7435
58182,in,O,7435
58183,a,O,7435
58184,cooperative,O,7435
58185,child,O,7435
58186,and,O,7435
58187,provides,O,7435
58188,quickly,O,7435
58189,captured,O,7435
58190,wide-angle,O,7435
58191,images,O,7435
58192,These,O,7435
58193,are,O,7435
58194,excellent,O,7435
58195,for,O,7435
58196,assisting,O,7435
58197,the,O,7435
58198,clinician,O,7435
58199,in,O,7435
58200,the,O,7435
58201,diagnosis,O,7435
58202,and,O,7435
58203,monitoring,O,7435
58204,of,O,7435
58205,both,O,7435
58206,pediatric,B-NAME_OF_DISEASE,7435
58207,retinal,I-NAME_OF_DISEASE,7435
58208,disease,I-NAME_OF_DISEASE,7435
58209,retinoblastoma,B-NAME_OF_DISEASE,7435
58210,and,O,7435
58211,posterior,B-NAME_OF_DISEASE,7435
58212,uveitis,I-NAME_OF_DISEASE,7436
58213,Fluorescein,B-DIAGNOSTIC_TEST,7436
58214,angiography,I-DIAGNOSTIC_TEST,7436
58215,and,O,7436
58216,the,B-DIAGNOSTIC_TEST,7436
58217,autofluorescence,I-DIAGNOSTIC_TEST,7436
58218,functions,I-DIAGNOSTIC_TEST,7436
58219,of,I-DIAGNOSTIC_TEST,7436
58220,digital,I-DIAGNOSTIC_TEST,7436
58221,imaging,I-DIAGNOSTIC_TEST,7436
58222,systems,I-DIAGNOSTIC_TEST,7436
58223,have,O,7436
58224,similarly,O,7436
58225,assisted,O,7436
58226,accurate,O,7436
58227,diagnosis,O,7436
58228,and,O,7436
58229,delineation,O,7437
58230,of,O,7437
58231,maculopathy,B-NAME_OF_DISEASE,7437
58232,retinal,B-NAME_OF_DISEASE,7437
58233,ischemia,I-NAME_OF_DISEASE,7437
58234,and,O,7437
58235,subretinal,B-NAME_OF_DISEASE,7437
58236,neovascular,I-NAME_OF_DISEASE,7437
58237,membranes,I-NAME_OF_DISEASE,7437
58238,in,O,7437
58239,pediatric,B-NAME_OF_DISEASE,7437
58240,retinal,I-NAME_OF_DISEASE,7437
58241,disease,I-NAME_OF_DISEASE,7437
58242,Digital,B-DIAGNOSTIC_TEST,7438
58243,imaging,I-DIAGNOSTIC_TEST,7438
58244,equipment,I-DIAGNOSTIC_TEST,7438
58245,for,O,7438
58246,documenting,O,7438
58247,eye,O,7438
58248,movements,O,7438
58249,using,O,7438
58250,eye-tracking,O,7438
58251,software,O,7438
58252,has,O,7438
58253,become,O,7438
58254,more,O,7438
58255,widely,O,7438
58256,available,O,7438
58257,These,O,7438
58258,instruments,O,7438
58259,provide,O,7438
58260,detailed,O,7439
58261,information,O,7439
58262,for,O,7439
58263,both,O,7439
58264,the,O,7439
58265,assessment,O,7439
58266,of,O,7439
58267,nystagmus,B-NAME_OF_DISEASE,7439
58268,and,O,7439
58269,other,O,7439
58270,neuro-ophthalmic,O,7439
58271,abnormalities,O,7439
58272,affecting,O,7439
58273,saccades,O,7439
58274,and,O,7439
58275,smooth,O,7439
58276,pursuit,O,7439
58277,eye,O,7439
58278,movements,O,7439
58279,This,O,7439
58280,has,O,7439
58281,allowed,O,7439
58282,a,O,7439
58283,more,O,7439
58284,accurate,O,7440
58285,diagnosis,O,7440
58286,and,O,7440
58287,the,O,7440
58288,planning,O,7440
58289,of,O,7440
58290,surgery,O,7440
58291,for,O,7440
58292,nystagmus,B-NAME_OF_DISEASE,7440
58293,related,O,7440
58294,abnormal,O,7440
58295,head,O,7440
58296,posture,O,7440
58297,Advances,O,7440
58298,in,O,7440
58299,treatment,O,7440
58300,options,O,7440
58301,for,O,7440
58302,children,O,7440
58303,with,O,7440
58304,eye,O,7440
58305,disease,O,7440
58306,The,O,7440
58307,last,O,7441
58308,quarter,O,7441
58309,of,O,7441
58310,a,O,7441
58311,century,O,7441
58312,has,O,7441
58313,seen,O,7441
58314,many,O,7441
58315,changes,O,7441
58316,to,O,7441
58317,the,O,7441
58318,way,O,7441
58319,we,O,7441
58320,treat,O,7441
58321,ophthalmic,O,7441
58322,disorders,O,7441
58323,in,O,7441
58324,children,O,7441
58325,both,O,7441
58326,medically,O,7441
58327,and,O,7441
58328,surgically,O,7441
58329,There,O,7442
58330,have,O,7442
58331,been,O,7442
58332,concurrent,O,7442
58333,changes,O,7442
58334,to,O,7442
58335,care,O,7442
58336,pathways,O,7442
58337,and,O,7442
58338,huge,O,7442
58339,improvements,O,7442
58340,in,O,7442
58341,surgical,O,7442
58342,equipment,O,7442
58343,and,O,7442
58344,techniques,O,7442
58345,Advances,O,7442
58346,in,O,7442
58347,our,O,7442
58348,understanding,O,7442
58349,of,O,7442
58350,the,O,7442
58351,natural,O,7442
58352,history,O,7442
58353,of,O,7442
58354,strabismus,B-NAME_OF_DISEASE,7442
58355,and,O,7442
58356,the,O,7442
58357,role,O,7442
58358,of,O,7442
58359,refractive,B-NAME_OF_DISEASE,7442
58360,error,I-NAME_OF_DISEASE,7442
58361,in,O,7442
58362,the,O,7442
58363,etiology,O,7442
58364,of,O,7442
58365,squints,O,7442
58366,have,O,7442
58367,led,O,7442
58368,to,O,7442
58369,more,O,7442
58370,conservative,O,7442
58371,management,O,7443
58372,and,O,7443
58373,less,O,7443
58374,strabismus,B-TREATMENT,7443
58375,surgery,I-TREATMENT,7443
58376,is,O,7443
58377,performed,O,7443
58378,on,O,7443
58379,children,O,7443
58380,There,O,7443
58381,has,O,7443
58382,consequently,O,7443
58383,been,O,7443
58384,less,O,7443
58385,need,O,7443
58386,for,O,7443
58387,re-operations,O,7443
58388,Alternative,O,7443
58389,treatment,O,7443
58390,options,O,7443
58391,such,O,7443
58392,as,O,7443
58393,chemodenervation,B-TREATMENT,7443
58394,of,I-TREATMENT,7443
58395,extraocular,I-TREATMENT,7443
58396,muscles,I-TREATMENT,7443
58397,via,I-TREATMENT,7444
58398,botulinum,I-TREATMENT,7444
58399,toxin,I-TREATMENT,7444
58400,Botox,B-CHEMICAL_COMPOUND,7444
58401,have,O,7444
58402,been,O,7444
58403,introduced,O,7444
58404,over,O,7444
58405,the,O,7444
58406,last,O,7444
58407,30,O,7444
58408,years,O,7444
58409,for,O,7444
58410,the,O,7444
58411,management,O,7444
58412,of,O,7444
58413,pediatric,O,7444
58414,squint,B-NAME_OF_DISEASE,7444
58415,with,O,7444
58416,comparable,O,7444
58417,results,O,7444
58418,to,O,7444
58419,surgery,O,7444
58420,for,O,7445
58421,the,O,7445
58422,management,O,7445
58423,of,O,7445
58424,infantile,B-NAME_OF_DISEASE,7445
58425,esotropia,I-NAME_OF_DISEASE,7445
58426,Botox,B-CHEMICAL_COMPOUND,7445
58427,is,O,7445
58428,particularly,O,7445
58429,helpful,O,7445
58430,for,O,7445
58431,the,O,7445
58432,management,O,7445
58433,of,O,7445
58434,acute,B-NAME_OF_DISEASE,7445
58435,esotropia,I-NAME_OF_DISEASE,7445
58436,with,O,7445
58437,or,O,7445
58438,without,O,7445
58439,sixth,B-SIGN_AND_SYMPTOM,7445
58440,nerve,I-SIGN_AND_SYMPTOM,7445
58441,palsy,I-SIGN_AND_SYMPTOM,7445
58442,,O,7445
58443,This,O,7445
58444,may,O,7445
58445,have,O,7446
58446,also,O,7446
58447,contributed,O,7446
58448,to,O,7446
58449,the,O,7446
58450,reduction,O,7446
58451,in,O,7446
58452,surgery,O,7446
58453,and,O,7446
58454,better,O,7446
58455,outcomes,O,7446
58456,Advances,O,7446
58457,in,O,7446
58458,surgical,O,7446
58459,instruments,O,7446
58460,and,O,7446
58461,techniques,O,7447
58462,used,O,7447
58463,in,O,7447
58464,pediatric,O,7447
58465,intraocular,O,7447
58466,surgery,O,7447
58467,have,O,7447
58468,reduced,O,7447
58469,complications,O,7447
58470,and,O,7447
58471,improved,O,7447
58472,surgical,O,7447
58473,outcomes,O,7448
58474,In,O,7448
58475,pediatric,O,7448
58476,cataract,B-TREATMENT,7448
58477,surgery,I-TREATMENT,7448
58478,the,O,7448
58479,performance,O,7448
58480,of,O,7448
58481,a,B-TREATMENT,7448
58482,posterior,I-TREATMENT,7448
58483,capsulotomy,I-TREATMENT,7448
58484,and,O,7448
58485,anterior,B-TREATMENT,7448
58486,vitrectomy,I-TREATMENT,7449
58487,at,O,7449
58488,the,O,7449
58489,time,O,7449
58490,of,O,7449
58491,lensectomy,O,7449
58492,has,O,7449
58493,reduced,O,7449
58494,visual,O,7449
58495,axis,O,7449
58496,re-opacification,O,7449
58497,rates,O,7449
58498,The,O,7449
58499,use,O,7449
58500,of,O,7449
58501,smaller,O,7449
58502,incisions,O,7449
58503,23,O,7449
58504,and,O,7449
58505,25,O,7449
58506,gauge,O,7449
58507,atraumatic,B-TREATMENT,7449
58508,surgical,I-TREATMENT,7449
58509,technique,I-TREATMENT,7449
58510,and,O,7450
58511,rigorous,O,7450
58512,peri,B-TREATMENT,7450
58513,and,I-TREATMENT,7450
58514,postoperative,I-TREATMENT,7450
58515,anti-inflammatory,I-TREATMENT,7450
58516,regimes,I-TREATMENT,7450
58517,have,O,7450
58518,reduced,O,7450
58519,postoperative,O,7450
58520,inflammation,O,7450
58521,It,O,7450
58522,is,O,7450
58523,likely,O,7450
58524,that,O,7450
58525,as,O,7450
58526,in,O,7450
58527,adults,O,7450
58528,the,O,7450
58529,use,O,7450
58530,of,O,7450
58531,intraocular,B-TREATMENT,7450
58532,antibiotics,I-TREATMENT,7450
58533,at,O,7450
58534,the,O,7450
58535,surgery,O,7450
58536,has,O,7450
58537,reduced,O,7450
58538,the,O,7450
58539,rate,O,7450
58540,of,O,7450
58541,postoperative,B-NAME_OF_DISEASE,7450
58542,endophthalmitis,I-NAME_OF_DISEASE,7450
58543,Other,O,7450
58544,major,O,7451
58545,advances,O,7451
58546,include,O,7451
58547,a,O,7451
58548,better,O,7451
58549,understanding,O,7451
58550,of,O,7451
58551,the,O,7451
58552,indications,O,7451
58553,in,O,7451
58554,the,O,7451
58555,management,O,7451
58556,of,O,7451
58557,infantile,O,7451
58558,and,O,7451
58559,childhood,O,7451
58560,glaucoma,B-NAME_OF_DISEASE,7451
58561,for,O,7451
58562,different,O,7451
58563,surgical,O,7452
58564,procedures,O,7452
58565,-,O,7452
58566,particularly,O,7452
58567,the,O,7452
58568,increasing,O,7452
58569,role,O,7452
58570,of,O,7452
58571,modern,O,7452
58572,Seton,B-TREATMENT,7452
58573,devices,I-TREATMENT,7452
58574,such,I-TREATMENT,7452
58575,as,I-TREATMENT,7452
58576,Baerveldt,I-TREATMENT,7452
58577,and,I-TREATMENT,7452
58578,Ahmed,I-TREATMENT,7452
58579,tubes,I-TREATMENT,7452
58580,for,O,7452
58581,congenital,B-NAME_OF_DISEASE,7452
58582,and,I-NAME_OF_DISEASE,7452
58583,aphakic,I-NAME_OF_DISEASE,7452
58584,glaucoma,I-NAME_OF_DISEASE,7452
58585,Babies,O,7452
58586,born,O,7452
58587,prematurely,O,7452
58588,are,O,7453
58589,now,O,7453
58590,not,O,7453
58591,only,O,7453
58592,more,O,7453
58593,likely,O,7453
58594,to,O,7453
58595,survive,O,7453
58596,than,O,7453
58597,25,O,7453
58598,years,O,7453
58599,ago,O,7453
58600,but,O,7453
58601,are,O,7453
58602,also,O,7453
58603,likely,O,7453
58604,to,O,7453
58605,have,O,7453
58606,better,O,7453
58607,structural,O,7453
58608,and,O,7453
58609,visual,O,7453
58610,outcomes,O,7453
58611,This,O,7453
58612,is,O,7453
58613,as,O,7453
58614,a,O,7453
58615,result,O,7453
58616,of,O,7453
58617,improved,O,7453
58618,screening,O,7453
58619,programs,O,7454
58620,for,O,7454
58621,ROP,B-NAME_OF_DISEASE,7454
58622,and,O,7454
58623,a,O,7454
58624,better,O,7454
58625,knowledge,O,7454
58626,of,O,7454
58627,when,O,7454
58628,and,O,7454
58629,how,O,7454
58630,to,O,7454
58631,treat,O,7454
58632,sight-threatening,O,7454
58633,ROP,B-NAME_OF_DISEASE,7454
58634,The,B-NAME_OF_STUDY,7454
58635,ET-ROP,I-NAME_OF_STUDY,7454
58636,study,I-NAME_OF_STUDY,7454
58637,and,O,7454
58638,BEAT-ROP,B-NAME_OF_STUDY,7454
58639,studies,I-NAME_OF_STUDY,7454
58640,have,O,7454
58641,been,O,7454
58642,key,O,7454
58643,in,O,7454
58644,guiding,O,7455
58645,clinicians,O,7455
58646,in,O,7455
58647,when,O,7455
58648,and,O,7455
58649,how,O,7455
58650,to,O,7455
58651,treat,O,7455
58652,ROP,B-NAME_OF_DISEASE,7455
58653,with,O,7455
58654,laser,B-TREATMENT,7455
58655,or,O,7455
58656,intravitreal,B-TREATMENT,7455
58657,anti-VEGF,I-TREATMENT,7455
58658,injections,I-TREATMENT,7455
58659,The,O,7455
58660,RCOphth,O,7455
58661,guidelines,O,7455
58662,for,O,7455
58663,ROP,B-NAME_OF_DISEASE,7455
58664,screening,O,7455
58665,and,O,7455
58666,treatment,O,7455
58667,in,O,7455
58668,2006,O,7455
58669,defined,O,7455
58670,optimal,O,7455
58671,screening,O,7456
58672,ages,O,7456
58673,and,O,7456
58674,intervals,O,7456
58675,These,O,7456
58676,will,O,7456
58677,evolve,O,7456
58678,as,O,7456
58679,the,O,7456
58680,use,O,7456
58681,of,O,7456
58682,anti-VEGF,B-TREATMENT,7456
58683,agents,I-TREATMENT,7456
58684,becomes,O,7456
58685,more,O,7456
58686,widespread,O,7456
58687,Surgical,O,7456
58688,management,O,7456
58689,of,O,7456
58690,stage,B-NAME_OF_DISEASE,7456
58691,IV,I-NAME_OF_DISEASE,7457
58692,ROP,I-NAME_OF_DISEASE,7457
58693,has,O,7457
58694,also,O,7457
58695,advanced,O,7457
58696,tremendously,O,7457
58697,in,O,7457
58698,recent,O,7457
58699,years,O,7457
58700,Minimally,B-TREATMENT,7457
58701,invasive,I-TREATMENT,7457
58702,endoscopic,I-TREATMENT,7457
58703,vitrectomy,I-TREATMENT,7457
58704,has,O,7457
58705,improved,O,7457
58706,anatomical,O,7457
58707,outcomes,O,7457
58708,and,O,7457
58709,reduced,O,7457
58710,the,O,7457
58711,need,O,7457
58712,for,O,7457
58713,lensectomy,O,7457
58714,in,O,7457
58715,infants,O,7457
58716,who,O,7458
58717,would,O,7458
58718,previously,O,7458
58719,have,O,7458
58720,faced,O,7458
58721,a,O,7458
58722,dismal,O,7458
58723,outcome,O,7458
58724,Anti-VEGF,B-TREATMENT,7458
58725,intravitreal,I-TREATMENT,7458
58726,injections,I-TREATMENT,7458
58727,have,O,7458
58728,also,O,7458
58729,been,O,7458
58730,utilized,O,7458
58731,in,O,7458
58732,other,O,7458
58733,areas,O,7458
58734,of,O,7458
58735,pediatric,O,7458
58736,ophthalmology,O,7458
58737,such,O,7458
58738,as,O,7458
58739,in,O,7458
58740,Coat,B-NAME_OF_DISEASE,7458
58741,s,I-NAME_OF_DISEASE,7458
58742,disease,I-NAME_OF_DISEASE,7458
58743,Best,B-NAME_OF_DISEASE,7458
58744,s,I-NAME_OF_DISEASE,7458
58745,disease,I-NAME_OF_DISEASE,7458
58746,and,O,7458
58747,in,O,7458
58748,the,O,7458
58749,treatment,O,7459
58750,of,O,7459
58751,subretinal,B-NAME_OF_DISEASE,7459
58752,neovascular,I-NAME_OF_DISEASE,7459
58753,membranes,I-NAME_OF_DISEASE,7459
58754,in,O,7459
58755,inflammatory,O,7459
58756,eye,O,7459
58757,disease,O,7459
58758,Visual,O,7459
58759,and,O,7459
58760,structural,O,7459
58761,outcomes,O,7459
58762,for,O,7459
58763,children,O,7459
58764,with,O,7459
58765,uveitis,B-NAME_OF_DISEASE,7459
58766,have,O,7459
58767,improved,O,7459
58768,over,O,7459
58769,the,O,7459
58770,last,O,7459
58771,25,O,7459
58772,years,O,7459
58773,due,O,7459
58774,to,O,7460
58775,several,O,7460
58776,factors,O,7460
58777,Better,O,7460
58778,screening,O,7460
58779,of,O,7460
58780,at-risk,O,7460
58781,patients,O,7460
58782,such,O,7460
58783,as,O,7460
58784,those,O,7460
58785,with,O,7460
58786,juvenile,B-NAME_OF_DISEASE,7460
58787,idiopathic,I-NAME_OF_DISEASE,7460
58788,arthritis,I-NAME_OF_DISEASE,7460
58789,JIA,I-NAME_OF_DISEASE,7460
58790,has,O,7460
58791,allowed,O,7460
58792,earlier,O,7460
58793,diagnosis,O,7460
58794,and,O,7460
58795,intervention,O,7460
58796,for,O,7460
58797,JIA,B-NAME_OF_DISEASE,7461
58798,uveitis,I-NAME_OF_DISEASE,7461
58799,before,O,7461
58800,complications,O,7461
58801,occur,O,7461
58802,Better,O,7461
58803,care,O,7461
58804,pathways,O,7461
58805,have,O,7461
58806,indicated,O,7461
58807,early,O,7461
58808,treatment,O,7461
58809,with,O,7461
58810,immunosuppressive,B-TREATMENT,7461
58811,drugs,I-TREATMENT,7461
58812,when,O,7461
58813,the,O,7462
58814,ocular,O,7462
58815,disease,O,7462
58816,is,O,7462
58817,not,O,7462
58818,controlled,O,7462
58819,topically,O,7462
58820,with,O,7462
58821,more,O,7462
58822,efficacious,O,7462
58823,immunosuppression,O,7462
58824,options,O,7462
58825,now,O,7462
58826,available,O,7462
58827,such,O,7463
58828,as,O,7463
58829,methotrexate,B-NAME_OF_DRUG,7463
58830,and,O,7463
58831,anti-TNF,B-TREATMENT,7463
58832,agents,I-TREATMENT,7463
58833,Multidisciplinary,O,7463
58834,care,O,7463
58835,of,O,7463
58836,children,O,7463
58837,with,O,7463
58838,uveitis,B-NAME_OF_DISEASE,7463
58839,in,O,7463
58840,conjunction,O,7463
58841,with,O,7463
58842,pediatric,O,7463
58843,rheumatologists,O,7463
58844,has,O,7463
58845,meant,O,7463
58846,that,O,7463
58847,the,O,7463
58848,incidence,O,7463
58849,of,O,7463
58850,visual,B-NAME_OF_DISEASE,7463
58851,impairment,I-NAME_OF_DISEASE,7463
58852,and,O,7463
58853,blindness,B-NAME_OF_DISEASE,7463
58854,has,O,7464
58855,been,O,7464
58856,substantially,O,7464
58857,reduced,O,7464
58858,Advances,O,7464
58859,in,O,7464
58860,evidence-based,O,7464
58861,medicine,O,7464
58862,for,O,7464
58863,pediatric,O,7464
58864,ophthalmology,O,7464
58865,Twenty-five,O,7464
58866,years,O,7464
58867,ago,O,7464
58868,there,O,7464
58869,was,O,7464
58870,little,O,7464
58871,robust,O,7464
58872,evidence,O,7464
58873,for,O,7464
58874,most,O,7464
58875,of,O,7464
58876,the,O,7464
58877,interventions,O,7464
58878,and,O,7464
58879,treatments,O,7464
58880,commonly,O,7464
58881,used,O,7464
58882,in,O,7464
58883,pediatric,O,7464
58884,ophthalmology,O,7464
58885,Complex,O,7465
58886,ethical,O,7465
58887,issues,O,7465
58888,mean,O,7465
58889,recruitment,O,7465
58890,to,O,7465
58891,research,O,7465
58892,studies,O,7465
58893,in,O,7465
58894,children,O,7465
58895,is,O,7465
58896,still,O,7465
58897,difficult,O,7465
58898,with,O,7465
58899,much,O,7465
58900,progress,O,7465
58901,still,O,7465
58902,to,O,7465
58903,be,O,7465
58904,made,O,7465
58905,New,O,7465
58906,regulatory,O,7465
58907,requirements,O,7465
58908,for,O,7465
58909,pharmaceutical,O,7465
58910,companies,O,7466
58911,requiring,O,7466
58912,evaluation,O,7466
58913,of,O,7466
58914,medicines,O,7466
58915,in,O,7466
58916,children,O,7466
58917,has,O,7466
58918,resulted,O,7466
58919,in,O,7466
58920,more,O,7466
58921,interest,O,7466
58922,in,O,7466
58923,carrying,O,7466
58924,out,O,7466
58925,clinical,O,7466
58926,trials,O,7466
58927,in,O,7466
58928,pediatric,O,7466
58929,ophthalmology,O,7466
58930,There,O,7466
58931,are,O,7466
58932,for,O,7466
58933,example,O,7466
58934,current,O,7466
58935,or,O,7466
58936,forthcoming,O,7466
58937,trials,O,7466
58938,into,O,7466
58939,the,O,7466
58940,use,O,7466
58941,of,O,7466
58942,anti-VEGF,B-NAME_OF_DRUG,7466
58943,treatment,O,7467
58944,for,O,7467
58945,ROP,B-NAME_OF_DISEASE,7467
58946,gene,O,7467
58947,therapy,O,7467
58948,for,O,7467
58949,some,O,7467
58950,retinal,B-NAME_OF_DISEASE,7467
58951,dystrophies,I-NAME_OF_DISEASE,7467
58952,and,O,7467
58953,evaluation,O,7467
58954,of,O,7467
58955,low,O,7467
58956,dose,O,7467
58957,atropine,B-NAME_OF_DRUG,7467
58958,in,O,7467
58959,retardation,O,7467
58960,of,O,7467
58961,myopia,B-NAME_OF_DISEASE,7467
58962,development,O,7467
58963,The,O,7467
58964,majority,O,7468
58965,of,O,7468
58966,drugs,O,7468
58967,used,O,7468
58968,for,O,7468
58969,children,O,7468
58970,in,O,7468
58971,the,O,7468
58972,past,O,7468
58973,were,O,7468
58974,off,O,7468
58975,label,O,7468
58976,use,O,7468
58977,-,O,7468
58978,as,O,7468
58979,they,O,7468
58980,had,O,7468
58981,not,O,7468
58982,been,O,7468
58983,licensed,O,7468
58984,for,O,7468
58985,use,O,7468
58986,in,O,7468
58987,children,O,7468
58988,There,O,7468
58989,has,O,7468
58990,recently,O,7468
58991,been,O,7468
58992,an,O,7468
58993,increase,O,7468
58994,in,O,7468
58995,the,O,7469
58996,number,O,7469
58997,of,O,7469
58998,licensed,O,7469
58999,topical,O,7469
59000,treatments,O,7469
59001,for,O,7469
59002,children,O,7469
59003,giving,O,7469
59004,clinicians,O,7469
59005,greater,O,7469
59006,confidence,O,7469
59007,when,O,7469
59008,prescribing,O,7469
59009,for,O,7469
59010,children,O,7469
59011,Evidence,O,7469
59012,provided,O,7469
59013,by,O,7469
59014,several,O,7469
59015,key,O,7470
59016,studies,O,7470
59017,has,O,7470
59018,changed,O,7470
59019,how,O,7470
59020,we,O,7470
59021,treat,O,7470
59022,children,O,7470
59023,with,O,7470
59024,certain,O,7470
59025,eye,O,7470
59026,conditions,O,7470
59027,The,B-NAME_OF_STUDY,7470
59028,Infant,I-NAME_OF_STUDY,7470
59029,Aphakia,I-NAME_OF_STUDY,7470
59030,Treatment,I-NAME_OF_STUDY,7470
59031,Study,I-NAME_OF_STUDY,7470
59032,was,O,7470
59033,an,O,7470
59034,American,O,7470
59035,randomized,O,7470
59036,prospective,O,7470
59037,study,O,7470
59038,of,O,7470
59039,114,O,7470
59040,infants,O,7470
59041,It,O,7470
59042,has,O,7471
59043,provided,O,7471
59044,outcome,O,7471
59045,data,O,7471
59046,for,O,7471
59047,children,O,7471
59048,with,O,7471
59049,unilateral,B-NAME_OF_DISEASE,7471
59050,congenital,I-NAME_OF_DISEASE,7471
59051,cataract,I-NAME_OF_DISEASE,7471
59052,who,O,7471
59053,underwent,O,7471
59054,surgery,O,7471
59055,under,O,7471
59056,the,O,7471
59057,age,O,7471
59058,of,O,7471
59059,six,O,7471
59060,months,O,7471
59061,either,O,7471
59062,with,O,7471
59063,or,O,7471
59064,without,O,7471
59065,an,B-TREATMENT,7471
59066,intraocular,I-TREATMENT,7471
59067,lens,I-TREATMENT,7471
59068,The,B-NAME_OF_STUDY,7471
59069,IOLu2,I-NAME_OF_STUDY,7471
59070,study,I-NAME_OF_STUDY,7471
59071,in,O,7471
59072,the,B-GPE,7471
59073,UK,B-GPE,7471
59074,was,O,7471
59075,a,O,7471
59076,prospective,O,7471
59077,cohort,O,7471
59078,study,O,7471
59079,looking,O,7471
59080,at,O,7471
59081,outcomes,O,7471
59082,in,O,7471
59083,children,O,7471
59084,undergoing,O,7471
59085,cataract,B-TREATMENT,7471
59086,surgery,I-TREATMENT,7471
59087,under,O,7471
59088,the,O,7472
59089,age,O,7472
59090,of,O,7472
59091,two,O,7472
59092,years,O,7472
59093,both,O,7472
59094,with,O,7472
59095,and,O,7472
59096,without,O,7472
59097,an,B-TREATMENT,7472
59098,IOL,I-TREATMENT,7472
59099,The,B-NAME_OF_STUDY,7472
59100,SYCAMORE,I-NAME_OF_STUDY,7472
59101,study,I-NAME_OF_STUDY,7472
59102,was,O,7473
59103,the,O,7473
59104,first,O,7473
59105,multicentre,O,7473
59106,UK,B-GPE,7473
59107,prospective,O,7473
59108,randomized,O,7473
59109,controlled,O,7473
59110,trial,O,7473
59111,of,O,7473
59112,the,O,7473
59113,use,O,7473
59114,of,O,7473
59115,Adalimumab,B-NAME_OF_DRUG,7473
59116,an,I-NAME_OF_DRUG,7473
59117,anti-TNF,I-NAME_OF_DRUG,7473
59118,agent,I-NAME_OF_DRUG,7473
59119,in,O,7473
59120,children,O,7473
59121,with,O,7473
59122,JIA-associated,O,7473
59123,uveitis,O,7473
59124,Diagnosis,O,7473
59125,and,O,7473
59126,testing,O,7473
59127,for,O,7473
59128,genetic,O,7473
59129,eye,O,7473
59130,conditions,O,7473
59131,in,O,7473
59132,childhood,O,7473
59133,Twenty-five,O,7473
59134,years,O,7473
59135,ago,O,7473
59136,many,O,7473
59137,children,O,7473
59138,with,O,7473
59139,complex,O,7473
59140,ocular,O,7473
59141,disease,O,7474
59142,suffered,O,7474
59143,a,O,7474
59144,significant,O,7474
59145,delay,O,7474
59146,in,O,7474
59147,diagnosis,O,7474
59148,sometimes,O,7474
59149,until,O,7474
59150,late,O,7474
59151,childhood,O,7474
59152,or,O,7474
59153,adulthood,O,7474
59154,if,O,7475
59155,at,O,7475
59156,all,O,7475
59157,The,O,7475
59158,precise,O,7475
59159,diagnosis,O,7475
59160,was,O,7475
59161,not,O,7475
59162,possible,O,7475
59163,in,O,7475
59164,many,O,7475
59165,cases,O,7475
59166,and,O,7475
59167,thus,O,7475
59168,provision,O,7475
59169,of,O,7476
59170,prognosis,O,7476
59171,and,O,7476
59172,accurate,O,7476
59173,genetic,O,7476
59174,counseling,O,7476
59175,was,O,7476
59176,not,O,7476
59177,possible,O,7476
59178,Advances,O,7476
59179,in,O,7476
59180,high,O,7476
59181,throughput,O,7476
59182,genetic,B-DIAGNOSTIC_TEST,7476
59183,testing,I-DIAGNOSTIC_TEST,7476
59184,using,I-DIAGNOSTIC_TEST,7476
59185,either,I-DIAGNOSTIC_TEST,7476
59186,multi-gene,I-DIAGNOSTIC_TEST,7476
59187,panels,I-DIAGNOSTIC_TEST,7476
59188,or,I-DIAGNOSTIC_TEST,7477
59189,via,I-DIAGNOSTIC_TEST,7477
59190,whole,I-DIAGNOSTIC_TEST,7477
59191,exome,I-DIAGNOSTIC_TEST,7477
59192,or,I-DIAGNOSTIC_TEST,7477
59193,whole,I-DIAGNOSTIC_TEST,7477
59194,genome,I-DIAGNOSTIC_TEST,7477
59195,sequencing,I-DIAGNOSTIC_TEST,7477
59196,have,O,7477
59197,meant,O,7477
59198,that,O,7477
59199,genetic,B-DIAGNOSTIC_TEST,7477
59200,testing,I-DIAGNOSTIC_TEST,7477
59201,is,O,7477
59202,now,O,7477
59203,part,O,7477
59204,of,O,7477
59205,routine,O,7477
59206,care,O,7477
59207,across,O,7477
59208,medicine,O,7477
59209,This,O,7477
59210,has,O,7477
59211,impacted,O,7477
59212,on,O,7477
59213,the,O,7477
59214,investigation,O,7477
59215,of,O,7477
59216,many,O,7477
59217,pediatric,O,7478
59218,ophthalmic,O,7478
59219,conditions,O,7478
59220,such,O,7478
59221,as,O,7478
59222,retinal,B-NAME_OF_DISEASE,7478
59223,dystrophies,I-NAME_OF_DISEASE,7478
59224,pediatric,O,7478
59225,cataracts,B-NAME_OF_DISEASE,7478
59226,and,O,7478
59227,pediatric,O,7478
59228,glaucoma,B-NAME_OF_DISEASE,7478
59229,Joint,O,7478
59230,genetic,O,7478
59231,ophthalmology,O,7479
59232,services,O,7479
59233,have,O,7479
59234,been,O,7479
59235,established,O,7479
59236,in,O,7479
59237,major,O,7479
59238,centers,O,7479
59239,to,O,7479
59240,manage,O,7479
59241,access,O,7479
59242,to,O,7479
59243,testing,O,7479
59244,laboratory,O,7479
59245,services,O,7479
59246,for,O,7479
59247,testing,O,7479
59248,analysis,O,7480
59249,and,O,7480
59250,interpretation,O,7480
59251,of,O,7480
59252,results,O,7480
59253,and,O,7480
59254,genetic,O,7480
59255,counseling,O,7480
59256,New,O,7480
59257,genomic,B-DIAGNOSTIC_TEST,7480
59258,testing,I-DIAGNOSTIC_TEST,7480
59259,techniques,O,7480
59260,now,O,7480
59261,mean,O,7480
59262,that,O,7480
59263,it,O,7480
59264,is,O,7480
59265,possible,O,7480
59266,for,O,7480
59267,a,O,7480
59268,patient,O,7480
59269,with,O,7480
59270,bilateral,B-NAME_OF_DISEASE,7480
59271,congenital,I-NAME_OF_DISEASE,7480
59272,cataract,I-NAME_OF_DISEASE,7480
59273,or,O,7480
59274,inherited,B-NAME_OF_DISEASE,7480
59275,retinal,I-NAME_OF_DISEASE,7480
59276,dystrophy,I-NAME_OF_DISEASE,7480
59277,to,O,7480
59278,receive,O,7480
59279,a,O,7480
59280,rapid,O,7480
59281,precise,O,7480
59282,diagnosis,O,7480
59283,of,O,7480
59284,the,O,7480
59285,cause,O,7480
59286,with,O,7481
59287,the,O,7481
59288,exclusion,O,7481
59289,of,O,7481
59290,associated,O,7481
59291,syndromic,O,7481
59292,and,O,7481
59293,metabolic,O,7481
59294,causes,O,7481
59295,thus,O,7481
59296,avoiding,O,7481
59297,unproductive,O,7481
59298,systemic,O,7481
59299,and,O,7481
59300,metabolic,O,7481
59301,investigations,O,7481
59302,Speculation,O,7481
59303,on,O,7481
59304,future,O,7481
59305,developments,O,7481
59306,in,O,7481
59307,pediatric,O,7481
59308,ophthalmology,O,7481
59309,Pediatric,O,7481
59310,ophthalmologists,O,7482
59311,are,O,7482
59312,the,O,7482
59313,last,O,7482
59314,generalists,O,7482
59315,,O,7482
59316,They,O,7482
59317,require,O,7482
59318,a,O,7482
59319,skill,O,7482
59320,set,O,7482
59321,that,O,7482
59322,enables,O,7482
59323,them,O,7482
59324,to,O,7482
59325,interact,O,7482
59326,with,O,7482
59327,and,O,7482
59328,put,O,7482
59329,at,O,7482
59330,ease,O,7482
59331,both,O,7482
59332,the,O,7482
59333,child,O,7482
59334,and,O,7482
59335,their,O,7482
59336,family,O,7482
59337,-,O,7482
59338,as,O,7483
59339,well,O,7483
59340,as,O,7483
59341,being,O,7483
59342,able,O,7483
59343,to,O,7483
59344,carry,O,7483
59345,out,O,7483
59346,a,O,7483
59347,thorough,O,7483
59348,and,O,7483
59349,effective,O,7483
59350,examination,O,7483
59351,in,O,7483
59352,often,O,7483
59353,sub-optimal,O,7483
59354,circumstances,O,7483
59355,It,O,7483
59356,will,O,7483
59357,remain,O,7483
59358,one,O,7483
59359,of,O,7483
59360,the,O,7483
59361,most,O,7483
59362,challenging,O,7483
59363,and,O,7483
59364,rewarding,O,7483
59365,subspecialties,O,7483
59366,in,O,7483
59367,ophthalmology,O,7483
59368,Great,O,7483
59369,advances,O,7484
59370,continue,O,7484
59371,to,O,7484
59372,be,O,7484
59373,made,O,7484
59374,in,O,7484
59375,the,O,7484
59376,diagnosis,O,7484
59377,and,O,7484
59378,management,O,7484
59379,of,O,7484
59380,pediatric,O,7484
59381,eye,O,7484
59382,disease,O,7484
59383,Advances,O,7484
59384,in,O,7484
59385,genomics,O,7484
59386,will,O,7484
59387,play,O,7485
59388,a,O,7485
59389,key,O,7485
59390,role,O,7485
59391,and,O,7485
59392,genetic,B-DIAGNOSTIC_TEST,7485
59393,testing,I-DIAGNOSTIC_TEST,7485
59394,will,O,7485
59395,become,O,7485
59396,much,O,7485
59397,more,O,7485
59398,integrated,O,7485
59399,into,O,7485
59400,clinical,O,7485
59401,care,O,7485
59402,This,O,7485
59403,will,O,7485
59404,allow,O,7485
59405,rapid,O,7485
59406,accurate,O,7485
59407,diagnosis,O,7485
59408,and,O,7485
59409,personalized,O,7485
59410,targeted,O,7485
59411,management,O,7486
59412,for,O,7486
59413,each,O,7486
59414,child,O,7486
59415,together,O,7486
59416,with,O,7486
59417,the,O,7486
59418,provision,O,7486
59419,of,O,7486
59420,prognosis,O,7486
59421,the,O,7486
59422,potential,O,7486
59423,for,O,7486
59424,treatment,O,7486
59425,and,O,7486
59426,appropriate,O,7487
59427,counseling,O,7487
59428,for,O,7487
59429,the,O,7487
59430,family,O,7487
59431,Genomic,O,7487
59432,proteomic,O,7487
59433,and,O,7487
59434,metabolomic,O,7487
59435,translational,O,7487
59436,medicine,O,7487
59437,will,O,7487
59438,enable,O,7487
59439,the,O,7487
59440,introduction,O,7487
59441,of,O,7487
59442,new,O,7487
59443,exciting,O,7487
59444,therapies,O,7487
59445,Precise,O,7487
59446,molecular,B-DIAGNOSTIC_TEST,7487
59447,diagnosis,I-DIAGNOSTIC_TEST,7487
59448,will,O,7487
59449,be,O,7488
59450,of,O,7488
59451,particular,O,7488
59452,benefit,O,7488
59453,to,O,7488
59454,children,O,7488
59455,in,O,7488
59456,whom,O,7488
59457,gene,B-TREATMENT,7488
59458,therapy,I-TREATMENT,7488
59459,may,O,7488
59460,be,O,7488
59461,indicated,O,7488
59462,The,O,7488
59463,increasing,O,7488
59464,number,O,7488
59465,of,O,7488
59466,clinical,O,7488
59467,trials,O,7488
59468,of,O,7489
59469,medication,O,7489
59470,and,O,7489
59471,treatment,O,7489
59472,for,O,7489
59473,children,O,7489
59474,will,O,7489
59475,ensure,O,7489
59476,that,O,7489
59477,the,O,7489
59478,evidence,O,7489
59479,base,O,7489
59480,will,O,7489
59481,continue,O,7489
59482,to,O,7489
59483,build,O,7489
59484,so,O,7489
59485,that,O,7489
59486,pediatric,O,7489
59487,ophthalmologists,O,7490
59488,can,O,7490
59489,be,O,7490
59490,sure,O,7490
59491,they,O,7490
59492,are,O,7490
59493,delivering,O,7490
59494,the,O,7490
59495,best,O,7490
59496,care,O,7490
59497,for,O,7490
59498,their,O,7490
59499,patients,O,7490
59500,The,O,7490
59501,results,O,7490
59502,of,O,7490
59503,such,O,7490
59504,research,O,7490
59505,will,O,7490
59506,mean,O,7490
59507,that,O,7490
59508,the,O,7490
59509,range,O,7490
59510,of,O,7490
59511,treatments,O,7490
59512,routinely,O,7490
59513,available,O,7490
59514,for,O,7490
59515,treating,O,7490
59516,eye,O,7491
59517,conditions,O,7491
59518,in,O,7491
59519,children,O,7491
59520,will,O,7491
59521,continue,O,7491
59522,to,O,7491
59523,expand,O,7491
59524,Advances,O,7491
59525,in,O,7491
59526,imaging,O,7491
59527,technology,O,7491
59528,will,O,7491
59529,continue,O,7491
59530,and,O,7492
59531,techniques,O,7492
59532,will,O,7492
59533,become,O,7492
59534,increasingly,O,7492
59535,suitable,O,7492
59536,for,O,7492
59537,use,O,7492
59538,in,O,7492
59539,children,O,7492
59540,and,O,7492
59541,therefore,O,7492
59542,used,O,7492
59543,to,O,7492
59544,assess,O,7492
59545,a,O,7492
59546,wider,O,7492
59547,range,O,7492
59548,of,O,7492
59549,pediatric,O,7492
59550,eye,O,7492
59551,conditions,O,7492
59552,Big,O,7492
59553,Data,O,7492
59554,sets,O,7492
59555,are,O,7492
59556,likely,O,7493
59557,to,O,7493
59558,be,O,7493
59559,analyzed,O,7493
59560,with,O,7493
59561,the,O,7493
59562,help,O,7493
59563,of,O,7493
59564,artificial,O,7493
59565,intelligence,O,7493
59566,techniques,O,7493
59567,further,O,7493
59568,improving,O,7493
59569,early,O,7493
59570,identification,O,7493
59571,of,O,7493
59572,potential,O,7493
59573,biomarkers,O,7493
59574,of,O,7493
59575,disease,O,7493
59576,and,O,7493
59577,thus,O,7493
59578,indicators,O,7493
59579,for,O,7493
59580,more,O,7493
59581,effective,O,7493
59582,intervention,O,7493
59583,Telemedicine,B-TREATMENT,7493
59584,based,O,7493
59585,on,O,7493
59586,digital,B-DIAGNOSTIC_TEST,7493
59587,imaging,I-DIAGNOSTIC_TEST,7493
59588,is,O,7493
59589,likely,O,7493
59590,to,O,7494
59591,be,O,7494
59592,more,O,7494
59593,widely,O,7494
59594,utilized,O,7494
59595,for,O,7494
59596,a,O,7494
59597,larger,O,7494
59598,range,O,7494
59599,of,O,7494
59600,conditions,O,7494
59601,The,O,7494
59602,clinical,O,7494
59603,expertise,O,7494
59604,of,O,7494
59605,the,O,7494
59606,pediatric,O,7494
59607,ophthalmologist,O,7494
59608,will,O,7494
59609,in,O,7494
59610,our,O,7494
59611,opinion,O,7494
59612,remain,O,7494
59613,important,O,7494
59614,but,O,7494
59615,the,O,7494
59616,role,O,7494
59617,will,O,7494
59618,evolve,O,7494
59619,and,O,7494
59620,develop,O,7494
59621,alongside,O,7494
59622,these,O,7494
59623,exciting,O,7494
59624,changes,O,7494
59625,Traditional,B-SURGICAL_INSTRUMENT,7494
59626,longitudinal,I-SURGICAL_INSTRUMENT,7494
59627,ultrasound,I-SURGICAL_INSTRUMENT,7494
59628,when,O,7494
59629,first,O,7494
59630,introduced,O,7494
59631,in,O,7494
59632,phacoemulsification,B-TREATMENT,7494
59633,was,O,7494
59634,employed,O,7495
59635,only,O,7495
59636,in,O,7495
59637,the,O,7495
59638,continuous,O,7495
59639,mode,O,7495
59640,As,O,7495
59641,the,O,7495
59642,name,O,7495
59643,implies,O,7495
59644,this,O,7495
59645,mode,O,7495
59646,provides,O,7495
59647,continuous,O,7495
59648,delivery,O,7495
59649,of,O,7495
59650,ultrasound,B-SURGICAL_INSTRUMENT,7495
59651,energy,I-SURGICAL_INSTRUMENT,7495
59652,without,O,7495
59653,any,O,7496
59654,pause,O,7496
59655,time,O,7496
59656,whenever,O,7496
59657,the,O,7496
59658,surgeon,O,7496
59659,is,O,7496
59660,in,O,7496
59661,footpedal,O,7496
59662,position,O,7496
59663,The,O,7496
59664,delivery,O,7496
59665,of,O,7497
59666,power,O,7497
59667,is,O,7497
59668,controlled,O,7497
59669,linearly,O,7497
59670,using,O,7497
59671,the,O,7497
59672,footpedal,O,7497
59673,and,O,7497
59674,the,O,7497
59675,maximum,O,7497
59676,power,O,7497
59677,is,O,7497
59678,preset,O,7497
59679,by,O,7497
59680,the,O,7498
59681,surgeon,O,7498
59682,As,O,7498
59683,the,O,7498
59684,footpedal,O,7498
59685,is,O,7498
59686,depressed,O,7498
59687,the,O,7498
59688,power,O,7498
59689,rises,O,7498
59690,from,O,7498
59691,0%,O,7498
59692,to,O,7498
59693,the,O,7498
59694,preset,O,7499
59695,maximum,O,7499
59696,power,O,7499
59697,up,O,7499
59698,to,O,7499
59699,100%,O,7499
59700,,O,7499
59701,Today,O,7499
59702,the,O,7499
59703,aim,O,7499
59704,of,O,7499
59705,cataract,B-TREATMENT,7499
59706,surgery,I-TREATMENT,7499
59707,is,O,7499
59708,not,O,7499
59709,only,O,7499
59710,to,O,7499
59711,restore,O,7499
59712,vision,O,7499
59713,by,O,7499
59714,removing,O,7499
59715,and,O,7499
59716,replacing,O,7499
59717,the,O,7499
59718,cataractous,O,7499
59719,lens,O,7500
59720,but,O,7500
59721,also,O,7500
59722,to,O,7500
59723,simultaneously,O,7500
59724,provide,O,7500
59725,instant,O,7500
59726,and,O,7500
59727,high-quality,O,7500
59728,visual,O,7500
59729,rehabilitation,O,7500
59730,Achieving,O,7500
59731,a,O,7500
59732,clear,O,7500
59733,cornea,B-PART_OF_THE_EYES,7500
59734,immediately,O,7500
59735,after,O,7500
59736,surgery,O,7500
59737,is,O,7500
59738,the,O,7500
59739,first,O,7500
59740,step,O,7500
59741,in,O,7500
59742,this,O,7500
59743,endeavor,O,7500
59744,One,O,7500
59745,of,O,7500
59746,the,O,7501
59747,most,O,7501
59748,important,O,7501
59749,barriers,O,7501
59750,to,O,7501
59751,achieving,O,7501
59752,clear,O,7501
59753,corneas,B-PART_OF_THE_EYES,7501
59754,and,O,7501
59755,sharp,O,7501
59756,vision,O,7501
59757,immediately,O,7501
59758,after,O,7501
59759,cataract,B-TREATMENT,7501
59760,surgery,I-TREATMENT,7501
59761,is,O,7501
59762,damage,O,7501
59763,from,O,7501
59764,ultrasound,B-SURGICAL_INSTRUMENT,7501
59765,energy,I-SURGICAL_INSTRUMENT,7501
59766,induced,O,7501
59767,during,O,7501
59768,the,O,7501
59769,procedure,O,7501
59770,The,O,7501
59771,advent,O,7501
59772,of,O,7501
59773,ultrasound,B-SURGICAL_INSTRUMENT,7501
59774,power,I-SURGICAL_INSTRUMENT,7501
59775,modulation,I-SURGICAL_INSTRUMENT,7501
59776,has,O,7501
59777,dramatically,O,7501
59778,increased,O,7501
59779,the,O,7501
59780,efficiency,O,7501
59781,of,O,7501
59782,ultrasound,B-SURGICAL_INSTRUMENT,7502
59783,energy,I-SURGICAL_INSTRUMENT,7502
59784,and,O,7502
59785,minimized,O,7502
59786,heat,O,7502
59787,production,O,7502
59788,thereby,O,7502
59789,decreasing,O,7502
59790,the,O,7502
59791,risk,O,7502
59792,of,O,7502
59793,thermal,O,7502
59794,injury,O,7502
59795,that,O,7502
59796,contributes,O,7502
59797,to,O,7502
59798,endothelial,B-SIGN_AND_SYMPTOM,7502
59799,cell,I-SIGN_AND_SYMPTOM,7502
59800,loss,I-SIGN_AND_SYMPTOM,7502
59801,and,O,7502
59802,corneal,B-SIGN_AND_SYMPTOM,7502
59803,edema,I-SIGN_AND_SYMPTOM,7503
59804,The,O,7503
59805,goal,O,7503
59806,in,O,7503
59807,cataract,B-TREATMENT,7503
59808,surgery,I-TREATMENT,7503
59809,is,O,7503
59810,perfection,O,7503
59811,in,O,7503
59812,nuclear,B-TREATMENT,7503
59813,disassembly,I-TREATMENT,7503
59814,performed,O,7503
59815,with,O,7503
59816,just,O,7503
59817,the,O,7503
59818,right,O,7503
59819,amount,O,7503
59820,of,O,7503
59821,phaco,O,7503
59822,energy-not,O,7503
59823,too,O,7503
59824,much,O,7504
59825,not,O,7504
59826,too,O,7504
59827,little-according,O,7504
59828,to,O,7504
59829,Dr,B-PERSON,7504
59830,Lisa,I-PERSON,7504
59831,Park,I-PERSON,7504
59832,associate,I-PERSON,7504
59833,professor,I-PERSON,7504
59834,at,O,7504
59835,Columbia,B-ORGANIZATION,7504
59836,University,I-ORGANIZATION,7504
59837,Vagelos,I-ORGANIZATION,7504
59838,College,I-ORGANIZATION,7504
59839,of,I-ORGANIZATION,7504
59840,Physicians,I-ORGANIZATION,7504
59841,and,I-ORGANIZATION,7504
59842,Surgeons,I-ORGANIZATION,7504
59843,in,O,7504
59844,New,B-GPE,7504
59845,York,I-GPE,7504
59846,United,I-GPE,7504
59847,States,I-GPE,7505
59848,Phacoemulsification,B-TREATMENT,7505
59849,is,O,7505
59850,a,O,7505
59851,surgical,O,7505
59852,procedure,O,7505
59853,that,O,7505
59854,is,O,7505
59855,used,O,7505
59856,to,O,7505
59857,remove,O,7505
59858,cataracts,B-NAME_OF_DISEASE,7505
59859,a,B-SIGN_AND_SYMPTOM,7505
59860,clouding,I-SIGN_AND_SYMPTOM,7505
59861,of,I-SIGN_AND_SYMPTOM,7505
59862,the,I-SIGN_AND_SYMPTOM,7505
59863,eye,I-SIGN_AND_SYMPTOM,7505
59864,s,I-SIGN_AND_SYMPTOM,7505
59865,natural,I-SIGN_AND_SYMPTOM,7505
59866,lens,I-SIGN_AND_SYMPTOM,7505
59867,It,O,7506
59868,is,O,7506
59869,a,O,7506
59870,minimally,O,7506
59871,invasive,O,7506
59872,procedure,O,7506
59873,that,O,7506
59874,is,O,7506
59875,performed,O,7506
59876,under,O,7506
59877,local,O,7506
59878,anesthesia,O,7506
59879,It,O,7506
59880,has,O,7506
59881,largely,O,7506
59882,replaced,O,7506
59883,traditional,O,7506
59884,cataract,B-TREATMENT,7506
59885,surgery,I-TREATMENT,7506
59886,as,O,7506
59887,the,O,7506
59888,most,O,7506
59889,common,O,7506
59890,method,O,7507
59891,for,O,7507
59892,removing,O,7507
59893,cataracts,B-NAME_OF_DISEASE,7507
59894,Excessive,O,7507
59895,ultrasound,B-SURGICAL_INSTRUMENT,7507
59896,can,O,7507
59897,result,O,7507
59898,in,O,7507
59899,endothelial,B-SIGN_AND_SYMPTOM,7507
59900,cell,I-SIGN_AND_SYMPTOM,7507
59901,loss,I-SIGN_AND_SYMPTOM,7507
59902,corneal,B-SIGN_AND_SYMPTOM,7507
59903,edema,I-SIGN_AND_SYMPTOM,7508
59904,and,O,7508
59905,corneal,B-SIGN_AND_SYMPTOM,7508
59906,wound,I-SIGN_AND_SYMPTOM,7508
59907,burn,I-SIGN_AND_SYMPTOM,7508
59908,Too,O,7508
59909,little,O,7508
59910,energy,O,7508
59911,can,O,7508
59912,result,O,7508
59913,in,O,7508
59914,movement,O,7508
59915,of,O,7508
59916,the,B-PART_OF_THE_EYES,7508
59917,capsular,I-PART_OF_THE_EYES,7508
59918,bag,I-PART_OF_THE_EYES,7508
59919,or,O,7508
59920,ophth,O,7508
59921,stress,O,7508
59922,difficult,O,7508
59923,nuclear,B-TREATMENT,7508
59924,disassembly,I-TREATMENT,7508
59925,over-use,O,7508
59926,of,O,7508
59927,irrigation,O,7508
59928,fluid,O,7508
59929,and,O,7508
59930,long,O,7508
59931,surgical,O,7508
59932,times,O,7508
59933,Transversal,B-SURGICAL_INSTRUMENT,7508
59934,Torsional,I-SURGICAL_INSTRUMENT,7508
59935,Phaco,I-SURGICAL_INSTRUMENT,7508
59936,Traditional,B-SURGICAL_INSTRUMENT,7508
59937,longitudinal,B-SURGICAL_INSTRUMENT,7508
59938,phaco,I-SURGICAL_INSTRUMENT,7508
59939,is,O,7508
59940,a,O,7508
59941,powerful,O,7508
59942,technology,O,7508
59943,designed,O,7509
59944,to,O,7509
59945,break,O,7509
59946,up,O,7509
59947,very,O,7509
59948,dense,O,7509
59949,nuclei,O,7509
59950,using,O,7509
59951,a,O,7509
59952,back-and-forth,O,7509
59953,jackhammer,O,7509
59954,motion,O,7509
59955,but,O,7509
59956,it,O,7509
59957,comes,O,7510
59958,with,O,7510
59959,disadvantages,O,7510
59960,Dr,B-PERSON,7510
59961,Park,I-PERSON,7510
59962,explained,O,7510
59963,that,O,7510
59964,the,O,7510
59965,procedure,O,7510
59966,with,O,7510
59967,its,O,7511
59968,long,O,7511
59969,stroke,O,7511
59970,length,O,7511
59971,and,O,7511
59972,high,O,7511
59973,power,O,7511
59974,can,O,7511
59975,result,O,7511
59976,in,O,7511
59977,repulsion,O,7511
59978,of,O,7511
59979,nuclear,O,7511
59980,fragments,O,7511
59981,at,O,7511
59982,the,B-SURGICAL_INSTRUMENT,7511
59983,phaco,I-SURGICAL_INSTRUMENT,7511
59984,tip,I-SURGICAL_INSTRUMENT,7511
59985,and,O,7511
59986,no,O,7511
59987,cutting,O,7511
59988,performed,O,7511
59989,during,O,7511
59990,the,O,7511
59991,backward,O,7511
59992,movement,O,7512
59993,of,O,7512
59994,the,O,7512
59995,tip,O,7512
59996,In,O,7512
59997,addition,O,7512
59998,it,O,7512
59999,is,O,7512
60000,important,O,7512
60001,to,O,7512
60002,limit,O,7512
60003,the,O,7512
60004,power,O,7512
60005,settings,O,7513
60006,to,O,7513
60007,avoid,O,7513
60008,excessive,O,7513
60009,heat,O,7513
60010,build-up,O,7513
60011,which,O,7513
60012,can,O,7513
60013,potentially,O,7513
60014,damage,O,7513
60015,ocular,B-PART_OF_THE_EYES,7513
60016,tissues,I-PART_OF_THE_EYES,7513
60017,New,O,7513
60018,developments,O,7513
60019,in,O,7513
60020,phaco,B-SURGICAL_INSTRUMENT,7514
60021,technology,I-SURGICAL_INSTRUMENT,7514
60022,involve,O,7514
60023,delivery,O,7514
60024,of,O,7514
60025,power,O,7514
60026,using,O,7514
60027,lateral,O,7514
60028,and,O,7514
60029,rotational,O,7514
60030,motions,O,7514
60031,referred,O,7514
60032,to,O,7514
60033,as,O,7514
60034,transversal,B-SURGICAL_INSTRUMENT,7514
60035,and,I-SURGICAL_INSTRUMENT,7514
60036,torsional,I-SURGICAL_INSTRUMENT,7514
60037,phaco,I-SURGICAL_INSTRUMENT,7514
60038,In,O,7514
60039,contrast,O,7515
60040,to,O,7515
60041,the,O,7515
60042,jackhammer,O,7515
60043,effect,O,7515
60044,of,O,7515
60045,longitudinal,B-SURGICAL_INSTRUMENT,7515
60046,phaco,I-SURGICAL_INSTRUMENT,7515
60047,a,O,7515
60048,combination,O,7515
60049,approach,O,7515
60050,combines,O,7515
60051,simultaneous,O,7515
60052,back-and-forth,O,7516
60053,motion,O,7516
60054,with,O,7516
60055,transversal,O,7516
60056,movement,O,7516
60057,in,O,7516
60058,an,O,7516
60059,elliptical,O,7516
60060,path,O,7516
60061,This,O,7516
60062,adds,O,7516
60063,to,O,7516
60064,the,O,7516
60065,cutting,O,7516
60066,efficiency,O,7516
60067,because,O,7516
60068,the,O,7516
60069,nuclear,O,7516
60070,material,O,7516
60071,is,O,7516
60072,emulsified,O,7516
60073,in,O,7516
60074,more,O,7516
60075,than,O,7516
60076,one,O,7516
60077,direction,O,7516
60078,Dr,B-PERSON,7517
60079,Park,I-PERSON,7517
60080,said,O,7517
60081,In,O,7517
60082,torsional,B-SURGICAL_INSTRUMENT,7517
60083,phaco,I-SURGICAL_INSTRUMENT,7517
60084,the,O,7517
60085,tip,O,7517
60086,oscillates,O,7517
60087,in,O,7517
60088,a,O,7517
60089,rotational,O,7517
60090,path,O,7517
60091,along,O,7517
60092,its,O,7517
60093,primary,O,7518
60094,axis,O,7518
60095,to,O,7518
60096,provide,O,7518
60097,an,O,7518
60098,additional,O,7518
60099,cutting,O,7518
60100,movement,O,7518
60101,through,O,7518
60102,the,O,7518
60103,nucleus,O,7518
60104,Dr,B-PERSON,7518
60105,Park,I-PERSON,7518
60106,explained,O,7518
60107,that,O,7518
60108,this,O,7518
60109,procedure,O,7518
60110,works,O,7519
60111,best,O,7519
60112,with,O,7519
60113,an,B-SURGICAL_INSTRUMENT,7519
60114,angled,I-SURGICAL_INSTRUMENT,7519
60115,phaco,I-SURGICAL_INSTRUMENT,7519
60116,needle,I-SURGICAL_INSTRUMENT,7519
60117,The,O,7519
60118,primary,O,7519
60119,advantage,O,7519
60120,is,O,7520
60121,an,O,7520
60122,increase,O,7520
60123,in,O,7520
60124,energy,O,7520
60125,efficiency,O,7520
60126,with,O,7520
60127,minimal,O,7520
60128,repulsion,O,7520
60129,at,O,7520
60130,the,O,7520
60131,tip,O,7520
60132,the,O,7520
60133,disadvantages,O,7520
60134,are,O,7520
60135,that,O,7520
60136,a,B-SURGICAL_INSTRUMENT,7520
60137,curved,I-SURGICAL_INSTRUMENT,7520
60138,phaco,I-SURGICAL_INSTRUMENT,7520
60139,tip,I-SURGICAL_INSTRUMENT,7520
60140,can,O,7520
60141,be,O,7520
60142,difficult,O,7520
60143,to,O,7520
60144,move,O,7520
60145,through,O,7520
60146,a,O,7520
60147,dense,O,7520
60148,nucleus,O,7520
60149,and,O,7521
60150,there,O,7521
60151,is,O,7521
60152,significant,O,7521
60153,movement,O,7521
60154,of,O,7521
60155,the,O,7521
60156,tip,O,7521
60157,Phaco,O,7521
60158,Timing,O,7521
60159,The,O,7521
60160,timing,O,7521
60161,of,O,7521
60162,power,O,7521
60163,delivery,O,7521
60164,can,O,7521
60165,be,O,7521
60166,modified,O,7521
60167,to,O,7521
60168,increase,O,7521
60169,phaco,O,7521
60170,efficiency,O,7521
60171,The,O,7521
60172,basic,O,7521
60173,settings,O,7521
60174,are,O,7521
60175,for,O,7522
60176,continuous,O,7522
60177,pulse,O,7522
60178,and,O,7522
60179,burst,O,7522
60180,power,O,7522
60181,When,O,7522
60182,power,O,7522
60183,is,O,7522
60184,continuous,O,7522
60185,power,O,7522
60186,delivery,O,7522
60187,is,O,7522
60188,controlled,O,7522
60189,by,O,7522
60190,depressing,O,7522
60191,the,B-SURGICAL_INSTRUMENT,7522
60192,foot,I-SURGICAL_INSTRUMENT,7522
60193,pedal,I-SURGICAL_INSTRUMENT,7522
60194,the,O,7522
60195,power,O,7522
60196,increases,O,7522
60197,with,O,7522
60198,the,O,7522
60199,degree,O,7522
60200,of,O,7522
60201,depression,O,7522
60202,of,O,7522
60203,the,B-SURGICAL_INSTRUMENT,7522
60204,foot,I-SURGICAL_INSTRUMENT,7522
60205,pedal,I-SURGICAL_INSTRUMENT,7522
60206,The,O,7522
60207,amount,O,7522
60208,of,O,7522
60209,power,O,7523
60210,delivered,O,7523
60211,can,O,7523
60212,be,O,7523
60213,limited,O,7523
60214,by,O,7523
60215,using,O,7523
60216,phaco,O,7523
60217,pulse,O,7523
60218,mode,O,7523
60219,After,O,7523
60220,each,O,7523
60221,pulse,O,7523
60222,there,O,7523
60223,is,O,7523
60224,a,O,7523
60225,period,O,7523
60226,of,O,7523
60227,time,O,7523
60228,in,O,7523
60229,which,O,7523
60230,no,O,7523
60231,energy,O,7523
60232,is,O,7523
60233,delivered,O,7523
60234,These,O,7523
60235,rest,O,7523
60236,periods,O,7523
60237,allow,O,7523
60238,cooling,O,7523
60239,of,O,7523
60240,the,B-SURGICAL_INSTRUMENT,7523
60241,phaco,I-SURGICAL_INSTRUMENT,7523
60242,needle,I-SURGICAL_INSTRUMENT,7524
60243,and,O,7524
60244,reduce,O,7524
60245,the,O,7524
60246,heat,O,7524
60247,and,O,7524
60248,energy,O,7524
60249,delivered,O,7524
60250,to,O,7524
60251,the,O,7524
60252,eye,O,7524
60253,The,O,7524
60254,on-and-off,O,7524
60255,periods,O,7524
60256,in,O,7524
60257,pulse,O,7524
60258,mode,O,7524
60259,are,O,7524
60260,referred,O,7524
60261,to,O,7524
60262,as,O,7524
60263,the,O,7524
60264,duty,O,7524
60265,cycle,O,7524
60266,Standard,O,7524
60267,pulse,O,7524
60268,has,O,7524
60269,a,O,7525
60270,50%,O,7525
60271,duty,O,7525
60272,cycle,O,7525
60273,during,O,7525
60274,which,O,7525
60275,the,O,7525
60276,ultrasound,O,7525
60277,is,O,7525
60278,on,O,7525
60279,half,O,7525
60280,of,O,7525
60281,the,O,7525
60282,time,O,7525
60283,no,O,7525
60284,matter,O,7525
60285,how,O,7525
60286,many,O,7525
60287,pulses,O,7525
60288,per,O,7525
60289,second,O,7525
60290,are,O,7525
60291,delivered,O,7525
60292,The,O,7525
60293,duty,O,7525
60294,cycle,O,7525
60295,can,O,7525
60296,be,O,7525
60297,altered,O,7526
60298,to,O,7526
60299,change,O,7526
60300,the,O,7526
60301,ratio,O,7526
60302,of,O,7526
60303,on,O,7526
60304,to,O,7526
60305,off,O,7526
60306,time,O,7526
60307,For,O,7526
60308,example,O,7526
60309,a,O,7526
60310,20%,O,7526
60311,duty,O,7526
60312,cycle,O,7526
60313,results,O,7526
60314,in,O,7526
60315,20,B-TIME_DURATION,7526
60316,milliseconds,I-TIME_DURATION,7526
60317,on,O,7526
60318,and,O,7526
60319,80,B-TIME_DURATION,7526
60320,milliseconds,I-TIME_DURATION,7526
60321,off,O,7527
60322,per,O,7527
60323,cycle,O,7527
60324,Higher,O,7527
60325,or,O,7527
60326,lower,O,7527
60327,duty,O,7527
60328,cycles,O,7527
60329,are,O,7527
60330,used,O,7527
60331,for,O,7527
60332,different,O,7527
60333,purposes,O,7527
60334,During,O,7527
60335,sculpting,O,7527
60336,energy,O,7527
60337,is,O,7527
60338,needed,O,7527
60339,to,O,7528
60340,create,O,7528
60341,a,O,7528
60342,groove,O,7528
60343,in,O,7528
60344,the,B-PART_OF_THE_EYES,7528
60345,lens,I-PART_OF_THE_EYES,7528
60346,so,O,7528
60347,higher,O,7528
60348,rates,O,7528
60349,work,O,7528
60350,better,O,7528
60351,because,O,7528
60352,the,O,7528
60353,shorter,O,7528
60354,time,O,7528
60355,between,O,7528
60356,pulses,O,7528
60357,results,O,7528
60358,in,O,7528
60359,smoother,O,7528
60360,delivery,O,7528
60361,of,O,7528
60362,energy,O,7528
60363,When,O,7528
60364,nuclear,O,7528
60365,quadrants,O,7528
60366,are,O,7528
60367,being,O,7528
60368,removed,O,7528
60369,a,O,7529
60370,lower,O,7529
60371,duty,O,7529
60372,cycle,O,7529
60373,is,O,7529
60374,better,O,7529
60375,because,O,7529
60376,the,O,7529
60377,long,O,7529
60378,interval,O,7529
60379,between,O,7529
60380,the,O,7529
60381,pulses,O,7529
60382,facilitates,O,7529
60383,emulsification,O,7529
60384,and,O,7529
60385,aspiration,O,7529
60386,of,O,7529
60387,the,O,7529
60388,fragments,O,7529
60389,Finally,O,7529
60390,using,O,7529
60391,burst,O,7529
60392,mode,O,7530
60393,each,O,7530
60394,burst,O,7530
60395,has,O,7530
60396,the,O,7530
60397,same,O,7530
60398,power,O,7530
60399,but,O,7530
60400,the,O,7530
60401,interval,O,7530
60402,between,O,7530
60403,bursts,O,7530
60404,decreases,O,7530
60405,with,O,7530
60406,foot-pedal,B-SURGICAL_INSTRUMENT,7530
60407,depression,O,7531
60408,the,O,7531
60409,more,O,7531
60410,the,B-SURGICAL_INSTRUMENT,7531
60411,foot,I-SURGICAL_INSTRUMENT,7531
60412,pedal,I-SURGICAL_INSTRUMENT,7531
60413,is,O,7531
60414,depressed,O,7531
60415,the,O,7531
60416,shorter,O,7531
60417,the,O,7531
60418,off,O,7531
60419,time,O,7531
60420,is,O,7531
60421,between,O,7531
60422,bursts,O,7531
60423,The,O,7532
60424,identical,O,7532
60425,bursts,O,7532
60426,of,O,7532
60427,energy,O,7532
60428,are,O,7532
60429,delivered,O,7532
60430,more,O,7532
60431,and,O,7532
60432,more,O,7532
60433,rapidly,O,7532
60434,with,O,7532
60435,foot-pedal,B-SURGICAL_INSTRUMENT,7532
60436,depression,O,7532
60437,with,O,7532
60438,maximal,O,7532
60439,depression,O,7532
60440,the,O,7532
60441,time,O,7532
60442,interval,O,7532
60443,between,O,7532
60444,bursts,O,7532
60445,is,O,7532
60446,very,O,7532
60447,small,O,7532
60448,making,O,7532
60449,for,O,7532
60450,continuous,O,7532
60451,energy,O,7533
60452,delivery,O,7533
60453,Dr,B-PERSON,7533
60454,Park,I-PERSON,7533
60455,said,O,7533
60456,Burst,O,7533
60457,mode,O,7533
60458,allows,O,7533
60459,for,O,7533
60460,TRUE,O,7533
60461,phaco-assisted,O,7533
60462,aspiration,O,7534
60463,of,O,7534
60464,the,O,7534
60465,nucleus,O,7534
60466,the,O,7534
60467,fluidics,O,7534
60468,and,O,7534
60469,vacuum,O,7534
60470,can,O,7534
60471,be,O,7534
60472,used,O,7534
60473,for,O,7534
60474,aspiration,O,7534
60475,and,O,7534
60476,give,O,7534
60477,small,O,7534
60478,bursts,O,7534
60479,of,O,7534
60480,power,O,7534
60481,as,O,7534
60482,needed,O,7534
60483,Lower,O,7534
60484,phaco,O,7534
60485,power,O,7534
60486,settings,O,7534
60487,should,O,7534
60488,be,O,7534
60489,used,O,7534
60490,in,O,7534
60491,burst,O,7534
60492,mode,O,7534
60493,compared,O,7534
60494,with,O,7534
60495,pulse,O,7534
60496,or,O,7534
60497,continuous,O,7534
60498,mode,O,7534
60499,because,O,7535
60500,of,O,7535
60501,the,O,7535
60502,absence,O,7535
60503,of,O,7535
60504,linear,O,7535
60505,control,O,7535
60506,at,O,7535
60507,the,O,7535
60508,phaco,O,7535
60509,power,O,7535
60510,level,O,7535
60511,Regarding,O,7535
60512,the,O,7535
60513,choice,O,7535
60514,of,O,7536
60515,these,O,7536
60516,three,O,7536
60517,modes,O,7536
60518,Dr,B-PERSON,7536
60519,Park,I-PERSON,7536
60520,noted,O,7536
60521,that,O,7536
60522,the,O,7536
60523,ability,O,7536
60524,to,O,7536
60525,programme,O,7536
60526,timing,O,7536
60527,and,O,7536
60528,duration,O,7536
60529,combined,O,7536
60530,with,O,7536
60531,the,O,7536
60532,directional,O,7536
60533,modes,O,7536
60534,i.e,O,7537
60535,transverse,B-SURGICAL_INSTRUMENT,7537
60536,and,I-SURGICAL_INSTRUMENT,7537
60537,torsional,I-SURGICAL_INSTRUMENT,7537
60538,phaco,I-SURGICAL_INSTRUMENT,7537
60539,allow,O,7537
60540,the,O,7537
60541,surgeon,O,7537
60542,to,O,7537
60543,have,O,7537
60544,highly,O,7537
60545,elegant,O,7537
60546,control,O,7537
60547,and,O,7537
60548,precise,O,7537
60549,ultrasound,O,7538
60550,power,O,7538
60551,delivery,O,7538
60552,,O,7538
60553,Femtosecond,B-TREATMENT,7538
60554,Laser-Assisted,I-TREATMENT,7538
60555,Cataract,I-TREATMENT,7538
60556,Surgery,I-TREATMENT,7538
60557,This,O,7538
60558,is,O,7538
60559,another,O,7538
60560,technology,O,7538
60561,that,O,7538
60562,has,O,7538
60563,resulted,O,7538
60564,in,O,7538
60565,increased,O,7538
60566,efficiency,O,7538
60567,in,O,7538
60568,nuclear,O,7538
60569,disassembly,O,7538
60570,femtosecond,B-TREATMENT,7538
60571,laser-assisted,I-TREATMENT,7538
60572,cataract,B-TREATMENT,7538
60573,surgery,I-TREATMENT,7539
60574,FLACS,B-TREATMENT,7539
60575,works,O,7539
60576,through,O,7539
60577,photodisruption,O,7539
60578,which,O,7539
60579,vaporises,O,7539
60580,the,O,7539
60581,targeted,O,7539
60582,tissues,O,7539
60583,This,O,7539
60584,is,O,7539
60585,similar,O,7539
60586,to,O,7540
60587,the,O,7540
60588,mechanism,O,7540
60589,of,O,7540
60590,phaco,O,7540
60591,but,O,7540
60592,it,O,7540
60593,occurs,O,7540
60594,at,O,7540
60595,the,O,7540
60596,near-infrared,O,7540
60597,wavelength,O,7540
60598,which,O,7540
60599,is,O,7540
60600,not,O,7540
60601,absorbed,O,7540
60602,by,O,7540
60603,optically,O,7540
60604,clear,O,7540
60605,tissues,O,7540
60606,The,O,7540
60607,laser,O,7540
60608,is,O,7540
60609,focused,O,7540
60610,to,O,7540
60611,3,O,7540
60612,microns,O,7540
60613,and,O,7540
60614,is,O,7540
60615,especially,O,7540
60616,useful,O,7540
60617,for,O,7540
60618,targeting,O,7540
60619,specific,O,7540
60620,depths,O,7541
60621,The,O,7541
60622,waves,O,7541
60623,dissipate,O,7541
60624,approximately,O,7541
60625,100,O,7541
60626,microns,O,7541
60627,from,O,7541
60628,the,O,7541
60629,targeted,O,7541
60630,tissue,O,7541
60631,and,O,7541
60632,the,O,7541
60633,endothelium,O,7541
60634,is,O,7541
60635,not,O,7541
60636,affected,O,7541
60637,Dr,B-PERSON,7541
60638,Park,I-PERSON,7541
60639,explained,O,7541
60640,that,O,7541
60641,femtosecond,B-TREATMENT,7541
60642,pre-treatment,I-TREATMENT,7541
60643,significantly,O,7541
60644,reduces,O,7542
60645,the,O,7542
60646,effective,O,7542
60647,phaco,O,7542
60648,time,O,7542
60649,compared,O,7542
60650,with,O,7542
60651,conventional,O,7542
60652,phaco,O,7542
60653,surgery,O,7542
60654,thus,O,7543
60655,reducing,O,7543
60656,loss,O,7543
60657,of,O,7543
60658,endothelial,O,7543
60659,cells,O,7543
60660,and,O,7543
60661,allowing,O,7543
60662,faster,O,7543
60663,visual,O,7543
60664,rehabilitation,O,7543
60665,FLACS,B-TREATMENT,7543
60666,allows,O,7543
60667,the,O,7543
60668,surgeon,O,7543
60669,to,O,7543
60670,decide,O,7543
60671,the,O,7543
60672,pattern,O,7544
60673,of,O,7544
60674,lens,O,7544
60675,fragmentation,O,7544
60676,Using,O,7544
60677,FLACS,B-TREATMENT,7544
60678,to,O,7544
60679,create,O,7544
60680,the,O,7544
60681,quadrants,O,7544
60682,there,O,7544
60683,is,O,7544
60684,no,O,7544
60685,need,O,7545
60686,to,O,7545
60687,use,O,7545
60688,phaco,O,7545
60689,to,O,7545
60690,sculpt,O,7545
60691,the,B-PART_OF_THE_EYES,7545
60692,lens,I-PART_OF_THE_EYES,7545
60693,the,O,7545
60694,surgeon,O,7545
60695,can,O,7545
60696,go,O,7545
60697,directly,O,7545
60698,to,O,7545
60699,removal,O,7545
60700,of,O,7545
60701,the,O,7546
60702,quadrants,O,7546
60703,after,O,7546
60704,nuclear,O,7546
60705,disassembly,O,7546
60706,along,O,7546
60707,the,O,7546
60708,lines,O,7546
60709,created,O,7546
60710,by,O,7546
60711,the,O,7546
60712,laser,O,7546
60713,As,O,7546
60714,a,O,7546
60715,result,O,7546
60716,lower,O,7547
60717,total,O,7547
60718,energy,O,7547
60719,is,O,7547
60720,used,O,7547
60721,in,O,7547
60722,the,O,7547
60723,eye,O,7547
60724,making,O,7547
60725,nuclear,O,7547
60726,removal,O,7547
60727,easier,O,7547
60728,The,O,7547
60729,disadvantages,O,7547
60730,of,O,7547
60731,FLACS,B-TREATMENT,7547
60732,for,O,7547
60733,experienced,O,7547
60734,high-volume,O,7547
60735,surgeons,O,7547
60736,are,O,7547
60737,the,O,7547
60738,cost,O,7548
60739,increased,O,7548
60740,surgical,O,7548
60741,time,O,7548
60742,and,O,7548
60743,minimal,O,7548
60744,long-term,O,7548
60745,enhanced,O,7548
60746,visual,O,7548
60747,outcome,O,7548
60748,However,O,7549
60749,FLACS,B-TREATMENT,7549
60750,may,O,7549
60751,be,O,7549
60752,advantageous,O,7549
60753,for,O,7549
60754,use,O,7549
60755,on,O,7549
60756,brunescent,B-TREATMENT,7550
60757,cataracts,I-TREATMENT,7550
60758,in,O,7550
60759,patients,O,7550
60760,with,O,7550
60761,Fuchs,B-TREATMENT,7550
60762,dystrophy,I-TREATMENT,7550
60763,There,O,7550
60764,are,O,7550
60765,many,O,7550
60766,means,O,7550
60767,of,O,7550
60768,modulating,O,7550
60769,phaco,O,7550
60770,power,O,7550
60771,to,O,7550
60772,achieve,O,7550
60773,outstanding,O,7550
60774,results,O,7550
60775,in,O,7550
60776,cataract,B-TREATMENT,7550
60777,surgery,I-TREATMENT,7550
60778,and,O,7550
60779,provide,O,7550
60780,the,O,7550
60781,best,O,7550
60782,patient,O,7550
60783,care,O,7550
60784,Dr,B-PERSON,7550
60785,Park,I-PERSON,7550
60786,concluded,O,7550
60787,Noninfectious,B-NAME_OF_DISEASE,7550
60788,uveitis,B-NAME_OF_DISEASE,7550
60789,involving,O,7550
60790,the,O,7551
60791,posterior,O,7551
60792,segment,O,7551
60793,is,O,7551
60794,an,O,7551
60795,important,O,7551
60796,cause,O,7551
60797,of,O,7551
60798,vision,B-SIGN_AND_SYMPTOM,7551
60799,loss,I-SIGN_AND_SYMPTOM,7551
60800,Oral,B-TREATMENT,7551
60801,corticosteroid,I-TREATMENT,7551
60802,therapy,I-TREATMENT,7551
60803,is,O,7551
60804,the,O,7551
60805,mainstay,O,7551
60806,for,O,7551
60807,initial,O,7552
60808,treatment,O,7552
60809,but,O,7552
60810,depending,O,7552
60811,on,O,7552
60812,its,O,7552
60813,underlying,O,7552
60814,cause,O,7552
60815,uveitis,B-NAME_OF_DISEASE,7552
60816,often,O,7552
60817,cannot,O,7552
60818,be,O,7552
60819,controlled,O,7552
60820,after,O,7552
60821,tapering,O,7552
60822,of,O,7552
60823,the,O,7552
60824,steroid,B-NAME_OF_DRUG,7552
60825,to,O,7553
60826,a,O,7553
60827,dose,O,7553
60828,that,O,7553
60829,is,O,7553
60830,safe,O,7553
60831,for,O,7553
60832,chronic,O,7553
60833,treatment,O,7553
60834,Steroid-sparing,B-TREATMENT,7553
60835,immunosuppressive,I-TREATMENT,7553
60836,therapy,I-TREATMENT,7553
60837,and,O,7553
60838,local,B-TREATMENT,7553
60839,corticosteroid,I-TREATMENT,7553
60840,injections,I-TREATMENT,7553
60841,can,O,7553
60842,have,O,7553
60843,a,O,7554
60844,role,O,7554
60845,for,O,7554
60846,providing,O,7554
60847,long-term,O,7554
60848,suppression,O,7554
60849,of,O,7554
60850,inflammation,O,7554
60851,while,O,7554
60852,mitigating,O,7554
60853,the,O,7554
60854,risks,O,7554
60855,of,O,7554
60856,systemic,O,7554
60857,steroids,B-NAME_OF_DRUG,7554
60858,Dexamethasone,B-NAME_OF_DRUG,7554
60859,has,O,7554
60860,potent,O,7554
60861,anti-inflammatory,O,7554
60862,properties,O,7554
60863,with,O,7554
60864,a,O,7555
60865,favorable,O,7555
60866,side-effect,O,7555
60867,profile,O,7555
60868,Uveitis,B-NAME_OF_DISEASE,7555
60869,of,O,7555
60870,the,O,7555
60871,posterior,O,7555
60872,segment,O,7555
60873,encompasses,O,7555
60874,a,O,7555
60875,variety,O,7555
60876,of,O,7555
60877,diagnostic,O,7555
60878,descriptions,O,7555
60879,namely,O,7555
60880,intermediate,B-NAME_OF_DISEASE,7555
60881,uveitis,I-NAME_OF_DISEASE,7556
60882,posterior,B-NAME_OF_DISEASE,7556
60883,uveitis,I-NAME_OF_DISEASE,7556
60884,and,O,7556
60885,panuveitis,B-NAME_OF_DISEASE,7556
60886,Uveitis,B-NAME_OF_DISEASE,7556
60887,affecting,O,7556
60888,the,O,7556
60889,posterior,O,7556
60890,segment,O,7556
60891,can,O,7556
60892,be,O,7556
60893,infectious,O,7556
60894,although,O,7556
60895,most,O,7556
60896,cases,O,7556
60897,are,O,7556
60898,noninfectious,O,7556
60899,Corticosteroids,B-NAME_OF_DRUG,7556
60900,and,O,7556
60901,immunomodulatory,B-NAME_OF_DRUG,7556
60902,drugs,I-NAME_OF_DRUG,7556
60903,are,O,7556
60904,the,O,7556
60905,cornerstones,O,7556
60906,for,O,7556
60907,treatment,O,7556
60908,of,O,7556
60909,noninfectious,B-NAME_OF_DISEASE,7556
60910,uveitis,I-NAME_OF_DISEASE,7557
60911,in,O,7557
60912,the,O,7557
60913,posterior,O,7557
60914,segment,O,7557
60915,Treatment,O,7557
60916,of,O,7557
60917,posterior,B-NAME_OF_DISEASE,7557
60918,uveitis,I-NAME_OF_DISEASE,7557
60919,generally,O,7557
60920,necessitates,O,7557
60921,the,O,7557
60922,use,O,7557
60923,of,O,7557
60924,intraocular,B-TREATMENT,7557
60925,injections,I-TREATMENT,7558
60926,implants,I-TREATMENT,7558
60927,or,O,7558
60928,systemic,B-TREATMENT,7558
60929,therapies,I-TREATMENT,7558
60930,Local,O,7558
60931,corticosteroids,B-NAME_OF_DRUG,7558
60932,are,O,7558
60933,used,O,7558
60934,when,O,7558
60935,inflammation,O,7558
60936,or,O,7558
60937,residual,O,7558
60938,inflammation,O,7558
60939,in,O,7558
60940,the,O,7558
60941,case,O,7558
60942,of,O,7558
60943,a,O,7558
60944,systemically,O,7558
60945,treated,O,7558
60946,patient,O,7558
60947,is,O,7558
60948,limited,O,7558
60949,to,O,7559
60950,the,O,7559
60951,eye,O,7559
60952,Subtenon,B-TREATMENT,7559
60953,triamcinolone,I-TREATMENT,7559
60954,injections,I-TREATMENT,7559
60955,are,O,7559
60956,most,O,7559
60957,commonly,O,7559
60958,used,O,7559
60959,in,O,7559
60960,clinical,O,7559
60961,practice,O,7559
60962,As,O,7559
60963,with,O,7559
60964,all,O,7559
60965,treatments,O,7559
60966,there,O,7559
60967,are,O,7560
60968,some,O,7560
60969,limitations,O,7560
60970,Clinical,O,7560
60971,experience,O,7560
60972,has,O,7560
60973,shown,O,7560
60974,that,O,7560
60975,a,O,7560
60976,percentage,O,7560
60977,of,O,7560
60978,patients,O,7560
60979,will,O,7560
60980,develop,O,7560
60981,high,B-NAME_OF_DISEASE,7560
60982,IOP,I-NAME_OF_DISEASE,7560
60983,and,O,7560
60984,or,O,7560
60985,cataract,B-NAME_OF_DISEASE,7561
60986,as,O,7561
60987,a,O,7561
60988,result,O,7561
60989,of,O,7561
60990,these,O,7561
60991,injections,O,7561
60992,and,O,7561
60993,it,O,7561
60994,is,O,7561
60995,difficult,O,7561
60996,to,O,7561
60997,predict,O,7561
60998,which,O,7561
60999,patients,O,7561
61000,will,O,7561
61001,have,O,7561
61002,that,O,7561
61003,response,O,7561
61004,As,O,7561
61005,for,O,7561
61006,systemic,O,7562
61007,treatments,O,7562
61008,corticosteroids,B-NAME_OF_DRUG,7562
61009,are,O,7562
61010,the,O,7562
61011,first-line,O,7562
61012,drug,O,7562
61013,in,O,7562
61014,noninfectious,O,7562
61015,inflammatory,O,7562
61016,conditions,O,7562
61017,including,O,7562
61018,posterior,B-NAME_OF_DISEASE,7562
61019,segment,I-NAME_OF_DISEASE,7563
61020,uveitis,I-NAME_OF_DISEASE,7563
61021,When,O,7563
61022,10,B-NAME_OF_DRUG,7563
61023,mg,I-NAME_OF_DRUG,7563
61024,d,I-NAME_OF_DRUG,7563
61025,corticosteroid,I-NAME_OF_DRUG,7563
61026,treatment,O,7563
61027,is,O,7563
61028,needed,O,7563
61029,to,O,7563
61030,keep,O,7563
61031,ocular,O,7563
61032,inflammation,O,7563
61033,controlled,O,7563
61034,immunomodulatory,B-TREATMENT,7563
61035,therapies,I-TREATMENT,7563
61036,IMTs,I-TREATMENT,7563
61037,are,O,7563
61038,used,O,7564
61039,In,O,7564
61040,Europe,B-GPE,7564
61041,cyclosporine,B-NAME_OF_DRUG,7564
61042,mycophenolate,B-NAME_OF_DRUG,7564
61043,azathioprine,B-NAME_OF_DRUG,7564
61044,and,O,7564
61045,methotrexate,B-NAME_OF_DRUG,7564
61046,are,O,7564
61047,the,O,7564
61048,most,O,7564
61049,common,O,7564
61050,IMTs,B-TREATMENT,7564
61051,used,O,7564
61052,for,O,7564
61053,noninfectious,B-NAME_OF_DISEASE,7564
61054,posterior,I-NAME_OF_DISEASE,7564
61055,segment,I-NAME_OF_DISEASE,7564
61056,uveitis,B-NAME_OF_DISEASE,7564
61057,For,O,7565
61058,patients,O,7565
61059,whose,O,7565
61060,uveitis,B-NAME_OF_DISEASE,7565
61061,is,O,7565
61062,refractory,O,7565
61063,to,O,7565
61064,traditional,O,7565
61065,immunosuppressants,B-NAME_OF_DRUG,7565
61066,infliximab,B-NAME_OF_DRUG,7565
61067,and,O,7565
61068,adalimumab,B-NAME_OF_DRUG,7565
61069,are,O,7565
61070,the,O,7565
61071,anti-TNF-a,B-CHEMICAL_COMPOUND,7565
61072,biologics,O,7565
61073,that,O,7565
61074,are,O,7565
61075,most,O,7566
61076,often,O,7566
61077,used,O,7566
61078,There,O,7566
61079,is,O,7566
61080,evidence,O,7566
61081,that,O,7566
61082,patients,O,7566
61083,with,O,7566
61084,certain,O,7566
61085,systemic,O,7566
61086,etiologies,O,7566
61087,are,O,7566
61088,best,O,7566
61089,treated,O,7566
61090,early,O,7567
61091,with,O,7567
61092,the,O,7567
61093,anti-TNF-a,B-CHEMICAL_COMPOUND,7567
61094,medications,O,7567
61095,Adamantiades-Behçet,B-NAME_OF_DISEASE,7567
61096,disease,I-NAME_OF_DISEASE,7567
61097,is,O,7567
61098,believed,O,7567
61099,to,O,7567
61100,respond,O,7567
61101,well,O,7567
61102,to,O,7567
61103,infliximab,B-NAME_OF_DRUG,7567
61104,and,O,7567
61105,pediatric,B-NAME_OF_DISEASE,7567
61106,posterior,I-NAME_OF_DISEASE,7567
61107,segment,I-NAME_OF_DISEASE,7567
61108,uveitis,I-NAME_OF_DISEASE,7567
61109,patients,O,7567
61110,including,O,7567
61111,those,O,7567
61112,whose,O,7567
61113,condition,O,7567
61114,is,O,7567
61115,associated,O,7567
61116,with,O,7567
61117,juvenile,B-NAME_OF_DISEASE,7567
61118,idiopathic,I-NAME_OF_DISEASE,7567
61119,arthritis,I-NAME_OF_DISEASE,7567
61120,do,O,7567
61121,well,O,7567
61122,on,O,7567
61123,adalimumab,B-NAME_OF_DRUG,7567
61124,Regarding,O,7568
61125,other,O,7568
61126,biologics,O,7568
61127,interferon,B-CHEMICAL_COMPOUND,7568
61128,and,O,7568
61129,the,B-CHEMICAL_COMPOUND,7568
61130,interleukin-6,I-CHEMICAL_COMPOUND,7568
61131,inhibitor,I-CHEMICAL_COMPOUND,7568
61132,tocilizumab,I-CHEMICAL_COMPOUND,7568
61133,are,O,7568
61134,beginning,O,7568
61135,to,O,7568
61136,be,O,7568
61137,used,O,7568
61138,more,O,7568
61139,The,O,7568
61140,results,O,7568
61141,of,O,7568
61142,a,O,7568
61143,small,O,7569
61144,retrospective,O,7569
61145,cohort,O,7569
61146,study,O,7569
61147,has,O,7569
61148,been,O,7569
61149,published,O,7569
61150,recently,O,7569
61151,showing,O,7569
61152,success,O,7569
61153,when,O,7569
61154,treating,O,7569
61155,inflammatory,B-SIGN_AND_SYMPTOM,7569
61156,macular,B-SIGN_AND_SYMPTOM,7569
61157,edema,I-SIGN_AND_SYMPTOM,7569
61158,refractory,O,7569
61159,to,O,7569
61160,the,O,7569
61161,anti-TNF-a,B-CHEMICAL_COMPOUND,7569
61162,medications,O,7570
61163,Interferon,B-CHEMICAL_COMPOUND,7570
61164,is,O,7570
61165,used,O,7570
61166,mostly,O,7570
61167,in,O,7570
61168,Germany,B-GPE,7570
61169,and,O,7570
61170,Turkey,B-GPE,7570
61171,mainly,O,7570
61172,in,O,7570
61173,Behçet,B-NAME_OF_DISEASE,7570
61174,disease,I-NAME_OF_DISEASE,7570
61175,and,O,7570
61176,in,O,7570
61177,cases,O,7570
61178,with,O,7570
61179,macular,B-SIGN_AND_SYMPTOM,7570
61180,edema,I-SIGN_AND_SYMPTOM,7570
61181,An,O,7570
61182,advantage,O,7570
61183,of,O,7570
61184,interferon,B-CHEMICAL_COMPOUND,7570
61185,is,O,7570
61186,that,O,7570
61187,when,O,7570
61188,treatment,O,7570
61189,is,O,7570
61190,stopped,O,7571
61191,a,O,7571
61192,high,O,7571
61193,percentage,O,7571
61194,of,O,7571
61195,patients,O,7571
61196,remain,O,7571
61197,in,O,7571
61198,remission,O,7571
61199,LOUVRE,B-NAME_OF_STUDY,7571
61200,2,I-NAME_OF_STUDY,7571
61201,STUDY,I-NAME_OF_STUDY,7571
61202,FINDINGS,O,7571
61203,IN,O,7571
61204,LOUVRE,B-NAME_OF_STUDY,7571
61205,2,I-NAME_OF_STUDY,7571
61206,a,O,7572
61207,French,O,7572
61208,postmarketing,O,7572
61209,prospective,O,7572
61210,observational,O,7572
61211,study,O,7572
61212,confirm,O,7572
61213,the,O,7572
61214,real-world,O,7572
61215,efficacy,O,7573
61216,of,O,7573
61217,the,O,7573
61218,dexamethasone,O,7573
61219,0,O,7573
61220,mg,O,7573
61221,intravitreal,O,7573
61222,implant,O,7573
61223,Ozurdex,B-NAME_OF_DRUG,7573
61224,Allergan,B-ORGANIZATION,7573
61225,for,O,7574
61226,treating,O,7574
61227,relatively,O,7574
61228,long-standing,O,7574
61229,non-infectious,B-NAME_OF_DISEASE,7574
61230,posterior,I-NAME_OF_DISEASE,7574
61231,segment,I-NAME_OF_DISEASE,7574
61232,uveitis,B-NAME_OF_DISEASE,7574
61233,The,O,7574
61234,findings,O,7574
61235,also,O,7574
61236,provide,O,7574
61237,insight,O,7574
61238,into,O,7574
61239,the,O,7574
61240,characteristics,O,7574
61241,of,O,7574
61242,patients,O,7574
61243,ophthalmologists,O,7574
61244,choose,O,7574
61245,for,O,7574
61246,treatment,O,7574
61247,with,O,7574
61248,the,O,7575
61249,sustained-release,O,7575
61250,corticosteroid,B-NAME_OF_DRUG,7575
61251,implant,O,7575
61252,Noninfectious,B-NAME_OF_DISEASE,7575
61253,posterior,I-NAME_OF_DISEASE,7575
61254,segment,I-NAME_OF_DISEASE,7575
61255,uveitis,B-NAME_OF_DISEASE,7575
61256,NIPU,B-NAME_OF_DISEASE,7575
61257,is,O,7575
61258,the,O,7575
61259,least,O,7575
61260,common,O,7575
61261,form,O,7575
61262,of,O,7575
61263,uveitis,B-NAME_OF_DISEASE,7575
61264,yet,O,7575
61265,it,O,7575
61266,is,O,7575
61267,the,O,7575
61268,most,O,7575
61269,vision-threatening,O,7576
61270,form,O,7576
61271,In,O,7576
61272,addition,O,7576
61273,to,O,7576
61274,its,O,7576
61275,potential,O,7576
61276,to,O,7576
61277,cause,O,7576
61278,sudden,B-SIGN_AND_SYMPTOM,7576
61279,severe,I-SIGN_AND_SYMPTOM,7576
61280,vision,I-SIGN_AND_SYMPTOM,7576
61281,loss,I-SIGN_AND_SYMPTOM,7576
61282,it,O,7576
61283,can,O,7576
61284,be,O,7576
61285,associated,O,7576
61286,with,O,7576
61287,painful,B-SIGN_AND_SYMPTOM,7576
61288,symptoms,O,7576
61289,Because,O,7576
61290,of,O,7576
61291,its,O,7576
61292,sequelae,O,7576
61293,NIPU,B-NAME_OF_DISEASE,7576
61294,can,O,7576
61295,lead,O,7576
61296,to,O,7576
61297,a,O,7577
61298,marked,O,7577
61299,decrease,O,7577
61300,in,O,7577
61301,quality,O,7577
61302,of,O,7577
61303,life,O,7577
61304,In,O,7577
61305,this,O,7577
61306,cohort,O,7577
61307,of,O,7577
61308,patients,O,7577
61309,seen,O,7577
61310,in,O,7577
61311,routine,O,7577
61312,clinical,O,7577
61313,practice,O,7578
61314,consisting,O,7578
61315,mostly,O,7578
61316,of,O,7578
61317,individuals,O,7578
61318,previously,O,7579
61319,treated,O,7579
61320,for,O,7579
61321,uveitis,B-NAME_OF_DISEASE,7579
61322,for,O,7579
61323,an,O,7579
61324,average,O,7579
61325,of,O,7579
61326,5,B-TIME_DURATION,7579
61327,years,I-TIME_DURATION,7579
61328,the,B-NAME_OF_DRUG,7579
61329,intravitreal,I-NAME_OF_DRUG,7579
61330,dexamethasone,I-NAME_OF_DRUG,7579
61331,implant,I-NAME_OF_DRUG,7579
61332,maintained,O,7579
61333,its,O,7579
61334,functional,O,7579
61335,and,O,7579
61336,anatomic,O,7579
61337,efficacy,O,7580
61338,In,O,7580
61339,addition,O,7580
61340,the,O,7580
61341,tolerability,O,7580
61342,of,O,7580
61343,the,B-TREATMENT,7580
61344,steroid,I-TREATMENT,7580
61345,implant,I-TREATMENT,7580
61346,treatment,I-TREATMENT,7580
61347,was,O,7580
61348,consistent,O,7580
61349,with,O,7580
61350,what,O,7580
61351,has,O,7580
61352,been,O,7580
61353,reported,O,7580
61354,in,O,7580
61355,the,O,7580
61356,literature,O,7580
61357,With,O,7580
61358,its,O,7581
61359,approval,O,7581
61360,in,O,7581
61361,July,O,7581
61362,2010,O,7581
61363,the,B-NAME_OF_DRUG,7581
61364,dexamethasone,I-NAME_OF_DRUG,7581
61365,intravitreal,I-NAME_OF_DRUG,7581
61366,implant,I-NAME_OF_DRUG,7581
61367,became,O,7581
61368,the,O,7581
61369,first,O,7581
61370,specialized,O,7581
61371,treatment,O,7581
61372,for,O,7581
61373,NIPU,B-NAME_OF_DISEASE,7581
61374,in,O,7581
61375,Europe,B-GPE,7581
61376,Thereafter,O,7581
61377,the,O,7581
61378,prospective,O,7581
61379,multicenter,O,7581
61380,observational,O,7582
61381,LOUVRE,B-NAME_OF_STUDY,7582
61382,2,I-NAME_OF_STUDY,7582
61383,study,I-NAME_OF_STUDY,7582
61384,was,O,7582
61385,implemented,O,7582
61386,in,O,7582
61387,France,B-GPE,7582
61388,to,O,7582
61389,evaluate,O,7582
61390,the,O,7582
61391,real-world,O,7582
61392,efficacy,O,7582
61393,safety,O,7583
61394,and,O,7583
61395,use,O,7584
61396,of,O,7584
61397,the,O,7584
61398,implant,O,7584
61399,in,O,7584
61400,patients,O,7584
61401,affected,O,7584
61402,by,O,7584
61403,NIPU,B-NAME_OF_DISEASE,7584
61404,The,O,7584
61405,study,O,7584
61406,enrolled,O,7584
61407,consecutively,O,7584
61408,presenting,O,7584
61409,patients,O,7584
61410,with,O,7584
61411,inflammation,B-SIGN_AND_SYMPTOM,7584
61412,of,I-SIGN_AND_SYMPTOM,7585
61413,the,I-SIGN_AND_SYMPTOM,7585
61414,posterior,I-SIGN_AND_SYMPTOM,7585
61415,ocular,I-SIGN_AND_SYMPTOM,7585
61416,segment,I-SIGN_AND_SYMPTOM,7586
61417,due,O,7586
61418,to,O,7586
61419,NIPU,B-NAME_OF_DISEASE,7586
61420,Twenty,O,7586
61421,randomly,O,7587
61422,selected,O,7587
61423,injection,O,7588
61424,centers,O,7588
61425,participated,O,7588
61426,in,O,7588
61427,the,O,7588
61428,study,O,7588
61429,Both,O,7588
61430,treatment-naive,O,7588
61431,and,O,7588
61432,previously,O,7588
61433,treated,O,7588
61434,patients,O,7588
61435,were,O,7588
61436,eligible,O,7588
61437,for,O,7588
61438,enrollment,O,7588
61439,Patients,O,7588
61440,who,O,7588
61441,were,O,7588
61442,treated,O,7588
61443,with,O,7588
61444,the,B-NAME_OF_DRUG,7588
61445,dexamethasone,B-NAME_OF_DRUG,7588
61446,implant,I-NAME_OF_DRUG,7588
61447,on,O,7588
61448,study,O,7588
61449,entry,O,7588
61450,could,O,7588
61451,be,O,7588
61452,retreated,O,7589
61453,with,O,7589
61454,the,O,7589
61455,implant,O,7589
61456,and,O,7589
61457,or,O,7589
61458,alternative,O,7589
61459,therapies,O,7589
61460,during,O,7589
61461,follow-up,O,7589
61462,According,O,7589
61463,to,O,7589
61464,the,O,7589
61465,protocol,O,7589
61466,outcomes,O,7589
61467,would,O,7589
61468,be,O,7589
61469,analyzed,O,7589
61470,using,O,7589
61471,data,O,7589
61472,from,O,7589
61473,visits,O,7589
61474,at,O,7589
61475,months,O,7589
61476,2,O,7589
61477,6,O,7590
61478,and,O,7590
61479,18,O,7590
61480,after,O,7591
61481,patient,O,7591
61482,enrollment,O,7591
61483,A,O,7591
61484,batch,O,7591
61485,recall,O,7591
61486,of,O,7591
61487,the,O,7592
61488,implant,O,7592
61489,at,O,7592
61490,the,O,7592
61491,end,O,7592
61492,of,O,7592
61493,2018,O,7593
61494,led,O,7593
61495,to,O,7593
61496,early,O,7593
61497,termination,O,7594
61498,of,O,7594
61499,the,O,7594
61500,study,O,7594
61501,and,O,7594
61502,only,O,7594
61503,a,O,7594
61504,few,O,7594
61505,patients,O,7594
61506,reached,O,7594
61507,the,O,7594
61508,month,O,7594
61509,18,O,7594
61510,visit,O,7594
61511,Efficacy,O,7594
61512,assessments,O,7594
61513,included,O,7594
61514,changes,O,7595
61515,in,O,7595
61516,best,B-DIAGNOSTIC_TEST,7596
61517,corrected,I-DIAGNOSTIC_TEST,7596
61518,visual,I-DIAGNOSTIC_TEST,7597
61519,acuity,I-DIAGNOSTIC_TEST,7597
61520,BCVA,B-DIAGNOSTIC_TEST,7597
61521,and,O,7597
61522,central,B-DIAGNOSTIC_TEST,7597
61523,retinal,I-DIAGNOSTIC_TEST,7597
61524,thickness,I-DIAGNOSTIC_TEST,7597
61525,CRT,B-DIAGNOSTIC_TEST,7597
61526,,O,7597
61527,Safety,O,7597
61528,evaluations,O,7597
61529,reviewed,O,7597
61530,AE,O,7597
61531,reports,O,7597
61532,Baseline,O,7597
61533,data,O,7597
61534,were,O,7597
61535,available,O,7597
61536,for,O,7597
61537,241,O,7598
61538,patients,O,7598
61539,including,O,7598
61540,97,O,7598
61541,who,O,7598
61542,were,O,7599
61543,treated,O,7599
61544,with,O,7599
61545,the,B-NAME_OF_DRUG,7599
61546,dexamethasone,B-NAME_OF_DRUG,7599
61547,implant,I-NAME_OF_DRUG,7599
61548,at,O,7599
61549,study,O,7599
61550,entry,O,7599
61551,The,O,7599
61552,patients,O,7599
61553,who,O,7599
61554,were,O,7599
61555,treated,O,7599
61556,with,O,7599
61557,dexamethasone,B-NAME_OF_DRUG,7599
61558,had,O,7599
61559,on,O,7599
61560,average,O,7599
61561,a,O,7599
61562,5-year,O,7599
61563,history,O,7599
61564,of,O,7600
61565,NIPU,B-NAME_OF_DISEASE,7600
61566,and,O,7600
61567,80%,O,7600
61568,had,O,7600
61569,received,O,7600
61570,prior,O,7600
61571,treatment,O,7600
61572,Compared,O,7600
61573,with,O,7600
61574,the,O,7600
61575,group,O,7600
61576,of,O,7600
61577,144,O,7600
61578,patients,O,7600
61579,that,O,7600
61580,did,O,7600
61581,not,O,7600
61582,receive,O,7600
61583,the,O,7600
61584,implant,O,7600
61585,those,O,7600
61586,treated,O,7600
61587,who,O,7600
61588,received,O,7601
61589,the,B-NAME_OF_DRUG,7601
61590,dexamethasone,B-NAME_OF_DRUG,7601
61591,implant,I-NAME_OF_DRUG,7601
61592,were,O,7601
61593,7,O,7601
61594,years,O,7601
61595,older,O,7601
61596,on,O,7601
61597,average,O,7601
61598,and,O,7601
61599,had,O,7601
61600,a,O,7601
61601,thicker,O,7601
61602,mean,O,7601
61603,CRT,B-DIAGNOSTIC_TEST,7601
61604,mean,O,7601
61605,difference,O,7601
61606,91,O,7602
61607,µm,O,7602
61608,,O,7602
61609,In,O,7602
61610,addition,O,7602
61611,the,O,7602
61612,group,O,7602
61613,treated,O,7602
61614,with,O,7602
61615,the,B-NAME_OF_DRUG,7602
61616,dexamethasone,B-NAME_OF_DRUG,7602
61617,implant,I-NAME_OF_DRUG,7602
61618,included,O,7602
61619,greater,O,7602
61620,proportions,O,7602
61621,of,O,7602
61622,patients,O,7602
61623,with,O,7602
61624,cataract,B-NAME_OF_DISEASE,7602
61625,20,O,7602
61626,difference,O,7602
61627,macular,B-SIGN_AND_SYMPTOM,7602
61628,edema,I-SIGN_AND_SYMPTOM,7602
61629,26.2,O,7603
61630,difference,O,7603
61631,and,O,7603
61632,inflammation-associated,O,7603
61633,pathology,O,7603
61634,8.8,O,7603
61635,difference,O,7603
61636,,O,7603
61637,Half,O,7603
61638,the,O,7603
61639,patients,O,7603
61640,treated,O,7603
61641,with,O,7603
61642,the,B-NAME_OF_DRUG,7603
61643,dexamethasone,B-NAME_OF_DRUG,7603
61644,implant,I-NAME_OF_DRUG,7603
61645,at,O,7603
61646,entry,O,7603
61647,into,O,7603
61648,LOUVRE,B-NAME_OF_STUDY,7603
61649,2,I-NAME_OF_STUDY,7603
61650,were,O,7603
61651,not,O,7603
61652,retreated,O,7603
61653,at,O,7603
61654,month,O,7603
61655,6,O,7603
61656,mainly,O,7603
61657,because,O,7603
61658,they,O,7603
61659,had,O,7603
61660,sufficient,O,7603
61661,improvement,O,7603
61662,of,O,7603
61663,their,O,7603
61664,disease,O,7603
61665,state,O,7603
61666,The,O,7603
61667,proportion,O,7603
61668,of,O,7603
61669,dexamethasone-treated,O,7604
61670,patients,O,7604
61671,achieving,O,7604
61672,a,O,7604
61673,greater,O,7604
61674,than,O,7604
61675,or,O,7604
61676,equal,O,7604
61677,to,O,7604
61678,15-letter,O,7604
61679,gain,O,7604
61680,in,O,7604
61681,BCVA,B-DIAGNOSTIC_TEST,7604
61682,from,O,7604
61683,baseline,O,7605
61684,was,O,7605
61685,25%,O,7605
61686,at,O,7605
61687,month,O,7605
61688,2,O,7605
61689,and,O,7605
61690,19.4,O,7605
61691,at,O,7605
61692,month,O,7605
61693,6,O,7605
61694,Mean,O,7605
61695,improvement,O,7605
61696,from,O,7605
61697,baseline,O,7605
61698,BCVA,B-DIAGNOSTIC_TEST,7605
61699,was,O,7605
61700,6,O,7605
61701,letters,O,7605
61702,at,O,7605
61703,2,B-TIME_DURATION,7605
61704,months,I-TIME_DURATION,7605
61705,and,O,7605
61706,4,O,7605
61707,letters,O,7605
61708,at,O,7606
61709,6,B-TIME_DURATION,7606
61710,months,I-TIME_DURATION,7606
61711,Central,B-SIGN_AND_SYMPTOM,7606
61712,retinal,I-SIGN_AND_SYMPTOM,7606
61713,dryness,I-SIGN_AND_SYMPTOM,7606
61714,was,O,7606
61715,maintained,O,7606
61716,at,O,7606
61717,months,O,7606
61718,2,O,7606
61719,and,O,7607
61720,6,O,7607
61721,with,O,7607
61722,mean,O,7607
61723,decreases,O,7607
61724,from,O,7607
61725,baseline,O,7607
61726,of,O,7607
61727,27,O,7608
61728,and,O,7608
61729,18,O,7608
61730,mum,O,7608
61731,respectively,O,7608
61732,The,O,7608
61733,observed,O,7608
61734,functional,O,7608
61735,gains,O,7608
61736,are,O,7608
61737,clinically,O,7608
61738,relevant,O,7608
61739,and,O,7608
61740,were,O,7608
61741,achieved,O,7609
61742,despite,O,7609
61743,prior,O,7609
61744,treatment,O,7609
61745,with,O,7609
61746,the,B-NAME_OF_DRUG,7609
61747,dexamethasone,B-NAME_OF_DRUG,7609
61748,implant,I-NAME_OF_DRUG,7609
61749,in,O,7609
61750,55.7,O,7609
61751,of,O,7609
61752,the,O,7609
61753,patients,O,7609
61754,followed,O,7609
61755,prospectively,O,7609
61756,These,O,7609
61757,findings,O,7609
61758,substantiate,O,7609
61759,the,O,7609
61760,efficacy,O,7609
61761,of,O,7609
61762,the,B-NAME_OF_DRUG,7609
61763,dexamethasone,B-NAME_OF_DRUG,7609
61764,implant,I-NAME_OF_DRUG,7609
61765,for,O,7609
61766,improving,O,7609
61767,visual,O,7610
61768,function,O,7610
61769,among,O,7610
61770,patients,O,7610
61771,with,O,7610
61772,NIPU,B-NAME_OF_DISEASE,7610
61773,in,O,7610
61774,seen,O,7610
61775,the,O,7610
61776,clinical,O,7610
61777,setting,O,7610
61778,The,O,7610
61779,most,O,7610
61780,frequently,O,7610
61781,reported,O,7610
61782,AE,O,7610
61783,occurring,O,7610
61784,in,O,7610
61785,patients,O,7610
61786,treated,O,7610
61787,with,O,7610
61788,the,B-NAME_OF_DRUG,7610
61789,dexamethasone,B-NAME_OF_DRUG,7610
61790,implant,I-NAME_OF_DRUG,7610
61791,was,O,7610
61792,transient,O,7610
61793,ocular,B-NAME_OF_DISEASE,7610
61794,hypertension,I-NAME_OF_DISEASE,7610
61795,which,O,7610
61796,occurred,O,7611
61797,at,O,7611
61798,a,O,7611
61799,rate,O,7611
61800,of,O,7611
61801,6.90%,O,7611
61802,This,O,7611
61803,finding,O,7611
61804,is,O,7611
61805,similar,O,7611
61806,to,O,7611
61807,the,O,7611
61808,experience,O,7611
61809,reported,O,7611
61810,with,O,7611
61811,the,B-NAME_OF_DRUG,7611
61812,dexamethasone,B-NAME_OF_DRUG,7611
61813,implant,I-NAME_OF_DRUG,7611
61814,in,O,7611
61815,prior,O,7611
61816,prospective,O,7611
61817,and,O,7611
61818,retrospective,O,7611
61819,studies,O,7611
61820,20-20-20,B-TREATMENT,7611
61821,screen,I-TREATMENT,7611
61822,rule,I-TREATMENT,7611
61823,has,O,7611
61824,been,O,7611
61825,suggested,O,7611
61826,for,O,7611
61827,a,O,7611
61828,long,O,7611
61829,time,O,7611
61830,as,O,7612
61831,a,O,7612
61832,strategy,O,7612
61833,to,O,7612
61834,reduce,O,7612
61835,eye,B-SIGN_AND_SYMPTOM,7612
61836,strain,I-SIGN_AND_SYMPTOM,7612
61837,while,O,7612
61838,staring,O,7612
61839,at,O,7612
61840,a,O,7612
61841,computer,O,7612
61842,screen,O,7612
61843,Scientists,O,7612
61844,at,O,7612
61845,Aston,B-ORGANIZATION,7612
61846,University,I-ORGANIZATION,7612
61847,have,O,7612
61848,now,O,7612
61849,confirmed,O,7612
61850,the,B-TREATMENT,7612
61851,20-20-20,I-TREATMENT,7612
61852,rule,I-TREATMENT,7612
61853,which,O,7612
61854,suggests,O,7612
61855,taking,O,7612
61856,breaks,O,7612
61857,of,O,7612
61858,at,O,7612
61859,least,O,7612
61860,20,O,7612
61861,seconds,O,7612
61862,every,O,7612
61863,20,O,7612
61864,minutes,O,7612
61865,to,O,7612
61866,look,O,7612
61867,at,O,7612
61868,least,O,7612
61869,20,O,7612
61870,feet,O,7612
61871,away,O,7612
61872,to,O,7612
61873,reduce,O,7613
61874,some,O,7613
61875,of,O,7613
61876,the,O,7613
61877,side,O,7613
61878,effects,O,7613
61879,of,O,7613
61880,extended,O,7613
61881,computer,O,7613
61882,use,O,7613
61883,This,O,7613
61884,is,O,7613
61885,the,O,7613
61886,first,O,7613
61887,time,O,7613
61888,that,O,7613
61889,the,B-TREATMENT,7613
61890,20-20-20,I-TREATMENT,7613
61891,guidance,I-TREATMENT,7614
61892,rule,I-TREATMENT,7614
61893,has,O,7614
61894,been,O,7614
61895,properly,O,7614
61896,validated,O,7614
61897,Digital,B-NAME_OF_DISEASE,7614
61898,eye,I-NAME_OF_DISEASE,7614
61899,strain,I-NAME_OF_DISEASE,7614
61900,which,O,7614
61901,can,O,7614
61902,cause,O,7614
61903,headaches,B-SIGN_AND_SYMPTOM,7614
61904,or,I-SIGN_AND_SYMPTOM,7614
61905,impaired,I-SIGN_AND_SYMPTOM,7614
61906,vision,I-SIGN_AND_SYMPTOM,7614
61907,is,O,7614
61908,believed,O,7614
61909,to,O,7614
61910,affect,O,7614
61911,at,O,7614
61912,least,O,7614
61913,half,O,7614
61914,of,O,7614
61915,those,O,7614
61916,who,O,7614
61917,use,O,7615
61918,computers,O,7615
61919,regularly,O,7615
61920,at,O,7615
61921,work,O,7615
61922,It,O,7615
61923,can,O,7615
61924,also,O,7615
61925,cause,O,7615
61926,irritation,B-SIGN_AND_SYMPTOM,7615
61927,and,I-SIGN_AND_SYMPTOM,7615
61928,dryness,I-SIGN_AND_SYMPTOM,7615
61929,of,I-SIGN_AND_SYMPTOM,7616
61930,the,I-SIGN_AND_SYMPTOM,7616
61931,eye,I-SIGN_AND_SYMPTOM,7616
61932,surface,I-SIGN_AND_SYMPTOM,7616
61933,Humans,O,7616
61934,normally,O,7616
61935,blink,O,7616
61936,around,O,7616
61937,15,O,7616
61938,times,O,7616
61939,each,O,7616
61940,minute,O,7616
61941,This,O,7616
61942,number,O,7616
61943,usually,O,7616
61944,drops,O,7616
61945,to,O,7616
61946,half,O,7616
61947,that,O,7616
61948,rate,O,7616
61949,or,O,7616
61950,less,O,7616
61951,when,O,7616
61952,looking,O,7616
61953,at,O,7616
61954,screens,O,7616
61955,This,O,7616
61956,can,O,7616
61957,cause,O,7616
61958,dry,B-SIGN_AND_SYMPTOM,7616
61959,itchy,I-SIGN_AND_SYMPTOM,7616
61960,and,I-SIGN_AND_SYMPTOM,7616
61961,fatigued,I-SIGN_AND_SYMPTOM,7616
61962,eyes,I-SIGN_AND_SYMPTOM,7616
61963,but,O,7617
61964,focusing,O,7617
61965,on,O,7617
61966,something,O,7617
61967,else,O,7617
61968,for,O,7617
61969,20,O,7617
61970,seconds,O,7617
61971,will,O,7617
61972,allow,O,7617
61973,the,O,7617
61974,eyes,O,7617
61975,to,O,7617
61976,relax,O,7617
61977,and,O,7617
61978,lessen,O,7617
61979,the,O,7617
61980,tension,O,7617
61981,The,O,7617
61982,study,O,7617
61983,Researchers,O,7617
61984,at,O,7617
61985,Aston,B-ORGANIZATION,7617
61986,University,I-ORGANIZATION,7617
61987,s,I-ORGANIZATION,7617
61988,College,I-ORGANIZATION,7617
61989,of,I-ORGANIZATION,7617
61990,Health,I-ORGANIZATION,7617
61991,and,I-ORGANIZATION,7617
61992,Life,I-ORGANIZATION,7617
61993,Sciences,I-ORGANIZATION,7617
61994,conducted,O,7617
61995,their,O,7617
61996,study,O,7617
61997,with,O,7617
61998,the,O,7617
61999,help,O,7618
62000,of,O,7618
62001,29,O,7618
62002,participants,O,7618
62003,who,O,7618
62004,suffer,O,7618
62005,from,O,7618
62006,symptoms,O,7618
62007,of,O,7618
62008,eye,B-SIGN_AND_SYMPTOM,7618
62009,strain,I-SIGN_AND_SYMPTOM,7618
62010,The,O,7618
62011,built-in,O,7618
62012,laptop,O,7618
62013,camera,O,7618
62014,was,O,7618
62015,employed,O,7618
62016,by,O,7618
62017,specialized,O,7618
62018,software,O,7619
62019,that,O,7619
62020,was,O,7619
62021,downloaded,O,7619
62022,onto,O,7619
62023,the,O,7619
62024,participants,O,7619
62025,personal,O,7619
62026,laptop,O,7619
62027,computers,O,7619
62028,to,O,7619
62029,periodically,O,7619
62030,check,O,7619
62031,if,O,7619
62032,a,O,7619
62033,user,O,7619
62034,was,O,7619
62035,seated,O,7619
62036,at,O,7619
62037,the,O,7619
62038,screen,O,7619
62039,and,O,7619
62040,track,O,7619
62041,their,O,7619
62042,gaze,O,7619
62043,direction,O,7619
62044,The,O,7619
62045,program,O,7619
62046,flashed,O,7619
62047,up,O,7619
62048,a,O,7619
62049,message,O,7619
62050,urging,O,7619
62051,users,O,7619
62052,to,O,7619
62053,take,O,7619
62054,a,O,7619
62055,break,O,7619
62056,for,O,7619
62057,20,O,7619
62058,seconds,O,7620
62059,while,O,7620
62060,focusing,O,7620
62061,on,O,7620
62062,any,O,7620
62063,distant,O,7620
62064,target,O,7620
62065,that,O,7620
62066,was,O,7620
62067,roughly,O,7620
62068,20,O,7620
62069,feet,O,7620
62070,away,O,7620
62071,such,O,7621
62072,as,O,7621
62073,out,O,7621
62074,the,O,7621
62075,window,O,7621
62076,or,O,7621
62077,across,O,7621
62078,the,O,7621
62079,room,O,7621
62080,after,O,7621
62081,20,O,7621
62082,minutes,O,7621
62083,of,O,7621
62084,nonstop,O,7621
62085,screen,O,7621
62086,staring,O,7621
62087,Before,O,7621
62088,the,O,7621
62089,task,O,7621
62090,had,O,7621
62091,been,O,7621
62092,completed,O,7621
62093,appropriately,O,7621
62094,as,O,7621
62095,determined,O,7621
62096,by,O,7621
62097,the,O,7621
62098,app,O,7621
62099,the,O,7622
62100,message,O,7622
62101,could,O,7622
62102,not,O,7622
62103,be,O,7622
62104,erased,O,7622
62105,Before,O,7622
62106,and,O,7622
62107,after,O,7622
62108,using,O,7622
62109,the,O,7622
62110,reminders,O,7622
62111,for,B-TIME_DURATION,7622
62112,two,I-TIME_DURATION,7622
62113,weeks,I-TIME_DURATION,7622
62114,as,O,7622
62115,well,O,7622
62116,as,O,7622
11613,Daily,O,10551
11614,lutein,B-CHEMICAL_COMPOUND,10551
11615,supplements,O,10551
11616,of,O,10551
11617,10,O,10551
11618,mg,O,10551
11619,or,O,10551
11620,more,O,10551
11621,increased,O,10551
11622,macular,B-PART_OF_THE_EYES,10551
11623,pigment,I-PART_OF_THE_EYES,10551
11624,after,O,10551
11625,3,B-TIME_DURATION,10551
11626,months,I-TIME_DURATION,10551
11627,Studies,O,10552
11628,of,O,10552
11629,dietary,O,10552
11630,sources,O,10552
11631,of,O,10552
11632,lutein,B-CHEMICAL_COMPOUND,10552
11633,generally,O,10552
11634,used,O,10552
11635,lower,O,10552
11636,daily,O,10552
11637,doses,O,10552
11638,of,O,10552
11639,lutein,B-CHEMICAL_COMPOUND,10552
11640,over,O,10552
11641,a,O,10552
11642,short,O,10552
11643,period,O,10552
11644,of,O,10552
11645,time,O,10552
11646,6,B-TIME_DURATION,10552
11647,months,I-TIME_DURATION,10552
11648,or,O,10552
11649,less,O,10552
11650,While,O,10553
11651,bariatric,B-TREATMENT,10553
11652,surgery,I-TREATMENT,10553
11653,was,O,10553
11654,associated,O,10553
11655,with,O,10553
11656,fewer,O,10553
11657,cases,O,10553
11658,of,O,10553
11659,all,O,10553
11660,and,O,10553
11661,sight-threatening,B-NAME_OF_DISEASE,10553
11662,DR,I-NAME_OF_DISEASE,10553
11663,early,O,10553
11664,worsening,O,10553
11665,was,O,10553
11666,more,O,10553
11667,severe,O,10553
11668,in,O,10553
11669,patients,O,10553
11670,with,O,10553
11671,existing,O,10553
11672,sight-threatening,B-NAME_OF_DISEASE,10553
11673,DR,I-NAME_OF_DISEASE,10553
11674,Sight-threatening,B-NAME_OF_DISEASE,10554
11675,DR,I-NAME_OF_DISEASE,10554
11676,was,O,10554
11677,defined,O,10554
11678,as,O,10554
11679,proliferative,B-NAME_OF_DISEASE,10554
11680,or,I-NAME_OF_DISEASE,10554
11681,preproliferative,I-NAME_OF_DISEASE,10554
11682,DR,I-NAME_OF_DISEASE,10554
11683,or,O,10554
11684,diabetic,B-NAME_OF_DISEASE,10554
11685,maculopathy,I-NAME_OF_DISEASE,10554
11686,or,O,10554
11687,severe,O,10554
11688,nonproliferative,B-NAME_OF_DISEASE,10554
11689,DR,I-NAME_OF_DISEASE,10554
11690,MITF,B-CHEMICAL_COMPOUND,10555
11691,is,O,10555
11692,well-established,O,10555
11693,as,O,10555
11694,a,O,10555
11695,transcription,O,10555
11696,factor,O,10555
11697,found,O,10555
11698,predominantly,O,10555
11699,expressed,O,10555
11700,in,O,10555
11701,RPE,B-PART_OF_THE_EYES,10555
11702,whereas,O,10555
11703,RGCs,B-PART_OF_THE_EYES,10555
11704,express,O,10555
11705,ATOH7,B-CHEMICAL_COMPOUND,10555
11706,and,O,10555
11707,BRN3a,B-CHEMICAL_COMPOUND,10555
11708,BRN3b,B-CHEMICAL_COMPOUND,10555
11709,transcription,O,10555
11710,factors,O,10555
11711,Why,O,10556
11712,has,O,10556
11713,the,O,10556
11714,eye,O,10556
11715,proved,O,10556
11716,to,O,10556
11717,be,O,10556
11718,well-suited,O,10556
11719,for,O,10556
11720,cell,B-TREATMENT,10556
11721,and,I-TREATMENT,10556
11722,gene,I-TREATMENT,10556
11723,therapies,I-TREATMENT,10556
11724,It,O,10557
11725,is,O,10557
11726,easily,O,10557
11727,accessible,O,10557
11728,immune-privileged,O,10557
11729,and,O,10557
11730,well,O,10557
11731,suited,O,10557
11732,for,O,10557
11733,clinical,O,10557
11734,imaging,O,10557
11735,because,O,10557
11736,of,O,10557
11737,the,O,10557
11738,transparent,O,10557
11739,cornea,B-PART_OF_THE_EYES,10557
11740,and,O,10557
11741,lens,B-PART_OF_THE_EYES,10557
11742,There,O,10558
11743,have,O,10558
11744,been,O,10558
11745,several,O,10558
11746,clinical,O,10558
11747,trials,O,10558
11748,to,O,10558
11749,test,O,10558
11750,the,O,10558
11751,safety,O,10558
11752,and,O,10558
11753,efficacy,O,10558
11754,of,O,10558
11755,RPE,B-PART_OF_THE_EYES,10558
11756,derived,O,10558
11757,from,O,10558
11758,ESCs,B-PART_OF_THE_EYES,10558
11759,iPSCs,B-PART_OF_THE_EYES,10558
11760,for,O,10558
11761,the,O,10558
11762,treatment,O,10558
11763,of,O,10558
11764,AMD,B-NAME_OF_DISEASE,10558
11765,Fetal,O,10559
11766,retinal,B-PART_OF_THE_EYES,10559
11767,progenitor,I-PART_OF_THE_EYES,10559
11768,cells,I-PART_OF_THE_EYES,10559
11769,RPCs,I-PART_OF_THE_EYES,10559
11770,are,O,10559
11771,currently,O,10559
11772,in,O,10559
11773,phase,O,10559
11774,IIIa,O,10559
11775,clinical,O,10559
11776,trials,O,10559
11777,and,O,10559
11778,have,O,10559
11779,shown,O,10559
11780,promising,O,10559
11781,results,O,10559
11782,in,O,10559
11783,a,O,10559
11784,phase,O,10559
11785,IIb,O,10559
11786,clinical,O,10559
11787,trial,O,10559
11788,for,O,10559
11789,the,O,10559
11790,treatment,O,10559
11791,of,O,10559
11792,RP,B-NAME_OF_DISEASE,10559
11793,The,O,10560
11794,use,O,10560
11795,of,O,10560
11796,RPCs,B-PART_OF_THE_EYES,10560
11797,as,O,10560
11798,a,O,10560
11799,cell,O,10560
11800,therapy,O,10560
11801,continues,O,10560
11802,to,O,10560
11803,be,O,10560
11804,an,O,10560
11805,exciting,O,10560
11806,prospect,O,10560
11807,for,O,10560
11808,the,O,10560
11809,treatment,O,10560
11810,of,O,10560
11811,inherited,B-NAME_OF_DISEASE,10560
11812,retinopathies,I-NAME_OF_DISEASE,10560
11813,AbbVie,B-ORGANIZATION,10561
11814,Allergan,B-ORGANIZATION,10561
11815,AGN-190584,B-NAME_OF_STUDY,10561
11816,Two,I-NAME_OF_STUDY,10561
11817,Phase,I-NAME_OF_STUDY,10561
11818,3,I-NAME_OF_STUDY,10561
11819,clinical,I-NAME_OF_STUDY,10561
11820,trials,I-NAME_OF_STUDY,10561
11821,Gemini,I-NAME_OF_STUDY,10561
11822,I,I-NAME_OF_STUDY,10561
11823,and,I-NAME_OF_STUDY,10561
11824,II,I-NAME_OF_STUDY,10561
11825,with,O,10561
11826,a,O,10561
11827,total,O,10561
11828,of,O,10561
11829,750,O,10561
11830,participants,O,10561
11831,have,O,10561
11832,been,O,10561
11833,completed,O,10561
11834,The,O,10562
11835,utilization,O,10562
11836,of,O,10562
11837,intraocular,B-TREATMENT,10562
11838,injections,I-TREATMENT,10562
11839,implants,I-TREATMENT,10562
11840,or,O,10562
11841,systemic,B-TREATMENT,10562
11842,medications,I-TREATMENT,10562
11843,is,O,10562
11844,typically,O,10562
11845,required,O,10562
11846,for,O,10562
11847,the,O,10562
11848,treatment,O,10562
11849,of,O,10562
11850,posterior,B-NAME_OF_DISEASE,10562
11851,uveitis,I-NAME_OF_DISEASE,10562
11852,After,O,10563
11853,anterior,O,10563
11854,and,O,10563
11855,panuveitis,B-NAME_OF_DISEASE,10563
11856,respectively,O,10563
11857,posterior,B-NAME_OF_DISEASE,10563
11858,uveitis,B-NAME_OF_DISEASE,10563
11859,is,O,10563
11860,the,O,10563
11861,third,O,10563
11862,most,O,10563
11863,prevalent,O,10563
11864,kind,O,10563
11865,of,O,10563
11866,uveitis,B-NAME_OF_DISEASE,10563
11867,in,O,10563
11868,the,B-GPE,10563
11869,US,I-GPE,10563
11870,However,O,10564
11871,posterior,B-NAME_OF_DISEASE,10564
11872,uveitis,I-NAME_OF_DISEASE,10564
11873,which,O,10564
11874,accounts,O,10564
11875,for,O,10564
11876,53%,O,10564
11877,of,O,10564
11878,nonanterior,O,10564
11879,instances,O,10564
11880,in,O,10564
11881,people,O,10564
11882,under,O,10564
11883,the,O,10564
11884,age,O,10564
11885,of,O,10564
11886,65,O,10564
11887,is,O,10564
11888,more,O,10564
11889,common,O,10564
11890,than,O,10564
11891,other,O,10564
11892,types,O,10564
11893,of,O,10564
11894,nonanterior,O,10564
11895,inflammation,O,10564
11896,Are,O,10565
11897,the,O,10565
11898,retinal,O,10565
11899,vessels,O,10565
11900,or,O,10565
11901,the,O,10565
11902,head,O,10565
11903,of,O,10565
11904,the,B-PART_OF_THE_EYES,10565
11905,optic,I-PART_OF_THE_EYES,10565
11906,nerve,I-PART_OF_THE_EYES,10565
11907,involved,O,10565
11908,Do,O,10566
11909,the,O,10566
11910,clinical,O,10566
11911,characteristics,O,10566
11912,point,O,10566
11913,to,O,10566
11914,a,O,10566
11915,recognized,O,10566
11916,infectious,O,10566
11917,or,O,10566
11918,noninfectious,O,10566
11919,entity,O,10566
11920,Exist,O,10566
11921,any,O,10566
11922,problems,O,10566
11923,vitritis,B-NAME_OF_DISEASE,10566
11924,or,O,10566
11925,inflammation,B-SIGN_AND_SYMPTOM,10566
11926,in,I-SIGN_AND_SYMPTOM,10566
11927,the,I-SIGN_AND_SYMPTOM,10566
11928,anterior,I-SIGN_AND_SYMPTOM,10566
11929,segment,I-SIGN_AND_SYMPTOM,10566
11930,Toxoplasmosis,B-CAUSE_OF_DISEASE,10567
11931,was,O,10567
11932,the,O,10567
11933,most,O,10567
11934,frequent,O,10567
11935,cause,O,10567
11936,of,O,10567
11937,posterior,B-NAME_OF_DISEASE,10567
11938,uveitis,I-NAME_OF_DISEASE,10567
11939,in,O,10567
11940,a,O,10567
11941,2015,O,10567
11942,study,O,10567
11943,by,O,10567
11944,Bajwa,B-PERSON,10567
11945,et,O,10567
11946,al,O,10567
11947,Significant,O,10568
11948,systemic,O,10568
11949,consequences,O,10568
11950,from,O,10568
11951,syphilis,B-CAUSE_OF_DISEASE,10568
11952,TB,B-CAUSE_OF_DISEASE,10568
11953,sarcoidosis,B-CAUSE_OF_DISEASE,10568
11954,and,O,10568
11955,Lyme,B-CAUSE_OF_DISEASE,10568
11956,disease,I-CAUSE_OF_DISEASE,10568
11957,can,O,10568
11958,all,O,10568
11959,result,O,10568
11960,in,O,10568
11961,uveitis,B-NAME_OF_DISEASE,10568
11962,It,O,10569
11963,has,O,10569
11964,been,O,10569
11965,estimated,O,10569
11966,that,O,10569
11967,American,O,10569
11968,adults,O,10569
11969,consume,O,10569
11970,2-Jan,O,10569
11971,mg,O,10569
11972,of,O,10569
11973,lutein,B-CHEMICAL_COMPOUND,10569
11974,zeaxanthin,B-CHEMICAL_COMPOUND,10569
11975,per,O,10569
11976,day,O,10569
11977,from,O,10569
11978,dietary,O,10569
11979,sources,O,10569
11980,Macular,B-DIAGNOSTIC_TEST,10570
11981,pigment,I-DIAGNOSTIC_TEST,10570
11982,optical,I-DIAGNOSTIC_TEST,10570
11983,density,I-DIAGNOSTIC_TEST,10570
11984,MPOD,I-DIAGNOSTIC_TEST,10570
11985,is,O,10570
11986,a,O,10570
11987,measure,O,10570
11988,of,O,10570
11989,the,O,10570
11990,concentrations,O,10570
11991,of,O,10570
11992,lutein,B-CHEMICAL_COMPOUND,10570
11993,zeaxanthin,B-CHEMICAL_COMPOUND,10570
11994,in,O,10570
11995,the,B-PART_OF_THE_EYES,10570
11996,macula,I-PART_OF_THE_EYES,10570
11997,A,O,10571
11998,state-of-the-art,O,10571
11999,summary,O,10571
12000,of,O,10571
12001,evidence,O,10571
12002,shows,O,10571
12003,there,O,10571
12004,is,O,10571
12005,a,O,10571
12006,moderate,O,10571
12007,level,O,10571
12008,of,O,10571
12009,evidence,O,10571
12010,linking,O,10571
12011,10,O,10571
12012,milligrams,O,10571
12013,of,O,10571
12014,lutein,B-CHEMICAL_COMPOUND,10571
12015,zeaxanthin,B-CHEMICAL_COMPOUND,10571
12016,per,O,10571
12017,day,O,10571
12018,with,O,10571
12019,eye,O,10571
12020,function,O,10571
12021,While,O,10572
12022,more,O,10572
12023,research,O,10572
12024,would,O,10572
12025,be,O,10572
12026,helpful,O,10572
12027,this,O,10572
12028,study,O,10572
12029,of,O,10572
12030,studies,O,10572
12031,finds,O,10572
12032,that,O,10572
12033,the,O,10572
12034,indicator,O,10572
12035,of,O,10572
12036,normal,O,10572
12037,eye,O,10572
12038,structure,O,10572
12039,called,O,10572
12040,macular,B-DIAGNOSTIC_TEST,10572
12041,pigment,I-DIAGNOSTIC_TEST,10572
12042,optical,I-DIAGNOSTIC_TEST,10572
12043,density,I-DIAGNOSTIC_TEST,10572
12044,MPOD,I-DIAGNOSTIC_TEST,10572
12045,improved,O,10572
12046,with,O,10572
12047,intake,O,10572
12048,of,O,10572
12049,the,O,10572
12050,carotenoid,B-CHEMICAL_COMPOUND,10572
12051,lutein,B-CHEMICAL_COMPOUND,10572
12052,zeaxanthin,B-CHEMICAL_COMPOUND,10572
12053,Lutein,B-CHEMICAL_COMPOUND,10573
12054,zeaxanthin,B-CHEMICAL_COMPOUND,10573
12055,is,O,10573
12056,found,O,10573
12057,in,O,10573
12058,leafy,O,10573
12059,green,O,10573
12060,vegetables,O,10573
12061,squash,O,10573
12062,corn,O,10573
12063,egg,O,10573
12064,yolks,O,10573
12065,avocados,O,10573
12066,and,O,10573
12067,dietary,O,10573
12068,supplements,O,10573
12069,The,O,10574
12070,state,O,10574
12071,of,O,10574
12072,the,O,10574
12073,art,O,10574
12074,evidence,O,10574
12075,titled,O,10574
12076,The,B-NAME_OF_STUDY,10574
12077,Effect,I-NAME_OF_STUDY,10574
12078,of,I-NAME_OF_STUDY,10574
12079,Lutein,I-NAME_OF_STUDY,10574
12080,Zeaxanthin,I-NAME_OF_STUDY,10574
12081,Intake,I-NAME_OF_STUDY,10574
12082,on,I-NAME_OF_STUDY,10574
12083,Human,I-NAME_OF_STUDY,10574
12084,MPOD,I-NAME_OF_STUDY,10574
12085,A,I-NAME_OF_STUDY,10574
12086,Systematic,I-NAME_OF_STUDY,10574
12087,Review,I-NAME_OF_STUDY,10574
12088,and,I-NAME_OF_STUDY,10574
12089,Meta-Analysis,I-NAME_OF_STUDY,10574
12090,is,O,10574
12091,published,O,10574
12092,in,O,10574
12093,the,B-PUBLICATION_VENUE,10574
12094,peer-reviewed,I-PUBLICATION_VENUE,10574
12095,journal,I-PUBLICATION_VENUE,10574
12096,Advances,I-PUBLICATION_VENUE,10574
12097,in,I-PUBLICATION_VENUE,10574
12098,Nutrition,I-PUBLICATION_VENUE,10574
12099,MPOD,B-DIAGNOSTIC_TEST,10575
12100,is,O,10575
12101,a,O,10575
12102,measure,O,10575
12103,of,O,10575
12104,lutein,B-CHEMICAL_COMPOUND,10575
12105,zeaxanthin,B-CHEMICAL_COMPOUND,10575
12106,concentration,O,10575
12107,in,O,10575
12108,the,B-PART_OF_THE_EYES,10575
12109,macula,I-PART_OF_THE_EYES,10575
12110,and,O,10575
12111,is,O,10575
12112,associated,O,10575
12113,with,O,10575
12114,visual,O,10575
12115,function,O,10575
12116,As,O,10576
12117,the,O,10576
12118,disease,O,10576
12119,progresses,O,10576
12120,individuals,O,10576
12121,may,O,10576
12122,experience,O,10576
12123,Patchy,B-SIGN_AND_SYMPTOM,10576
12124,blind,I-SIGN_AND_SYMPTOM,10576
12125,spots,I-SIGN_AND_SYMPTOM,10576
12126,in,I-SIGN_AND_SYMPTOM,10576
12127,the,I-SIGN_AND_SYMPTOM,10576
12128,peripheral,I-SIGN_AND_SYMPTOM,10576
12129,or,I-SIGN_AND_SYMPTOM,10576
12130,central,I-SIGN_AND_SYMPTOM,10576
12131,vision,I-SIGN_AND_SYMPTOM,10576
12132,Tunnel,I-SIGN_AND_SYMPTOM,10576
12133,vision,I-SIGN_AND_SYMPTOM,10576
12134,Difficulty,I-SIGN_AND_SYMPTOM,10576
12135,adjusting,I-SIGN_AND_SYMPTOM,10576
12136,to,I-SIGN_AND_SYMPTOM,10576
12137,darkness,I-SIGN_AND_SYMPTOM,10576
12138,Blurred,I-SIGN_AND_SYMPTOM,10576
12139,vision,I-SIGN_AND_SYMPTOM,10576
12140,Halos,I-SIGN_AND_SYMPTOM,10576
12141,around,I-SIGN_AND_SYMPTOM,10576
12142,lights,I-SIGN_AND_SYMPTOM,10576
12143,Headaches,I-SIGN_AND_SYMPTOM,10576
12144,Eye,I-SIGN_AND_SYMPTOM,10576
12145,pain,I-SIGN_AND_SYMPTOM,10576
12146,Redness,I-SIGN_AND_SYMPTOM,10576
12147,in,I-SIGN_AND_SYMPTOM,10576
12148,the,I-SIGN_AND_SYMPTOM,10576
12149,eye,I-SIGN_AND_SYMPTOM,10576
15209,Topical,B-NAME_OF_DRUG,20676
15210,steroids,I-NAME_OF_DRUG,20676
15211,These,O,20676
15212,are,O,20676
15213,often,O,20676
15214,an,O,20676
15215,essential,O,20676
15216,tool,O,20676
15217,in,O,20676
15218,advanced,O,20676
15219,stages,O,20676
15220,of,O,20676
15221,NK,B-NAME_OF_DISEASE,20676
15222,Of,O,20677
15223,course,O,20677
15224,while,O,20677
15225,topical,B-NAME_OF_DRUG,20677
15226,steroids,I-NAME_OF_DRUG,20677
15227,can,O,20677
15228,be,O,20677
15229,a,O,20677
15230,tremendous,O,20677
15231,tool,O,20677
15232,in,O,20677
15233,managing,O,20677
15234,inflammation,O,20677
15235,in,O,20677
15236,these,O,20677
15237,patients,O,20677
15238,they,O,20677
15239,may,O,20677
15240,be,O,20677
15241,associated,O,20677
15242,with,O,20677
15243,corneal,O,20677
15244,thinning,O,20677
15245,cataract,B-NAME_OF_DISEASE,20677
15246,formation,O,20677
15247,and,O,20677
15248,elevations,O,20677
15249,in,O,20677
15250,IOP,O,20677
15251,with,O,20677
15252,long-term,O,20677
15253,use,O,20677
15254,Therefore,O,20678
15255,low-dose,B-NAME_OF_DRUG,20678
15256,preservative-free,I-NAME_OF_DRUG,20678
15257,steroids,I-NAME_OF_DRUG,20678
15258,should,O,20678
15259,be,O,20678
15260,considered,O,20678
15261,in,O,20678
15262,stabilizing,O,20678
15263,disease,O,20678
15264,progression,O,20678
15265,in,O,20678
15266,these,O,20678
15267,patients,O,20678
15268,Autologous,B-NAME_OF_DRUG,20679
15269,serum,I-NAME_OF_DRUG,20679
15270,tears,I-NAME_OF_DRUG,20679
15271,Autologous,B-NAME_OF_DRUG,20679
15272,serum,I-NAME_OF_DRUG,20679
15273,contains,O,20679
15274,proteins,B-CHEMICAL_COMPOUND,20679
15275,lysozyme,B-CHEMICAL_COMPOUND,20679
15276,lactoferrin,B-CHEMICAL_COMPOUND,20679
15277,albumin,B-CHEMICAL_COMPOUND,20679
15278,and,O,20679
15279,immunoglobulins,B-CHEMICAL_COMPOUND,20679
15280,growth,O,20679
15281,factors,O,20679
15282,epidermal,O,20679
15283,growth,O,20679
15284,factor,O,20679
15285,vitamins,B-CHEMICAL_COMPOUND,20679
15286,A,I-CHEMICAL_COMPOUND,20679
15287,and,I-CHEMICAL_COMPOUND,20679
15288,C,I-CHEMICAL_COMPOUND,20679
15289,antioxidants,B-CHEMICAL_COMPOUND,20679
15290,and,O,20679
15291,electrolytes,B-CHEMICAL_COMPOUND,20679
15292,sodium,B-CHEMICAL_COMPOUND,20679
15293,potassium,B-CHEMICAL_COMPOUND,20679
15294,chloride,B-CHEMICAL_COMPOUND,20679
15295,bicarbonate,B-CHEMICAL_COMPOUND,20679
15296,magnesium,B-CHEMICAL_COMPOUND,20679
15297,calcium,B-CHEMICAL_COMPOUND,20679
15298,The,O,20680
15299,mechanism,O,20680
15300,of,O,20680
15301,action,O,20680
15302,of,O,20680
15303,autologous,B-NAME_OF_DRUG,20680
15304,serum,I-NAME_OF_DRUG,20680
15305,eye,I-NAME_OF_DRUG,20680
15306,drops,I-NAME_OF_DRUG,20680
15307,is,O,20680
15308,to,O,20680
15309,mimic,O,20680
15310,the,O,20680
15311,biochemical,O,20680
15312,properties,O,20680
15313,of,O,20680
15314,natural,O,20680
15315,basal,O,20680
15316,tears,O,20680
15317,but,O,20680
15318,in,O,20680
15319,a,O,20680
15320,highly,O,20680
15321,concentrated,O,20680
15322,form,O,20680
15323,to,O,20680
15324,heal,O,20680
15325,the,B-PART_OF_THE_EYES,20680
15326,ocular,I-PART_OF_THE_EYES,20680
15327,surface,I-PART_OF_THE_EYES,20680
15328,epithelium,I-PART_OF_THE_EYES,20680
15329,Cenegermin-bkbj,B-NAME_OF_DRUG,20681
15330,ophthalmic,I-NAME_OF_DRUG,20681
15331,solution,I-NAME_OF_DRUG,20681
15332,0.00%,I-NAME_OF_DRUG,20681
15333,20,I-NAME_OF_DRUG,20681
15334,mcg,I-NAME_OF_DRUG,20681
15335,mL,I-NAME_OF_DRUG,20681
15336,Known,O,20681
15337,as,O,20681
15338,Oxervate,B-NAME_OF_DRUG,20681
15339,Dompé,I-NAME_OF_DRUG,20681
15340,this,O,20681
15341,is,O,20681
15342,a,O,20681
15343,recombinant,O,20681
15344,human,O,20681
15345,nerve,O,20681
15346,growth,O,20681
15347,factor,O,20681
15348,in,O,20681
15349,the,O,20681
15350,form,O,20681
15351,of,O,20681
15352,a,O,20681
15353,topical,O,20681
15354,agent,O,20681
15355,dosed,O,20681
15356,6,O,20681
15357,times,O,20681
15358,a,O,20681
15359,day,O,20681
15360,for,O,20681
15361,an,O,20681
15362,8-week,B-TIME_DURATION,20681
15363,course,O,20681
15364,Oxervate,B-NAME_OF_DRUG,20682
15365,was,O,20682
15366,approved,O,20682
15367,in,O,20682
15368,August,O,20682
15369,2018,O,20682
15370,as,O,20682
15371,an,O,20682
15372,orphan,O,20682
15373,drug,O,20682
15374,for,O,20682
15375,NK,B-NAME_OF_DISEASE,20682
15376,Oxervate,B-NAME_OF_DRUG,20683
15377,was,O,20683
15378,shown,O,20683
15379,safe,O,20683
15380,and,O,20683
15381,effective,O,20683
15382,in,O,20683
15383,the,O,20683
15384,corneal,O,20683
15385,healing,O,20683
15386,of,O,20683
15387,moderate-tosevere,O,20683
15388,NK,B-NAME_OF_DISEASE,20683
15389,Antibiotic,B-NAME_OF_DRUG,20684
15390,drops,I-NAME_OF_DRUG,20684
15391,NK,B-NAME_OF_DISEASE,20684
15392,patients,O,20684
15393,are,O,20684
15394,at,O,20684
15395,risk,O,20684
15396,for,O,20684
15397,developing,O,20684
15398,bacterial,B-SIGN_AND_SYMPTOM,20684
15399,superinfections,I-SIGN_AND_SYMPTOM,20684
15400,due,O,20684
15401,to,O,20684
15402,their,O,20684
15403,epithelial,O,20684
15404,defect,O,20684
15405,creating,O,20684
15406,a,O,20684
15407,break-down,O,20684
15408,of,O,20684
15409,the,O,20684
15410,natural,O,20684
15411,barrier,O,20684
15412,to,O,20684
15413,microorganisms,O,20684
15414,For,O,20685
15415,this,O,20685
15416,reason,O,20685
15417,it,O,20685
15418,is,O,20685
15419,often,O,20685
15420,helpful,O,20685
15421,to,O,20685
15422,protect,O,20685
15423,the,O,20685
15424,patient,O,20685
15425,with,O,20685
15426,a,B-NAME_OF_DRUG,20685
15427,topical,I-NAME_OF_DRUG,20685
15428,antibiotic,I-NAME_OF_DRUG,20685
15429,drop,I-NAME_OF_DRUG,20685
15430,Conjunctival,B-TREATMENT,20686
15431,flap,I-TREATMENT,20686
15432,Gunderson,I-TREATMENT,20686
15433,flap,I-TREATMENT,20686
15434,with,I-TREATMENT,20686
15435,without,I-TREATMENT,20686
15436,a,I-TREATMENT,20686
15437,tarsorrhaphy,I-TREATMENT,20686
15438,In,O,20686
15439,severe,O,20686
15440,cases,O,20686
15441,in,O,20686
15442,which,O,20686
15443,corneal,B-SIGN_AND_SYMPTOM,20686
15444,thinning,I-SIGN_AND_SYMPTOM,20686
15445,is,O,20686
15446,more,O,20686
15447,advanced,O,20686
15448,and,O,20686
15449,potentially,O,20686
15450,associated,O,20686
15451,with,O,20686
15452,a,O,20686
15453,risk,O,20686
15454,of,O,20686
15455,perforation,O,20686
15456,the,B-PART_OF_THE_EYES,20686
15457,ocular,I-PART_OF_THE_EYES,20686
15458,surface,I-PART_OF_THE_EYES,20686
15459,may,O,20686
15460,be,O,20686
15461,stabilized,O,20686
15462,by,O,20686
15463,advancement,B-TREATMENT,20686
15464,of,I-TREATMENT,20686
15465,the,I-TREATMENT,20686
15466,perilimbal,I-TREATMENT,20686
15467,conjunctiva,I-TREATMENT,20686
15468,over,I-TREATMENT,20686
15469,the,I-TREATMENT,20686
15470,corneal,I-TREATMENT,20686
15471,surface,I-TREATMENT,20686
15472,A,B-TREATMENT,20687
15473,temporary,I-TREATMENT,20687
15474,or,I-TREATMENT,20687
15475,permanent,I-TREATMENT,20687
15476,tarsorrhaphy,I-TREATMENT,20687
15477,is,O,20687
15478,a,O,20687
15479,helpful,O,20687
15480,adjunct,O,20687
15481,in,O,20687
15482,such,O,20687
15483,advanced,O,20687
15484,cases,O,20687
15485,Getting,O,20688
15486,a,O,20688
15487,Head,O,20688
15488,Start,O,20688
15489,NK,B-NAME_OF_DISEASE,20688
15490,may,O,20688
15491,be,O,20688
15492,more,O,20688
15493,common,O,20688
15494,than,O,20688
15495,initially,O,20688
15496,thought,O,20688
15497,thanks,O,20688
15498,to,O,20688
15499,a,O,20688
15500,fresh,O,20688
15501,focus,O,20688
15502,on,O,20688
15503,the,O,20688
15504,condition,O,20688
15505,spurred,O,20688
15506,by,O,20688
15507,recent,O,20688
15508,treatment,O,20688
15509,offerings,O,20688
15510,There,O,20689
15511,are,O,20689
15512,many,O,20689
15513,different,O,20689
15514,etiologies,O,20689
15515,of,O,20689
15516,NK,B-NAME_OF_DISEASE,20689
15517,however,O,20689
15518,all,O,20689
15519,of,O,20689
15520,them,O,20689
15521,are,O,20689
15522,characterized,O,20689
15523,by,O,20689
15524,impaired,B-CAUSE_OF_DISEASE,20689
15525,trigeminal,I-CAUSE_OF_DISEASE,20689
15526,innervation,I-CAUSE_OF_DISEASE,20689
15527,Deep,O,20690
15528,learning,O,20690
15529,has,O,20690
15530,been,O,20690
15531,largely,O,20690
15532,reported,O,20690
15533,to,O,20690
15534,be,O,20690
15535,capable,O,20690
15536,of,O,20690
15537,achieving,O,20690
15538,automated,O,20690
15539,screening,O,20690
15540,and,O,20690
15541,diagnosis,O,20690
15542,of,O,20690
15543,common,O,20690
15544,vision-threatening,O,20690
15545,diseases,O,20690
15546,such,O,20690
15547,as,O,20690
15548,diabetic,B-NAME_OF_DISEASE,20690
15549,retinopathy,I-NAME_OF_DISEASE,20690
15550,DR,I-NAME_OF_DISEASE,20690
15551,glaucoma,B-NAME_OF_DISEASE,20690
15552,age-related,B-NAME_OF_DISEASE,20690
15553,macular,I-NAME_OF_DISEASE,20690
15554,degeneration,I-NAME_OF_DISEASE,20690
15555,AMD,I-NAME_OF_DISEASE,20690
15556,and,O,20690
15557,retinopathy,B-NAME_OF_DISEASE,20690
15558,of,I-NAME_OF_DISEASE,20690
15559,prematurity,I-NAME_OF_DISEASE,20690
15560,ROP,I-NAME_OF_DISEASE,20690
15561,Automatic,B-DIAGNOSTIC_TEST,20691
15562,retinal,I-DIAGNOSTIC_TEST,20691
15563,image,I-DIAGNOSTIC_TEST,20691
15564,analysis,I-DIAGNOSTIC_TEST,20691
15565,ARIA,I-DIAGNOSTIC_TEST,20691
15566,is,O,20691
15567,a,O,20691
15568,complex,O,20691
15569,task,O,20691
15570,that,O,20691
15571,has,O,20691
15572,significant,O,20691
15573,applications,O,20691
15574,for,O,20691
15575,diagnostic,O,20691
15576,purposes,O,20691
15577,for,O,20691
15578,a,O,20691
15579,host,O,20691
15580,of,O,20691
15581,retinal,O,20691
15582,neurological,O,20691
15583,and,O,20691
15584,vascular,O,20691
15585,diseases,O,20691
15586,A,O,20692
15587,number,O,20692
15588,of,O,20692
15589,approaches,O,20692
15590,for,O,20692
15591,the,O,20692
15592,automatic,O,20692
15593,analysis,O,20692
15594,of,O,20692
15595,the,O,20692
15596,retinal,O,20692
15597,images,O,20692
15598,have,O,20692
15599,been,O,20692
15600,studied,O,20692
15601,for,O,20692
15602,the,O,20692
15603,past,O,20692
15604,two,O,20692
15605,decades,O,20692
15606,but,O,20692
15607,the,O,20692
15608,recent,O,20692
15609,success,O,20692
15610,of,O,20692
15611,deep,O,20692
15612,learning,O,20692
15613,DL,O,20692
15614,for,O,20692
15615,a,O,20692
15616,range,O,20692
15617,of,O,20692
15618,computer,O,20692
15619,vision,O,20692
15620,and,O,20692
15621,image,O,20692
15622,analysis,O,20692
15623,tasks,O,20692
15624,has,O,20692
15625,now,O,20692
15626,permeated,O,20692
15627,medical,O,20692
15628,imaging,O,20692
15629,and,O,20692
15630,ARIA,B-DIAGNOSTIC_TEST,20692
15631,Since,O,20693
15632,Helmholtzs,B-PERSON,20693
15633,pioneering,O,20693
15634,invention,O,20693
15635,of,O,20693
15636,the,O,20693
15637,ophthalmoscope,O,20693
15638,in,O,20693
15639,the,O,20693
15640,19th,O,20693
15641,century,O,20693
15642,direct,B-DIAGNOSTIC_TEST,20693
15643,and,I-DIAGNOSTIC_TEST,20693
15644,indirect,I-DIAGNOSTIC_TEST,20693
15645,ophthalmoscopy,I-DIAGNOSTIC_TEST,20693
15646,serve,O,20693
15647,as,O,20693
15648,the,O,20693
15649,standard,O,20693
15650,methodology,O,20693
15651,for,O,20693
15652,the,O,20693
15653,diagnostic,O,20693
15654,assessment,O,20693
15655,and,O,20693
15656,management,O,20693
15657,of,O,20693
15658,retinal,B-NAME_OF_DISEASE,20693
15659,diseases,I-NAME_OF_DISEASE,20693
15660,As,O,20694
15661,image,O,20694
15662,acquisition,O,20694
15663,instrumentation,O,20694
15664,evolved,O,20694
15665,technologies,O,20694
15666,such,O,20694
15667,as,O,20694
15668,echography,B-DIAGNOSTIC_TEST,20694
15669,and,O,20694
15670,ultrawidefield,B-DIAGNOSTIC_TEST,20694
15671,fundus,I-DIAGNOSTIC_TEST,20694
15672,photography,I-DIAGNOSTIC_TEST,20694
15673,have,O,20694
15674,emerged,O,20694
15675,to,O,20694
15676,assist,O,20694
15677,or,O,20694
15678,in,O,20694
15679,some,O,20694
15680,cases,O,20694
15681,supplant,O,20694
15682,standard,O,20694
15683,funduscopic,B-DIAGNOSTIC_TEST,20694
15684,examination,I-DIAGNOSTIC_TEST,20694
15685,Ophthalmology,O,20695
15686,and,O,20695
15687,specifically,O,20695
15688,the,O,20695
15689,field,O,20695
15690,of,O,20695
15691,retina,B-PART_OF_THE_EYES,20695
15692,has,O,20695
15693,the,O,20695
15694,opportunity,O,20695
15695,to,O,20695
15696,capitalize,O,20695
15697,on,O,20695
15698,the,O,20695
15699,offerings,O,20695
15700,of,O,20695
15701,AI,O,20695
15702,given,O,20695
15703,the,O,20695
15704,myriad,O,20695
15705,clinical,O,20695
15706,data,O,20695
15707,and,O,20695
15708,multimodal,O,20695
15709,imaging,O,20695
15710,routinely,O,20695
15711,performed,O,20695
15712,Diabetic,B-NAME_OF_DISEASE,20696
15713,Retinopathy,I-NAME_OF_DISEASE,20696
15714,Given,O,20697
15715,the,O,20697
15716,increasing,O,20697
15717,burden,O,20697
15718,of,O,20697
15719,diabetic,B-NAME_OF_DISEASE,20697
15720,retinopathy,I-NAME_OF_DISEASE,20697
15721,DR,B-NAME_OF_DISEASE,20697
15722,and,O,20697
15723,its,O,20697
15724,far-reaching,O,20697
15725,public,O,20697
15726,health,O,20697
15727,and,O,20697
15728,societal,O,20697
15729,implications,O,20697
15730,DR,B-NAME_OF_DISEASE,20697
15731,screening,O,20697
15732,has,O,20697
15733,been,O,20697
15734,a,O,20697
15735,major,O,20697
15736,focus,O,20697
15737,of,O,20697
15738,AI,O,20697
15739,efforts,O,20697
15740,Despite,O,20698
15741,being,O,20698
15742,the,O,20698
15743,leading,O,20698
15744,cause,O,20698
15745,of,O,20698
15746,vision,B-SIGN_AND_SYMPTOM,20698
15747,loss,I-SIGN_AND_SYMPTOM,20698
15748,among,O,20698
15749,working-age,O,20698
15750,adults,O,20698
15751,in,O,20698
15752,the,B-GPE,20698
15753,United,I-GPE,20698
15754,States,I-GPE,20698
15755,only,O,20698
15756,40%,O,20698
15757,of,O,20698
15758,diabetic,O,20698
15759,patients,O,20698
15760,obtain,O,20698
15761,their,O,20698
15762,annual,O,20698
15763,recommended,O,20698
15764,screening,O,20698
15765,A,O,20699
15766,2016,O,20699
15767,pivotal,O,20699
15768,study,O,20699
15769,by,O,20699
15770,Google,B-ORGANIZATION,20699
15771,Inc,I-ORGANIZATION,20699
15772,highlighted,O,20699
15773,the,O,20699
15774,potential,O,20699
15775,of,O,20699
15776,deep,O,20699
15777,learning,O,20699
15778,in,O,20699
15779,DR,B-NAME_OF_DISEASE,20699
15780,screening,O,20699
15781,by,O,20699
15782,showing,O,20699
15783,that,O,20699
15784,referable,O,20699
15785,DR,B-NAME_OF_DISEASE,20699
15786,could,O,20699
15787,be,O,20699
15788,identified,O,20699
15789,from,O,20699
15790,a,B-DIAGNOSTIC_TEST,20699
15791,single,I-DIAGNOSTIC_TEST,20699
15792,fundus,I-DIAGNOSTIC_TEST,20699
15793,photo,I-DIAGNOSTIC_TEST,20699
15794,with,O,20699
15795,a,O,20699
15796,sensitivity,O,20699
15797,of,O,20699
15798,97.50%,O,20699
15799,and,O,20699
15800,specificity,O,20699
15801,of,O,20699
15802,98.50%,O,20699
15803,Since,O,20700
15804,then,O,20700
15805,autonomous,O,20700
15806,AI,O,20700
15807,systems,O,20700
15808,have,O,20700
15809,been,O,20700
15810,developed,O,20700
15811,and,O,20700
15812,approved,O,20700
15813,for,O,20700
15814,DR,B-NAME_OF_DISEASE,20700
15815,screening,O,20700
15816,In,O,20701
15817,April,O,20701
15818,2018,O,20701
15819,the,B-DIAGNOSTIC_TEST,20701
15820,IDx-DR,I-DIAGNOSTIC_TEST,20701
15821,IDx,I-DIAGNOSTIC_TEST,20701
15822,became,O,20701
15823,the,O,20701
15824,first,O,20701
15825,US,B-GPE,20701
15826,Food,B-ORGANIZATION,20701
15827,and,I-ORGANIZATION,20701
15828,Drug,I-ORGANIZATION,20701
15829,Administration,I-ORGANIZATION,20701
15830,approved,O,20701
15831,fully,O,20701
15832,autonomous,O,20701
15833,AI-based,O,20701
15834,medical,O,20701
15835,device,O,20701
15836,to,O,20701
15837,detect,O,20701
15838,more,B-NAME_OF_DISEASE,20701
15839,than,I-NAME_OF_DISEASE,20701
15840,mild,I-NAME_OF_DISEASE,20701
15841,diabetic,I-NAME_OF_DISEASE,20701
15842,retinopathy,I-NAME_OF_DISEASE,20701
15843,mtmDR,I-NAME_OF_DISEASE,20701
15844,This,O,20702
15845,system,O,20702
15846,uses,O,20702
15847,45-degree,B-DIAGNOSTIC_TEST,20702
15848,fundus,I-DIAGNOSTIC_TEST,20702
15849,photos,I-DIAGNOSTIC_TEST,20702
15850,which,O,20702
15851,are,O,20702
15852,uploaded,O,20702
15853,and,O,20702
15854,analyzed,O,20702
15855,using,O,20702
15856,cloud-based,O,20702
15857,software,O,20702
15858,for,O,20702
15859,the,O,20702
15860,detection,O,20702
15861,of,O,20702
15862,mtmDR,B-NAME_OF_DISEASE,20702
15863,The,O,20703
15864,images,O,20703
15865,can,O,20703
15866,be,O,20703
15867,taken,O,20703
15868,during,O,20703
15869,the,O,20703
15870,patients,O,20703
15871,primary,O,20703
15872,care,O,20703
15873,appointment,O,20703
15874,and,O,20703
15875,the,O,20703
15876,patient,O,20703
15877,referred,O,20703
15878,to,O,20703
15879,an,O,20703
15880,ophthalmologist,O,20703
15881,if,O,20703
15882,mtmDR,B-NAME_OF_DISEASE,20703
15883,is,O,20703
15884,detected,O,20703
15885,In,O,20704
15886,the,O,20704
15887,pivotal,O,20704
15888,prospective,O,20704
15889,study,O,20704
15890,using,O,20704
15891,this,O,20704
15892,system,O,20704
15893,sensitivity,O,20704
15894,was,O,20704
15895,87.20%,O,20704
15896,and,O,20704
15897,specificity,O,20704
15898,was,O,20704
15899,90.70%,O,20704
15900,for,O,20704
15901,the,O,20704
15902,detection,O,20704
15903,of,O,20704
15904,mtmDR,B-NAME_OF_DISEASE,20704
15905,Additional,O,20705
15906,systems,O,20705
15907,including,O,20705
15908,the,B-DIAGNOSTIC_TEST,20705
15909,iGradingM,I-DIAGNOSTIC_TEST,20705
15910,Medalytix,I-DIAGNOSTIC_TEST,20705
15911,Emis,I-DIAGNOSTIC_TEST,20705
15912,Health,I-DIAGNOSTIC_TEST,20705
15913,EyeArt,B-DIAGNOSTIC_TEST,20705
15914,EyeNuk,I-DIAGNOSTIC_TEST,20705
15915,Inc,I-DIAGNOSTIC_TEST,20705
15916,and,O,20705
15917,Retmarker,B-DIAGNOSTIC_TEST,20705
15918,Retmarker,I-DIAGNOSTIC_TEST,20705
15919,Ltd,I-DIAGNOSTIC_TEST,20705
15920,have,O,20705
15921,been,O,20705
15922,approved,O,20705
15923,in,O,20705
15924,Europe,B-GPE,20705
15925,for,O,20705
15926,the,O,20705
15927,automated,O,20705
15928,screening,O,20705
15929,of,O,20705
15930,DR,B-NAME_OF_DISEASE,20705
15931,using,O,20705
15932,fundus,B-DIAGNOSTIC_TEST,20705
15933,photography,I-DIAGNOSTIC_TEST,20705
15934,In,O,20706
15935,the,O,20706
15936,assessment,O,20706
15937,of,O,20706
15938,102856,O,20706
15939,fundus,O,20706
15940,photos,O,20706
15941,of,O,20706
15942,20258,O,20706
15943,patients,O,20706
15944,the,O,20706
15945,EyeArt,B-DIAGNOSTIC_TEST,20706
15946,and,O,20706
15947,Retmarker,B-DIAGNOSTIC_TEST,20706
15948,systems,O,20706
15949,achieved,O,20706
15950,sensitivities,O,20706
15951,of,O,20706
15952,93.80%,O,20706
15953,and,O,20706
15954,85.00%,O,20706
15955,respectively,O,20706
15956,for,O,20706
15957,referable,O,20706
15958,retinopathy,O,20706
15959,and,O,20706
15960,sensitivities,O,20706
15961,of,O,20706
15962,99.60%,O,20706
15963,and,O,20706
15964,97.90%,O,20706
15965,for,O,20706
15966,proliferative,O,20706
15967,disease,O,20706
15968,respectively,O,20706
15969,Both,O,20707
15970,the,O,20707
15971,Retmarker,B-DIAGNOSTIC_TEST,20707
15972,and,O,20707
15973,EyeArt,B-DIAGNOSTIC_TEST,20707
15974,systems,O,20707
15975,have,O,20707
15976,been,O,20707
15977,validated,O,20707
15978,to,O,20707
15979,have,O,20707
15980,acceptable,O,20707
15981,sensitivity,O,20707
15982,to,O,20707
15983,capture,O,20707
15984,referable,O,20707
15985,retinopathy,O,20707
15986,when,O,20707
15987,compared,O,20707
15988,to,O,20707
15989,human,O,20707
15990,graders,O,20707
15991,potentially,O,20707
15992,making,O,20707
15993,them,O,20707
15994,a,O,20707
15995,cost-effective,O,20707
15996,alternative,O,20707
15997,to,O,20707
15998,manual,O,20707
15999,grading,O,20707
16000,alone,O,20707
16001,In,O,20708
16002,the,O,20708
16003,pivotal,O,20708
16004,clinical,O,20708
16005,study,O,20708
16006,using,O,20708
16007,the,B-DIAGNOSTIC_TEST,20708
16008,EyeArt,I-DIAGNOSTIC_TEST,20708
16009,system,I-DIAGNOSTIC_TEST,20708
16010,a,O,20708
16011,sensitivity,O,20708
16012,of,O,20708
16013,96%,O,20708
16014,and,O,20708
16015,specificity,O,20708
16016,of,O,20708
16017,88%,O,20708
16018,were,O,20708
16019,found,O,20708
16020,for,O,20708
16021,detection,O,20708
16022,of,O,20708
16023,mtmDR,B-NAME_OF_DISEASE,20708
16024,This,O,20709
16025,system,O,20709
16026,gained,O,20709
16027,FDA,B-ORGANIZATION,20709
16028,clearance,O,20709
16029,in,O,20709
16030,the,B-GPE,20709
16031,United,I-GPE,20709
16032,States,I-GPE,20709
16033,for,O,20709
16034,automated,O,20709
16035,DR,B-NAME_OF_DISEASE,20709
16036,screening,O,20709
16037,in,O,20709
16038,August,O,20709
16039,2020,O,20709
16040,Other,O,20710
16041,imaging,O,20710
16042,modalities,O,20710
16043,such,O,20710
16044,as,O,20710
16045,optical,B-DIAGNOSTIC_TEST,20710
16046,coherence,I-DIAGNOSTIC_TEST,20710
16047,tomography,I-DIAGNOSTIC_TEST,20710
16048,OCT,I-DIAGNOSTIC_TEST,20710
16049,and,O,20710
16050,OCT,B-DIAGNOSTIC_TEST,20710
16051,angiography,I-DIAGNOSTIC_TEST,20710
16052,OCTA,I-DIAGNOSTIC_TEST,20710
16053,are,O,20710
16054,actively,O,20710
16055,being,O,20710
16056,investigated,O,20710
16057,for,O,20710
16058,DR,B-NAME_OF_DISEASE,20710
16059,screening,O,20710
16060,and,O,20710
16061,management,O,20710
16062,Prognostic,O,20711
16063,models,O,20711
16064,have,O,20711
16065,been,O,20711
16066,developed,O,20711
16067,to,O,20711
16068,predict,O,20711
16069,retinal,O,20711
16070,response,O,20711
16071,to,O,20711
16072,anti-VEGF,B-TREATMENT,20711
16073,treatments,I-TREATMENT,20711
16074,in,O,20711
16075,patients,O,20711
16076,with,O,20711
16077,macular,B-NAME_OF_DISEASE,20711
16078,edema,I-NAME_OF_DISEASE,20711
16079,through,O,20711
16080,the,O,20711
16081,analysis,O,20711
16082,of,O,20711
16083,OCT,B-DIAGNOSTIC_TEST,20711
16084,images,O,20711
16085,Retinopathy,B-NAME_OF_DISEASE,20712
16086,of,I-NAME_OF_DISEASE,20712
16087,Prematurity,I-NAME_OF_DISEASE,20712
16088,Substantial,O,20713
16089,challenges,O,20713
16090,exist,O,20713
16091,in,O,20713
16092,the,O,20713
16093,screening,O,20713
16094,and,O,20713
16095,diagnosis,O,20713
16096,of,O,20713
16097,retinopathy,B-NAME_OF_DISEASE,20713
16098,of,I-NAME_OF_DISEASE,20713
16099,prematurity,I-NAME_OF_DISEASE,20713
16100,given,O,20713
16101,the,O,20713
16102,diseases,O,20713
16103,clinical,O,20713
16104,variability,O,20713
16105,and,O,20713
16106,limitations,O,20713
16107,to,O,20713
16108,access,O,20713
16109,to,O,20713
16110,trained,O,20713
16111,screening,O,20713
16112,specialists,O,20713
16113,Given,O,20714
16114,that,O,20714
16115,the,O,20714
16116,Early,O,20714
16117,Treatment,O,20714
16118,of,O,20714
16119,ROP,B-NAME_OF_DISEASE,20714
16120,study,O,20714
16121,identified,O,20714
16122,plus,O,20714
16123,disease,O,20714
16124,as,O,20714
16125,one,O,20714
16126,of,O,20714
16127,the,O,20714
16128,most,O,20714
16129,important,O,20714
16130,parameters,O,20714
16131,for,O,20714
16132,identifying,O,20714
16133,treatment-level,O,20714
16134,ROP,B-NAME_OF_DISEASE,20714
16135,great,O,20714
16136,emphasis,O,20714
16137,has,O,20714
16138,been,O,20714
16139,placed,O,20714
16140,on,O,20714
16141,identifying,O,20714
16142,it,O,20714
16143,on,O,20714
16144,screening,O,20714
16145,examinations,O,20714
16146,Creating,O,20715
16147,a,O,20715
16148,standardized,O,20715
16149,ROP,B-NAME_OF_DISEASE,20715
16150,screening,O,20715
16151,system,O,20715
16152,that,O,20715
16153,is,O,20715
16154,both,O,20715
16155,reliable,O,20715
16156,and,O,20715
16157,repeatable,O,20715
16158,has,O,20715
16159,become,O,20715
16160,a,O,20715
16161,major,O,20715
16162,goal,O,20715
16163,and,O,20715
16164,computer-based,O,20715
16165,image,O,20715
16166,analysis,O,20715
16167,stands,O,20715
16168,to,O,20715
16169,make,O,20715
16170,a,O,20715
16171,significant,O,20715
16172,impact,O,20715
16173,Multiple,O,20716
16174,algorithms,O,20716
16175,have,O,20716
16176,demonstrated,O,20716
16177,promise,O,20716
16178,for,O,20716
16179,detecting,O,20716
16180,plus,O,20716
16181,or,O,20716
16182,pre-plus,O,20716
16183,disease,O,20716
16184,with,O,20716
16185,achieved,O,20716
16186,accuracies,O,20716
16187,of,O,20716
16188,95%,O,20716
16189,while,O,20716
16190,outperforming,O,20716
16191,human,O,20716
16192,ROP,B-NAME_OF_DISEASE,20716
16193,experts,O,20716
16194,evaluating,O,20716
16195,the,O,20716
16196,same,O,20716
16197,data,O,20716
16198,set,O,20716
16199,The,B-DIAGNOSTIC_TEST,20717
16200,DeepROP,I-DIAGNOSTIC_TEST,20717
16201,system,I-DIAGNOSTIC_TEST,20717
16202,incorporates,O,20717
16203,both,O,20717
16204,ROP,B-NAME_OF_DISEASE,20717
16205,zone,O,20717
16206,and,O,20717
16207,stage,O,20717
16208,into,O,20717
16209,its,O,20717
16210,classification,O,20717
16211,model,O,20717
16212,and,O,20717
16213,grades,O,20717
16214,images,O,20717
16215,as,O,20717
16216,either,O,20717
16217,normal,O,20717
16218,minor,O,20717
16219,ROP,B-NAME_OF_DISEASE,20717
16220,or,O,20717
16221,severe,O,20717
16222,ROP,B-NAME_OF_DISEASE,20717
16223,The,B-DIAGNOSTIC_TEST,20718
16224,i-ROP,I-DIAGNOSTIC_TEST,20718
16225,system,I-DIAGNOSTIC_TEST,20718
16226,is,O,20718
16227,capable,O,20718
16228,of,O,20718
16229,categorizing,O,20718
16230,fundus,O,20718
16231,photos,O,20718
16232,into,O,20718
16233,type,O,20718
16234,1,O,20718
16235,type,O,20718
16236,2,O,20718
16237,and,O,20718
16238,pre-plus,O,20718
16239,ROP,B-NAME_OF_DISEASE,20718
16240,with,O,20718
16241,probability,O,20718
16242,scores,O,20718
16243,of,O,20718
16244,0.96,O,20718
16245,and,O,20718
16246,0.91,O,20718
16247,for,O,20718
16248,detecting,O,20718
16249,type,B-NAME_OF_DISEASE,20718
16250,1,I-NAME_OF_DISEASE,20718
16251,ROP,B-NAME_OF_DISEASE,20718
16252,and,O,20718
16253,clinically,O,20718
16254,significant,O,20718
16255,ROP,B-NAME_OF_DISEASE,20718
16256,respectively,O,20718
16257,The,O,20719
16258,i-ROP,B-DIAGNOSTIC_TEST,20719
16259,score,O,20719
16260,has,O,20719
16261,been,O,20719
16262,shown,O,20719
16263,to,O,20719
16264,be,O,20719
16265,noninferior,O,20719
16266,to,O,20719
16267,human,O,20719
16268,diagnosis,O,20719
16269,when,O,20719
16270,identifying,O,20719
16271,vascular,O,20719
16272,changes,O,20719
16273,in,O,20719
16274,pre-plus,O,20719
16275,and,O,20719
16276,plus,O,20719
16277,disease,O,20719
16278,These,O,20720
16279,programs,O,20720
16280,demonstrate,O,20720
16281,that,O,20720
16282,deep,O,20720
16283,learning,O,20720
16284,may,O,20720
16285,minimize,O,20720
16286,the,O,20720
16287,interobserver,O,20720
16288,variability,O,20720
16289,that,O,20720
16290,has,O,20720
16291,challenged,O,20720
16292,ROP,B-NAME_OF_DISEASE,20720
16293,screening,O,20720
16294,and,O,20720
16295,play,O,20720
16296,a,O,20720
16297,continued,O,20720
16298,role,O,20720
16299,in,O,20720
16300,the,O,20720
16301,screening,O,20720
16302,particularly,O,20720
16303,in,O,20720
16304,resource-limited,O,20720
16305,settings,O,20720
16306,Age-related,B-NAME_OF_DISEASE,20721
16307,Macular,I-NAME_OF_DISEASE,20721
16308,Degeneration,I-NAME_OF_DISEASE,20721
16309,Timely,O,20722
16310,detection,O,20722
16311,and,O,20722
16312,treatment,O,20722
16313,of,O,20722
16314,AMD,B-NAME_OF_DISEASE,20722
16315,specifically,O,20722
16316,neovascular,B-NAME_OF_DISEASE,20722
16317,AMD,I-NAME_OF_DISEASE,20722
16318,often,O,20722
16319,leads,O,20722
16320,to,O,20722
16321,better,O,20722
16322,visual,O,20722
16323,outcomes,O,20722
16324,In-office,O,20723
16325,examinations,O,20723
16326,as,O,20723
16327,well,O,20723
16328,as,O,20723
16329,home,O,20723
16330,monitoring,O,20723
16331,tools,O,20723
16332,such,O,20723
16333,as,O,20723
16334,the,O,20723
16335,Amsler,O,20723
16336,grid,O,20723
16337,and,O,20723
16338,portable,O,20723
16339,devices,O,20723
16340,Foresee,O,20723
16341,Preferential,O,20723
16342,Hyperacuity,O,20723
16343,Perimeter,O,20723
16344,Reichert,O,20723
16345,Technologies,O,20723
16346,have,O,20723
16347,customarily,O,20723
16348,been,O,20723
16349,employed,O,20723
16350,for,O,20723
16351,detecting,O,20723
16352,AMD,B-NAME_OF_DISEASE,20723
16353,progression,O,20723
16354,Although,O,20724
16355,AI,O,20724
16356,DR,B-NAME_OF_DISEASE,20724
16357,screening,O,20724
16358,relies,O,20724
16359,primarily,O,20724
16360,on,O,20724
16361,fundus,B-TREATMENT,20724
16362,photography,I-TREATMENT,20724
16363,AI,O,20724
16364,systems,O,20724
16365,in,O,20724
16366,the,O,20724
16367,context,O,20724
16368,of,O,20724
16369,AMD,B-NAME_OF_DISEASE,20724
16370,have,O,20724
16371,focused,O,20724
16372,heavily,O,20724
16373,on,O,20724
16374,OCT,B-DIAGNOSTIC_TEST,20724
16375,images,O,20724
16376,Trained,O,20725
16377,neural,O,20725
16378,networks,O,20725
16379,have,O,20725
16380,demonstrated,O,20725
16381,strong,O,20725
16382,accuracy,O,20725
16383,in,O,20725
16384,the,O,20725
16385,differentiation,O,20725
16386,of,O,20725
16387,OCT,B-DIAGNOSTIC_TEST,20725
16388,images,O,20725
16389,of,O,20725
16390,normal,O,20725
16391,and,O,20725
16392,AMD,B-NAME_OF_DISEASE,20725
16393,patients,O,20725
16394,with,O,20725
16395,a,O,20725
16396,sensitivity,O,20725
16397,and,O,20725
16398,specificity,O,20725
16399,of,O,20725
16400,92.64%,O,20725
16401,in,O,20725
16402,normal,O,20725
16403,patients,O,20725
16404,and,O,20725
16405,93.69%,O,20725
16406,in,O,20725
16407,AMD,B-NAME_OF_DISEASE,20725
16408,patients,O,20725
16409,In,O,20726
16410,the,O,20726
16411,context,O,20726
16412,of,O,20726
16413,diagnosing,O,20726
16414,exudative,B-NAME_OF_DISEASE,20726
16415,AMD,I-NAME_OF_DISEASE,20726
16416,AI,O,20726
16417,had,O,20726
16418,upwards,O,20726
16419,of,O,20726
16420,91.00%,O,20726
16421,accuracy,O,20726
16422,and,O,20726
16423,95.50%,O,20726
16424,accuracy,O,20726
16425,for,O,20726
16426,predicting,O,20726
16427,the,O,20726
16428,need,O,20726
16429,for,O,20726
16430,injection,O,20726
16431,treatment,O,20726
16432,Software,O,20727
16433,has,O,20727
16434,also,O,20727
16435,reliably,O,20727
16436,detected,O,20727
16437,subretinal,O,20727
16438,and,O,20727
16439,sub-RPE,O,20727
16440,fluid,O,20727
16441,with,O,20727
16442,high,O,20727
16443,accuracy,O,20727
16444,24,O,20728
16445,Fundus,B-DIAGNOSTIC_TEST,20728
16446,image,I-DIAGNOSTIC_TEST,20728
16447,models,I-DIAGNOSTIC_TEST,20728
16448,have,O,20728
16449,also,O,20728
16450,demonstrated,O,20728
16451,promising,O,20728
16452,results,O,20728
16453,The,B-DIAGNOSTIC_TEST,20729
16454,DeepSeeNet,I-DIAGNOSTIC_TEST,20729
16455,program,I-DIAGNOSTIC_TEST,20729
16456,performed,O,20729
16457,better,O,20729
16458,than,O,20729
16459,retina,B-PART_OF_THE_EYES,20729
16460,specialists,O,20729
16461,in,O,20729
16462,the,O,20729
16463,accuracy,O,20729
16464,0.671,O,20729
16465,vs,O,20729
16466,0.599,O,20729
16467,sensitivity,O,20729
16468,0.59,O,20729
16469,vs,O,20729
16470,0.512,O,20729
16471,and,O,20729
16472,specificity,O,20729
16473,0.93,O,20729
16474,vs,O,20729
16475,0.916,O,20729
16476,in,O,20729
16477,classifying,O,20729
16478,eyes,O,20729
16479,based,O,20729
16480,on,O,20729
16481,the,B-DIAGNOSTIC_TEST,20729
16482,AREDS,I-DIAGNOSTIC_TEST,20729
16483,severity,I-DIAGNOSTIC_TEST,20729
16484,score,I-DIAGNOSTIC_TEST,20729
16485,The,O,20730
16486,program,O,20730
16487,has,O,20730
16488,also,O,20730
16489,demonstrated,O,20730
16490,the,O,20730
16491,capability,O,20730
16492,to,O,20730
16493,identify,O,20730
16494,geographic,B-NAME_OF_DISEASE,20730
16495,atrophy,I-NAME_OF_DISEASE,20730
16496,with,O,20730
16497,an,O,20730
16498,accuracy,O,20730
16499,comparable,O,20730
16500,to,O,20730
16501,human,O,20730
16502,graders,O,20730
16503,Artificial,B-DIAGNOSTIC_TEST,20731
16504,intelligence,I-DIAGNOSTIC_TEST,20731
16505,models,I-DIAGNOSTIC_TEST,20731
16506,have,O,20731
16507,also,O,20731
16508,been,O,20731
16509,used,O,20731
16510,in,O,20731
16511,a,O,20731
16512,prognostic,O,20731
16513,context,O,20731
16514,in,O,20731
16515,AMD,B-NAME_OF_DISEASE,20731
16516,A,O,20732
16517,predictive,O,20732
16518,model,O,20732
16519,using,O,20732
16520,OCT,B-DIAGNOSTIC_TEST,20732
16521,features,O,20732
16522,and,O,20732
16523,demographic,O,20732
16524,factors,O,20732
16525,of,O,20732
16526,495,O,20732
16527,fellow,O,20732
16528,eyes,O,20732
16529,from,O,20732
16530,the,B-NAME_OF_STUDY,20732
16531,HARBOR,I-NAME_OF_STUDY,20732
16532,trial,I-NAME_OF_STUDY,20732
16533,differentiated,O,20732
16534,converting,O,20732
16535,vs,O,20732
16536,nonconverting,O,20732
16537,eyes,O,20732
16538,with,O,20732
16539,a,O,20732
16540,performance,O,20732
16541,of,O,20732
16542,0.68,O,20732
16543,and,O,20732
16544,0.8,O,20732
16545,for,O,20732
16546,the,O,20732
16547,development,O,20732
16548,of,O,20732
16549,choroidal,B-NAME_OF_DISEASE,20732
16550,neovascularization,I-NAME_OF_DISEASE,20732
16551,and,O,20732
16552,geographic,B-NAME_OF_DISEASE,20732
16553,atrophy,I-NAME_OF_DISEASE,20732
16554,respectively,O,20732
16555,Models,O,20733
16556,have,O,20733
16557,also,O,20733
16558,been,O,20733
16559,developed,O,20733
16560,with,O,20733
16561,the,O,20733
16562,purpose,O,20733
16563,of,O,20733
16564,predicting,O,20733
16565,visual,O,20733
16566,acuity,O,20733
16567,response,O,20733
16568,to,O,20733
16569,treatment,O,20733
16570,with,O,20733
16571,anti-VEGF,B-TREATMENT,20733
16572,therapy,I-TREATMENT,20733
16573,using,O,20733
16574,baseline,O,20733
16575,OCT,B-DIAGNOSTIC_TEST,20733
16576,images,O,20733
16577,Sickle,B-NAME_OF_DISEASE,20734
16578,cell,I-NAME_OF_DISEASE,20734
16579,disease,I-NAME_OF_DISEASE,20734
16580,is,O,20734
16581,one,O,20734
16582,of,O,20734
16583,the,O,20734
16584,most,O,20734
16585,common,O,20734
16586,inherited,O,20734
16587,genetic,O,20734
16588,diseases,O,20734
16589,with,O,20734
16590,various,O,20734
16591,ocular,O,20734
16592,manifestations,O,20734
16593,in,O,20734
16594,the,B-PART_OF_THE_EYES,20734
16595,retina,I-PART_OF_THE_EYES,20734
16596,warranting,O,20734
16597,careful,O,20734
16598,monitoring,O,20734
16599,and,O,20734
16600,treatment,O,20734
16601,OCTA,B-DIAGNOSTIC_TEST,20735
16602,features,O,20735
16603,such,O,20735
16604,as,O,20735
16605,blood,O,20735
16606,vessel,O,20735
16607,diameter,O,20735
16608,and,O,20735
16609,tortuosity,O,20735
16610,vessel,O,20735
16611,perimeter,O,20735
16612,index,O,20735
16613,foveal,O,20735
16614,avascular,O,20735
16615,zone,O,20735
16616,area,O,20735
16617,contour,O,20735
16618,irregularity,O,20735
16619,and,O,20735
16620,parafoveal,O,20735
16621,avascular,O,20735
16622,density,O,20735
16623,have,O,20735
16624,been,O,20735
16625,used,O,20735
16626,to,O,20735
16627,train,O,20735
16628,algorithms,O,20735
16629,to,O,20735
16630,identify,O,20735
16631,retinopathy,B-NAME_OF_DISEASE,20735
16632,with,O,20735
16633,an,O,20735
16634,average,O,20735
16635,accuracy,O,20735
16636,of,O,20735
16637,95%,O,20735
16638,Algorithms,O,20736
16639,have,O,20736
16640,also,O,20736
16641,been,O,20736
16642,able,O,20736
16643,to,O,20736
16644,differentiate,O,20736
16645,between,O,20736
16646,mild,B-NAME_OF_DISEASE,20736
16647,sickle-cell,I-NAME_OF_DISEASE,20736
16648,retinopathy,I-NAME_OF_DISEASE,20736
16649,stage,I-NAME_OF_DISEASE,20736
16650,II,I-NAME_OF_DISEASE,20736
16651,and,O,20736
16652,severe,B-NAME_OF_DISEASE,20736
16653,sickle-cell,I-NAME_OF_DISEASE,20736
16654,retinopathy,I-NAME_OF_DISEASE,20736
16655,stage,I-NAME_OF_DISEASE,20736
16656,III,I-NAME_OF_DISEASE,20736
16657,with,O,20736
16658,an,O,20736
16659,accuracy,O,20736
16660,rate,O,20736
16661,of,O,20736
16662,97%,O,20736
16663,Models,O,20737
16664,have,O,20737
16665,accurately,O,20737
16666,determined,O,20737
16667,a,O,20737
16668,patients,O,20737
16669,age,O,20737
16670,sex,O,20737
16671,smoking,O,20737
16672,status,O,20737
16673,and,O,20737
16674,systolic,O,20737
16675,blood,O,20737
16676,pressure,O,20737
16677,from,O,20737
16678,a,B-DIAGNOSTIC_TEST,20737
16679,single,I-DIAGNOSTIC_TEST,20737
16680,fundus,I-DIAGNOSTIC_TEST,20737
16681,photograph,I-DIAGNOSTIC_TEST,20737
16682,The,B-ORGANIZATION,20738
16683,National,I-ORGANIZATION,20738
16684,Institutes,I-ORGANIZATION,20738
16685,of,I-ORGANIZATION,20738
16686,Health,I-ORGANIZATION,20738
16687,through,O,20738
16688,its,O,20738
16689,collaborative,O,20738
16690,community,O,20738
16691,projects,O,20738
16692,is,O,20738
16693,working,O,20738
16694,on,O,20738
16695,these,O,20738
16696,areas,O,20738
16697,of,O,20738
16698,unmet,O,20738
16699,needs,O,20738
16700,for,O,20738
16701,various,O,20738
16702,ophthalmic,O,20738
16703,conditions,O,20738
16704,As,O,20739
16705,the,O,20739
16706,capabilities,O,20739
16707,of,O,20739
16708,AI,O,20739
16709,evolve,O,20739
16710,more,O,20739
16711,commercially,O,20739
16712,available,O,20739
16713,products,O,20739
16714,for,O,20739
16715,not,O,20739
16716,only,O,20739
16717,DR,B-NAME_OF_DISEASE,20739
16718,but,O,20739
16719,other,O,20739
16720,diseases,O,20739
16721,will,O,20739
16722,begin,O,20739
16723,to,O,20739
16724,appear,O,20739
